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Abstract  
Since the introduction of the National Human Papillomavirus Vaccine Program 
(NHPVP) in 2007, few studies have assessed women’s knowledge, beliefs and 
attitudes towards cervical screening and human papillomavirus (HPV) vaccination in 
Australia.  It is imperative to ascertain this, as substantial changes are anticipated to 
the National Cervical Screening Program (NCSP) through a process called ‘the 
Renewal’, to ensure any changes that are introduced will be acceptable and well 
understood by women.   
The objectives of this study were to describe Queensland women’s current 
knowledge of cervical cancer/screening and HPV, their beliefs and attitudes towards 
Pap smears and the HPV vaccine and seek their advice on effective methods for 
communicating changes to the NCSP in their communities.  This research was a 
descriptive-exploratory study that incorporated a combination of qualitative and 
quantitative methods within the context of the Health Belief Model (HBM).  A 
computer-assisted telephone interview (CATI) survey of 1002 Queensland women 
was conducted in Phase 1 of the study.  During Phase 2 of the study, 23 focus groups 
were conducted throughout Queensland to gather in-depth information about 
women’s knowledge, awareness and acceptance about cervical cancer prevention 
strategies.   
This study found high levels of awareness of HPV (over 60%) and the HPV 
vaccine (over 86%) amongst Queensland women.  However, it also identified 
considerable uncertainty amongst participants about perceived susceptibility to 
cervical cancer, especially, the link between cervical cancer, HPV and sexual 
activity.  Women also had limited understanding of the benefit of the Pap smear as a 
preventative strategy, with many women thinking the main purpose of the Pap smear 
was for the early detection of cancer.  Despite high awareness of HPV, women 
participating in this study also had significant knowledge deficits about their 
susceptibility to HPV and the severity of HPV infection.  Queensland women had 
high levels of awareness of the HPV vaccine, which was most commonly via the 
media.  High acceptance of the HPV vaccine was found amongst participants 
although awareness of the full benefits of vaccination was not evident with little 
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acknowledgement that the quadrivalent vaccine used in the NHPVP would also 
prevent genital warts.   
Extensive barriers to having Pap smears, including physical and psychological 
discomfort, were identified and the most common barriers to vaccination were 
concerns about side effects and a lack of information upon which to make a decision 
about consent.  Women described enablers for screening participation, such as 
reminder systems and practitioner characteristics, and expressed positive views 
towards self collected testing as an enabler, particularly for women who did not 
attend screening.  
As this study was conducted with Queensland women it may therefore not be 
representative of women from other parts of Australia and as participants were more 
likely to report they were regular screeners than Queensland women overall, these 
results may not be representative of women least likely to participate in cervical 
screening.  The use of self-reported cervical screening history may also have led to 
over-reporting of screening status and previous abnormalities by participants.  This 
study reveals significant gaps in Queensland women’s knowledge that require 
effective communication strategies to address.  Recommendations from this study 
highlight the need for increased community education to raise awareness about 
primary and secondary cervical cancer prevention strategies, training of cervical 
screening providers in sensitive examination techniques, a reduction in costs 
associated with screening, the exploration of alternative service models and 
communication plans that incorporate methods women trust and recommend for 
disseminating information about changes to the NCSP.   
This study is the first large study to explore women’s perceptions of the Pap 
smear and barriers to screening, their knowledge about HPV and their attitudes 
towards the HPV vaccine in Queensland, since the introduction of the NHPVP.  It 
highlights considerable uncertainty about many aspects of cervical cancer and 
primary and secondary prevention strategies available in Australia and identified 
many barriers to cervical screening and concerns about HPV vaccination.  These 
knowledge gaps and barriers need to be taken into account and addressed within the 
context of anticipated changes to the NCSP to ensure benefits are maximised for 
women in future primary and secondary cervical cancer prevention strategies in the 
Australian context.   
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Chapter 1: Introduction 
Background information relevant to this thesis is described in the first section 
(Section 1.1) of this chapter followed by the context of this study (Section 1.2), and 
the rationale for undertaking this research (Section 1.3). In Section 1.4 the 
significance and scope of this research is described and the remaining chapters of the 
thesis are outlined in Section 1.5. 
1.1 BACKGROUND 
Australia has the second lowest rate of cervical cancer in the world, which has 
largely been attributed to the introduction of an organised approach to cervical 
screening in 1991, known as the National Cervical Screening Program (NCSP).  The 
NCSP is a secondary prevention program based on a screening policy that has 
remained unchanged for 20 years, and promotes eligible women to have two yearly 
Pap smears to screen for precancerous epithelial abnormalities, which can be treated 
before cancer develops (Tomatis and Huff, 2001).  Since the introduction of the 
NCSP in 1991, cervical cancer incidence and mortality rates have more than halved 
in Australia demonstrating the success of the NCSP as a public health intervention 
(AIHW, 2011). 
Up to 90% of squamous cell carcinoma of the cervix can be prevented through 
regular participation in cervical screening (Hakama, Miller and Day, 1986).  In 
Australia in 2008/09, more than 58.6% of women participated in two yearly cervical 
screening as recommended by the NCSP (AIHW, 2011).  Women who do not 
participate regularly in the screening program are more likely to be diagnosed with 
cervical cancer. More than 81% of women diagnosed with squamous cell carcinoma 
in Queensland in 2008 had not been screened for more than four years prior to their 
diagnosis (CSSB, 2011).  Aboriginal and Torres Strait Islander women are more 
likely to be diagnosed with or die from cervical cancer than non-Indigenous women, 
which is largely attributed to their lower rates of screening participation (AIHW, 
2011. 2007. 2005b; Homewood, Coory and Dinh, 2005).   
Cervical screening participation rates in Australia have been monitored through 
analysis of Pap Smear Registry data and differ by age, locality and socioeconomic 
 Chapter 1: Introduction 2 
status (SES) and in cohort studies, by marital status, parity, education level, ethnicity 
and Indigenous status (CSSB, 2011; Coory et al., 2002; AIHW, 2007; Siahpush and 
Singh, 2002; Mitchell et al., 1997).  The state-wide participation rate for the target 
age group of women aged 20 to 69 years in Queensland was 57.0% in 2008/09 and is 
consistently one of the lowest participation rates in Australia (CSSB, 2011).  
Queensland’s participation rates are specifically impacted by a number of factors 
including the geographical distribution of the population across the state, rapid 
population increases and workforce issues (including limited availability of female 
Pap smear providers and poor access to bulk billing services [no out-of-pocket costs], 
especially in rural and remote areas) (Kirk et al., 1998; CSSU, 2007c. 2005; Kelaher 
et al., 1997).   
1.2 CONTEXT 
Advances in scientific knowledge and molecular detection methods have led to 
significant breakthroughs and technological advancements for the prevention of 
cervical cancer.  Human papillomavirus (HPV) has been universally recognised as 
the necessary though not sufficient cause of cervical cancer.  A prophylactic vaccine 
against the two most common oncogenic strains of HPV has been developed as a 
method of primary prevention, as vaccination protects against the inception of the 
pathologic process caused by HPV that is associated with cervical cancer (Tomatis 
and Huff, 2001; Frazer et al., 2006; Walboomers et al., 1999).  The implementation 
of the National Human Papillomavirus Vaccination Program (NHPVP) in Australia 
in April 2007 is anticipated to further reduce its incidence.  The primary target age 
group in NHPVP is girls at school aged 12 years.  The two vaccines currently 
available in Australia provide 90–100% protection against persistent HPV infection 
and cervical/genital disease due to the two most common anogenital oncogenic HPV 
types (types 16 and 18), estimated to cause approximately 70-80% of cervical 
cancers in Australia (NCIRS, 2006b).  Due to already existing infections, the 
effectiveness of these vaccines in reducing cervical cancer incidence will not impact 
cervical cancer rates for at least one to two decades and is dependent on high rates of 
vaccine uptake (Brotherton, Kaldor and Garland, 2010; Wright, Van Damme, et al., 
2006; Gertig, Brotherton and Saville, 2011).   
Successful introduction of a new vaccine program is dependent upon a number 
of factors including political will, vaccine supply, service delivery capacity, coverage 
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rates, surveillance of vaccine coverage and safety, and funding (Wright, Van 
Damme, et al., 2006).  One of the key challenges for policy makers and health care 
providers specific to the HPV vaccine is the need to continue a secondary prevention 
program, the NCSP, within the context of a primary prevention program.  There have 
been discussions about whether branding the HPV vaccine as a vaccine against 
cervical cancer, rather than a preventive for a sexually transmitted infection, will 
influence vaccine acceptability with parents (McClelland and Liamputtong, 2006; 
Hoover, Carfioli and Moench, 2000).  There is also concern that vaccinated women 
will not participate in screening, which may place them at increased risk for cervical 
cancer as the vaccine only protects against two oncogenic types of HPV (Brotherton, 
2008).   
The community needs clear information about HPV and its link with cervical 
cancer, the link between sexual activity and the acquisition of HPV, the vaccine itself 
(including the schedule, side effects and efficacy) and the need for cervical screening 
irrespective of vaccination status (Zimet et al., 2006; Pitts and Clarke, 2002; Waller, 
McCaffery and Wardle, 2004a).  If this is not achieved, the public health impact of 
the NHPVP may be less than anticipated, especially as low levels of knowledge 
about the link between HPV and cervical cancer are frequently found in the 
community (Pitts et al., 2010a; Zimet et al., 2006; Waller, McCaffery and Wardle, 
2004a; Pitts and Clarke, 2002; McClelland and Liamputtong, 2006).  The majority of 
these studies have been conducted overseas, although increasingly research has been 
undertaken in the Australian setting.  There are limited studies in Australian of sub-
populations whose health status differs from that of the general population, such as 
women living in rural and remote communities, women from culturally and 
linguistically diverse backgrounds and Aboriginal and Torres Strait Islander women.  
Recent Australian studies have shown an increase in awareness of HPV and the 
vaccine as a result of the NHPVP and subsequent media coverage; however 
knowledge about risk factors and the link between HPV and cervical cancer remain 
poor (Pitts et al., 2007; Giles and Garland, 2006; Marshall et al., 2007). 
In addition to knowledge, women’s beliefs and attitudes towards cervical 
screening and vaccination are important factors influencing their uptake of 
preventative health behaviours (Pitts et al., 2007; Rosenstock, 1974).  There is 
limited information on these factors from the geographically dispersed population of 
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Queensland where cervical screening participation rates remain below the national 
average and are amongst the lowest in the country.   
Advances in scientific understanding of the role of HPV in the development of 
cervical cancer and the availability of prophylactic vaccines have prompted debate 
about cervical screening policies worldwide, and there are calls for a review of the 
NCSP in Australia (Wain, 2006; NCSP, 2005; Franco et al., 2006).  This review, 
officially named the Renewal, will investigate the role of new technologies such as 
HPV DNA testing, including the potential for it to replace the Pap smear as the 
primary screening test used within the NCSP (NCSP, 2012b).  In addition, the 
screening policy will be reviewed as it is out of date with contemporary international 
recommendations, especially the age of commencement for screening and the 
screening interval, as women in Australia commence screening at a much younger 
age and screen more frequently than women in other countries with organised 
screening programs (National Health Service, 2012; NCSP, 2012b; IARC, 2005).  
Women need adequate information with which to make informed choices about 
cervical screening and vaccination, and understand changes related to the NCSP 
screening policy (Hawkins et al., 2011). 
1.3 PURPOSE 
This in-depth exploration aimed to describe women’s knowledge of cervical 
cancer and screening and HPV, and their beliefs and attitudes towards Pap smears 
and the HPV vaccine, to identify women’s sources of health information about 
cervical cancer/screening, HPV and the vaccine and sought their advice on effective 
methods of disseminating information in their communities.  This was the first large 
study of this topic conducted in the Queensland setting following the implementation 
of the HPV vaccine.   
The outcomes of this study will assist in evaluating previous strategies aimed at 
reducing the incidence of cervical cancer in Queensland women and inform policy, 
service delivery and the development of education programs for health providers and 
women.  This aims to ensure the implementation of the NHPVP and any subsequent 
changes to the NCSP screening policy are based on consumer needs and input.   
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1.4 SIGNIFICANCE, SCOPE AND DEFINITIONS 
1.4.1 Significance 
This study investigated for the first time in Queensland, a broad age group of 
women, between 18 and 70 years of age, explored differences by locality and SES 
and considered the impact of screening history on women’s knowledge about 
cervical cancer/screening, HPV and HPV vaccination.  With the Renewal of the 
NCSP, this thesis focused on identifying women’s perceptions of the current NCSP 
and the NHPVP.  The timeliness of this research will assist in the development of 
communication strategies to assist women to make informed choices about screening 
and vaccination and be comfortable with the anticipated changes to the NCSP in the 
next few years, given the current screening policy has remained unchanged for over 
20 years.   
1.4.2 Scope 
This study was not designed to provide information on specific sub-
populations, such as Aboriginal and Torres Strait Islander women, women from 
culturally and linguistically diverse backgrounds, women with disabilities or lesbian, 
bisexual, intersex, transgender women.  The framework used in this study may be 
useful for other researchers and can be readily adapted for use with women from 
diverse populations. 
1.4.3 Definitions 
The definitions appropriate to this study are described below: 
 Area of socio-economic disadvantage - An area could have a low score 
if there are (among other things), many households with low income, 
many people with no qualifications, or many people in low skilled 
occupations whilst an area may have a high score if there are (among 
other things), few households with low incomes, few people with no 
qualifications or in low skilled occupations (ABS, 2006b). 
 National Cervical Screening Program - the organised approach to 
cervical cancer screening in Australia, which promotes routine 
screening with Pap smears every two years for women between the 
ages of 18 (or two years after first sexual intercourse, whichever is 
later) and 69 years (NCSP, 2012a). 
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 National HPV Vaccination Program - the Australian Government 
funded school-based program routinely delivered to girls in the first 
year of secondary school (National Immunisation Program, 2012). 
 Primary prevention - measures aimed at preventing the start of a 
pathologic process or the occurrence of a disease (Tomatis and Huff, 
2001). 
 Secondary prevention - measures for the early detection and prompt 
intervention on a clinically asymptomatic disease (Tomatis and Huff, 
2001). 
 Sexual debut - the commencement of sexual activity. 
 Underscreened women – women who have Pap smears less frequently 
than the recommended NCSP interval.  For the purposes of this study 
these women have not had a Pap smear for more than three years. 
 Unscreened women – women who have never had a Pap smear. 
1.5 THESIS OUTLINE 
This thesis is organised as follows.  Chapter 2 provides an overview of cervical 
cancer and describes primary and secondary prevention strategies in Australia, 
including community knowledge, awareness and acceptability of these strategies. In 
Chapter 3, the overarching research design of this mixed methods study is described 
followed by a description of the research design employed for Phase 1 of the study, 
the methods of the quantitative survey in Chapter 4 and the findings of this survey in 
Chapter 5.  The research design for the qualitative phase of the study, a series of 
focus groups with women across Queensland, is described in Chapter 6 and the 
findings of this phase follow in Chapter 7.   
In Chapter 8, the research findings from both phases of the study are 
summarised and discussed within the context of existing research and in the final 
chapter, Chapter 9, the strengths and limitations of the study are described before 
discussing the implications of this research for policy makers, health providers and 
the community and further research into primary and secondary prevention strategies 
in Australia. 
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Chapter 2: Primary and Secondary Cervical 
Cancer Prevention  
This chapter begins with the background to cervical cancer incidence and 
mortality (Section 2.1) and primary and secondary cervical cancer prevention 
strategies in Australia including the National Cervical Screening Program (NCSP) 
and the National Human Papillomavirus Vaccination Program (NHPVP) (Section 
2.2).  The search strategy used to conduct this literature review is outlined in Section 
2.3 and in Section 2.4, community knowledge and awareness of cervical cancer 
prevention strategies, including Pap smears, human papillomavirus (HPV) and HPV 
vaccination are discussed.  The acceptability of cervical cancer prevention strategies, 
including barriers that impact upon women’s uptake of screening and HPV vaccine 
acceptability by women and parents involved in decision-making processes about 
vaccination are described in Section 2.5 and the implications from the literature are 
summarised in Section 2.6. 
2.1 BACKGROUND 
Worldwide, cervical cancer is the second most common cancer among women. 
In the year 2000, an estimated 471,000 women were diagnosed with cervical cancer 
and approximately 233,000 died from this debilitating disease (Ferlay et al., 2001).  
In developing countries, where almost 80% of cases occur, cervical cancer is the 
most common cancer among women in many regions (IARC, 2005).  Cervical cancer 
comprised 1.6% cancers in women in 2007 and the mean age of diagnosis was 51.2 
years (AIHW, 2011).  Squamous cell carcinoma is the most common subtype of 
cervical cancer worldwide and in Australia was responsible for 63.4% of new cases 
of cervical cancer reported in 2007 (AIHW, 2011).  Other subtypes include 
adenocarcinoma and adenosquamous carcinoma which comprised almost 25% and 
less than four percent, respectively, of cervical cancers diagnosed in women that 
same year (AIHW, 2011). 
Risk factors associated with cervical cancer (and HPV) include  those that 
increase the risk of acquiring a sexually transmitted infection, such as multiple sexual 
partners, early sexual debut, not using condoms, having an uncircumcised sexual 
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partner and oral contraceptive use.  Additional factors include non-participation in 
cervical screening, high parity and smoking (IARC, 2005; Reid, 2001; Bosch and 
Muñoz, 2002).   
In Australia, the NCSP has been highly successful in reducing the incidence 
and mortality from squamous cell carcinoma of the cervix due to an organised 
population-based approach to cervical screening and is one of the great public health 
stories in this country (Farnsworth and Mitchell, 2003).  Incidence rates have 
decreased from 17.1/100,000 new cases (women aged 20–69 ASR) in 1991 
(13.2/100,000 – women - all ages – ASR) to 9.0/100,000 new cases (women aged 
20–69 ASR; [6.8/100,000  women of all ages – ASR]) in 2007  (AIHW, 2011).   
Cervical cancer has decreased from being the sixth most common cause of 
cancer death affecting women in 1989 (prior to the introduction of the NCSP) to the 
18th most common cause in 2007, which demonstrates the effectiveness of this 
organised population-based cervical screening program as a secondary prevention 
strategy (AIHW, 2011).  In 2007, 208 women died from cervical cancer (AIHW, 
2011).  The risk of dying from cervical cancer by 75 years of age was one in 817 and 
one in 502 women by 85 years of age (AIHW, 2011).  Mortality rates amongst 
women of all ages have decreased from 4.0/100,000 in 1991 to 1.9/100,000 in 2007 
(age-standardised rates [ASR]).  Mortality was highest in women aged 85 years and 
older (10.5/100,000).  Cervical cancer incidence and mortality rates in Queensland 
have followed national trends.  Incidence and mortality rates in Queensland for the 
period 2003–2007 were 10.7/100,000 women and 2.2 per 100,000 women 
respectively.   
Cervical cancer incidence and mortality in Australia has been reported to differ 
by a number of factors including age, geographic location and ethnicity.  The 
incidence of cervical cancer was highest in women aged 35–39 years of age in 2007 
and lowest for women aged 20–24 years.  Age-specific cancer mortality increases 
with age and was highest for women in the eligible screening population (20 – 69 
years) in women aged 60 to 64 years (AIHW, 2011).  In 2003–2007, incidence was 
higher amongst women from remote locations and very remote areas compared to 
those in regional areas and major cities at 12.2 new cases per 100,000  women, as 
were mortality rates with 4.1 per 100,000 women dying from cervical cancer during 
this period (AIHW, 2011).  More recently deaths from cervical cancer have also been 
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found to be higher amongst women in the lowest socio-economic (SES) group 
compared to the highest SES group (AIHW, 2011).   
Despite the success of the NCSP in Australia, Aboriginal and Torres Strait 
Islander women are more likely to be diagnosed with, or die from cervical cancer 
than non-Indigenous women (AIHW, 2011. 2007. 2005b; Homewood, Coory and 
Dinh, 2005).  In jurisdictions where data is of sufficient quality for analysis 
(Queensland, Northern Territory, Western Australia and South Australia), incidence 
and mortality rates amongst Aboriginal and Torres Strait Islander women were 20.6 
and 10.6 per 100,000 women respectively, in 2003–2007 compared to 8.6 new cases 
and 1.9 deaths per 100,000 non-Indigenous women, respectively (AIHW, 2011).  
This demonstrates a disproportionate burden of cervical cancer affecting Aboriginal 
and Torres Strait Islander women.  
There is limited data on cervical cancer incidence and mortality for women in 
Australia by ethnicity; however higher rates of cervical cancer have been reported in 
Australia for women from specific countries, such as the former Yugoslavia, 
Vietnam and Thailand (Taylor et al., 2003; Fernbach, 2002; Jirojwong and 
Manderson, 2001).  The NCSP has, as demonstrated, been highly effective in 
reducing cervical cancer incidence and mortality in the Australian setting, but 
specific groups are considered to be at increased risk of disease, primarily due to 
lower participation in the screening program as described in the next section. 
2.2 PRIMARY AND SECONDARY CERVICAL CANCER PREVENTION 
STRATEGIES IN AUSTRALIA 
The detection of pre-cancerous lesions through regular screening of women 
using the Pap smear has been one of the most widely adopted and effective strategies 
for preventing cancer related deaths in the world (Anderson, Haas and Shanahan, 
2008).  The finding that 99.7% of cervical cancer occurs in women who are infected 
with specific types of high-risk HPV has led to changes in the way the medical and 
scientific community are approaching the prevention of cervical cancer (Walboomers 
et al., 1999; Munoz, 2000).  Evidence that HPV is a necessary cause of cervical 
cancer has led to increased technology beyond the Pap smear for the prevention of 
cervical cancer.  This includes prophylactic vaccines against specific types of HPV 
and the development of molecular methods for detecting HPV that aim to improve 
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the detection of high grade cervical cancer precursor lesions (Wright, Bosch, et al., 
2006). 
Primary and secondary prevention programs are available in Australia as 
population-based strategies to reduce the incidence and mortality of cervical cancer.  
Primary prevention through the NHPVP was introduced in 2007, whilst secondary 
prevention through the NCSP, was formally introduced in 1991.  These programs are 
described more fully in the next section. 
2.2.1 Cervical Screening  
Up to 90% of squamous cell carcinoma can be prevented through regular 
participation in cervical screening (Hakama, Miller and Day, 1986).  The Pap smear, 
discovered by Dr George Papanicolaou in the early 1940s has led to a dramatic 
reduction in deaths from cancer of the cervix uteri and is the most common test used 
to screen for cervical cancer (Barter, 1992). Cervical screening at a population level 
has been adopted in Australia, North America, Britain and Western European 
countries (Luke et al., 2007; IARC, 2005).  Population-based screening requires 
significant resources and infrastructure if it is to be effective, which has prohibited its 
introduction in developing countries (IARC, 2005). 
Screening for the prevention of cancer of the cervix using the Papanicolaou 
smear, has been available in Australia since the 1960s; however it was not until the 
introduction of an organised approach to cervical screening that significant 
reductions in cervical cancer incidence and mortality were achieved in this country 
(AHMAC, 1991; AIHW, 2007).  A national cervical screening policy was introduced 
in 1991 and revised slightly in 1998 (Commonwealth Department of Health and 
Family Services, 1998).  This policy informs cervical screening practice throughout 
Australia as it specifies the target population to be screened.  The current national 
cervical screening policy in Australia is: 
1. Routine screening with Pap smears should be carried out every two years for 
women who have no symptoms or history suggestive of cervical pathology.  
2. All women who have ever been sexually active should start having Pap 
smears between the ages of 18 and 20 years, or one or two years after first 
having sexual intercourse, whichever is later.  
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3. Pap smears may cease at the age of 70 years for women who have had two 
normal Pap smears within the last five years. Women over 70 years who have 
never had a Pap smear, or who request a Pap smear, should be screened 
(NCSP, 2012a). 
The NCSP is based on the Australian Population-based Screening Framework 
which stipulates the screening program will provide more benefit than harm to the 
people being screened.  This framework is based on the World Health Organisation 
principles of screening developed by Wilson and Junger in which the condition 
should be an important health problem and have a recognisable latent or early 
symptomatic stage (Screening Subcommittee, 2008; WHO, 2007a).  Other principles 
included in the framework relate to the benefits and reliability of the test, the 
importance of a screening pathway and the availability of effective treatment 
(Screening Subcommittee, 2008).  Cervical screening using the Pap smear has been 
deemed to meet these principles when conducted in the context of an organised 
screening program (IARC, 2005). 
The organised approach to cervical screening has been deemed cost-effective; 
however the cost-effectiveness and rationale for maintaining a secondary prevention 
program based on two yearly screening within the context of a primary prevention 
program has been called into question (Wain, 2006).  This has resulted from 
advanced understanding of the natural history of HPV infection and its role in the 
development of cervical cancer, the implementation of the NHPVP in Australia and 
the availability of new technologies, such as HPV DNA testing (Wain, 2006; Canfell, 
Sitas and Beral, 2006; Bosch et al., 2002).  
Regular participation in cervical screening is the primary indicator used to 
monitor the success of the NCSP.  The participation rate is calculated by taking the 
number of women who had a Pap smear at least once over a two-year period as a 
percentage of the target population of eligible women aged 20–69 years (CSSU, 
2007b).  The target population is derived from the 2005–2006 Estimated Resident 
Female Population obtained from the Bureau of Statistics (ABS), and adjusted for the 
proportion of women estimated to have undergone a hysterectomy.  Each woman is 
counted once only, despite the number of Pap smears she may have had during the 
reporting period.  Pap smear data is obtained from jurisdictional Pap smear registers, 
therefore women who choose to opt off i.e. not have their details sent or recorded on 
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the Register (estimated as 0.5 to 1.5% of eligible women) are not able to be counted 
and are excluded from this rate (CSSB, 2011).   
In Australia in 2008/09, more than 58% of women participated in two yearly 
cervical screening as recommended by the NCSP (AIHW, 2011).  Women who are 
unscreened (women with no history of a previous Pap smear) or underscreened 
(women whose screening history was less than the recommended screening interval) 
are more likely to be diagnosed with cervical cancer.  In 2008, of the 65 Queensland 
women aged 30–69 years diagnosed with squamous cell carcinoma on histology, 53 
(81.5%) did not have a Pap smear recorded on the Pap Smear Register (PSR) in the 
four years prior to their diagnosis and 41 (63.1%) had not had a routine Pap smear 
recorded for more than 10 years (CSSB, 2011). 
The state-wide participation rate for the target age group of women aged 20 to 
69 years in Queensland was 57% in 2008/09 and is consistently one of the lowest 
participation rates in Australia (AIHW, 2011).  A number of strategies have been 
specifically aimed at increasing the participation of women in Queensland, such as a 
social marketing campaign conducted between 2006 and 2009, the Mobile Women’s 
Health Service, the Healthy Women’s Initiative and workforce strategies, for 
example, the GP Cervical Screening Update Program (CSSU, 2007c).  The Mobile 
Women’s Health Service is a network of 15 registered nurses and two Aboriginal and 
Torres Strait Islander health workers who travel to rural and remote areas to provide 
cervical screening and other women’s health services, whilst the Healthy Women’s 
Initiative is a network of Aboriginal and Torres Strait Islander health workers whose 
role is to promote cervical screening in their communities and support women to 
access services, including follow up and treatment.  These two strategies were 
implemented in Queensland to help address access issues facing the widely dispersed 
population in Queensland and assist women to access to female providers (CSSU, 
2007c). 
Cervical screening participation rates in Australia have been shown to differ by 
age, locality, socioeconomic status (SES), marital status, parity, education level, 
ethnicity and Indigenous status (Coory et al., 2002; AIHW, 2007; Siahpush and 
Singh, 2002; Mitchell et al., 1997; CSSU, 2007b).  PSR data reveal that unscreened 
and underscreened women in Queensland reflect those identified nationally.  
Queensland women under 30 and over 60 years of age are less likely to have two 
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yearly Pap smears, as are women who live in areas of high socio-economic 
disadvantage, remote or large outer metropolitan areas (other metropolitan areas – 
Australian Standard Geographical Classification (CSSU, 2007b).  Queensland’s 
participation rates are thought to be affected by a number of factors including the 
geographical distribution of the state, rapid population increases and workforce 
issues, including the availability of female providers and bulk billing services, 
especially in rural and remote areas (CSSU, 2007c). 
Demographic factors identified in cohort studies that impact on women’s 
participation in cervical screening or incidence of cervical abnormalities/cancer 
include socioeconomic status, rurality and education level (Luke et al., 2007; 
Dietsch, Gibb and Francis, 2003; Siahpush and Singh, 2002).  Marital status was the 
strongest predictor of awareness, receipt and recency of Pap smear amongst women 
who participated in the 1995 National Health Survey (Siahpush and Singh, 2002).  
There is also evidence in both Australian and international studies, that women who 
smoke are less likely to have regular Pap smears (Pearlman et al., 1999; Smith et al., 
2011; Coughlin et al., 2004). 
There is limited recent data available on cervical screening participation rates 
for women by Indigenous status and ethnicity as Pap smear registers do not receive 
information about women’s cultural background.  In Queensland, cervical screening 
participation rates of Aboriginal and Torres Strait Islander women have been 
estimated by discrete communities (where the proportion of Aboriginal and Torres 
Strait Islander Australians is estimated to be greater than 90% of the resident 
population) or through self-reported cohort studies (Coory et al., 2002; Binns and 
Condon, 2006).  The overall cervical screening participation rate in discrete 
Aboriginal and Torres Strait Islander communities in Queensland in 1999–2000 was 
41.1% (95% C.I. 40.2%–42.7%), which was 30% lower than the state average rate of 
59.1% (Coory et al., 2002).  These findings are similar to Aboriginal and Torres 
Strait Islander women’s cervical screening participation rates in the Northern 
Territory where participation for the same reporting period was 44% (95% C.I. 
42.7%–45.4%) and lower than national average participation rates (Binns and 
Condon, 2006; Coory et al., 2002; Bowden F et al., 1998).   
There have been multiple reasons identified as to why Queensland Aboriginal 
and Torres Strait Islander women are less likely to participate in regular Pap smears.  
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These include low levels of knowledge and awareness of cervical cancer, cervical 
screening and the concept of prevention, confusion about Pap smears and tests for 
detecting sexually transmitted infections (STIs), associating the need for Pap smears 
with current sexual activity commonly expressed as “No sex, no Pap” and only 
having Pap smears when pregnant.  Other reasons include fear about lack of 
confidentiality, cancer or having an abnormality detected, lack of access and/or 
choice of service providers particularly in remote areas and a lack of culturally 
effective and culturally safe resources and services (Kirk et al., 1998). 
Lower cervical screening participation rates have also been reported for women 
from culturally and linguistically diverse (CALD) backgrounds in Australia 
(Jirojwong and Manderson, 2001; Fernbach, 2002; Taylor et al., 2003; Kelaher et al., 
1997).  The factors for low participation are similar to those documented for 
Aboriginal and Torres Strait Islander women and also include lack of awareness of 
cervical screening practices in Australia, specific cultural and spiritual beliefs about 
health and illness and the belief cancer is incurable (Kelaher et al., 1997).  Poor 
knowledge of screening was identified in the National Women’s Health Survey 
(2005) as the most significant risk for lack of cervical screening for women born in 
the Middle East and Asia (Siahpush and Singh, 2002). 
Secondary prevention through cervical screening has been a long standing 
program in the Australian setting; however advances in scientific understandings 
about the role of HPV has revolutionised cervical cancer prevention strategies as 
described in the next section. 
2.2.2 HPV Vaccination 
The causal role of HPV in cervical cancer  has been firmly established and it is 
widely accepted that infection with HPV is necessary, but not sufficient for the 
development of cervical cancer, due to overwhelming evidence that over 99.7% of 
cervical cancers test positive for HPV (Walboomers et al., 1999; Munoz et al., 2006).  
There are more than 100 types of HPV that have been characterised molecularly, of 
which 40 are known to preferentially infect the squamous epithelium of the genital 
tract (Wright, Bosch, et al., 2006).  High risk genital HPV genotypes are those that 
have been linked with the development of cervical cancer and comprise 15 of the 
genotypes that infect the human anogenital tract (Baseman and Koutsky, 2005).   
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Genital HPV is the most common sexually transmitted infection worldwide.  
Over 50% of sexually active women in most populations (and probably men) are 
thought to be infected with HPV at some point in their lives (Wright, Bosch, et al., 
2006).  HPV infection is most common in the first few years of sexual activity and is 
frequently detected by the Pap smear as an acute lesion on the cervix, commonly 
reported as a low grade squamous intraepithelial lesion, although it may also 
manifest as a high grade lesion  (Stoler, 2000).  The natural history of HPV infection 
is not completely understood, although it is known that HPV is not sufficient for the 
development of cervical cancer.  The average duration of infection with HPV is eight 
to 14 months and the majority of lesions (98%) resolve spontaneously without 
treatment (Baseman and Koutsky, 2005; Munoz et al., 2006). 
Some women, however, have persistent infection with high risk HPV.  For 
some this does not lead to any adverse consequences but for a small number of 
women (less than 1%), this persistent infection can progress to cervical cancer over a 
period of 10–20 years (Munoz et al., 2006).  The biological characteristics of 
persistence are not well characterised,  but some factors are thought to increase the 
risk of progression from persistent HPV infection to cervical cancer (Wright, Bosch, 
et al., 2006).  These include immunosuppression (e.g. women taking immune 
suppressant therapy and HIV positive women), higher parity, long term oral 
contraceptive use, age (greater than 30 years), the size and severity of the precursor 
lesion and smoking (Bosch and de SanjosÃ, 2003).   
Worldwide prevalence (for all major world regions) of cervical HPV DNA in 
women with normal cytology has been estimated at any point in time at 10%, with 
highest prevalence (17%) amongst women under 34 years of age (de Sanjose et al., 
2007).  In a meta-analysis of 78 published studies, a second peak in HPV prevalence 
in women over 45 years was observed in all regions excluding Asia.  No data were 
available for Australia or New Zealand for inclusion in this meta-analysis.  The 
overall prevalence of HPV infection in women with normal cytology was estimated 
to be 15.5% in less developed world regions and 10% in more developed regions (de 
Sanjose et al., 2007). 
The majority of studies used in large meta-analyses to determine HPV 
prevalence worldwide have been conducted in Europe, Asia, North America and 
South/Central America and Africa.  A large study, the Women Human 
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Papillomavirus Indigenous Non-Indigenous Urban Rural Study (WHINURS), was 
undertaken to determine HPV genotype prevalence in Australia.  This study found 
the prevalence of types 16 and 18 HPV infection in the Australian female population 
did not differ by Indigenous status or age, but differences were found in the 
prevalence of risk factors, such as smoking and Pap smear abnormalities (Garland et 
al., 2011a).  A meta-analysis of seven Australian studies containing 553 cervical 
cancers found over 80% of cervical cancers contained types 16 and 18  and that 
77.7% of cervical cancers (excluding those containing both types), could have been 
prevented through vaccination (Brotherton, 2008).   
The development of prophylactic vaccines against HPV has been one of the 
most significant breakthroughs in the prevention of cervical cancer.  In developing 
countries, the primary aim of HPV vaccination is to prevent cervical cancer.  In most 
developed countries with organised screening programs (and corresponding low 
cervical cancer incidence), the most important goal of HPV vaccination programs 
will be to reduce the number of women with abnormal cytology results, particularly 
high-grade abnormalities, which cause a significant burden to women and the health 
care system (Wright, Bosch, et al., 2006; Kyrgiou et al., 2006). 
There are currently two vaccines approved for use in Australia, Gardasil® and 
Cervarix®.  The former, a quadrivalent vaccine, protects against HPV types 6, 11, 16 
and 18 (types 6 and 11 are responsible for 90% of genital wart infections) whilst the 
latter is a bivalent vaccine that protects against HPV 16 and 18 only (NCIRS, 2006b; 
Wright, Bosch, et al., 2006).  The findings of phase 2 and 3 clinical trials of healthy 
young women who were naïve for the HPV types included in the vaccines, found 
both vaccines to be highly immunogenic with seroconversion rates to all targeted 
types of HPV of over 98% and durability of protection of 36 months for the 
quadrivalent vaccine and 53 months for the bivalent vaccine (Koutsky and Harper, 
2006; Garland, 2007b).  In addition, both appear to be generally safe and well 
tolerated with injection site and minor systemic events the most commonly reported 
adverse events (Koutsky and Harper, 2006).  The vaccine is administered by a series 
of three injections given within a six month period and has been shown to be highly 
effective at preventing  infection with HPV types 16 and 18 and therefore is 
estimated to prevent up to 70% of cervical cancers (Garland, 2007b).  The vaccine is 
most effective if given to females prior to the commencement of sexual activity and 
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has also been found to be more immunogenic if administered to adolescent girls 
(Frazer et al., 2006; NCIRS, 2006b).   
In Australia, Gardasil® was initially approved for use for females aged nine to 
26 years and males nine to 12 years by the Therapeutic Goods Administration 
(TGA), and has been on the market since August 2006.  More recently it has been 
approved for use in females aged nine to 45 years and males nine to 26 years 
(National Immunisation Program, 2012).  Cervarix® was approved by the TGA in 
June 2007 for women aged 10–45 years.  The Australian Health Minister made a 
public announcement in November 2006 that Australia would become the first nation 
in the world to introduce a publicly funded primary prevention program against 
cervical cancer by implementing the NHPVP from April 2007.  The NHPVP is a 
school-based program targeting girls aged 12–13 years.  A catch-up program for girls 
attending school was introduced in 2007 until 2009 where older girls attending 
school (until the final year) were offered vaccination.  In addition a catch-up program 
for young women up to the age of 26 years (available from July 2007 until 2009) was 
introduced through general practice or alternative health services that traditionally 
offer vaccination programs (e.g. Aboriginal Medical Centres, Community Health 
Centres etc).  In November 2011, the Pharmaceutical Benefits Advisory Council 
Public announced a recommendation to extend the NHPVP to include males, 12 to 
13 years of age, and a two year catch-up program; and on 12 July 2012, it was 
publicly announced boys would be included in the NHPVP (Australian Government, 
2012). 
Reported HPV vaccination coverage rates in Australia are encouraging with 
coverage rates equivalent to other vaccines in adolescents.  As at March 2011, three-
dose coverage was approximately 70% in the school-based program with lower rates 
observed in the catch-up program (Gertig, Brotherton and Saville, 2011).  HPV 
vaccination coverage is monitored through the National HPV Vaccination Register, 
which receives data from all jurisdictions and will be invaluable in evaluating the 
impact of the vaccine on HPV related cervical disease if linkage with Pap smear 
registers occurs in the future. 
With increased knowledge about the natural history of HPV, advances in 
screening technologies have also occurred and are described next. 
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2.2.3 New Technologies  
The Pap smear has remained the most effective cervical screening test for use 
in population screening programs in high and medium resourced countries despite its 
poor sensitivity (International Agency for Research on Cancer, 2005).  Attempts to 
increase the sensitivity and automate cervical screening have led to the development 
of a number of new technologies.  These include liquid-based cytology, such as 
ThinPrep® and SurePath® and automated screening devices, for example the Thin-
Prep Imager® and FocalPoint®.  Liquid-based cytology is not publicly funded in 
Australia at present as a review conducted by the Medical Screening Advisory 
Committee in 1998 determined there would be limited benefit and substantial cost 
involved in publicly funding these technologies given the effectiveness of the NCSP 
(AHTAC, 1998).   
Testing methods to determine the presence of HPV or persistent HPV infection 
have been the focal point of research into new testing methods since the confirmation 
of this virus as the necessary cause of cervical cancer.  The role of HPV DNA testing 
has been explored as it has many applications within the context of organised 
screening.  HPV DNA testing has been considered as a primary screening tool to 
replace cytology, as a triage test for women following an equivocal Pap smear result, 
and as a ‘test-of-cure’ following treatment for a high-grade abnormality (Garland, 
2007a).  HPV DNA testing in Australia has only been endorsed to date as a ‘test of 
cure’ (National Cervical Screening Program, 2005; Garland, 2007a).   
HPV DNA testing is reported as highly sensitive for primary screening and the 
detection of underlying high-grade disease (Arbyn et al., 2006).  One of the 
drawbacks of primary screening with HPV DNA testing however, is the test’s low 
specificity in excluding the absence of high-grade cervical intraepithelial lesions 
when compared to cytology screening, especially in women under the age of 30 
years (Goldie, Kim and Wright, 2004; Arbyn et al., 2006).  HPV screening in young 
women has been reported as inefficient as HPV infections and associated mild 
lesions almost always spontaneously regress and therefore a positive result will 
potentially lead to unnecessary investigations (Arbyn et al., 2006).   
With the advent of the HPV vaccine; however, the role of HPV DNA testing as 
a primary screening tool is gaining increased attention (Cuzick et al., 2000; Franco et 
al., 2006).  The low sensitivity of the Pap smear and subsequent high false-positive 
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rate has been described as its most critical limitation (Franco et al., 2006).  The 
sensitivity of the Pap smear is increased through repeated testing and requires 
significant resources for the establishment of systems to ensure coverage, quality and 
compliance (International Agency for Research on Cancer, 2005).  The use of the 
most highly sensitive test (HPV DNA testing) for primary screening and a highly 
specific test (the Pap smear) for triaging cases has been suggested in recent cervical 
screening algorithms currently under consideration and has recently been endorsed as 
the screening pathway in the Netherlands (Meijer, 2011; Wright, Bosch, et al., 2006; 
Franco et al., 2006).   
Self testing for HPV DNA has also been explored as an alternative testing 
method for women in low resource countries and for increasing the participation of 
non-responders in countries with organised screening programs (Anhang et al., 2005; 
De Alba et al., 2008; Igidbashian et al., 2011; Waller et al., 2006).  HPV DNA is 
found in the cells shed from the surface epithelium of the cervix and vagina, 
therefore testing of these exfoliated cells is an alternative method of screening 
(Morris and Rose, 2007).  The findings from studies investigating the diagnostic 
accuracy of self collected HPV specimens have been positive (Quincy, Turbow and 
Dabinett, 2012). The sensitivity and specificity of self-collected HPV samples when 
compared to physician collected samples has been found to be as sensitive in 
detecting high risk HPV DNA in a meta-analysis of 18 studies (Petignat et al., 2007).  
The sensitivity and specificity of self collected tests when compared with physician 
samples as the gold standard for detecting high risk HPV and cervical abnormalities 
found the self collected specimen had a sensitivity of 92.6% and specificity of 87.1% 
for detecting high risk HPV.  A higher sensitivity for detecting cervical abnormalities 
than physician collected samples was also evident, although the latter was not 
significant (De Alba et al., 2008).  These studies indicate the role of self collection 
for HPV DNA requires consideration in future screening programs. 
The Renewal 
Advances in understanding the role of HPV in the development of cervical 
cancer and the availability of prophylactic vaccines have prompted debate about 
cervical screening policies worldwide and there are calls for a review of the NCSP in 
Australia (Wain, 2006; NCSP, 2005; Franco et al., 2006).  With these advances there 
is increasing marketing of technologies by commercial interests, including liquid-
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based cytology; adjunctive HPV DNA testing and self collected testing for HPV 
DNA and cytology in the lay press and via the Internet.  These are promoted as 
essential methods for protecting women against cervical cancer, despite a reported 
lack of evidence they are of any benefit within the context of the NCSP (AHTAC, 
1998).  As a result women are faced with confusing messages from both health 
providers and the media about HPV, cervical cancer and effective prevention 
methods.   
Women’s knowledge and understanding of HPV and cervical cancer will be 
critical to avoid unnecessary psychological distress if HPV testing is introduced as a 
screening tool and to ensure they have adequate information on which to make 
informed choices about cervical screening and vaccination (McCaffery et al., 2006; 
Giles and Garland, 2006; Marlow, Waller and Wardle, 2007).  In addition, this 
knowledge is essential to assist women to understand policy changes related to the 
NCSP and the subsequent management of women with screen-detected abnormalities 
(Hawkins et al., 2011). 
The consideration of these issues is under consideration with the Renewal of 
the NCSP which commenced in 2011.  The objectives of the Renewal are to: 
 assess the evidence for screening tests and pathways, the screening 
interval, age range and commencement for both vaccinated and non-
vaccinated women;  
 determine a cost-effective screening pathway and program model;  
 investigate options for improved national data collection systems and 
registry functions to enable policy, planning, service delivery and 
quality management; and  
 assess the feasibility and acceptability of the renewed NCSP for women 
(NCSP, 2012b). 
The Renewal aims to ensure that all Australian women have access to an 
evidence-based program that continues to improve health outcomes of Australian 
women.  It is therefore imperative that the renewed NCSP reaches a higher 
proportion of women at risk for cervical cancer and participation in cervical cancer 
prevention strategies, such as cervical screening and vaccination are improved.   
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A key challenge, therefore, is to encourage eligible women who are unscreened 
and underscreened for cervical cancer to participate regularly and achieve high 
population rates of vaccination in younger cohorts.  Understanding why women do 
not participate in cervical cancer prevention strategies in the Australian setting is 
crucial to achieve higher participation rates and coverage (Garland, Skinner and 
Brotherton, 2011b).   
Factors such as age, locality, socioeconomic disadvantage, and Indigenous 
status are linked with decreased cervical screening participation along with a number 
of knowledge deficits and barriers.  Knowledge about cervical cancer and screening 
and barriers to screening participation are described in the next section. 
2.3 SEARCH STRATEGY 
A review of the literature was undertaken to inform the design of this study and 
provide insight into existing research about women’s knowledge of HPV and 
cervical cancer and knowledge and attitudes about cervical screening and the HPV 
vaccine.  Searches of medical, nursing and allied health databases including 
Academic Search Elite, Medline and CINHAL were undertaken using the key words, 
cervical cancer, cervical screening, Pap smears/tests, human papillomavirus (HPV), 
HPV vaccination, awareness, acceptability and other terms generated by these 
searches.  In addition, citations included in publications resulting from these searches 
were sourced and also led to the identification of other citations relevant to this 
inquiry.   
2.4 COMMUNITY KNOWLEDGE AND AWARENESS 
Knowledge is recognised as a significant predictor of action in all social 
cognition models of behaviour, although knowledge alone does not lead to behaviour 
change (Pitts and Phillips, 1998).  Whilst health behaviour theories are underpinned 
by the understanding that individuals’ perceptions, motivation and skills and the 
social environment in which they live influences their behaviour, it is also recognised 
that cognitions, namely what people know and think, affects how they act and that 
knowledge is necessary, although not sufficient, to produce most behaviour change 
(Rimer and Glanz, 2005). 
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Knowledge about cervical cancer/screening has been explored as an important 
factor that influences women’s participation in cervical screening over the past three 
decades with the inclusion of knowledge of HPV and HPV vaccination in more 
recent studies.  Whilst many studies explore all these factors simultaneously, they are 
described in the following sections separately. 
2.4.1 Cervical Cancer/Screening Knowledge 
Australian women have been found to have high levels of uncertainty about the 
cause and risks associated with cervical cancer, good knowledge about the 
recommended frequency of screening and poor knowledge about when to commence 
and cease screening (Giles and Garland, 2006; Shand, Burney and Fletcher, 2010; 
Jirojwong and Manderson, 2001; Wollin and Elder, 2003).  In a cross-sectional 
computer assisted telephone interview (CATI) survey conducted in South Australia 
prior to the introduction of the HPV vaccine, 79% of male and female respondents 
were uncertain about what caused cervical cancer with only seven percent identifying 
the cause was viral (Marshall et al., 2007).   
Quantitative and qualitative studies conducted in other countries with young 
women and women of all ages also reveal high levels of uncertainty and limited 
awareness of the causes and risk factors associated with cervical cancer (Smith, 
French and Barry, 2003; Pitts and Clarke, 2002; Waller, McCaffery and Wardle, 
2004a; Waller et al., 2005; Marlow, Waller and Wardle, 2007; Mays et al., 2000; 
Pearlman et al., 1999).  In most studies, women identify that sexual activity is a risk 
factor; however, there is limited understanding of how sex is linked with cervical 
cancer and whether this is trauma-related or related to the acquisition of a sexually 
transmitted disease (Waller et al., 2005; Agius et al., 2010b; Marshall et al., 2007; 
Waller, McCaffery and Wardle, 2004a).   
This uncertainty about the link between sexual activity and cervical cancer has 
been attributed to suppression of this information in public messages and policy, to 
avoid increasing stigma and anxiety amongst women about participating in cervical 
screening, as they may perceive others to consider them as promiscuous if they were 
to receive a positive result (Braun and Gavey, 1999. 1999b; Waller et al., 2005).  
However, failure to make this explicit has also led to uncertainty, whereby women 
may either not perceive themselves at risk, as they are not ‘promiscuous’, despite 
having had more than one sexual partner in their lifetime or are not empowered 
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through appropriate information to engage in activities to reduce their risk of 
acquiring HPV (Braun and Gavey, 1999b).   
The importance of ensuring women have accurate knowledge of the sex-related 
risks associated with cervical cancer was also found in a British study as women who 
knew of the link between cervical cancer and HPV as a sexually transmitted infection 
were more readily able to integrate new information about HPV into their existing 
causal framework than less knowledgeable participants (Waller et al., 2005).  
Armstrong and Murphy (2008), in their study also concluded that when women don’t 
know about HPV and its link with sexual activity and cervical cancer they weave 
their own meanings from health messages that are not explicit or contain incomplete 
or fragmented information, which often leads to misconceptions. 
In other studies, women also had limited knowledge of the purpose of Pap 
smears or the meaning of an abnormal result, with the Pap smear often associated 
with the prevention of other cancers or gynecological conditions (Mays et al., 2000; 
Moreira et al., 2006; Eaker, Adami and Sparen, 2001).  Differences in knowledge 
were observed by marital status, parity, education, race, income and screening status, 
although not all studies included representative samples or employed methods to 
adjust for confounding (Eaker, Adami and Sparen, 2001; Moreira et al., 2006; 
Pearlman et al., 1999; Hawkins et al., 2011).  Age, educational status and screening 
status were factors associated with differences in cervical cancer/screening 
knowledge when representative sampling and regression models were employed 
(Eaker, Adami and Sparen, 2001; Pearlman et al., 1999; Waller, McCaffery and 
Wardle, 2004a). 
2.4.2 HPV Awareness and Knowledge 
The majority of studies exploring HPV awareness and knowledge have focused 
predominantly on women and even when studies included both males and females, 
women were frequently over-represented (Waller, McCaffery and Wardle, 2004a; 
Baer, Allen and Braun, 2000; Mays, Sturm and Zimet, 2004).  Both qualitative and 
quantitative methods have been used by researchers in their investigations abut HPV 
knowledge, with some studies using a combination of methodologies.   
Awareness of HPV and its link with cervical cancer has increased in Australia 
following the introduction of the NHPVP.  Prior to its introduction, HPV awareness 
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and knowledge was poor in the few studies conducted, with the exception of one 
study in which 89% of participants aged 18 to 30 years of age had heard of HPV 
(Giles and Garland, 2006; Pitts et al., 2007; McClelland and Liamputtong, 2006).  
However, as the authors acknowledged this high awareness was attributed to 
selection bias as it included women participating in a vaccination trial and attendees 
at a dysplasia clinic (Giles and Garland, 2006).  Awareness amongst a university 
sample of women conducted in the first phase of the NHPVP was found to be much 
lower, with only 45% of young women whose average age was 19 years having 
heard of HPV (Juraskova et al., 2011). 
Public knowledge has been compared and substantial increases in awareness of 
HPV identified in the Australian context; from 12% in 2006 to 51% in 2007 and 63% 
in 2008 (Pitts et al., 2010a).  The majority of men and women aged 18–70 years 
participating in the fourth wave of the Australian Longitudinal Study of Health and 
Relationships Study (66%) were aware HPV was associated with cervical cancer, 
50% knew it was associated with abnormal Pap smears and 44.5% were aware of its 
association with genital warts.  Significant predictors of knowledge were associated 
with age, higher education and older age of sexual debut.  There was still, however, 
considerable uncertainty about the link between HPV and cervical cancer amongst 
women with 25% of women responding ‘don’t know’ (Pitts et al., 2010a).  Increased 
awareness of HPV and its link with cervical cancer is expected given mass media 
campaigns and information dissemination regarding the HPV vaccine.  Of note; 
however is that increased awareness of the link between HPV and abnormal Pap 
smears and genital warts was not found in this study, which was conducted after the 
implementation of the NHPVP (Pitts et al., 2010a). 
Awareness and knowledge amongst Australian year 10 and 12 high school 
students in 2008 was not as high as their older counterparts, with only 33% having 
heard of HPV and only 25% knowing of the association with cervical cancer (Agius 
et al., 2010b).  Increased awareness of HPV was also found in an on-line 
questionnaire of 18–26 year olds in which 94% had heard of HPV, although this was 
a small non-representative sample.  Whilst most participants had heard of HPV, their 
responses indicated misconceptions, for example, 72% believed that HPV causes 
infertility (Shand, Burney and Fletcher, 2010).  This was also found in a qualitative 
study conducted with girls and parents in NSW who had low levels of knowledge 
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about HPV, how it is transmitted and the association with cervical cancer, despite 
receiving information through the school-based vaccination program and making 
decisions about whether to participate in HPV vaccination (Cooper Robbins et al., 
2010a).  
Women reported the majority of the information they received on HPV was 
through the media which is expected given the extensive media coverage resulting 
from its introduction and the awarding of ‘Australian of the Year’ to one of the 
vaccines’ creators and leading researchers, Professor Ian Frazer (Juraskova et al., 
2011; Pitts et al., 2007).  Significant information gaps in newspaper articles 
published between October 2006 and December 2009, have been identified 
particularly in relation to the absence of an association between sexual activity and 
HPV and highlight the importance of ensuring additional sources of information are 
available to supplement the information the community is exposed to through mass 
media (Cooper Robbins, Pang and Leask, 2011; Kelly et al., 2009). 
Knowledge and awareness studies conducted overseas also indicate low levels 
of awareness of HPV and its link with cervical cancer.  Many studies were conducted 
with women and often involved university samples or women attending health 
clinics, including obstetric/gynaecology and sexual health clinics (Mays et al., 2000; 
Waller et al., 2003; Pitts and Clarke, 2002; Donders et al., 2009).  Awareness of the 
link between HPV and sex ranged from 11% to 33% across studies and was found to 
differ significantly by age, education and income in an omnibus survey conducted in 
the United Kingdom (Marlow, Waller and Wardle, 2007).   
Studies exploring in-depth knowledge of HPV, including focus groups and in-
depth interviews found knowledge deficits amongst participants about the 
transmission of HPV, symptoms, prevention and the link with cervical cancer 
(Vanslyke et al., 2008; Baer, Allen and Braun, 2000; Hoover, Carfioli and Moench, 
2000; Moreira et al., 2006).  Awareness increased with the introduction of the HPV 
vaccine as observed in Australia, but remained poor when no public awareness 
activities had been undertaken (Wong, 2011; Donders et al., 2009; Marlow, Waller 
and Wardle, 2007).  
Awareness and knowledge of HPV has implications on social acceptance of the 
HPV vaccine as research indicates vaccines against sexually transmitted infections 
are more acceptable if the disease they aim to prevent is viewed as an important 
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health issue with serious consequences (Zimet, 2005a).  This is particularly pertinent 
as one of the main factors associated with acceptance of HPV immunisation among 
mothers of teenage girls is perception of risk (Lazcano-Ponce et al., 2001).  Mays et 
al, (2004), argue that for less familiar infections such as HPV, comprehensive 
educational campaigns about the specific protective benefits of vaccines for sexually 
transmitted infections may be needed to enhance parental acceptance, especially as it 
is parents who play a key role in consenting to their children’s participation in HPV 
vaccination (Pitts et al., 2007; Zimet, 2005a).   
In the next section, the acceptability of cancer prevention strategies is explored 
with a focus on Pap smears which have been the primary screening test used in the 
Australian context, HPV testing which is under review for inclusion in future 
screening pathways and HPV vaccination. 
2.5 ACCEPTABILITY OF CERVICAL CANCER PREVENTION 
STRATEGIES 
2.5.1 Pap Smears  
The acceptability of the test used in a screening program is considered an 
important component of any population-based screening program (Screening 
Subcommittee, 2008).  Approximately 60% of Australian women participate 
regularly in cervical screening; however women who screen regularly and those who 
do not, describe a number of barriers that impact upon the acceptability of the Pap 
smear as a screening test.   
Barriers impacting upon women’s participation in cervical screening have been 
explored with women in all countries and are well documented.  The majority of 
studies have been conducted using convenience and non-random sampling methods.  
However, despite their limitations, many of these studies provide insight and often 
in-depth information about women’s perceptions and acceptance of cervical 
screening.  Lauver identified three types of barriers to cervical screening 
participation (Lauver, 1992).  These were practitioner, system and client related 
barriers.  Practitioner related barriers include concerns about client embarrassment, 
familiarity with the woman, lack of time and lack of discussion about screening 
between practitioner and client.  The majority of cervical screening in Australia 
occurs in the general practice setting and general practitioners (GPs) are well placed 
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to provide opportunistic and systematic cervical screening for clients due to their 
large female client base (CSSU, 2007c; Fiebig et al., 2009).  However, despite this, 
less than 30% of women in a CATI survey conducted in Queensland in 2005, 
reported they were prompted by general practice staff (GP, Practice Manager/Nurse 
or receptionist) to have their most recent Pap smear (CSSU, 2005).   
A study conducted in New South Wales found differences in GPs’ 
recommendations who were more likely to recommend screening to women of 
higher socioeconomic status and women who were not their regular patients (Fiebig 
et al., 2009).  Some medical practitioners are also not comfortable providing cervical 
screening, especially as this has not been a formal part of medical education in 
Australia (Robertson et al., 2003).   
System related barriers include barriers, such as accessibility of services in 
relation to location (the service is hard to get to), timing (many women work or care 
for children during office hours when most services are offered) and cost to the client 
of screening tests (Kwok, White and Roydhouse, 2011; Stewart and Thistlethwaite, 
2010; Smith, French and Barry, 2003).  Access is particularly important for women 
in rural and remote areas of Queensland who frequently have reduced access to a 
choice of provider and affordable services due to limited bulk billing services in 
these locations (CSSU, 2007c).  The costs associated with cervical screening have 
become increasingly important in the Australian setting and are reflected in lower 
participation rates by women from areas of high socio-economic disadvantage 
(Robertson, 2006; AIHW, 2011).  Unlike breast cancer and bowel cancer screening, 
the only other two population-based screening programs in Australia, women more 
often than not have to pay to participate in the NCSP.  This includes the cost of the 
consultation (above the Medicare rebate) unless the woman attends a bulk billing 
practice, laboratory fees if the test is not bulk billed and increasingly, the cost of 
adjunctive tests, such as liquid-based cytology and HPV DNA testing, if these are 
recommended by the practitioner. 
Client related barriers are associated with beliefs, norms and affect regarding 
screening (Lauver, 1992).  The most consistent client related barriers across studies 
are embarrassment and discomfort in both Australian and international studies 
(Jirojwong and Manderson, 2001; Van Til, MacQuarrie and Herbert, 2003; Blomberg 
et al., 2008; Fernbach, 2002; Vanslyke et al., 2008; Smith, French and Barry, 2003; 
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Orbell, 1996).  In focus groups conducted in the USA, women described this as the 
‘yucky factor’ (Smith, French and Barry, 2003).   
Studies have indicated that women prefer a female practitioner to provide 
cervical screening and lack of access to a female provider presents as a barrier.  
(Fiebig et al., 2009; Christie, Gamble and Creedy, 2005; Majeed et al., 1995; Van 
Til, MacQuarrie and Herbert, 2003; CSSU, 2005).  This is particularly relevant for 
Aboriginal and Torres Strait Islander women and women from CALD backgrounds 
(Kelaher et al., 1997; Kirk et al., 1998).  Other client related factors include lack of 
time, low knowledge of screening, low appreciation of the benefits of screening and 
perception of risk.  Uncertainty of the reliability of Pap smears and what an abnormal 
result means has been identified in overseas studies as factors that influence both 
older and younger women’s perception of the benefits of screening (Blomberg et al., 
2008; Kahn et al., 2007; Eaker, Adami and Sparen, 2001; Smith, French and Barry, 
2003).  Other factors that have been identified as client-related barriers include fear 
of the unknown, obtaining results or the procedure itself, lack of familiarity with the 
provider and previous negative experiences (Jirojwong and Manderson, 2001; Kirk et 
al., 1998; Fiebig et al., 2009; Kelaher et al., 1997; Blomberg et al., 2008; Vanslyke et 
al., 2008; Oscarsson, Wijma and Benzein, 2008).   
These barriers indicate some disparity between provider and client related 
barriers.  Women are more likely to have a Pap smear if their practitioner 
recommends it; however practitioners’ recommendations in some studies indicate 
this is not ideal or that this occurs differently for some women based on their limited 
familiarity with the provider or their socioeconomic status (Fiebig et al., 2009).  
Women on the other hand prefer to attend a provider they know and trust.  Enablers 
to assist women to overcome the barriers to screening include access to a female 
practitioner, the use of reminder systems to help prompt them to attend, access to 
free screening, public education and providers who have good communication skills 
and technique (Smith, French and Barry, 2003; Donders et al., 2009; Pearlman et al., 
1999; Wendt, Fridlund and Lidell, 2004).  
These factors suggest cervical screening has the potential to have negative 
consequences for some women and the need to ensure women are provided with pre-
test information and give informed consent is considered ethically imperative to 
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avoid harm (Posner et al., 2006; Barratt et al., 2002; Alder and Foxwell, 1999; 
Anderson and Nottingham, 1999; Chew-Graham et al., 2006).   
Exploration of the barriers impacting on women’s participation in cervical 
screening remains an important topic of research especially if more complex 
screening pathways for cervical cancer are to be introduced into the Australian 
setting.  These pathways include HPV DNA testing and women’s acceptance of this 
test also warrants attention and is discussed in the next section.  
2.5.2 HPV Testing  
Increasing evidence to support HPV DNA testing as a primary screening or 
reflex test for cervical cancer and support for its inclusion in screening pathways has 
prompted researchers to investigate women’s acceptance of this new technology.  Of 
particular interest are the issues that are raised with the incorporation of a test for a 
sexually transmitted infection into a cancer screening program (McCaffery et al., 
2006; Waller, McCaffery and Wardle, 2004a).  Prior to the discovery of HPV there 
was limited association in public health messages between sexual health and cervical 
screening and even with the advent of the HPV vaccine, its promotion as the 
‘cervical cancer vaccine’ in the Australian setting has supported this avoidance of 
being explicit about the vaccine preventing a sexually transmitted viral infection 
(Waller, McCaffery and Wardle, 2004a; Cooper Robbins, Pang and Leask, 2011).  
With low levels of HPV knowledge and its link with cervical cancer evident in all 
studies, irrespective of their representativeness as discussed earlier, there is concern 
that focusing on the role of a sexually transmitted infection as a cause of cervical 
cancer may lead to increased stigma, shame and distress for women and that women 
who receive a positive test may be labelled as promiscuous (McCaffery et al., 2006; 
Waller, McCaffery and Wardle, 2004a; Marshall et al., 2007). 
The psychological impact of HPV testing as a primary screening test has been 
investigated as a potential barrier for women.  Receiving a positive HPV DNA test  
was found to cause women to feel stigmatised, anxious, stressed and worried in a 
qualitative study of women involved in clinical trials of HPV DNA testing in the 
United Kingdom (McCaffery et al., 2006).  This finding was also found in a similar 
study conducted with women from different ethnic backgrounds who were shocked, 
worried, surprised and fearful when they were given information that cervical cancer 
was linked to a sexually transmitted infection (McCaffery et al., 2003).  The 
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possibility of receiving a positive HPV DNA test raised concern for these women, 
especially Indian and Pakistani women, that the test may be used as a test of fidelity 
or faithfulness and may potentially lead to unwanted messages being conveyed to 
partners, their families or the community (McCaffery et al., 2003).  Higher levels of 
anxiety, concern and distress were also found in women who received a positive 
HPV test conducted as a reflex test after a low grade Pap smear result (Maissi et al., 
2004).  There were three independent predictors of anxiety in this study; age 
(younger women had higher anxiety), perceived risk and uncertainty about the 
meaning of the result.  Perceived risk and uncertainty were associated with increased 
concern and distress.  These consequences were of higher magnitude in HPV positive 
women than those with normal Pap smear results and those with the same Pap smear 
result who were not tested or tested negative to HPV, although anxiety and distress in 
these women were found to be short term consequences in a follow-up study six 
months later (Maissi et al., 2004; Maissi et al., 2005). 
Younger women also expressed anticipated feelings of shame, stigma and guilt 
if they were diagnosed with HPV in a qualitative study of American adolescent and 
young women attending a teen health centre (Kahn et al., 2007).  Their cognitive 
understanding about HPV testing and Pap smears was found to profoundly influence 
how these young women created personal meaning from these results (Kahn et al., 
2007).  In a small study also conducted in USA in which 20 women aged 23–80 
years participated in in-depth interviews, women when faced with the choice 
between reflex testing for HPV after a potential abnormal Pap smear or a follow-up 
Pap smear in six months, chose the HPV DNA test despite their lack of familiarity 
with HPV and linking a positive result with infidelity, immorality and degenerative 
behaviour (Brown et al., 2007).   
HPV DNA testing as a primary screening test is proposed to reduce the number 
of Pap smears conducted in organised screening programs; however, there has been 
little research about women’s acceptance of HPV DNA testing as a replacement for 
the Pap smear.  One such study has shown that the majority of older women, between 
50 and 80 years of age, would have HPV DNA testing (64%) with a further 17% on 
physicians’ recommendation but despite having a negative Pap smear and HPV DNA 
result would continue with annual Pap smears, regardless of physician 
recommendations (Huang et al., 2008).  There were no predictors associated with this 
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finding and also of note was that women under 65 years of age would want more 
frequent Pap smears (between 2 and 4 per year) if they received a positive HPV 
DNA test result (Huang et al., 2008).  These findings indicate the need for more 
extensive research and community education to assist women to feel comfortable 
with changes to screening tests in the future, especially as policy changes can be 
viewed as being motivated by economic factors rather than science (Smith, French 
and Barry, 2003). 
In addition to the psychological impacts of receiving an abnormal HPV DNA 
test, the actual process for collecting HPV DNA is similar to the Pap smear 
procedure, therefore the same barriers, such as embarrassment, discomfort and 
familiarity of the provider, remain important when considering acceptability of this 
test.   
There has been increasing research into women’s acceptability of self collected 
tampons or swabs for HPV DNA testing given women’s dislike of the Pap smear, 
which results in some women not participating in screening (Morris and Rose, 2007).  
Women’s acceptability and satisfaction with self collected HPV DNA tests both 
within the clinical setting and at home, have found high levels of acceptance, 
satisfaction, comfort and ease of use and low levels of pain and embarrassment 
(Anhang et al., 2005; De Alba et al., 2008).  The use of self collected samples has 
been explored amongst women, who do not respond to invitations to screen in 
national population screening programs, to determine their likelihood of participating 
in cervical screening if an alternative testing method were available.  In these studies, 
women were more likely to return a self collected sample when invited to do so than 
return for a Pap smear if they received a recall letter; however response rates overall 
to these strategies were moderate 32–34% (Sanner et al., 2009; Bais et al., 2007).  
Despite this, the participation of these women, who are at increased risk of cervical 
cancer given they were not having regular Pap smears, was considered beneficial in 
both studies.   
There have been differing findings about women’s preference for self collected 
versus clinician collected samples.  Women’s preference for self collection was low 
(32%) in a study of low income women in the USA, although they were positive 
about the test; but the converse was found in a British study where 73% of women 
preferred self collection (Anhang et al., 2005; Waller et al., 2006).  When 
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considering the acceptability of either Pap smears or HPV DNA testing by women, 
the harms and benefits associated with the use of these tests within an organised 
screening program must also be considered.  Whilst both tests have the benefit of 
preventing cervical cancer through the identification of precancerous abnormalities, 
there are a number of harms that need to be considered in this changing context. 
Due to the expected high positive rate and in view of the transient nature of 
HPV infection in young women, the benefits of HPV primary screening are 
questioned in view of the potential harms, namely, the uncertain psychological 
impacts of a positive result and the potential for unnecessary intervention and over-
treatment of women who are HPV DNA positive but cytologically negative (Goldie, 
Kim and Wright, 2004).  In addition, the harms associated with the detection of 
transient HPV infection in young women also needs to be taken into account given 
the International Agency for Cancer Research in 2005 reported there is potentially 
more harm than benefit in screening young women under 25 years of age, as there is 
evidence of poorer reproductive health outcomes in young women following 
treatment for cervical abnormalities detected by screening (IARC, 2005; Kyrgiou et 
al., 2006).  In addition, there is a lack of evidence that cervical screening has any 
benefit in reducing the incidence of cervical cancer amongst women less than 25 
years at a population level (Canfell et al., 2004; Sasieni, Adams and Cuzick, 2003).  
These issues need to be taken into account when considering the acceptability of 
screening, whatever method is used for the secondary prevention of cervical cancer. 
With the recent development of a primary method of cervical cancer 
prevention, the acceptability of HPV vaccination has been widely researched and is 
discussed in the next section. 
2.5.3 HPV Vaccination 
Since a prophylactic vaccine against oncogenic HPV was first proposed, there 
has been an ‘explosion’ in funding for vaccine-related research (Sturm, Mays and 
Zimet, 2005).  This research has primarily focused on vaccine development, although 
increasingly studies have been undertaken to investigate acceptance of and attitudes 
towards HPV vaccination within the community.  The majority of studies described 
in this section are Australian studies given their relevance to this study. 
 Chapter 2: Primary and Secondary Cervical Cancer Prevention 33 
These studies have been undertaken to explore vaccine acceptability and to 
investigate whether poor knowledge of HPV and the association between sexual 
activity, a sexually transmitted infection (HPV) and cervical cancer influences 
vaccine uptake.  The importance of women and health providers having access to 
accurate information regarding these issues to inform decision-making regarding 
consent for vaccination, cervical screening and follow-up procedures is widely 
recommended in the literature (Garland, Skinner and Brotherton, 2011b; Waller et 
al., 2005; Kahn et al., 2003; Marlow, Waller and Wardle, 2007).   
The success of HPV vaccination as a primary prevention strategy against 
cervical cancer is dependent upon vaccine uptake in the population. Vaccine uptake 
in turn, is dependent upon young women’s acceptability of the vaccine and as the 
vaccine is anticipated to have the greatest impact if given to girls pre-sexual debut, 
their parents’ attitudes are important given they are required to consent for their 
daughters to be vaccinated (Sturm, Mays and Zimet, 2005; Mays, Sturm and Zimet, 
2004; Zimet et al., 2005b; Rosenthal et al., 2007; Katz et al., 2010).   
A consistent finding across all studies, irrespective of the setting, is high 
acceptance and positive attitudes towards HPV vaccination (McClelland and 
Liamputtong, 2006; Kahn et al., 2007; Marshall et al., 2007; Pitts et al., 2007; 
Cooper Robbins et al., 2010b; Dempsey et al., 2006; Gerend, Lee and Shepherd, 
2007; Zimet et al., 2005b).  The impact of parental age, socioeconomic status, 
gender, race/ethnicity and other socio-demographic characteristics on knowledge of 
HPV or attitudes to the HPV vaccine were not found to be of statistical significance 
in the majority of these studies, which may be due to study limitations, such as 
convenience sampling, poor response rates or limited sample size.  In a population-
based study of Victorian women aged 18–61 years, there was a significant positive 
correlation between a respondent’s age and her attitude towards vaccination (Pitts et 
al., 2007).  Significant differences were also found between six broadly defined 
ethnic and cultural groups in this study, with less positive attitudes towards 
vaccination expressed by Asian and/or Middle Eastern women (Pitts et al., 2007).  
Aboriginal and Torres Strait Islander women were not identified specifically in the 
findings of this study. 
However, these findings also suggest there are multiple factors involved in 
vaccine acceptability and that decision-making is a complex process that is not 
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standard amongst individuals (Cooper Robbins et al., 2010b; Katz et al., 2010).  With 
the implementation of the NHPVP, there has been extensive HPV vaccine research 
conducted in Australia with girls, parents, women of all ages and health providers.  A 
number of these studies have explored the factors associated with attitudes and 
decision-making processes about vaccination, including whether suppressing the 
association between cervical cancer and a sexually transmitted virus is beneficial to 
acceptability.  In an on-line survey of young women aged 18–26 years, 94% and 
98% of women had heard of HPV and the HPV vaccine, respectively; however most 
were unsure that HPV was linked to cervical cancer (Shand, Burney and Fletcher, 
2010).  This limited knowledge was also found amongst parents of girls involved in 
school-based vaccination in NSW who responded ‘don’t know’ to many items about 
HPV and HPV vaccination knowledge when interviewed, despite most consenting 
for their daughters to be vaccinated against HPV (Cooper Robbins et al., 2010b).  
However, poor knowledge has not been found to decrease acceptance of the HPV 
vaccine, nor consent and completion of the three dose regimen (Juraskova et al., 
2011; Cooper Robbins et al., 2010b; McClelland and Liamputtong, 2006).   
A model to assist in identifying and understanding vaccine uptake and 
completion has been proposed following a systematic review of the literature (Katz 
et al., 2010).  This model identifies structural and social factors, such as cost, access, 
socio-demographic factors and past vaccination related behaviours, caregiver factors, 
including health beliefs, healthcare utilisation and relationship with child, individual 
adolescent factors including relatedness to care-giver, developmental maturity, health 
beliefs, healthcare utility, knowledge and self-efficacy and adherence behaviours 
(Katz et al., 2010).   
Health beliefs have been the focus of a number of studies in the Australian 
setting.  Perception of risk, especially how HPV was transmitted, was found to be 
lower in women with lower levels of HPV knowledge, and amongst those with no 
personal experience of HPV (McClelland and Liamputtong, 2006).  In a study 
evaluating the Health Belief Model (HBM) for its ability to predict young women’s 
intent, perceived barriers and benefits were significant predictors of intent to have the 
HPV vaccine and subsequent uptake (Juraskova et al., 2011).  This study conducted 
in the first phase of the NHPVP of first year university students in Sydney, identified 
receiving information about HPV and cervical cancer and knowing someone with 
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cervical cancer or another cancer, was also associated with the intention to be 
vaccinated, in this convenience sample of well educated young women (Juraskova et 
al., 2011).   
These authors also investigated whether providing information about the 
vaccine primarily as a preventative for cervical cancer or including messages about 
the prevention of genital warts had an influence on young women’s intention to have 
the vaccine.  The sample was randomly assigned to receive a leaflet about how the 
vaccine protected against cervical cancer only or alternatively about both cervical 
cancer and genital warts.  The authors concluded perceived benefits and severity 
scores were higher in the group receiving the additional information about genital 
warts and that including information about HPV as a sexually transmitted infection 
did not influence vaccination intention in this sample (Juraskova et al., 2011).  
Studies with young women indicate attitudes and acceptance towards vaccination are 
not affected by making explicit the link between sexual activity, HPV and cervical 
cancer; however older women, from diverse cultural backgrounds participating in 
focus groups in Victoria, thought it best to keep the fact HPV was a sexually 
transmitted infection secret. (Rosenthal et al., 2007; Juraskova et al., 2011; 
McClelland and Liamputtong, 2006).  
Sexual health and the association of HPV with cervical cancer has been notably 
absent from Australian newspaper articles and public health messages before and 
after the implementation of the NHPVP media, with the majority of articles focusing 
primarily on cervical cancer prevention (Juraskova et al., 2011; Cooper Robbins, 
Pang and Leask, 2011).  Comfort levels in discussing sexual matters differ in the 
findings of studies with providers, parents and girls and the absence of fathers in 
decision-making about HPV vaccination was noted in one study (Skinner, Kang and 
Rosenthal, 2007; Brotherton, Leask, et al., 2010; Cooper Robbins et al., 2010b).  It is 
reassuring; however, that concerns that the vaccination of young girls against HPV 
will lead to increased sexual behaviour, is not of great concern in the Australian 
setting, despite this being an issue identified in overseas studies (Marshall et al., 
2007; Pitts et al., 2007; Garland, Skinner and Brotherton, 2011b; Olshen et al., 
2005). 
A consistent finding across all studies is that the recommendation or positive 
opinion of respected and trusted persons, including parents and authorities such as 
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teachers, health providers and the health department, is influential in women’s 
decision making about the HPV vaccination (Gerend, Lee and Shepherd, 2007; 
McClelland and Liamputtong, 2006; Rosenthal et al., 2007; Pitts et al., 2007; Cooper 
Robbins et al., 2010b; Cooper Robbins et al., 2010a; Cooper Robbins et al., 2010c).  
This highlights the importance of providing up-to-date information about cervical 
cancer, HPV and the HPV vaccine to these trusted sources of advice (Tan, Farrell 
and Allen, 2010; Garland, Skinner and Brotherton, 2011b; Brotherton, Leask, et al., 
2010; Cooper Robbins et al., 2010a; Marshall et al., 2007). 
Mass media is the most common source of consumer information about HPV 
and the vaccine in the Australian setting (Pitts et al., 2007; Rosenthal et al., 2007; 
Juraskova et al., 2011).  Increased knowledge regarding HPV was found in an 
American study following intensive media coverage of the vaccine, before and after 
it received approval by the Food and Drugs Administration (Kelly et al., 2009).  As 
previously mentioned, there are gaps in the messages conveyed through the media 
given their primarily role is not health education and therefore educational 
campaigns need to convey messages related to the transmission of HPV, what the 
vaccine protects against and the importance of cervical screening, irrespective of 
vaccination status, if these deficits are to be addressed (Garland, Skinner and 
Brotherton, 2011b; Cooper Robbins, Pang and Leask, 2011; Kelly et al., 2009).  The 
information sought by the community regarding HPV vaccination includes potential 
side-effects and risk associated with vaccination, efficacy and whether the vaccine 
was life-saving, the duration of protection, whether males should be vaccinated and 
if the vaccine was safe (Rosenthal et al., 2007; Cooper Robbins, Pang and Leask, 
2011; Marshall et al., 2007). 
The conclusions from studies conducted overseas are largely consistent with 
the findings of Australian studies. One of the main factors associated with acceptance 
of HPV immunisation amongst mothers of teenage girls is perception of risk 
(Lazcano-Ponce et al., 2001).  Mays et al, (2004), argue that for less familiar 
infections, such as HPV, comprehensive educational campaigns about the specific 
protective benefits of vaccines for sexually transmitted infections are needed to 
enhance parental acceptance, especially as it is parents who play a key role in 
consenting to their children’s participation in HPV vaccination (Pitts et al., 2007; 
Zimet, 2005a).   
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Another key aspect specific to the HPV vaccine that appears poorly understood 
is that maximal efficacy is achieved if the vaccine is given to young women pre-
sexual debut, which has had implications for the school-aged cohort in terms of 
vaccine acceptability by parents and their daughters (Zimet, 2005a; Pitts et al., 2007).  
This needs to be understood by Australian young women aged 18–26 years who had 
access to HPV vaccination through general practice until 2009 as they may have 
been exposed to HPV 16 or 18 prior to being vaccinated (NCIRS, 2006b).  
Vaccinated young women and women throughout Australia need to be aware of the 
importance of regular participation in cervical screening as the vaccine will not 
impact on pre-existing HPV infections and does not protect against all types of 
oncogenic HPV (NCSP, 2007a; Brotherton, 2007; NCIRS, 2006b).  This has 
prompted the NCSP, the NHVP and the National Centre for Immunisation Research 
and Surveillance to release statements promoting cervical screening on all HPV 
vaccination information and pharmaceutical companies marketing HPV vaccines in 
Australia have followed suit (NCSP, 2007b; NCIRS, 2006b).   
Concerns have also been raised that the women least likely to access 
vaccination are those who are also less likely to access cervical screening (IARC, 
2005).  This has led to recommendations for future research that focuses on women 
who are less likely to participate in cervical screening and who are therefore at 
higher risk of cervical cancer (Brewer and Fazekas, 2007; Marlow, Waller and 
Wardle, 2007).   
The majority of studies conducted to date have been undertaken in developed 
countries or in metropolitan areas; however it is well documented age, racial, 
cultural, accessibility and socio-economic factors are significantly associated with an 
increased risk of cervical cancer (Brewer and Fazekas, 2007; IARC, 2005; 
Homewood, Coory and Dinh, 2005).  Brewer and Fazekas, (2007), contend studies 
exploring vaccine acceptability amongst populations most affected by cervical cancer 
are required to ensure the existing disparities in health care access do not increase 
with the introduction of HPV vaccination.   
There is increasing information in the Australian setting regarding knowledge 
and awareness of HPV and its link to cervical cancer and attitudes towards HPV 
vaccination; however gaps remain particularly in relation to Aboriginal and Torres 
Strait Islander peoples’ views and those of people from culturally and linguistically 
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diverse backgrounds (Heffernan, 2007).  This research is necessary to determine the 
potential impact of the vaccine and to identify future policy and strategies to further 
reduce cervical cancer incidence and mortality across the entire population.  It is not 
known if women least likely to access cervical screening have less favourable 
attitudes towards HPV vaccination or whether they are less likely to consent to their 
daughters being vaccinated.  Research is needed to further explore this aspect of 
HPV immunisation amongst Queensland women, particularly those who are less 
likely to participate regularly in cervical screening. 
2.6 SUMMARY AND IMPLICATIONS 
Cervical screening programs need to be evaluated because the addition of HPV 
vaccination will make the existing approach of high-frequency screening by cytology 
too costly and inefficient for most public health budgets (Franco et al., 2006).  
Empirical data will not be available for some time to inform policy makers and 
health professionals involved in such evaluations and mathematical modelling is 
underway to provide local insight into the impact of the vaccine and changes to 
cervical screening policy.  In addition to modelling, behavioural research is required 
to enable greater understanding of the information needs and attitudes of women 
given the vast changes in our understanding of cervical cancer, the natural history of 
HPV and the advent of new technologies that have occurred over the past decade.   
As evident in studies conducted in Australia and overseas, women’s knowledge 
of cervical cancer prevention strategies and the link between cervical cancer and 
HPV is limited.  There is also limited data to assist policy makers and public health 
educators assess the impacts and outcomes of existing cervical cancer prevention 
strategies and inform future strategies to address the needs of women in Queensland.  
By specifically investigating Queensland women’s knowledge of HPV and cervical 
cancer and knowledge and attitudes about cervical screening and the HPV vaccine, 
knowledge deficits and barriers to screening can taken into account when decisions 
about communication strategies and changes to the NCSP screening policy are made.  
This will inform the development of targeted strategies that aim to increase rates of 
cervical screening participation and disseminate new information and knowledge 
about cervical cancer/screening, HPV and HPV vaccination to further reduce cervical 
cancer incidence and mortality in Queensland.  In addition, understanding what 
women currently perceive about cervical cancer prevention strategies will assist in 
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developing communication strategies to assist women to understand and accept 
anticipated changes to a well established screening program that has remained 
unchanged in Australia for over two decades.   
To address the lack of local information about Queensland women’s 
knowledge and attitudes towards cervical cancer prevention strategies, this study 
utilised quantitative and qualitative methods of inquiry.  This enabled exploration of 
socio-demographic and personal factors impacting on women’s knowledge and 
beliefs about cervical screening and HPV vaccination and provided insight into their 
beliefs and attitudes about primary and secondary cervical cancer prevention 
strategies, thereby adding to existing research in the Australian context. 
The methods used to conduct this study, which incorporate both quantitative 
and qualitative approaches, are described in the following chapter. 
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Chapter 3: Overarching Research Design  
This chapter describes the design adopted by this research to achieve the aims and 
objectives stated in Section 1.3 of Chapter 1, namely: 
 To determine what Queensland women know and say about: 
 cervical cancer/screening and their beliefs about and attitudes towards 
Pap smears,  
 human papillomavirus (HPV) and the HPV vaccine and their attitudes 
towards the vaccine.  
 To identify where Queensland women get their health information from and 
the most effective methods they recommend for communicating and 
promoting information to women should changes be made to the NCSP. 
 The methodology used in the study and when each phase was implemented is 
described in Section 3.1, which is followed by a description of the conceptual 
framework underpinning this study in Section 3.2.  The ethical considerations of the 
research are discussed in the final section of this chapter (Section 3.3). 
3.1 METHODOLOGY AND RESEARCH DESIGN 
3.1.1 Methodology 
This research was a descriptive-exploratory study that incorporated a 
combination of qualitative and quantitative methods (methodological triangulation).  
Methodological triangulation was adopted as quantitative data provides good 
descriptive data about the research topic of inquiry whilst qualitative methods assist 
to explore and explain the subject matter in detail (Ulin, Robinson and Tolley, 2005).  
The combination of methods aimed to provide a more complete picture than the use 
of one approach in isolation and be complementary to each other (Ulin, Robinson 
and Tolley, 2005). 
3.1.2 Research Design 
Phase 1 of the project used an inductive quantitative approach incorporating a 
computer-assisted telephone interview (CATI) survey of women across Queensland 
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(Appendix A).  This was conducted in the formative phase of the study to provide 
information about socio-demographic and structural differences in knowledge and 
attitudes between subgroups, for example, older women compared to younger 
women or by screening status and to guide the topics of inquiry in the qualitative 
phase. 
Phase 2 utilised focus groups to gather in-depth information about women’s 
knowledge, awareness and acceptance of cervical cancer prevention strategies and 
ascertain the sources women used and recommended for obtaining and disseminating 
health information and further explore and explain the findings of Phase 1.  A 
qualitative approach was incorporated into this study to produce information rich 
data and answer questions not suited to the structured format of the telephone survey, 
particularly those relating to sensitive subjects for example, perceptions about 
barriers to screening (Liamputtong and Ezzy, 2005). 
3.2 THE CONCEPTUAL FRAMEWORK 
The Health Belief Model (HBM) guided the process of inquiry for the 
qualitative component of this study.  The HBM is one of a number of social 
cognition models (SCMs) that has been widely adopted by researchers attempting to 
explain health related behaviour and was developed by a group of social 
psychologists in the 1950s (Roden, 2004; Rosenstock, 1974; Murray and McMillan, 
1993).   
Health related behaviours are activities undertaken to prevent or detect disease 
or improve one’s health or well-being (Connor and Norman, 2005).  SCMs provide a 
basis for understanding factors that determine behaviour or lead to behaviour change 
and assist in targeting interventions that might facilitate change.  Six factors have 
been postulated to influence health behaviours, namely: 
1. accessibility to services,  
2. attitudes to health,  
3. perceptions of disease threat,  
4. knowledge about disease,  
5. social networking characteristics, and,  
6. demographic factors (Connor and Norman, 2005).   
 Chapter 3: Overarching Research Design 42 
INDIVIDUAL PERCEPTIONS MODIFYING FACTORS LIKELIHOOD TO ACTION 
 
 
 
 
 
 
 
 
 
Figure 3.1. The Original Health Belief Model (Rosenstock, 1974) 
Factors 2–5 are social-cognitive factors, of interest to psychologists attempting 
to develop a greater understanding of factors that were open to change and may be 
influenced to promote behaviour change (Connor and Norman, 2005).  Early work 
was related to the public acceptance of programs to screen for disease, such as 
tuberculosis, or immunise against infections, for example, polio and influenza 
(Rosenstock, 1974; Burak and Meyer, 1997; Rimer and Glanz, 2005).  The HBM 
model was based on Kurt Lewin’s value-expectancy theory and was originally 
focused on two aspects thought to influence health behaviour in response to the 
threat of illness, namely perception of illness threat and evaluation of behaviours to 
counteract this threat (Rosenstock, 2000; Rimer and Glanz, 2005; Connor and 
Norman, 2005).  The perception of threat was based on two beliefs, perceived 
susceptibility and perceived severity to the disease of concern (Connor and Norman, 
2005). 
As outlined in Figure 3.1, perceived susceptibility to and perceived seriousness 
of disease and the benefits of taking action, perceived barriers and cues to action 
were the original key components of the HBM (Rimer and Glanz, 2005; Rosenstock, 
1974).  Perceived susceptibility to disease is based on the individual’s subjective risk 
they are at risk of disease.  When applied to screening, the individual also must 
perceive they are at risk even in the absence of any symptoms (Rosenstock, 1974).  
Demographic variables (age, sex, 
race, ethnicity, etc) 
Sociophysiological variables 
(personality, social class, peer and 
reference group pressure etc) 
Structural variables (knowledge 
about the disease, prior contact 
with the disease ,etc.) 
Perceived benefits of 
preventive action 
Minus 
Perceived barriers to 
preventive action 
Perceived susceptibility 
to disease “X” 
Perceived seriousness 
(severity) of disease “X” 
 
Likelihood of taking 
recommended 
preventive health 
action 
Perceived threat of disease “X” 
 
Cues to action 
Mass media campaigns 
Advice from others 
Reminder postcard from physician or 
dentist 
Illness of family member or friend 
Newspaper or magazine article 
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Perceived severity is based on beliefs about the seriousness of contracting an illness 
and potential consequences to personal and other factors in a person’s life including, 
for example, the impact on family and income (Rosenstock, 1974; Rimer and Glanz, 
2005).  Both susceptibility and severity have a strong cognitive component that is 
partly dependant on knowledge (Rosenstock, 1974).  Perceived benefits relate to 
beliefs about the effectiveness of a particular action in reducing the threat of the 
disease or the consequences and seriousness if the disease occurs, whilst perceived 
barriers include both material and psychological aspects of taking action including 
cost and access issues, embarrassment and pain (Roden, 2004; Rimer and Glanz, 
2005).  Cues to action are those factors that prompt or stimulate health behaviours 
and can be internal or external events (Burak and Meyer, 1997; Rimer and Glanz, 
2005).  External factors include the impact of mass media campaigns or receiving a 
recommendation or reminder letter from a health professional (Rosenstock, 1974).   
The HBM was further expanded over time until it was comprised of six main 
constructs thought to influence people’s decisions about participating in screening 
and preventative health activities and three modifying variables including 
demographic, psychosocial and structural variables (Rimer and Glanz, 2005; Murray 
and McMillan, 1993).  Self-efficacy was the sixth construct added to the model by 
Bandura (1977), and relates to an individual’s confidence to take action and the 
conviction that they are able to successfully carry out the behaviour (Rosenstock, 
2000; Rosenstock, 1974).  Bandura (1977), contends that people avoid threatening 
situations due to fear they will not cope well but will involve themselves in activities 
even if they consider them intimidating, if they judge themselves capable of handling 
the situation.  Self-efficacy was added to the model as it was found to be a key 
predictor of health behaviours and would therefore add to the predictive power of the 
HBM (Bandura, 1977; Rosenstock, Strecher and Becker, 1988). 
These beliefs are influenced by modifying factors including demographic, 
psychosocial and structural variables.  Demographic variables include socio-
demographic variables such as educational attainment, psychosocial variables, which 
include locus of control and emotional control, whilst knowledge of and contact with 
the disease are structural variables that impact on beliefs (Murray and McMillan, 
1993).  These modifying factors influence an individual’s likelihood of taking action 
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based on their perceived benefits of taking that action, minus the perceived barriers 
to action. 
A number of limitations of the HBM have been identified, including the 
absence of normative influences such as social pressures/desirability and the lack of 
a measure of behavioural intention, which has been found to one of the strongest 
predictors of behaviour (Carpenter, 2010; Abraham and Sheeran, 2005).  Therefore, 
the HBM does not directly address the issue of translating intentions into actions 
(Connor and Norman, 2005).  In addition, there is limited evidence of the 
predictability of the main constructs of the model to lead to behaviour change, which 
has been attributed in part, to difficulties in comparing studies based on the HBM.  
Constructs have been construed and measured in different ways due to lack of clarity 
of some constructs, for example, cues to action, and the lack of hierarchal or 
temporal relationships between cognitions (Yarbrough and Braden, 2001; Tanner-
smith and Brown, 2010; Abraham and Sheeran, 2005).  Two studies in which the 
HBM’s ability to predict intentions to participate in cervical screening or receive the 
human papillomavirus (HPV) vaccine and vaccine uptake behaviour have confirmed 
that the constructs of the model have limited impact on intention and behaviour 
(Juraskova et al., 2011; Burak and Meyer, 1997).  A meta-analysis conducted in 1984 
found evidence for the predictability of the four major constructs of the model, 
perceived susceptibility/ severity/ benefits and barriers; however this review has been 
criticised for the methods used to measure predictability and subsequent meta-
analysis have revealed conflicting findings (Abraham and Sheeran, 2005; Janz and 
Becker, 1984).  The HBM also fails to account for behaviours that are influenced by 
social and affective factors such as socio-economic costs (Tanner-smith and Brown, 
2010; Abraham and Sheeran, 2005).   
Despite these limitations, the HBM does specify a discrete set of common 
sense cognitions, which have been identified as useful for examining antecedents of 
self-efficacy and intention rather than predictors of behaviour and its applicability as 
an essential reference point in the development of messages to improve knowledge 
and change beliefs is acknowledged (Abraham and Sheeran, 2005; Nutbeam and 
Harris, 2004).  This model has been adopted and found to be relevant in both 
quantitative and qualitative studies aiming to explore knowledge and beliefs about 
cervical cancer prevention behaviours and continues to be used in descriptive studies 
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(Waller, McCaffery and Wardle, 2004a; Brewer and Fazekas, 2007; Murray and 
McMillan, 1993; Jirojwong and Manderson, 2001; McClelland and Liamputtong, 
2006; Juraskova et al., 2011; Dempsey et al., 2006).   
The HBM was adopted for the purposes of this study as it has been utilised 
extensively in both quantitative and qualitative cervical cancer prevention studies 
and enabled reflection of the findings of this study with those found in other studies 
conducted both locally and overseas (Waller, McCaffery and Wardle, 2004a; Brewer 
and Fazekas, 2007; Jirojwong and Manderson, 2001; McClelland and Liamputtong, 
2006; Juraskova et al., 2011; Dempsey et al., 2006; Cooper Robbins et al., 2010b).  
In addition, the constructs of the HBM provided a useful framework on which to 
develop the topic guide for the focus groups, which aimed to assess women’s beliefs, 
knowledge and attitudes towards cervical cancer/screening, HPV and the HPV 
vaccine.  The relationship between the research questions in this study and the 
constructs of the HBM are outlined in Table 3.1. 
The key constructs of the HBM were considered highly relevant to cervical 
cancer prevention health behaviours as they enabled the exploration of women’s 
beliefs about their perceived susceptibility to and severity of cervical cancer in the 
context of a setting in which incidence and mortality rates have decreased to such 
low levels that women are unlikely to have extensive experience with family or 
friends affected by this disease.  In addition, there have been limited studies 
exploring what Queensland women perceive about the benefits and barriers of 
cervical screening and their attitudes towards vaccination and what they perceive as 
cues to promote their participation in cervical cancer prevention strategies.  This 
study aimed to assess knowledge, attitudes and beliefs to inform future health 
promotion strategies largely aimed at disseminating changes to the screening policy 
and National Cervical Screening Program (NCSP), not measure women’s intention to 
participate in screening or vaccination.   
The HBM was therefore considered an appropriate model for the purposes of 
this study to explore Queensland women’s attitudes, beliefs and knowledge about 
cervical cancer prevention to inform future health promotion strategies in light of the 
anticipated changes to cervical screening in the near future, following the Renewal of 
the NCSP. 
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Table 3.1: Relationship of Research Questions to the HBM and Overarching Focus 
Group Questions 
Research Questions HBM 
Constructs 
Question 
What do women know about 
cervical cancer/screening and 
what are their attitudes 
towards Pap smears? 
 
 
Self-efficacy  
 
What do you think of the following statement:  
“Good health is largely a matter of good luck” 
Perceived 
susceptibility to 
disease 
What do you think causes cancer of the cervix? 
 
Do you think every woman has the same risk of 
getting cancer of the cervix? 
Perceived 
seriousness of 
disease 
If a woman gets cervical cancer, is there a cure?  
Do you think it would have a big impact on a 
woman’s health? 
Perceived 
benefits of 
taking action 
What do you know about Pap smears? 
Perceived 
barriers to 
action 
What do you think prevents some women from 
having Pap smears or putting them off?  
Cues to action What do you think prevents some women from 
having Pap smears or putting them off? 
 
Hypothetical - If there was a test that you could 
do at home, say a tampon or swab you could 
insert yourself and send in the mail – do you 
think women who don’t go for Pap smears now 
might do it? 
What do Queensland women 
know about HPV and what 
are their attitudes towards the 
cervical cancer/HPV vaccine? 
 
Perceived 
susceptibility to 
disease 
What do you know about human papillomavirus 
or HPV?   
 
Perceived 
benefits of 
taking action 
What do you know about the new vaccine for 
preventing cancer of the cervix? 
Cues to action  What do you think would prompt a woman to 
agree for her daughter to have the vaccine or to 
have the vaccine herself? 
What do they women 
perceive as the most effective 
methods of communicating 
and promoting new 
information should changes 
be made to the NCSP 
Cues to action Where do you get your health information from? 
The QCSP has developed a number of ways to 
provide information about HPV and cervical 
cancer –If there was new information we wanted 
to provide to women - what do you think is a 
good way to do this?  
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3.3 ETHICS  
3.3.1 Ethical Approval 
This research involved the participation of humans and was undertaken in 
accordance with the National Statement on Ethical Conduct in Research Involving 
Humans and the Australian Code for Responsible Research to ensure ethical conduct 
in all aspects of the study research (NHMRC, 2007a. 2007b).  Ethical approval for 
the use of data from the CATI survey, which was commissioned by Queensland 
Health, was sought and the research was conducted in accordance with the 
Queensland Health Research and Ethic Unit guidelines and policies and the Public 
Health Act 2005.  Ethical approval for the study was granted by the Queensland 
University of Technology University Human Research Ethics Committee – approval 
number 0800000366.   
3.3.2 Main Ethical Considerations 
Consent 
Verbal consent was obtained from women participating in the CATI survey by 
the agency conducting the survey on behalf of Queensland Health.  Women who 
wished to check the authenticity of the survey were given contact details for the 
Queensland Cervical Screening Program (QCSP) and one woman called to verify the 
authenticity of the study.  Women were also offered additional written information 
regarding the survey but this was not required.   
Written consent was sought from women participating in the focus groups.  An 
information sheet was provided with the consent form to inform women about the 
study and advise them participation was voluntary and they had the right to withdraw 
from the study at any time and could decline to answer any questions (Appendix B, 
Appendix C).  Verbal consent was sought from women to audiotape the focus 
groups. 
On a few occasions, women raised concerns about the consent process.  One 
woman was unhappy about the statement in the consent form “understand that you 
are free to withdraw at any time, without comment or penalty” as she felt this was 
patronising but still signed the form.  Two women in one group (an older woman and 
her daughter) did not want to sign the consent form or participate in the focus group 
(no reason sought or given), but wished to observe and the other women in the group 
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did not object so they observed the focus groups and then actively participated in the 
information session.  
In one of the first groups conducted, a woman arrived late and did not hear the 
information about the audio-tape recording and much later, on realising this, got up 
from the table and left the group.  The researcher spoke with her later and apologised 
and reassured her about the confidentiality of the recordings and data and she agreed 
for her input to be included if no names were used.  She disclosed she had escaped a 
domestic violence situation and was in hiding, which was why she reacted the way 
she did.  This issue informed the issue of late comers in future focus groups.  It was 
not often but the group organiser or the observer, if present, was asked to give late 
comers the forms to complete and advise them about the recording prior to joining 
the group.  This worked well and no further issues occurred with the recording of 
focus groups. 
Confidentiality and Storage of Data 
Survey data was provided electronically to the researcher from the CATI 
facility and was stored on the Queensland Health secure password protected server 
with daily back-up to a secure network at Queensland Health.  The network drive at 
Queensland Health is part of a secure network with a firewall and password 
authentication.  The database did not contain any identifying information.  Analysis 
was also undertaken at the researcher’s home and data and findings were stored on a 
secure password protected drive.   
There were no names or identifying information reported in focus group 
findings.  When women referred to potentially identifying information in transcripts 
about their locations for example, this was de-identified also.  Women’s names were 
recorded on the consent forms, which were kept separate in locked filing cabinets to 
the questionnaires they completed pre focus groups and those who wanted to receive 
a report of the findings provided personal details, which were also kept separate from 
the other study information.   
Qualitative data was recorded using audiotapes, which were transcribed and 
together with written notes taken during focus groups and survey responses were 
entered into NVivo by the researcher and five research assistants.  Each research 
assistant signed a confidentiality agreement prior to transcribing or entering data 
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(Appendix D).  This information was stored on the researcher’s personal computer 
on a secure password protected drive.  Consent forms were scanned and stored 
electronically by the researcher and stored on the Queensland Health secure 
password protected server. 
All paper based information was stored in a locked cabinet in the researcher’s 
office, which is located in a secured building.  Paper-based information was 
destroyed through commercial shredding as soon as possible once the information 
was recorded electronically in accordance with Queensland Health's guidelines for 
the storage and destruction of confidential research information. 
All publications and information released by the researcher is in the form of 
aggregated findings with the exception of de-identified quotes used to reinforce the 
outcomes of focus groups. These quotes do not contain any identifying information. 
Dissemination of Findings 
Research outcomes will be disseminated in the form of peer reviewed journal 
articles and will be also published and available in the form a doctoral thesis.  
Presentations have been made at national and international conferences and have 
been communicated to national and jurisdictional cervical screening programs and 
key stakeholders of the QCSP, including the Cancer Screening Services Branch 
Consumer Reference Group, the QCSP Quality Management Committee, Family 
Planning Queensland and Women’s Health Queensland Wide (Appendix E). 
A report on the findings of the focus groups was developed for participants and 
was disseminated to them prior to any written publication of focus group findings in 
the public domain (Appendix F).  All publications arising from the research will be 
accessible through the lead research agency, Queensland University of Technology. 
A media release will be provided at the conclusion of the project to ensure the wider 
public has access to the key findings of the research. 
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Chapter 4: Research Design Phase 1 
This chapter describes the design adopted by this research to achieve the aims 
of Phase 1 of the study.  Section 4.1 discusses the aims of Phase 1; Section 4.2 
details the participants in the study; Section 4.3 lists the instruments used in Phase 1 
and justifies their use; Section 4.4 outlines the procedures used and the timeline for 
completion of Phase 1; and Section 4.5 discusses how the data was analysed. 
4.1 RESEARCH QUESTIONS AND HYPOTHESES 
The research questions to be addressed in Phase 1 of the study were: 
 What do Queensland women know about cervical cancer/screening and does 
this differ by socio-demographic factors or cervical screening history? 
 How many Queensland women have heard of human papillomavirus (HPV) 
and does this differ by socio-demographic factors, cervical screening history 
or cervical cancer/screening knowledge? 
 What do Queensland women know about HPV and does this differ by socio-
demographic factors, cervical screening history, awareness and attitudes? 
 How many Queensland women are aware of the HPV vaccine, where did they 
hear about it and does awareness differ by socio-demographic factors, 
screening history, cervical cancer/screening knowledge or awareness?  
 What are Queensland women’s attitudes towards HPV vaccination and does 
this differ by socio-demographic factors, screening history, cervical 
cancer/screening knowledge or awareness? 
 
The hypotheses tested were: 
 H1:  Cervical cancer/screening knowledge differs between Queensland 
women from different socio-demographic groups and screening history 
groups. 
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 H1:  HPV awareness differs between Queensland women from different 
socio-demographic groups and screening history groups and by cervical 
cancer/screening knowledge. 
 H1:  HPV knowledge differs between Queensland women from different 
socio-demographic groups and screening history groups and by cervical 
cancer/screening knowledge, awareness of the HPV vaccine and 
attitudes towards vaccination. 
 H1:  Awareness of the HPV vaccine differs between Queensland women 
from different socio-demographic groups and by screening history 
groups and by knowledge and awareness. 
 H1:  Attitudes towards the HPV vaccine differs between Queensland 
women from different socio-demographic groups and by screening 
history, knowledge, awareness or attitudes. 
The variables collected in Phase 1, their relationship with the research 
questions and how they were measured are outlined in Appendix G. 
4.2 PARTICIPANTS 
Women aged 20 to 69 years who had not had a hysterectomy were invited to 
participate in the survey.  These criteria were used as this group of women are the 
primary target population for the National Cervical Screening Program (NCSP) in 
Australia.  An additional eligibility criterion was that women were required to be 
resident in Queensland. 
The survey sample frame was obtained from the Association of Market and 
Social Research Organisations (AMSRO) Random Digital Dialling (RDD) sample 
database.  RDD has been reported to select reasonable random samples as unlike 
other methods, such as Electronic White Pages listings, allows contact with people 
who have unlisted or recent connections (Choi, 2004; I-View Pty Ltd, 2008).  Those 
with unlisted numbers have been reported to be more likely to be living in 
metropolitan areas, be single, younger and be current smokers (Dal Grande, Taylor 
and Wilson, 2005).   
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4.2.1 Sample Size 
A total sample size of 1000 women was required to detect a clinically 
significant minimum meaningful difference (Battistutta, 2010b) of 1.5 (where the 
anticipated difference was 2) in mean cervical cancer/screening knowledge scores by 
age, locality and SES as these were key factors of interest as cervical screening 
participation rates differ by these factors in most Australian jurisdictions (AIHW, 
2011).  Clinical significance relates to the applicability of the research findings to the 
practical context, which in this case, is cervical cancer prevention (Battistutta, 
2010b).  This difference was determined from  previous studies conducted by Pitts 
and Clarke, (2002), in which the mean cervical cancer/screening knowledge score 
was 13.49 (SD 3.68) and Hancock et al, (1996), who determined a 10% difference in 
knowledge was significant when studying knowledge of cancer risk reduction 
practices in NSW.  A difference of 1.5 also reflects roughly one third to one half of a 
standard deviation of previous knowledge scores which is commonly associated with 
a meaningful difference.  The sample size was based on a type I error rate of 5% 
(two-tailed) and a type II error rate of 10% (power = 90%).   
The sample size was also inflated to allow for a response rate of 70% with a 
prediction that approximately 300 women would refuse to participate.  The response 
rate of 70% was determined from the participation rate achieved in a previous 
computer-assisted telephone interview (CATI) survey conducted by the QCSP in 
2005 (CSSU, 2005).  Sample size calculations for HPV knowledge and knowledge 
and attitudes towards vaccination were undertaken but are not reported as smaller 
sample sizes were required to detect meaningful differences.   
Some oversampling was undertaken to allow for meaningful comparisons by 
(socio-economic status) SES.  An area defined as most disadvantaged under socio-
economic indexes for areas (SEIFA) is deemed so if (among other things), it is 
comprised of many households with low income, many people with no 
qualifications, or many people in low skilled occupations (ABS, 2006b).  To 
optimise the chance of measuring differences in knowledge amongst women by 
locality and socio-economic disadvantage, the sampling strategy set quotas to take 
quintiles 1 and 2 samples to 25% each.  Based on random sampling of the population 
it was expected 18.7% and 17.6% of the sample would be from these quintiles 
respectively. The sampling strategy aimed to generate a minimum of 10% of total 
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sample in quintile 4 and 10% in quintile 5. In doing so, this allowed statistical 
significance to be achieved on the knowledge index if there was a mean difference in 
knowledge of 1.5 where the anticipated mean difference was 2.  
Respondents were assigned to each quota based on their location using their 
State Suburb Code, which was mapped to SEIFA categories by the CATI facility 
(ABS, 2006b).  In addition, quota control was implemented with permission from the 
researcher during data collection to minimise skew towards older age groups as the 
CATI facility reported older women were participating at a higher rate than younger 
women and there was concern they would be underrepresented in the sample had this 
not occurred. 
4.3 INSTRUMENT USED: CATI SURVEY 
A CATI survey was used as the data collection method as this provides ready 
access to a large sample including those living in remote and rural communities, 
access to instant results and is cost-effective and particularly useful for surveys in 
which sensitive topics are discussed (Choi, 2004; Smith et al., 2009; Dal Grande, 
Taylor and Wilson, 2005).  Computerisation also facilitates data collection through 
randomisation of questions and response options, consistency checks and automatic 
question skips (Choi, 2004).  The “Print Media and HPV Questionnaire” was the 
instrument used for the CATI survey and was originally designed to capture 
information for two purposes:  
1. to inform an interim evaluation of the QCSP social marketing campaign, 
and, 
2. to collect data for the purposes of this study. 
The QCSP social marketing campaign named, “Cervical Screening 
Participation Project: Prompting Action” commenced in 2005 with a goal to increase 
participation in cervical screening of women aged 20–69 years in Queensland. The 
campaign was conducted over a three year period with the primary strategy being a 
social marketing campaign, which included both mass media and non mass media.  
The campaign message was delivered in a targeted television advertisement 
that appeared in two media bursts in February/March 2007 and July/August 2007. 
The mass media evaluation survey was carried out to evaluate the effectiveness of 
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the television advertising component of the QCSP Social Marketing Campaign and 
assess women’s awareness of campaign message/messages and women’s intention to 
act, i.e. had they had or were they planning to have a Pap smear (QCSP, 2008).  The 
timing of the CATI survey was influenced by the QCSP Social Marketing Campaign 
as it was scheduled to be conducted prior to a subsequent burst of television 
advertising. 
To accommodate both purposes, the questionnaire therefore included a total of 
91 questions: 
 general health (three questions not included in this study) 
 women’s knowledge about cervical cancer/screening (nineteen questions) 
 women’s cervical screening history (five questions) 
  media recall and intent (eighteen questions not included in this study) 
 women’s knowledge about HPV (thirteen questions) 
 women’s knowledge of and attitudes towards vaccines and the HPV vaccine 
(seventeen questions) 
 behavioural and socio-demographic data (sixteen questions).  
Most questions were designed to capture data for both purposes of the CATI 
survey.  The “Print Media and HPV Questionnaire” dataset was separated upon 
receipt from the CATI facility and analysed separately for each purpose.  Responses 
to general health and media recall questions (italicised) and four socio-demographic 
questions from the overall CATI survey were not included in the dataset for the 
purposes of this study.  Sixty-six questions were specifically designed for the 
purposes of this study and are outlined in Appendix A.   
These questions were informed by tools used in previous studies of cervical 
cancer/screening and HPV knowledge and attitudinal studies about HPV vaccination 
as outlined in Table 4.1 (Pitts and Clarke, 2002; Pitts et al., 2007; Kahn et al., 2003; 
Waller, McCaffery and Wardle, 2004a; Brabin, Roberts and Kitchener, 2007; 
Marlow, Waller and Wardle, 2007).  Permission was sought and granted from 
Professor Pitts and Dr Kahn for the use of their instruments. 
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The instruments for assessing women’s knowledge about cervical 
cancer/screening, HPV and the HPV vaccine and attitudes towards the HPV vaccine 
were modified slightly as follows: 
 cervical cancer/screening knowledge items - modified from the items described 
by Pitts and Clarke (2002), by adding items used in recent, similar measures of 
cervical cancer/screening knowledge and specific questions about cervical 
screening recommendations in Australia (Marlow, Waller and Wardle, 2007). 
 HPV knowledge items – one item was added and there were slight 
modifications to the wording of four items in the HPV knowledge scale 
developed by Kahn et al, (2003) as follows: 
 the ‘Pap smear detects HPV’ was modified to ‘the Pap smear is a test 
for HPV’ to reduce the clinical nature of this statement 
 ‘HPV causes abnormal menses’ was modified to ‘HPV causes women 
to have abnormal periods’ as menses is not a frequently used term 
amongst women in the Queensland setting 
 ‘smoking increases chance of cancer’ was modified to ‘If you have 
HPV, smoking can increase your chance of cancer’ as the researcher 
was specifically interested in women’s views about smoking and its 
relationship with HPV and cancer rather than smoking more broadly 
 ‘HPV goes away with the right treatment’ was modified to ‘women 
often clear HPV without treatment’ as there was no measure in the 
original scale that assessed whether women thought it was possible to 
clear the virus spontaneously, which was deemed important by the 
researcher to assess. 
The HPV vaccination attitude scale was constructed prior to the 
implementation of the National HPV Vaccination Program (NHPVP), therefore, 
inappropriate items were removed and the scale was made gender specific as the 
vaccine was only publicly funded for females (NCSP, 2007a; Pitts et al., 2007).  This 
tool contained eight items relating to vaccination in general and six items relating to 
HPV vaccination.   
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Table 4.1  Content of Questionnaire and Sources Used 
Research questions Items in Survey Instrument Source of Items 
What do Queensland women know 
about cervical cancer/screening and 
does this differ by socio-
demographic factors or cervical 
screening history? 
 Cervical cancer/screening 
knowledge tool: 
 women’s knowledge about 
cervical cancer/screening 
(six items)  
 socio-demographic factors 
 cervical screening history 
(Pitts and Clarke, 2002; 
CSSU, 2005)  
 
 
 
(CSSU, 2005) 
(Christie, Gamble and 
Creedy, 2005; CSSU, 
2005) 
   
How many Queensland women 
have heard of HPV, where did they 
hear about it and does this differ by 
socio-demographic factors, cervical 
screening history cervical 
cancer/screening knowledge? 
 heard of HPV 
 socio-demographic factors 
 cervical screening history 
 cervical cancer/screening 
knowledge 
 
(Pitts and Clarke, 2002) 
 
 
   
What do Queensland women know 
about HPV and does this differ by 
socio-demographic factors, cervical 
screening history, cervical 
cancer/screening knowledge, 
awareness and attitudes? 
 HPV true/false knowledge 
scale 
 8 items re HPV  
 socio-demographic factors 
 cervical screening history 
 cervical cancer/screening 
knowledge 
 HPV vaccine awareness 
 General vaccine attitude scale 
 HPV vaccine attitude scale 
(Kahn et al., 2003) 
 
 
 
 
 
 
 
(Pitts et al., 2007) 
   
How many Queensland women 
have heard of HPV vaccine, where 
did they hear about it and does this 
differ by socio-demographic 
factors, cervical screening history 
cervical cancer/screening 
knowledge or awareness? 
 heard of HPV vaccine 
 where heard about HPV 
vaccine 
 socio-demographic factors 
 cervical screening history 
 cervical cancer/screening 
knowledge 
 HPV awareness 
(Pitts and Clarke, 2002) 
 
 
 
 
   
What are Queensland women’s 
attitudes towards HPV vaccination 
and does this differ by socio-
demographic factors, cervical 
screening history cervical 
cancer/screening knowledge, 
awareness or attitudes? 
 6 item scale attitudinal scale  
 socio-demographic factors 
 cervical screening history 
 cervical cancer/screening 
knowledge 
 HPV awareness 
 HPV vaccine awareness 
 General vaccine attitudes 
(Pitts et al., 2007) 
 
An additional two items developed for the tool, were unintentionally omitted 
prior to the survey being conducted due to an administrative error.   
 One item was added “The HPV vaccine works best when it is given before a 
young woman becomes sexually active” to explore if women were aware this 
was the reason the vaccine is targeted at 12 to 13 year old girls.   
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 As the majority of women in the study were not eligible to receive the publicly 
funded vaccine, due to age, questions were also modified to assess women’s 
acceptability of the vaccine within the context of providing consent for a child.  
This was framed as a hypothetical question: “If I had a 12 year old daughter....” 
so all women were eligible respondents.   
 The two items omitted accidently were “The HPV vaccine will prevent a high 
number of women from developing cervical cancer” and “Pap smears are not 
necessary if a woman has been vaccinated against HPV”.  To overcome this 
omission, these aspects of HPV vaccination were explored in Phase 2 of the 
study. 
Women participating in the survey completed all screening knowledge and 
vaccination attitude items.  Only women who responded they had heard of HPV were 
asked to respond to HPV knowledge items.   
Women were asked about their attitudes towards vaccination in general before 
completing the HPV vaccination scale to determine if any resulting differences in 
attitudes were specific to the HPV vaccine.  The following information was read out 
to participants prior to the HPV vaccination items being asked to ensure all women 
participating in the study could answer the HPV vaccination attitude questions, 
irrespective of whether they had previously heard of the vaccine or not:  “A vaccine 
has been developed against two types of the virus, HPV or human papillomavirus 
that cause up to 70% of cervical cancer.  This free cervical cancer vaccine is 
primarily targeted at girls aged 12 to 13 years of age who are attending school”.  
This statement also provided clarity for respondents that the HPV vaccine and 
cervical cancer vaccine were one and the same. 
The resulting Cervical Cancer/Screening and HPV Knowledge Tools and 
Vaccination Attitudes Scales are outlined in Appendix H.  Demographic information 
and cervical screening history questions were adopted from previous Queensland 
CATI surveys conducted by the QCSP. 
4.3.1 Validity of Survey Instruments 
Content validity 
Content validity is concerned with the sampling adequacy of the content area 
being measured and assesses how representative the questions on the test are of all 
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the questions that might be asked about the topic (Polit and Hungler, 1991).  Content 
validity of the instruments used in this survey was determined by two methods 
recommended in the literature, a) using questions and variables on similar topics that 
have been used in other studies, following a review of the literature and, b) through 
subject matter expert judgment (Cheng, 2009; Aday and Cornelius, 2006).  As 
described in Table 4.1, the questions used to measure cervical cancer/screening and 
HPV knowledge and the vaccination attitude scales were derived from previous 
studies with minor modifications.   
Content validity was also assessed during the development of the 
questionnaire.  Two experts were asked to review the items included in the 
knowledge instruments and provide validation of the items and responses used in 
these tools.  The knowledge items were confirmed as accurate by these two experts 
who were: 
 Dr Ian Hammond, Gynaecologist/Oncologist and Chairperson of the NCSP 
Review Committee for the National Health and Medical Research Council 
Guidelines for the Management of Women with Screen-detected Abnormalities 
Committee and the NCSP Renewal, and, 
 Dr Caroline Harvey, Medical Director, Family Planning Queensland and 
Chairperson of the QCSP Quality Management Committee.  
The instruments used in the CATI survey had not been validated in any of the 
original studies from which they were sourced and validation of these instruments 
was outside the scope of this study and is discussed further in the limitations section 
of this thesis (Section 9.3). 
4.4 PROCEDURE AND TIMELINE 
The CATI survey was conducted by an independent marketing agency, I-View 
Pty Ltd, engaged by Queensland Health.   
Survey preparation 
The Print Media and HPV Questionnaire (CATI survey) was developed by the 
researcher in collaboration with Ms Margaret Bright, an epidemiologist employed by 
Queensland Health.  The component of the CATI survey designed to address the 
questions in this study was developed solely by the researcher.   
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As the CATI survey was developed for two specific purposes, two Queensland 
Health staff with extensive expertise in the design of CATI surveys, Ms Margaret 
Bright and Dr Gayle Pollard then reviewed the content and flow of the instrument.  
The ordering of questions was modified to optimise women’s responses and provide 
a logical progression through the survey.  Once this was finalised, briefings were 
held with staff from I-View Pty Ltd to specify the requirements for data collection 
who engaged an interview team to conduct telephone interviews and the following 
assurances were given: 
 a dedicated project and supervisory team were allocated to the project 
 due to the sensitive nature of the topic, only female interviewers with a good 
track record of performance were engaged for the survey 
 all interviewers participated in a compulsory training, which encompassed 
six hours of theory, two hours (or more) of practical interviewing (live but 
not with a real client) and a two hour debriefing session following practice 
interviewing.   
The content of the training program included:  
 background to the study including relevant terminology 
 an overview of the questionnaire structure and purpose of each section so 
that interviewers gained confidence, spontaneity and familiarity with all 
survey materials 
 question by question coverage with techniques for probing as relevant 
 key code frames 
 participation maximisation techniques including correct use of survey 
introduction and how to handle difficult questions to ensure interviewers 
were able to respond with knowledge and conviction regarding the survey 
purpose whilst ensuring sensitivity to the needs of respondents 
 call procedures and sample management issues 
 protocols for telephone interviewing 
 query resolution and problem escalation procedures 
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 role play and practice surveys (I-View Pty Ltd, 2008). 
To ensure high quality of the interviews, interviewers were monitored for their 
first 10 real interviews.  In these interviews, the supervisor guided or advised the 
interviewer without the respondent being aware of the conversation.  The overall 
performance of each interviewer was also monitored during the telephone surveys 
and included daily monitoring by the project supervisor on the following: 
 refusal rates 
 probing techniques 
 correct use of “other specify” codes 
 incidence of use of “refusal” and “don’t know” codes at the question level 
 adherence to training guidelines and survey procedures 
 comprehensiveness of call history notations (I-View Pty Ltd, 2008). 
In addition, observation by remote listening device and validations through 
respondent re-contact and/or using remote listening equipment was conducted to 
validate 10% of the overall proportion of any interviewers’ workload (I-View Pty 
Ltd, 2008). 
These quality measures were reported to be higher than the standards set by 
Interviewer Quality Control Australia (IQCA) and interviewer training was also 
reported as beyond the guidelines set by the IQCA and the Australian Standard 
AS4752  (I-View Pty Ltd, 2008).  In addition, I-View adhered to the Privacy 
Principles as per the Federal Government’s Privacy Act and was accredited as 
meeting industry standards including the AS4752 and Australian Market and Social 
Research Society. 
The questionnaire was pilot tested by the CATI facility to test the content, flow 
and average completion time.  Thirty two surveys were conducted to pilot the 
instrument and there were no issues identified.  It was estimated during the pilot 
study that the average length of time to complete the survey was between 15 and 20 
minutes.  
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Call Routine 
The first attempt to contact women was made between 5pm and 8pm weekday 
evenings and between 10am and 5pm on weekends.  If this time was not convenient, 
a suitable time to call back was agreed.  Set protocols were in place for the following 
outcomes: 
 no answer or answering machines – delay two hours before re-issued to 
interviewers 
 at start of a new shift, no-answers from previous evening were randomly 
scattered over the 3.5 hour period to avoid the majority of them being 
allocated early in the shift 
 engaged numbers were delayed 15 minutes before re-issuing. - if engaged 
three times in a row, the number was not re-issued until one hour had passed 
 call back appointments were issued to the appointment making interviewer 
no more than 5 minutes before they became due or to other interviewers one 
minute after they became due 
 pre-dialled numbers were prioritised over unattempted numbers as follows: 
1. ‘hard’ appointments – time scheduled for return call 
2. ‘soft’ appointments – non-specific time made for return call or another 
household member suggested time to call when required person would be 
home 
3. engaged 
4. no-answer/machine 
5. numbers not yet attempted (I-View Pty Ltd, 2008). 
Timeline 
The CATI survey was conducted between June 22 and June 29 2008 to meet 
timeframes relevant to the QCSP Social Marketing Campaign.  The campaign was 
due to be aired again in July 2008 and it was important to gather data to inform a 
mid-term evaluation of the campaign prior to the next round of advertising.   
 Chapter 4: Research Design Phase 1 62 
4.5 QUANTITATIVE DATA ANALYSIS 
Phase 1 was analysed first and used formatively to guide and inform phase 2 of 
the study. 
4.5.1 Data Coding and Consistency Checking  
I-View Pty Ltd provided raw data to Queensland Health.  The coding 
framework was provided to the CATI facility with the original survey.  This data was 
provided with some back coding of ‘other - specifies’, which were assessed by the 
Coding Manager.  Additional codes were added to the existing code framework 
following approval by the Queensland Health team, including the researcher, for 
questions where multiple responses of a similar nature were provided by women that 
did not fit within the existing codes.  The CATI facility developed the questionnaire 
to include built-in response validation and verification to prevent out of range or 
illogical responses, which was tested prior to fielding (I-View Pty Ltd, 2008). 
In addition, the SPSS data file was cross checked by the I-View project team 
with the original data source (I-View Pty Ltd, 2008).  A two-stage output editing 
process was undertaken by the CATI facility.  Firstly a comprehensive computerised 
range and logic checks of the survey data was undertaken, which was followed by a 
detailed examination of survey frequencies to check the structure of survey data and 
the accuracy of any derived variables (I-View Pty Ltd, 2008). 
Researcher Data Cleaning 
Once the data file was received at Queensland Health, additional data cleaning 
was conducted.  This included: 
 range checks for all variables were conducted whereby none were found to 
contain out of range or invalid values 
 recoding “other specifies’ in variables where there were multiple responses 
that could be assigned to a specific category by the researcher who had 
content expertise 
 variables were refined/constructed as outlined in Section 4.5.3 
 additional consistency checks were undertaken and included: 
 refined/reconstructed variables were checked using cross-tabulations 
to assess for errors and were adjusted accordingly and rechecked. 
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4.5.2 Variable Definitions 
The variables and how they were derived are described in this section as they 
relate to each research question.  The research questions were previously outlined in 
Section 6.2. 
Outcome (dependant variables) 
Cervical cancer/screening knowledge was measured using a number of items 
that together formed the Cervical Cancer/Screening Knowledge Tool (Appendix H).  
The highest possible total score for the Cervical Cancer/Screening Knowledge Tool 
was 13 points (range 1–13).  Awareness of HPV was measured by asking women if 
they had heard of HPV (yes/no/don’t know). 
HPV knowledge was measured using the HPV Knowledge Tool (Appendix H).  
The highest possible score for the tool was 12 (range 0–12).  Awareness of the HPV 
vaccine was ascertained by asking women if they had heard of the HPV vaccine 
(yes/no/don’t know) and where they had heard of it (multiple responses permissible).   
Attitudes towards HPV vaccination was measured using the modified  
Victorian CATI survey attitude scale which contained six items (Pitts et al., 2007).  
This tool also contained eight items relating to vaccination in general, which were 
chosen as an outcome variable of interest to determine whether women’s attitudes 
were consistent with vaccination in general or specific to the HPV vaccine.  Attitude 
scores were compiled to form a score; the highest score was six (range 0–6) and eight 
(range 0–8) for HPV vaccination and general vaccination attitudes respectively, 
which were then converted to positive and negative attitudes. 
Explanatory (Independent Variables) 
Independent variables relevant to the study included socio-demographic 
factors, cervical screening history, awareness of HPV and the HPV vaccine, HPV 
vaccination status, cervical cancer/screening knowledge and general vaccination 
attitudes.  These variables and their definitions are outlined in Appendix G. 
Socio-demographic factors included age, location of residence, socioeconomic 
status, whether Australian born, Indigenous status, educational attainment, marital 
status, parity and smoking status.  These variables were included as items of interest 
as they have been linked with lower participation in cervical screening or cervical 
cancer/screening knowledge in the literature (Section 2.2.1).  Locality was measured 
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by collecting participants’ postcode, which was then mapped to local statistical areas 
(SLAs) using concordance tables provided by the Epidemiology Team at the QCSP.  
These tables are used to determine SLAs for the purposes of reporting cervical 
screening participation by locality using Queensland PSR data.  These SLAs were 
then mapped to the Australian Standard Geographical Classification (ASGC) as used 
by the Australian Bureau of Statistics (ABS) for the collection and dissemination of 
geographically classified statistics.  The ASGC was chosen as this was the 
classification system used for PSR reporting purposes at the time the study was 
undertaken (ABS, 2006a).  
Socio-economic status (SES) was also measured by collecting participants’ 
postcode and was mapped to the SEIFA, index of socioeconomic disadvantage by the 
CATI facility and provided in deciles and quintiles of relative disadvantage (ABS, 
2006b).  SEIFA measures relative advantage and disadvantage at an area level, not at 
an individual level and depends on the socio-economic conditions of a community or 
neighbourhood as a whole, such as indicators of income, education or employment 
and may include characteristics of the area itself, such as a lack of public resources, 
transport infrastructure or high levels of pollution (ABS, 2006c). 
Employment status and income were collected in the “Print Media and HPV 
Questionnaire” but were not used as markers of SES given women were assigned to 
SEIFA categories by residence as individual women’s SES was less relevant to this 
study than community data given the results are to inform population screening 
policy.  Educational attainment was ascertained by measuring three items, the highest 
level of schooling, if further qualifications were attained and what these were. 
Cervical screening history included cervical screening status and a history of 
having experienced an abnormal Pap smear.  Participant’s cervical screening status 
was determined by looking at the usual time intervals women reported having Pap 
smears in combination with when they reported having their last Pap smear.  
Underscreened women were defined as those who screened less frequently than the 
recommended screening interval and for the purposes of this study were defined as 
women who had not had a Pap smear for more than three years, regular screeners had 
a Pap smear every two years and overscreeners reported having Pap smears more 
frequently than every two years.  These variables were of interest to determine if 
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screening status or a history of an abnormal Pap smear were linked to knowledge and 
attiudes. 
Awareness of HPV and awareness of the HPV vaccine were used as 
independent or dependent variables according to the research question of interest as 
was cervical cancer/screening knowledge.  HPV knowledge was not used as an 
independent variable as it was made redundant by HPV awareness given women who 
had not heard of HPV did not complete it.  Finally, general vaccination attitudes 
were included as an independent variable in the analysis of HPV vaccination 
attitudes. 
4.5.3 Variable Derivation 
A number of continuous variables were converted to categorical variables and 
some categorical variables were collapsed into either dichotomous variables or into 
smaller groups.  The rationale for these modifications is described in this section and 
provided in summary in Appendix I. 
Age was collected as a continuous variable and converted into a categorical 
variable of 10 year age groups to enable meaningful comparisons between age 
groups and consistency with groupings used for reporting cervical screening 
participation rates.  A few respondents did not respond to this question and were 
asked by the interviewers for their date of birth.  Their age was calculated by 
subtracting this date from the date the survey was conducted. 
Locality was originally classified into five categories; however to avoid 
violation of the assumption of expected frequencies for the Chi square test during 
bivariate analyses and to maximise power in multivariable analysis, the remote, very 
remote locality categories were combined with the outer regional category.  
Socioeconomic status quintiles of most socioeconomic disadvantage were used 
without any changes to the coding provided from the CATI facility. 
‘Don’t know’ and ‘refused to answer’ were possible categories in the 
remaining socio-demographic, screening history and awareness questions.  These 
were infrequent responses and were combined with ‘no’ responses.  Only one person 
answered ‘don’t know’ when asked about educational attainment and was excluded 
from the analysis, as it was not considered appropriate to assume the educational 
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status of this respondent and the sample size was large enough that it would have no 
impact on power in the analysis. 
Educational status was measured by combining three variables into one, 
grouped to form the categories, ‘less than year 10’, ‘years 10 to 12’ schooling, 
‘certificate or diploma’ and ‘bachelor degree or higher’.  Respondents who indicated 
they had not completed a higher qualification were categorised by their level of 
schooling whilst those who indicated they had, were categorised by their highest 
qualification completed.  Marital status was collapsed into four categories – never 
married; married; defacto; separated, divorced and widowed to maximise power in 
the analysis due to small numbers in the separated, divorced and widowed categories.   
Cervical screening status was derived by combining the variables, usual time 
between Pap smears and time since last Pap smear.  These categories were not 
modified prior to combining into the one variable, although some women were 
assigned to an ‘other’ category.  This category was used for women who indicated 
they had never had a Pap smear as they did not answer this question in the survey; 
had only ever had one test or were too young to have been eligible for further 
screening according to the NCSP policy or did not screen regularly but had had a Pap 
smear in the previous two years.  Women’s age was also taken into account in the 
development of this variable.  Women who were over 23 years of age who reported 
they had only ever had one Pap smear or did not screen regularly were assigned to 
the category ‘underscreened’.   
The categories for smoking status were reclassified from categories, ‘I smoke 
daily’, ‘I smoke occasionally,’ ‘I don't smoke now but I used to’, ‘I've tried it a few 
times but I never smoked regularly’ or ‘I’ve never smoked’ to a dichotomous 
variable of current smoking status in which the first two categories were classified as 
‘yes’ and all other categories ‘no’. 
Cervical cancer/screening knowledge scores were derived by allocating a score 
of ‘1’ to the correct answer in each item about the purpose, recommendations and 
meaning of an abnormal result and combining this with the number of correct 
responses in the risk factor item.  Incorrect answers and responses of ‘don’t know’ 
scored ‘0’ (Appendix H).  Study participants’ cervical cancer/screening knowledge 
scores were converted into a dichotomous categorical variable of knowledge levels 
using above and below average (mean) knowledge scores.   
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HPV true/false knowledge items were converted to a summary knowledge 
score by allocating correct answers a score of ‘1’.  HPV knowledge scores were also 
converted into a dichotomous categorical variable of knowledge levels using above 
and below average (mean) knowledge scores.   
 
Table 4.2. Possible Confounders of the Relationship between Dependent and 
Independent Variables of Interest 
Independent variable Possible confounder 
Age Education, marital status, parity, smoking status, screening 
status, history of previous abnormalities 
Locality  Screening status 
Socio-economic status Education, marital status, parity, smoking status, screening 
status 
Australian born Education, marital status, parity, screening status  
Educational  attainment Age, parity 
Marital status Age, parity 
Parity Age, marital status 
Smoking status Age, education, marital status, parity 
Screening status Age, geographic location, SES 
History of previous abnormalities Age, screening status, smoking status 
Cervical cancer/screening knowledge Age, screening status, country of birth, history of previous 
abnormalities 
HPV awareness Age, screening status, country of birth, history of previous 
abnormalities 
HPV knowledge Age, country of birth 
HPV vaccination awareness Age, screening status, country of birth, 
General vaccination attitudes Age, screening status, country of birth 
HPV vaccination attitudes Age, country of birth 
 
An overall score for vaccination attitudes was ascertained by allocating a score 
of ‘1’ to positive scores to vaccination statements whilst negative statements scored 
‘0’ (Appendix H).  Neutral, ‘don’t know’ and ‘refused’ responses scored ‘0’ which is 
consistent with the method used by Pitts et al (2007).  Scores were converted into a 
dichotomous categorical variable, namely positive and negative attitudes, with 
negative attitudes representing all responses that were not positive including 
uncertainty.  Positive scores were those above three (central score of the scale) and 
negative scores were three and below.  
Knowledge and attitude scores were converted into dichotomous categorical 
variables - below and above average knowledge levels and positive and negative 
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attitudes as these outcomes were deemed to be of greater clinical relevance for the 
purposes of this study.  Identifying groups of women with above average and below 
average knowledge or those with postive and negative attitudes was considered more 
meaningful within the context of the researcher’s area of practice as a public health 
practitioner than measuring these outcomes continously.   
The conversion of attitude scores to positive and negative attitudes is also 
consistent with the method used by Pitts et al (2007) and therefore enabled 
comparisons to be made between relevant items in the two studies. 
Multiple checks using cross-tabulations were undertaken following the 
groupings of variables to ensure the validity of the recoding and transformation of 
variables. 
4.5.4 Confounding Variables  
Confounding occurs when a relationship between a dependent and an 
independent variable occurs in whole or in part due to a third factor that is associated 
with both variables (Webb, Bain and Pirozzo, 2005).  The potential for confounding 
of variables described in the explanatory variables section, such as age and 
education, marital status, parity and screening history, have been identified in the 
literature and are summarised in Table 4.2.  Multivariable modelling was used to 
adjust for potential confounding of the relationships between independent and 
dependent variables. 
4.6 STATISTICAL METHODS 
Analysis of data collected from the CATI survey was performed using the 
Statistical Package for the Social Sciences (SPSS) Version 16.  
4.6.1 Representativeness 
Representativeness of the sample was considered by comparing participant 
characteristics for age, Australian-born, marital status, parity, highest level of 
schooling and post school qualifications with the 2006 Census of Population and 
Housing (ABS, 2006).  Other characteristics, such as locality, SES, Indigenous status 
and smoking status, were compared with the Queensland Health Omnibus Survey 
data (Queensland Health, 2008).  The marital status of women in the sample could 
not be directly compared to the Queensland population due to differences in the 
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categorisation of marital status between the two groups, specifically defacto 
relationships.   
Data was received from the CATI facility unweighted; therefore weighting was 
applied to take into account the oversampling by socio-economic disadvantage and 
the quotas set for age.  The raw data was adjusted to reflect the socio-economic and 
age profile of the ‘benchmark population’, namely, the Estimated Residential 
Population for Queensland 2006 based on results from the 2006 Census of 
Population and Housing.  The weighting variable was provided to the researcher by 
the Queensland Health Epidemiology Team as this had also been applied to the 
QCSP Social Marketing Campaign component of the CATI survey.  Application of 
the weighting variable resulted in a decrease of sample size from 1002 to 999.   
Some variables, such as Indigenous (yes = 26; 3.2%) and HPV vaccination 
status (yes = 112; 13%), were excluded from bivariate and multivariate analysis due 
to the small numbers in these categories which would impact on the reliability of 
results due to lack of power.   
As HPV knowledge was made redundant by HPV awareness as an independent 
variable, that is, only women who were aware of HPV answered the knowledge 
items, these variables were assessed separately in bivariate and multivariate analysis 
with cervical cancer/screening knowledge, HPV vaccination awareness, general 
vaccination and HPV vaccination attitudes.   
4.6.2 Testing Assumptions for Tests and Models 
Appropriate assumption testing was applied prior to conducting bivariate and 
multivariable tests and models.   
When continuous scores were described for knowledge and attitude scores, the 
assumption of normality was established before means and standard deviations were 
derived.  Normality was established using the following criteria: 
 means within 10% of median 
 minimum and maximum are approximated by the mean + 3sd 
 skewness and kurtosis both within + 3 
 a roughly symmetrical histogram (Battistutta, 2010a). 
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Assumptions behind bivariate and multivariable test/models were also checked.  
Assumptions for the appropriate use of the Chi-square test were tested: 
 all expected cell counts were greater than five or categories were collapsed 
to meet this assumption as necessary (for example, locality) 
 the sample was randomly selected so there was independence of 
observations.  
Each participant came from a randomly sampled household across Queensland.  
It was therefore unlikely that selected households would influence each other with 
respect to cervical cancer/screening knowledge, HPV knowledge, awareness of HPV 
and the HPV vaccine and attitudes towards HPV vaccination. All categories were 
mutually exclusive with the exception of HPV awareness and HPV knowledge, 
which were not included together in any bivariate analysis or models. 
Prior to multivariable modelling testing for multicollinearity was undertaken to 
ensure none of the independent variables were measuring the same concept as this 
makes it difficult to assess the individual performance of an indicator (Field, 2009).  
A strong correlation between two or more variables in the model was not anticipated, 
nor present when assessed.  To prevent violation of the assumption of 
multicollinearity, known or suspected correlated independent variables in the model 
were tested by obtaining collinearity diagnostics for each model and obtaining 
tolerance and variance inflation factor (VIF) statistics as described by Field (2009).  
There were no tolerance values less than 0.1, nor VIF values greater than 10 found in 
any models (Appendix J).  Eigenvalues of the scaled, uncentred cross-products 
matrix were also considered acceptable with no large values identified and so all 
variables were retained in the models. 
4.6.3 Criteria Used for Reporting Significant Associations 
Significance testing was undertaken and results were determined to be 
statistically significant different at the pre-defined 5% significance level with a 95% 
confidence interval.  Clinical significance was defined for differences between 
cervical cancer/screening knowledge scores, HPV knowledge scores and vaccination 
attitude scores based on the findings of previous studies (Hancock et al., 1996; Pitts 
and Clarke, 2002).   
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As outlined in Section 4.2, sample sizes were originally calculated based on 
differences in mean knowledge scores; however it was decided to convert these 
scores into dichotomous categorical variables - below and above average knowledge 
levels and positive and negative attitudes as these outcomes were deemed to be of 
greater clinical relevance for the purposes of this study, and the planning of changes 
relevant to the QCSP.  
A difference of greater than 10% in the proportions of women in one group 
(e.g. younger women) achieving above average cervical cancer/screening and HPV 
knowledge levels and attitudes towards the HPV vaccine when stratified by 
independent variables was determined to be clinically significant.  These parameters 
were also applied to HPV and HPV vaccination awareness. 
4.6.4 Analysis of Correlates of Independent Variables 
Bivariate Analysis 
Bivariate analysis was undertaken to explore the relationships between 
knowledge and attitude scores and participant characteristics.  This was done using 
crosstabulation of frequencies and percentages and the Likelihood chi-square test for 
dichotomous categorical independent variables.  Bivariate results are provided in 
Appendix K. 
Multivariable Analysis 
As the study was non-experimental in design, a multivariable modelling 
approach was chosen to permit consideration of a range of factors already established 
to be associated with differences in knowledge and attitudes about cervical 
cancer/screening, HPV and the HPV vaccine.  As the main outcome variables were 
dichotomous categorical variables and all independent variables were also 
categorical variables, binary logistic regression was chosen for multivariable 
modelling. 
This assisted with determining significant relationships between variables and 
in identifying confounding variables.  Modelling was conducted to control for 
confounding between variables that have been explored in multiple studies about 
cervical cancer/screening knowledge, HPV knowledge and attitudes towards the 
HPV vaccine as previously identified (Sections 2.4.1, 2.4.2 and 2.5.3).   
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Referent groups were chosen based on those factors that have been linked with 
increased risk for cervical cancer or decreased participation in cervical screening as 
identified in the literature (Table 4.3).   
Independent variables were entered into each model by forced entry as this was 
an exploratory study (Field, 2009).  In all models, non-significant variables were then 
removed.  Each level of influence within the model was assessed using a pseudo-R
2 
statistic (Nagelkerke’s) to determine the relative contribution of each independent 
variable within the model. 
The effect size of some variables changed from the crude to the adjusted 
relationship.  Suspected confounding factors were removed from the final model one 
at a time and then returned.  A shift in the odds ratio of greater than 10% was 
assumed to explain the shift in effect size following adjustment.  
Table 4.3. Referent Variables Chosen for Multivariable Models 
Variable Referent Category  
Age  20–29 years 
Locality outer regional, remote, very remote 
Socioeconomic status quintile 1 
Australian born no 
Educational attainment year 10 or below 
Marital status never married 
Had children no 
Smoking status yes 
Screening status underscreened 
Abnormal Pap history yes 
Cervical cancer/screening knowledge below average 
HPV awareness no 
HPV vaccination awareness no 
General vaccination attitudes negative 
 
The best goodness of fit in all models as determined by the R
2 (Nagelkerke’s) 
was highest when all potential confounding variables were included.  Each final 
model therefore included all variables. 
Interactions between screening status and age, screening status and abnormal 
Pap smear and age and abnormal Pap smear were tested one at a time in the cervical 
cancer/screening knowledge model to assess for effect modification; however 
insufficient power in the model was reflected with large standard errors and wide 
confidence intervals and these interactions are not reported and were not tested in 
subsequent models.   
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The key findings relevant to the aims of Phase 1 as described in Section 4.1 are 
described in the next chapter, ‘What Queensland Women Know about Cervical 
Cancer/Screening, HPV and the HPV Vaccine’. 
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Chapter 5: What Queensland Women Know 
about Cervical Cancer/Screening, 
HPV and the HPV Vaccine 
This chapter describes the research findings from Phase 1: the quantitative component 
of the study, a computer-assisted telephone interview (CATI) survey of 1002 Queensland 
women.  The characteristics of women who participated in the survey are firstly described 
(Section 5.1), followed by women’s cervical screening history in Section 5.2.  The 
knowledge amongst participants in the survey about cervical cancer/screening (Section 5.3), 
awareness of human papillomavirus (HPV) (Section 5.4) and HPV knowledge (Section 5.5) 
is then outlined and the chapter concludes with Section 5.6, which describes women’s 
awareness and attitudes towards HPV vaccination. 
The secondary research questions and hypotheses to be tested in Phase 1 of the study 
are described in Section 4.1. 
5.1 SAMPLE CHARACTERISTICS AND REPRESENTATIVENESS 
5.1.1 Response Rate 
The response rate achieved for the survey as defined by the CATI facility was 76.9%, 
which was calculated as follows: (interviews + non qualifiers) / (interviews + non qualifiers + 
refusals) where there were 1002 interviews, 2730 non qualifiers (no women in household 
aged 20–69 years + respondent had hysterectomy) and 1123 refusals (I-View Pty Ltd, 2008).  
If non-qualifiers are excluded from these calculations the response rate calculated as follows:  
interviews / (interviews + refusals) was 47.2%. 
5.1.2 Socio-demographic Characteristics of Study Participants 
The mean unweighted age of study participants was 42.6 years (SD 13.03) with the 
majority of women aged between 30 and 49 years (47%).  Most women lived in major cities 
(40%) and lived in the area of most socio-economic disadvantage (26%).  Study participants 
were also more likely to be Australian born (82%) and non-Indigenous Australians (97%), be 
married (62%) and have had children (80%).  The majority had attended school beyond Year 
10 (63%) and had completed a post school qualification (64%), which was most commonly 
identified as a diploma or certificate and report they were not current smokers (79%).   
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Table 5.1. Characteristics in a Community Sample of 1002 Women, Queensland, 2008 
Socio-demographic Characteristics  
UNWEIGHTED WEIGHTED  
N = 1002 % N=999 % % (QLD) 
Age (10 year age groups)      
20–29 197 19.7 249 24.9 20.61 
30–39 238 23.8 260 26.0 22.9 
40–49 231 23.1 230 23.0 23.2 
50–59 212 21.2 164 16.5 20.1 
60–69 124 12.4 96 9.6 13.3 
Locality      
remote,very remote 33 3.3 30 3.0 2.4
2 
outer regional 237 23.7 223 22.4 17.4 
inner regional 326 32.5 296 29.7 26.7 
major cities 406 40.5 450 45.0 53.5 
Socio-economic Status      
quintile 1 (most disadv) 257 25.6 176 17.6 12.5
2 
quintile 2 234 23.4 184 18.4 21.5 
quintile 3 120 12.0 152 15.2 26.9 
quintile 4 159 15.9 194 19.4 23.0 
quintile 5 (least disadv) 232 23.2 294 29.4 16.1 
Country of Birth      
United Kingdom (UK)  52 5.2 48 4.8 6.4
1 
New Zealand (NZ) & Oceania 46 4.6 46 4.6 5.2 
Other 84 8.4 91 9.1 17.8 
Australia  820 81.8 814 81.5 70.6 
Aboriginal or Torres Strait Islander      
yes 26 3.2 26 3.2 2.9
2a 
no 793 96.7 787 96.7 97.1 
refused to answer 1 0.1 1 0.1 – 
Highest level completed at school      
never attended  4 0.4 3 0.3 0.5 
less than year 10 75 7.5 59 5.9 13.8 
year 10 or equiv  292 29.1 261 26.1 29.0 
greater than year 10 627 62.6 673 67.4 46.8 
don’t know/not stated 4 0.4 4 0.4 10.0 
Post school qualifications 
b 
     
yes 637 63.6 653 65.3 44.5
1 
no 365 36.4 346 34.6 54.8 
Post school qualifications - stated      
certificate or diploma 415 65.1 402 61.5 34.1
1
 
bachelor degree or higher 216 33.9 245 37.5 10.4
 
don't know/ not stated 6 0.9 6 0.9 – 
Educational attainment      
year 10 or below 201 20.1 175 17.5  
year 11or 12 165 16.5 173 17.3  
certificate or diploma 417 41.7 404 40.5  
bachelor degree or higher 217 21.7 246 24.7  
Marital status 
c 
     
never married 116 11.6 141 14.1 33.3
1;d 
married 625 62.4 595 59.5 55.1 
defacto 146 14.6 167 16.7 11.6 
separated/divorced/widowed 115 11.5 97 9.7 – 
Children      
no 201 20.1 242 24.2 25.8
1 
yes 801 79.9 757 75.8 68.5 
Smoking Status      
current smoker 210 21.0 206 20.6 21.8
3 
past smoker 241 24.1 236 23.6 26.4 
never smoked regularly 550 54.9 556 55.6 51.8 
refused to answer 1 0.1 1 0.1 0.0 
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Table 5.1 continued 
 
1. Source: Australian Census 2006 (ABS, 2006a) 
2. Source: Queensland Health Info Bank (Queensland Health, 2011) 
3 Source: Queensland Health Omnibus Survey (Queensland Health, 2008) 
a Age range in source database - 20 to 64 years 
b  Age range 15 years and over 
c Age range in source database – 20 to 74 years 
d Category is’ not married’ and includes separated/widowed/divorced 
 
Characteristics of study participants are outlined in Table 5.1 and have been presented 
unweighted and weighted and, where available, have been compared to women in the 
Queensland population as a whole.   
5.1.3 Representativeness 
When compared to the Queensland population (Table 5.1), the sample prior to 
weighting was similar by age across all 10 year age categories, Indigenous status and 
smoking status.  As designed, the sample was under-representative of those living in major 
cities and quintiles 3 and 4 and over-representative of women living in inner and outer 
regional and remote areas and quintile 1.  There were a higher number of women in the 
sample born in Australia (82%) compared to the Queensland population (71%) and a higher 
proportion of women in the sample who had children (80%).  Study participants were more 
likely to report they had attended school beyond Year 10 and completed post school 
qualifications.   
The marital status of women in the sample could not be directly compared to the 
Queensland population due to differences in the categorisation of marital status between the 
two groups, specifically in relation to the categories never married and not married.  Due to 
the differences between the sample and the Queensland population, the findings are not fully 
generalisable to the Queensland population with respect to location, socio-economic status 
(SES), country of birth, education, marital status and parity. 
When the weighting variable was applied, the mean age of participants was 40.1 years 
(SD 12.92) and the sample was more representative by locality, SES, having children, similar 
by Indigenous status, country of birth, post school qualifications and smoking and slightly 
less representative by education and age, the latter which was an effect of the weighting for 
SES when combined with the weight applied for age.  All results presented in the remainder 
of this chapter are weighted for age and SES. 
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5.2 CERVICAL SCREENING HISTORY 
To ascertain women’s cervical screening history, study participants were asked about 
their previous experience of screening, including how regularly they had Pap smears, how 
many previous Pap smears they had, when they last had a Pap smear and if they had ever had 
an abnormal Pap smear in the past.  The following section describes women’s screening 
history and describes factors associated with women’s screening status or history of a 
previous abnormal Pap smear. 
5.2.1 Personal Cervical Screening History 
The majority of study participants (96%) had had at least one Pap smear prior to 
completing the survey with two respondents indicating they did not know about the test.  
Most women who had never had a Pap smear (n=36) were less than 30 years of age and the 
majority of these women, when this category was explored further, were aged less than 25 
years (n=28) as highlighted in Figure 5.1.  Eighty-four percent of women said they had a Pap 
smear every two years or less, with most women (77%) reporting their last Pap smear was 
within the previous two years.  Just over three percent of respondents reported they had not 
had a Pap smear for five or more years (Table 5.2).  When compared with Queensland Pap 
Smear Register (PSR) data, the proportion of women in this study who reported they had had 
a Pap smear within the two year reporting period of 2007/08 was much higher.  The state-
wide participation rate for the target age group of women aged 20 to 69 years in Queensland 
was 57.9% in 2007/08 compared to 84% of women in this study (QCSP, 2012).  This 
suggests women who consented to participate in this study were either more likely to have 
regular Pap smears than women in the general population, or had under-estimated the length 
of time that had lapsed since their last Pap smear.  The implications of screening status on the 
findings of this study are discussed further in Section 9.3.2. 
Seventy-one percent reported the usual time between their Pap smears was greater than 
one and less than two years, whilst only two percent reported they did not have regular Pap 
smears (Table 5.2).  Forty percent of women had had more than 10 Pap smears in their 
lifetime.  Only 25 women reported only ever having had one test when asked about how 
regularly they had Pap smears whereas 53 women reported they had only ever had one test 
when asked how many times they had had a Pap smear.  Further exploration revealed that this 
discrepancy was due to 23 women who responded their usual time between Pap smears was 
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every one or two years, were young women who had previously only had one test, and 
suggests they were reporting their intended screening behaviour for the future. 
 
Table 5.2. Cervical Screening History in a Community Sample of 1002 
a
 Women, 
Queensland, 2008 
Screening history N = 999
a 
% 
Ever had a Pap smear   
yes 961 96.2 
no 36 3.6 
not sure 1 0.1 
don't know about this test 2 0.2 
Screening History   
never had a Pap smear 36 3.6 
only ever had 1 test 25 2.5 
screened every 2 years or less  838 83.8 
screened > 2 years or more  84 8.4 
don't know/refused to answer 17 1.7 
Last Pap smear 
b
   
< 1 year ago 444 44.5 
1 year to < 2 years ago 322 32.2 
2 years to < 3 years ago 124 12.4 
3 years to < 5 years ago 34 3.4 
5 or more years ago 34 3.4 
don't know 4 0.4 
Usual time between Pap smears 
b
   
1 year or less 156 16.3 
> 1 year to 2 years  681 70.9 
> 2 years to 3 years  37 3.8 
4 years or more  24 2.5 
only ever had 1 test 25 2.6 
don't have a regular test/other 23 2.4 
don't know/refused 14 1.5 
Number of times had Pap smear 
b
   
once 53 5.3 
twice 57 5.8 
3–5 times 176 17.7 
6–10 times 246 24.6 
11–20 times 269 26.9 
more than 20 times 127 12.8 
don't know / can't remember 31 3.1 
refused to answer 2 0.2 
a Weighted sample N = 999 
b Excludes women who had never had a Pap smear; or reported don't know/not sure when asked “Have you ever had a Pap 
smear'. 
 
5.2.2 Screening Status 
Cervical screening status was derived by combining the variables, usual time between 
Pap smears and time since last Pap smear as outlined in Section 4.5.3.  The majority  of  
women (62%) reported they were regular screeners with 15% of participants classified as 
underscreeners, 18% as overscreeners and four percent classified in the ‘other’ category 
(Figure 5.2).  The 41 women in the ‘other’ category included women who did not know when 
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they last had a Pap smear and/or how regularly they had them, young women who had only 
had one test and were not eligible for a repeat Pap smear as their last Pap smear was less than 
two years previously and women who did not test regularly but reported they had had a Pap 
smear in the previous two years.   
 
Figure 5.1. Study Participants who had never had a Pap Smear by Age Group (n=36) 
 
Women in the ‘other’ category were excluded from further analysis as they did not 
represent a screening category per se.  In addition, the number of women in this category was 
too small for meaningful analysis when screening status was stratified by other variables. 
 
Figure 5.2. Study Participant’s Screening Status (n=999) 
 
As evident in  
Table 5.3, there were no statistically significant differences observed in screening status 
by age, locality, country of birth or educational attainment.   
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Table 5.3. Cervical Screening Status and Characteristics in a Community Sample of 1002
a
 
Women, Queensland, 2008 
Screening Status n=958
b 
 
underscreened 
 regularly 
screened 
 
overscreened X
2 c 
P 
d 
N 
(151) 
% 
(15.7) 
 N 
(623) 
% 
(65.1) 
 N 
(184) 
% 
(19.2)   
Age         12.44 0.13 
20–29 45 21.0  131 60.6  40 18.5   
30–39 40 15.5  168 65.0  51 19.5   
40–49 29 12.9  154 67.9  44 19.2   
50–59 22 13.8  102 62.2  39 24.1   
60–69 13 14.5  69 74.0  11 11.6   
Locality 
e 
        2.41 0.66 
outer reg, rem, vremote 
e 
39 15.5  170 68.2  41 16.3   
major cities 66 15.7  267 63.2  89 21.1   
inner regional 46 16.0  186 64.9  54 19.0   
Socio-economic status         15.27 0.05 
quintile 1 (most disadv 
e
) 36 21.2  108 63.3  26 15.4   
quintile 2 24 13.8  124 70.2  28 16.0   
quintile 3 24 16.2  95 65.3  27 18.5   
quintile 4 25 13.4  132 69.6  32 17.0   
quintile 5 (least disadv) 41 14.9  164 59.5  70 25.5   
Australian born         1.36 0.51 
no 31 18.6  107 64.0  29 17.4   
yes 120 15.1  516 65.3  155 19.6   
Educational attainment         7.09 0.31 
year 10 or below 25 14.3  122 70.7  26 15.0   
year 11or 12 28 17.4  102 63.0  32 19.6   
cert or diploma 57 14.6  245 62.9  88 22.5   
Ba degree or higher 
f 
41 17.6  153 65.7  39 16.7   
Marital status         34.67 <0.01 
never married 37 31.4  58 49.6  22 18.9   
married 73 12.5  412 70.2  102 17.3   
defacto 19 12.2  99 62.7  40 25.1   
sep/div/wid 
f 
21 22.0  55 56.6  21 21.4   
Had children         9.56 0.01 
no 46 21.6  120 56.8  46 21.6   
yes 105 14.1  504 67.4  139 18.5   
Smoking status         11.41 <0.01 
yes 46 23.4  111 56.2  40 20.5   
no 105 13.7  513 67.3  144 18.9   
Abnormal Pap history         88.85 <0.01 
yes 22 7.4  163 55.7  108 36.9   
no 129 19.4  461 69.2  76 11.5   
a
 Weighted sample N = 958 
b Excludes women from the ‘other’ screening status category  
c 
Likelihood Ratio – Chi square 
d
 p = significance at < 0.05 
e
 outer regional, remote and very remote categories combined 
f 
outer reg, rem, vremote = outer regional, remote and very remote; disadvant – disadvantaged;  Ba degree = 
bachelor degree; sep/div/wid = separated, divorced, widowed 
 
Significant differences by screening status were observed by SES, marital status, 
having had children, smoking status and a past history of an abnormal Pap smear.  
Underscreened women were more likely to be from areas of most socio-economic 
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disadvantage (Likelihood X
2 
= 15.27, 8 df, p = 0.05), more likely to be never married 
(Likelihood X
2 
= 34.67, 6 df, p <0.0001), less likely to have children (Likelihood X
2 
= 9.56, 2 
df, p = 0.008), more likely to be smokers (Likelihood X
2 
= 11.41, 2 df, p = 0.003) and less 
likely to report a previous abnormal Pap smear result (Likelihood X
2 
= 88.85, 2 df, p 
<0.0001).  
5.2.3 History of Pap Smear Abnormalities 
Almost 30% of respondents reported having had an abnormal Pap smear in the past.  
This represents abnormalities detected over the entire span of these women’s screening 
history and as women were not asked to specify the abnormality, may also include benign or 
insignificant abnormalities including technically unsatisfactory smears, candida albicans 
(thrush) and atrophic smear results (Table 5.4). 
Women participating in the study who reported having had an abnormal Pap smear in 
the past were significantly more likely to be aged 30 to 39 years, live in remote and very 
remote areas, reside in quintile 3, be born in Australia, have completed a certificate or 
diploma or less than year 10 at school, be in a defacto relationship, have children and report 
they were current smokers (Table 5.4).   
5.3 CERVICAL CANCER/SCREENING KNOWLEDGE 
To ascertain what Queensland women know about cervical cancer/screening and 
whether this differs by socio-demographic factors or cervical screening history, study 
participants were asked about National Cervical Screening Program (NCSP) screening policy 
recommendations, the purpose of the Pap smear, the meaning of results and and risk factors 
for cervical cancer.   
5.3.1 Cervical Screening Knowledge 
Women’s knowledge of cervical cancer/screening varied with moderate to high 
knowledge levels observed in response to questions regarding the purpose, meaning of results 
and recommended frequency of Pap smears.  However, knowledge about the age range of the 
eligible target population was limited.  There were also high levels of uncertainty expressed 
about some risk factor items. 
The majority of respondents (82%) correctly identified the purpose of the Pap smear 
was to detect abnormal cells.  Nineteen percent of participants thought the Pap smear was a 
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treatment for cancer, seven percent incorrectly thought it could detect sexually transmitted 
infections, whilst less than one percent thought it was a test for HPV. 
Table 5.4. Abnormal Pap Smear History and Characteristics in a Community Sample of 
1002
a
 Women, Queensland, 2008 
Abnormal Pap history 
 Yes  No 
b
  
X
2 c
 P 
d
 
 N 
(293) 
% 
(29.6) 
 
N 
(706) 
% 
(70.4) 
 
Age in 10 yr groups       48.560 <0.0001 
20–29 39 15.8  210 84.2    
30–39 101 38.6  160 61.4    
40–49 77 33.3  153 66.7    
50–59 60 36.5  104 63.5    
60–69 17 17.4  79 82.6    
Locality       4.05 0.26 
remote,very remote 11 38.4  18 61.6    
outer regional 70 31.2  154 68.8    
inner regional 93 31.5  203 68.5    
major cities 118 26.3  331 73.7    
Socioeconomic status       2.95 0.57 
quintile 1 (most disadv 
e
) 49 28.0  127 72.0    
quintile 2 57 30.8  127 69.2    
quintile 3 52 34.3  100 65.7    
quintile 4 56 28.8  138 71.2    
quintile 5 (least disadv) 79 27.0  214 73.0    
Australian born       2.82 0.09 
no 45 24.3  140 75.7    
yes 248 30.5  566 69.5    
Educational attainment       9.02 0.03 
Yr 10 or below 57 32.4  118 67.6    
Yr 11or 12 46 26.4  127 73.6    
cert or diploma 
e 
134 33.1  270 66.9    
Ba degree or higher 
e
 57 23.1  189 76.9    
Marital status       19.7 <0.0001 
never married 21 15.1  120 84.9    
married 183 30.8  411 69.2    
defacto 59 35.1  108 64.9    
sep/div/wid 
e 
30 30.8  67 69.2    
Had children       19.19 <0.0001 
no 45 18.4  198 81.6    
yes 248 32.8  509 67.2    
Smoking status       3.86 0.05 
yes 72 34.9  134 65.1    
no 221 27.9  572 72.1    
a Weighted sample N = 999  
b Women who had never had a Pap smear included in ‘no’ category (n=36) 
c Likelihood ratio - Chi square 
d p = significance at p <0.05 
e disadvant = disadvantaged;  Ba degree = bachelor degree; sep/div/wid = separated, divorced, widowed 
 
A number of women (n=43) were very general in their responses, for example, ‘search 
for any issues’ and ‘making sure you’re right’ and these responses were assigned to the 
‘other’ category.  When asked what an abnormal Pap smear most commonly means, almost 
half the women sampled (49%) correctly identified an abnormal Pap smear as containing 
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abnormal or precancerous cells,  27% thought it most commonly meant that the woman had 
cancer and 11% did not know what an abnormal result meant (Table 5.5).   
Table 5.5. Cervical Screening Knowledge in a Community Sample of 1002
a
 Women, 
Queensland, 2008 
Cervical Screening Knowledge Questions N=999 % 
What do you think a Pap smear is a test for? 
b
   
A test to look for abnormal cells (correct response) 815 81.6 
Treatment for cancer 189 18.9 
A test for a sexually transmitted infection 74 7.4 
Other 43 4.4 
General women's health 14 1.4 
HPV 7 0.7 
Don’t know 10 1.0 
What do you think an abnormal Pap smear test most commonly means? 
c 
  
Abnormal, precancerous cells (correct answer) 494 49.4 
Cancer 275 27.5 
Something wrong / follow-up/further investigation/tests needed 178 17.9 
Infection 78 7.8 
Other 61 6.1 
Don’t know / no response 106 10.6 
How often do you think a woman should have a Pap smear?   
Every year 212 21.2 
Every 2 years (correct response) 724 72.4 
Every 3–5 years 17 1.7 
Some other time period 34 3.4 
Don’t know 13 1.3 
When or at what age do you think it is recommended to start having Pap smears?   
Less than 18 75 7.5 
18–20 (correct response) 163 16.3 
21–25 44 4.4 
>26 53 5.3 
When they become sexually active 587 58.7 
Other 30 3.0 
Don't know/refused (n=2) 48 4.8 
When do you think it is recommended women should stop having Pap smears?    
No specific time recommended 317 31.7 
Never 235 23.5 
70 years of age / over 70 years of age (correct response) 105 10.6 
At menopause 69 6.9 
When they are no longer sexually active 25 2.5 
Following a hysterectomy 12 1.2 
Other 45 4.5 
Don’t know 191 19.1 
a Weighted sample N = 999  
b Unprompted and multiple responses permissible – total responses 1153 
c Unprompted and multiple responses permissible – total responses 1199 
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Responses assigned to the ‘other’ category included ‘blockage and ‘disease inside’ and 
were too broad to include in a specific category. 
The majority of women (72%), correctly identified the recommended screening interval 
as every two years, although one fifth responded the recommendation was yearly.  Most 
women (59%), incorrectly believed sexual debut was the recommended time for women to 
start having Pap smears, with only 16% identifying the correct time of 18 to 20 years of age.  
Responses allocated to the ‘other’ category included ‘after marriage’, ‘at puberty’ and ‘as 
soon as they have a baby’.  Women were also unclear about when it was appropriate for 
cervical screening to cease with most women responding there was no recommendation 
(32%) or never (24%) (Table 5.5).  Only 11%  of respondents responded correctly that Pap 
smears could cease at 70 years of age and a further one percent were aware that women could 
cease having Pap smears after a hysterectomy.  Other responses included ‘when they are 
dying’, ‘when the doctor says so’ and ‘as long as they have a husband’. 
5.3.2 Knowledge about Risk Factors for Cervical Cancer 
Women’s responses to questions about risk factors for cervical cancer are described in 
this section.  When prompted, most women (74%), correctly identified HPV, not having 
regular Pap smears (73%) and smoking (61%) as risk factors for cervical cancer (Table 5.6).   
Table 5.6. Knowledge of Risk Factors for Cervical Cancer in a Community Sample of 1002
a
 
Women, Queensland, 2008 
Response to Whether Factor Increases a Woman's Risk of Cervical Cancer 
 Yes  No  Don't know 
 N %  N %  N % 
A family history of cervical cancer (no) 898 89.8  80 8.0  22 2.2 
HPV (yes) 739 74.0  84 8.4  176 17.6 
Not having regular Pap smears (yes) 733 73.3  244 24.4  23 2.3 
Having lots of sexual partners (yes) 718 71.9  231 23.1  51 5.1 
Smoking (yes) 609 60.9  279 27.9  111 11.1 
Not using condoms (yes) 591 59.1  351 35.2  57 5.7 
Having genital warts (no) 561 56.1  279 28.0  159 15.9 
Poor hygiene (no) 521 52.2  395 39.5  83 8.3 
Starting sex at a young age (yes) 490 49.0  413 41.3  97 9.7 
Stress (no) 481 48.2  425 42.6  93 9.3 
Taking the oral contraceptive pill (yes) 328 32.8  501 50.1  171 17.1 
Having lots of sex (no) 281 28.1  607 60.8  111 11.1 
Being overweight (no) 257 25.7  593 59.3  150 15.0 
Having many pregnancies/children (yes) 167 16.7  726 72.6  107 10.7 
a Weighted sample N = 999 
(yes) indicates correct response 
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The majority of participants also correctly identified factors associated with sexual 
activity (and therefore the acquisition of HPV) including not using condoms (59%), having 
lots of sexual partners (72%) and starting sex at a young age (49%), although there were also 
moderate proportions of women (35%, 23% and 41%, respectively) who did not consider 
these risk factors (Table 5.6).  Most women correctly identified that being overweight (59%) 
or having lots of sex (61%) were not identified risk factors for cervical cancer. 
Almost 90% of participants incorrectly believed family history increased a woman’s 
risk of cervical cancer with less than two percent unsure about this.  Poor hygiene, stress and 
having genital warts were also incorrectly identified as risk factors by approximately half of 
the participants.  Participants were also largely unaware that taking the oral contraceptive pill 
(50%) and having many pregnancies or children (73%) are factors that have been linked to 
increased risk of cervical cancer.  There was considerable uncertainty expressed about the 
role of some risk factors.  More than 17% of women indicated uncertainty about the role of 
HPV and the oral contraceptive pill and 10% of women or more did not know whether having 
genital warts, being overweight, smoking, having many pregnancies or children, having lots 
of sex or starting sex at a young age were important risk factors for cervical cancer (Figure 
5.3). 
 
Figure 5.3. Uncertain Responses to Risk Factors for Cervical Cancer (n=999) 
 
Women’s responses to cervical cancer/screening knowledge items were scored, 
summarised and then converted into above and below average scores for bivariate and 
multivariable analysis as described in Section 4.5.3.  The highest possible total score for 
cervical cancer/screening knowledge was 13 points.  The average cervical cancer/screening 
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knowledge score of the women surveyed was 6.64 (SD = 2.11).  Scores were normally 
distributed and the average knowledge score was similar to the central score of the scale.  
Two participants scored 12, the highest score obtained by participants on the knowledge 
scale, whilst one respondent answered all items incorrectly or with uncertainty and 
subsequently scored zero (Figure 5.4). 
 
 
Figure 5.4 Histogram of Cervical Cancer/Screening Knowledge Scores (n=999) 
 
 
When cervical cancer/screening knowledge was stratified by socio-demographic factors 
and cervical screening history, there was little variation observed through bivariate analysis 
by any factors except screening status (Appendix K).  Multivariable analysis was undertaken 
as a number of independent variables in the bivariate analysis were potential confounders of 
each other in their relationships with cervical cancer/screening knowledge, such as age and 
screening status.  Factors included in the final model explained only two percent 
(Nagelkerke’s R Square = 0.025) of the variation in cervical cancer/screening knowledge 
levels.  This reflects the small amount of variation in cervical cancer/screening knowledge in 
the sample and that there are other sources of variation in knowledge not captured in this 
study.   
Following mutual adjustment for all variables in the model, the lack of associations  
observed in bivariate analysis were confirmed as there was limited impact on the significance 
of any factors in relation to cervical cancer/screening knowledge scores (Table 5.7). 
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Table 5.7. Multivariable Relationships between Women with Above Average Cervical 
Screening Knowledge and Demographic and Screening History Variables in a Community 
Sample of 1002
a
 Women, Queensland, 2008 
Cervical Cancer/Screening Knowledge 
 
No of 
women
(999) 
% above 
average 
(55.4) 
 Crude 
OR
b 
Adjusted
c
 Sig
e 
 OR
c 
 95% C.I.
d
 
SOCIODEMOGRAPHIC         
Age (10 year age groups)          
20–29 249 55.5  1.00 1.00  (referent) 0.95 
30–39 260 55.4  1.00 0.91  0.60 1.37  
40–49 230 54.4  0.96 0.88  0.57 1.35  
50–59 164 55.0  0.98 0.86  0.54 1.39  
60–69 96 58.6  1.13 1.02  0.58 1.78  
Locality          
outer reg, rem, vremote 
f 
252 56.3  1.00 1.00  (referent) 0.26 
major cities 450 57.8  1.06 1.08  0.76 1.54  
inner reg 
f 
297 51.2  0.82 0.82  0.58 1.16  
Socioeconomic status          
quintile 1 (most disadv 
f
) 176 57.0  1.00 1.00  (referent) 0.55 
quintile 2 184 50.7  0.78 0.71  0.46 1.09  
quintile 3 152 56.4  0.98 0.93  0.59 1.48  
quintile 4 194 55.0  0.92 0.80  0.52 1.24  
quintile 5 (least disadv) 294 57.3  1.01 0.91  0.59 1.41  
Australian born          
no 185 57.1  1.00 1.00  (referent) 0.64 
yes 814 55.1  0.92 0.92  0.65 1.31  
Educational attainment          
year 10 or below 175 54.3  1.00 1.00  (referent) 0.82 
year 11or 12 173 56.2  1.08 1.07  0.67 1.69  
cert or diploma
f 
404 56.1  1.08 1.07  0.73 1.57  
Ba degree or higher 
f 
246 54.5  1.01 0.91  0.59 1.42  
Marital status          
never married 141 45.4  1.00 1.00  (referent) 0.78 
married 595 44.1  1.06 0.84  0.52 1.37  
defacto 167 45.4  1.00 0.77  0.46 1.29  
sep/div/wid 
f 
97 44.9  1.02 0.90  0.48 1.66  
Had children          
no 242 55.2  1.00 1.00  (referent) 0.97 
yes 757 55.5  1.01 0.99  0.68 1.45  
Smoking status          
yes 206 50.8  1.00 1.00  (referent) 0.32 
no 793 56.6  1.27 1.19  0.84 1.67  
SCREENING HISTORY          
Screening status          
underscreened 151 46.5  1.00 1.00  (referent) 0.04 
regularly screened 623 57.4  1.55 1.59  1.10 2.30  
overscreened 184 58.8  1.64 1.57  0.99 2.50  
Abnormal Pap          
yes 293 58.6  1.00 1.00  (referent) 0.27 
no 706 54.1  0.83 0.84  0.62 1.14  
a  
Weighted sample N = 969 (excludes women in the 'other' screening category)
 
b
 OR, odds ratios of above average cervical cancer/screening knowledge 
c
 odds ratios mutually adjusted for all variables adjusted in table 
d
 95% C.I., confidence interval for true estimate of adjusted odds ratio 
e
 statistical significance of adjusted OR 
f 
outer reg, rem, vremote = outer regional, remote and very remote, inner reg = inner regional; disadvant = 
disadvantaged;
  
Ba degree = bachelor degree; sep/div/wid = separated, divorced, widowed 
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In the adjusted model, differences in knowledge by screening status remained 
significant and there was virtually no difference between crude and adjusted odds ratios, 
reflecting a lack of confounding by other variables on screening status in the adjusted model.  
Women who reported they had regular Pap smears (95% C.I. 0.10–2.30) and overscreened 
women (95% C.I. 0.99–2.50) had 1.6–fold higher odds (p = 0.04) of having above average 
cervical cancer/screening knowledge levels relative to underscreened women.  This 
difference was also clinically significant as there was a proportional difference of 10% or 
more between underscreened women (46%) and regular screeners (57%) and overscreened 
women (59%) with above average knowledge (Table 5.7).  This finding confirms a positive 
relationship between knowledge and participation in cervical cancer/screening. 
5.3.3 Summary of Cervical Cancer/Screening Knowledge and Factors Associated with 
Knowledge Levels 
In answer to the question ‘What do Queensland women know about cervical 
cancer/screening and does this differ by socio-demographic factors or cervical screening 
history?’, whilst study participants correctly identified the purpose of the Pap smear and were 
familiar with the recommended frequency of participation in the NCSP, there was poor 
knowledge of the age range of the eligible population and considerable uncertainty expressed 
by participants about some risk factors for cervical cancer, especially the role of HPV and 
sexual behaviours.  
Bivariate analysis identified limited variation in cervical cancer/screening knowledge 
levels by socio-demographic factors and a history of an abnormal Pap smear.  Differences in 
knowledge levels were observed by screening status with underscreened women having 
lower knowledge compared to more regular screeners, which was confirmed by multivariable 
analyses in which knowledge was found to be an independent predictor of cervical 
cancer/screening knowledge.  The model was limited by poor goodness of fit as the model as 
a whole only accounted for 2% of the variation in cervical cancer/screening knowledge.   
5.4 HPV AWARENESS  
To ascertain current awareness of HPV and whether this differed by socio-demographic 
factors, cervical screening history or cervical cancer/screening knowledge, study participants 
were asked if they had heard of HPV.  Bivariate and multivariable analysis was conducted to 
assess differences in awareness of HPV by the factors outlined above. 
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5.4.1 HPV Awareness and Differences by Socio-demographic Factors, Screening 
History and Knowledge 
Approximately two thirds of the study participants (n = 633) indicated they had 
previously heard of HPV, whilst 367 women (38%) responded ‘no’ (n = 340) or ‘don’t know’ 
(n = 27) to this question (Table 5.8).  
A statistically significant difference in awareness of HPV following bivariate analysis 
was observed by educational attainment, children, smoking status, screening history and 
cervical cancer/screening knowledge (Appendix K).  Multivariable analysis was undertaken 
as a number of independent variables in the bivariate analysis were potential confounders of 
each other in their relationships with HPV awareness.  Factors included in the final model 
explained 18% (Nagelkerke’s R Square = 0.182) of the variation in HPV awareness,  which 
suggests there were other factors not measured in the study that are responsible for much of 
the variance in HPV awareness.   
Following mutual adjustment for all variables in the model, the associations observed in 
bivariate analysis remained statistically significant for differences in HPV awareness by 
education, abnormal Pap smear history and cervical cancer/screening knowledge but not for 
children, smoking status or screening status.  Birthplace and marital status showed significant 
associations with HPV awareness in the adjusted model, but were not associated in the crude 
models (Table 5.8).  
When variables were removed from the model then added back individually to 
determine the shift in odds ratios of each variable, there was little confounding or variation in 
odds ratios for education, abnormal Pap smear history and cervical cancer/screening 
knowledge.  The odds ratios for children were more significant when screening status (p = 
0.29) and education (p = 0.62) were removed from the model, and less significant when 
marital status (p = 1.40) was omitted.  The odds ratios for smoking were more significant 
when education (p = 0.71) and marital status (p = 0.62) were omitted from the model whilst 
screening status was more significant (p = 0.05) when history of an abnormal Pap smear was 
removed.  A decrease in odds ratios and significance for locality was observed when SES, 
and for education, when country of birth, was omitted from the model.  Marital status was 
less significant when cervical cancer/screening knowledge (p = 0.70) or children (p = 0.10) 
were removed from the model.  The influence of these variables on other variables validated 
their inclusion in the final model even though there was not always a significant shift in the 
odds ratios.  
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On adjustment for other factors associated with HPV awareness, the odds of women 
who had completed a trade certificate or diploma were 1.9–fold higher (OR 1.93; 95% C.I. 
1.28–2.89), and those with a bachelor degree or higher were four-fold higher for having heard 
of HPV, than women who had completed less than year 10 high school education (OR 4.00; 
95% C.I. 2.44–6.57; p <0.0001).  In addition, women who had no history of an abnormal Pap 
smear had lower odds of having heard of HPV (OR 0.68; 95% C.I. 0.48–0.95; p = 0.02) than 
women with an abnormal screening history.  Modelling also confirmed the significant finding 
that women with above average cervical cancer/screening knowledge had almost three-fold 
higher odds of having heard of HPV relative to those with below average knowledge (OR  
2.95; 95% C.I. 2.21–3.93; p <0.0001).  
A decrease in odds ratios between crude and adjusted analyses for the associations 
between HPV awareness and children, smoking and screening status was observed and were 
no longer significant, which suggests the model accounted for confounding between the 
variables included.  An increase in odds ratios between crude and adjusted analyses for the 
association between HPV awareness and living in an inner regional locality was observed; 
however a decrease was observed for women living in major cities.  Women living in inner 
regional areas had 1.4–fold higher odds of having heard of HPV relative to those living in 
more remote areas, (OR 1.43; 95% C.I. 0.98–2.10; P = 0.01), that was of borderline statistical 
significance due to the lower 95% confidence interval being just below 1.   
An increase in the odds ratio was observed in awareness of HPV and country of birth, 
with women born in Australia having 1.5–fold higher odds of having heard of HPV than 
those born overseas (OR 1.53; 95% C.I. 1.05–2.23; p = 0.03).  Marital status also gained 
significance from p = 0.21 (unadjusted) to p = 0.05 (adjusted), which was reflective of the 
difference between married women’s awareness (66%) when compared with never married 
women (60%).  Married women had almost two-fold higher odds of being aware of HPV (OR 
1.90; 95% C.I. 1.12–3.24; p = 0.05) than never married women (Table 5.8).  
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Table 5.8. Multivariable Relationships between Awareness of HPV and Demographic, 
Screening History and Knowledge Variables in a Community Sample of 1002
a
 women, 
Queensland, 2008 
HPV Awareness 
 Number 
women 
(633) 
% aware 
of HPV 
(63.0) 
 Crude 
OR 
b
 
Adjusted 
c
 Sig 
e
 
   OR 
c
  95% C.I. 
d
 
SOCIODEMOGRAPHIC         
Age in 10 yr groups          
20–29 249 63.5  1.00 1.00  (referent) 0.59 
30–39 260 63.5  1.00 0.91  0.58 1.41  
40–49 230 64.6  1.05 0.95  0.59 1.51  
50–59 164 66.5  1.14 1.18  0.70 1.99  
60–69 96 53.9  0.67 0.74  0.41 1.35  
Locality          
outer reg, rem, vremote 
f 
253 60.3  1.00 1.00  (referent) 0.01 
major cities 450 62.1  1.08 0.80  0.55 1.17  
inner reg 
f 
296 67.7  1.38 1.43  0.98 2.10  
Socioeconomic status          
quintile 1 (most disadv 
f
) 176 61.3  1.00 1.00  (referent) 0.08 
quintile 2 184 60.5  0.97 0.96  0.60 1.52  
quintile 3 152 56.1  0.81 0.74  0.45 1.20  
quintile 4 194 65.0  1.17 1.21  0.75 1.95  
quintile 5 (least disadv) 294 68.9  1.40 1.45  0.90 2.34  
Australian born          
no 185 59.8  1.00 1.00  (referent) 0.03 
yes 814 64.1  1.20 1.53  1.05 2.23  
Educational attainment          
year 10 or below 175 49.6  1.00 1.00  (referent) <0.0001 
year 11or 12 173 57.8  1.40 1.51  0.93 2.44  
cert or diploma 
f 
404 63.8  1.80 1.93  1.28 2.89  
Ba degree or higher 
f
 246 75.8  3.19 4.00  2.44 6.57  
Marital status          
never married 141 59.8  1.00 1.00  (referent) 0.05 
married 595 65.9  1.29 1.90  1.12 3.24  
defacto 167 58.3  0.94 1.18  0.67 2.07  
sep/div/wid 
f 
97 61.2  1.06 1.52  0.78 2.98  
Had children          
no 242 69.1  1.00 1.00  (referent) 0.12 
yes 757 61.4  0.71 0.71  0.46 1.09  
Smoking status          
yes 206 55.0  1.00 1.00  (referent) 0.27 
no 793 65.5  1.55 1.23  0.85 1.76  
CERVICAL SCREENING HISTORY         
Screening status          
underscreened 151 54.7  1.00 1.00  (referent) 0.46 
regularly screened 623 63.2  1.43 1.18  0.79 1.77  
overscreened 184 69.4  1.88 1.38  0.83 2.30  
Abnormal Pap history          
yes 293 68.7  1.00 1.00  (referent) 0.02 
no 706 61.1  0.71 0.68  0.48 0.95  
KNOWLEDGE          
Cx screen knowledge level          
below average 445 50.6  1.00 1.00  (referent) <0.0001 
above average 554 73.5  2.70 2.95  2.21 3.93  
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Table 5.8 continued 
a 
Weighted sample N = 969 (excludes women in the 'other' screening category) 
b 
OR, odds ratios of having heard of HPV prior to study 
c
 odds ratios mutually adjusted for all variables adjusted in table 
d
 C.I., confidence interval for true estimate of adjusted odds ratio 
e
 statistical significance of adjusted OR 
f 
outer reg, rem, vremote = outer regional, remote and very remote, inner reg = inner regional; disadvant = 
disadvantaged;
  
Ba degree = bachelor degree; sep/div/wid = separated, divorced, widowed 
 
5.4.2 Summary of HPV Awareness and Factors Associated with Awareness 
Just under two thirds of Queensland women (63%) had heard of HPV.  Following 
mutual adjustment for all variables included in the model, women who had heard of HPV 
were most consistently found to be: educated beyond high school, have had an abnormal Pap 
smear in the past, have above average cervical cancer/screening knowledge, be born in 
Australia and be married. 
Educational attainment and cervical cancer/screening knowledge were also defined as 
clinically significant.  Country of birth, marital status and a history of an abnormal Pap smear 
result did not meet the definition of clinical significance but the confidence intervals for these 
factors were consistent with these being independent predictors of HPV awareness.  The 
model as a whole accounted for 18% of the variance in HPV awareness amongst women in 
this sample. 
5.5 HPV KNOWLEDGE 
To ascertain what Queensland women know about HPV and if this differed by socio-
demographic factors or cervical screening history, women who had heard of HPV were asked 
a series of true/false questions about HPV.  Bivariate and multivariable analysis was 
conducted to assess differences in knowledge of HPV by these factors.  As HPV knowledge 
was made redundant by HPV awareness as an independent variable, it was not incorporated 
into further bivariate and multivariate analysis with the outcome variables, HPV vaccination 
awareness, general vaccination and HPV vaccination attitudes.  To assess the relationship of 
HPV knowledge with these outcomes, they were incorporated at this stage of analysis as 
independent variables as described in Section 4.5.2. 
5.5.1 HPV Knowledge and Differences by Socio-demographic Factors, Screening 
History and Knowledge 
Women’s knowledge of HPV was measured using a list of true/false items, which 
formed the HPV Knowledge Tool.  Only those who responded they had heard of HPV 
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(n=633) were asked to respond to these items, which were presented in randomized order for 
each study participant.  The majority of women (94%) knew about the asymptomatic nature 
of HPV infection, 85% about the need for some women to have more frequent Pap smears 
and 77% knew that HPV is a sexually transmitted infection.  More than 80% were aware that 
certain types of HPV can lead to cancer and 71% knew the vaccine could prevent some types 
of HPV (Table 5.9).  HPV knowledge was limited in many aspects with high responses of 
‘don’t know’ in the majority of categories (Figure 5.5).   
 
Table 5.9. Responses to HPV Knowledge Items in a Community Sample of 1002
a
 women, 
Queensland, 2008 
 
True False Don’t Know 
 
N % N % N % 
A person may be infected with HPV and not know it
1
 593 93.7 8 1.2 32 5.1 
Those with HPV may need Pap smears more often 539 85.2 32 5.0 62 9.8 
Certain types of HPV cause cancer of the cervix 528 83.5 21 3.4 83 13.1 
HPV is spread through sexual intercourse 485 76.6 64 10.0 84 13.3 
There is a vaccine to prevent some types of HPV 450 71.1 41 6.5 142 22.4 
Condoms do not always help protect you against HPV 386 60.9 148 23.4 99 15.7 
If you have HPV, smoking can increase your chance 
of cervical cancer 
370 58.4 96 15.2 167 26.3 
HPV can be cured with antibiotics 108 17.1 311 49.1 214 33.8 
HPV causes women to have abnormal periods 178 28.2 205 32.4 249 39.4 
The Pap smear is a test for HPV 342 54.1 193 30.4 98 15.5 
Women can often clear HPV without treatment 79 12.4 442 69.9 112 17.7 
HPV can cause problems with pregnancy 402 63.5 58 9.1 173 27.4 
Correct response in boldface 
 a  
Weighted sample N = 632 (who had heard of HPV before survey) 
 
Ten percent of women did not think HPV could be spread through sexual activity and 
only 12% understood the transient nature of HPV infection and that the majority of women 
may clear the virus spontaneously.  Thirty-four percent of women were not sure if antibiotics 
would cure HPV and 26% were unsure of the role of smoking in increasing women’s risk of 
developing cervical cancer.  More than one fifth of respondents were uncertain if there was a 
vaccine available to prevent HPV (22%) or if HPV caused problems with pregnancy (27%) or 
menstrual problems (39%).  More than half the women surveyed incorrectly thought the Pap 
smear was a test for HPV (54%) whilst more than 15% were unsure. 
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When responses were combined to form a score, the average HPV knowledge score 
was 6.54 (SD = 2.21) and scores were normally distributed (Figure 5.6).  One respondent 
scored the highest possible score of 12 and 13 respondents scored zero, of which about half 
responded ‘don’t know’ to every item.  Overall HPV knowledge was limited in this sample 
(Table 5.9; Figure 5.5). 
Summary HPV knowledge scores were converted to HPV knowledge levels by 
separating the scores using above and below average (mean) scores as described in Section 
4.5.3.  A difference of greater than 10% in HPV knowledge levels when stratified by 
independent variables was determined to be clinically significant. 
 
Figure 5.5. Uncertain Responses to HPV Knowledge Items (n=633) 
 
Fifty-six percent of respondents had above average knowledge of HPV.  Differences in 
HPV knowledge following bivariate analysis were observed by age, locality, educational 
attainment, children, abnormal Pap smear history, cervical cancer/screening knowledge, HPV 
vaccination awareness and attitudes (Appendix K). 
Multivariable analysis was undertaken as a number of independent variables in the 
bivariate analysis were potential confounders of each other in their relationships with HPV 
knowledge.  Factors included in the final model explained 18% (Nagelkerke’s R Square = 
0.181) of the variation in HPV knowledge.  Following mutual adjustment for all variables in 
the model, the associations observed in bivariate analysis remained statistically significant for 
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above average HPV knowledge amongst women in this sample for marital status, cervical 
cancer/screening knowledge, awareness of the HPV vaccine and HPV vaccination attitudes. 
 
Figure 5.6. Histogram of HPV Knowledge Scores (n=633) 
 
Factors that became non-significant in the adjusted model were age, (although 
significant differences between the oldest and youngest women were evident), locality, 
educational attainment, children and a history of an abnormal Pap smear suggesting 
confounding between factors in the model. 
When variables were removed from the model then added back individually to 
determine the shift in odds ratios of each variable, there was little confounding or variation in 
odds ratios for cervical cancer/screening knowledge.  A decrease in odds ratios of more than 
10% was observed for marital status when age was removed from the model but this had 
minimal impact on statistical significance (p = 0.006) and likewise an impact on the 
significance of the odds ratios for age was observed when marital status was removed from 
the model (p = 0.20).  The odds ratios for awareness of the HPV vaccine were more 
significant when attitudes towards HPV vaccination (p = 0.0004) was omitted from the model 
with an increase in significance for the odds ratios for HPV vaccination when awareness of 
the HPV vaccine was removed (p = 0.006).  There was no one variable that seemed to impact 
on the odds ratios for locality in the adjusted model.  A decrease in odds ratios and statistical 
significance for education (p = 0.70) was observed when age was omitted from the model, 
whilst the odds ratio for children became more significant (p = 0.16) when marital status was 
removed.  A number of variables influenced the significance of the odds ratios for abnormal 
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Pap smear history when removed from the model including screening status (p = 0.06), 
awareness of the HPV vaccine (p = 0.06) and attitudes towards vaccination (p = 0.04).  The 
influence of these variables on other variables validated their inclusion in the final model 
even though there was not always a significant shift in odds ratios. 
Older women aged over 50 years had lower odds of having above average HPV 
knowledge.  The largest difference was observed for women aged 60 to 69 years when 
compared with women 20 to 29 years.  Women aged over 60 years had much lower odds of 
having above average HPV knowledge relative to women aged 20 to 29 years (OR 0.38; 95% 
C.I. 0.17 – 0.84; p = 0.02).  Women aged 50 to 59 years also had lower odds of having above 
average knowledge than those in the youngest age group (OR 0.52; 95% C.I. 0.27–0.99; p = 
0.05) and the differences between both groups was clinically significant (Table 5.10).  A 
statistically significant difference was observed between these two groups when compared 
with the youngest age group at the sub-category level, although age was not found to be a 
significant predictor in the model overall (p=0.15). 
Married and defacto women had lower odds of having above average knowledge 
relative to never married women but the difference between women who were separated, 
divorced or widowed was not significant (OR 0.54; 95% C.I. 0.22–1.35).  This was in 
contrast to the finding that married women had higher awareness of HPV than never married 
women and suggests that awareness does not equate to knowledge. 
The differences between all groups relative to women who had never married were also 
of clinical significance.  Modelling also confirmed the significant finding that women with 
above average cervical cancer/screening knowledge had two-fold higher odds of having 
above average knowledge about HPV (O.R 2.19; 95% C.I. 1.52–3.15; p <0.0001) relative to 
women with below average cervical cancer/screening knowledge (Table 5.10). 
Having heard of the HPV vaccine and having positive attitudes towards the HPV 
vaccine were also confirmed as being associated with HPV knowledge, although there was a 
decrease in the odds ratios for HPV vaccination following mutual adjustment for all variables 
in the model.  Women who had heard of the HPV vaccine had three-fold higher odds of 
having above average HPV knowledge relative to those who had not (OR 3.19; 95% C.I. 
1.55–6.56; P <0.0001), whilst those with positive HPV vaccination attitudes had 1.7–fold 
higher odds of having higher HPV knowledge relative to those with negative attitudes (OR 
1.69; 95% C.I. 1.05–2.73; P = 0.03). 
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Table 5.10. Multivariable Relationships between Above Average HPV Knowledge and 
Demographic, Screening History, Knowledge and Attitude Variables in a Community Sample 
of 1002
a
 Women, Queensland, 2008 
HPV knowledge 
 
 
Number 
women 
(633) 
% 
above 
average 
(56) 
  Adjusted c  
 Crude 
OR 
b 
OR
c
  95% C.I. 
d
 Sig 
e 
          
SOCIO-DEMOGRAPHIC          
Age in 10 yr groups          
20–29 158 67.3  1.00 1.00  (referent) 0.14 
30–39 165 56.3  0.63 0.72  0.40 1.29  
40–49 148 54.6  0.58 0.67  0.37 1.22  
50–59 109 49.9  0.48 0.52  0.27 0.99  
60–69 52 37.4  0.29 0.38  0.17 0.84  
Locality          
outer reg, rem, vremote 
f 
153 51.0  1.00 1.00  (referent) 0.80 
major cities 279 62.0  1.57 1.18  0.72 1.93  
inner reg 
f 
201 51.7  1.04 1.17  0.73 1.87  
Socioeconomic status          
quintile 1 (most disadv 
f
) 108 52.3  1.00 1.00  (referent) 0.67 
quintile 2 111 51.1  0.95 0.99  0.55 1.77  
quintile 3 85 52.1  0.99 1.04  0.55 1.96  
quintile 4 126 53.8  1.06 0.88  0.49 1.60  
quintile 5 (least disadv) 202 63.6  1.60 1.32  0.73 2.40  
Australian born          
no 111 59.7  1.00 1.00  (referent) 0.17 
yes 522 55.2  0.83 0.71  0.43 1.16  
Educational attainment          
year 10 or below 87 43.1  1.00 1.00  (referent) 0.70 
year 11or 12 100 56.5  1.72 0.97  0.49 1.90  
cert or diploma 
f 
258 57.2  1.76 1.26  0.72 2.21  
Ba degree or higher 
f 
187 60.5  2.02 1.22  0.66 2.27  
Marital status          
never married 84 78.6  1.00 1.00  (referent) 0.004 
married 392 52.7  0.30 0.42  0.20 0.89  
defacto 97 50.3  0.28 0.24  0.11 0.53  
sep/div/wid 
f 
59 54.9  0.33 0.54  0.22 1.35  
Had children          
no 167 66.5  1.00 1.00  (referent) 0.55 
yes 465 52.2  0.55 0.86  0.53 1.40  
Smoking status          
yes 113 55.3  1.00 1.00  (referent) 0.57 
no 519 56.1  1.03 1.15  0.71 1.89  
CERVICAL SCREENING HISTORY         
Screening status          
underscreened 82 58.2  1.00 1.00  (referent) 0.84 
regularly screened 394 53.5  0.83 0.96  0.56 1.67  
overscreened 128 59  1.03 1.11  0.57 2.14  
Abnormal Pap history          
yes 201 61.6  1.00 1.00  (referent) 0.09 
no 431 53.4  0.71 0.71  0.47 1.06  
KNOWLEDGE AND AWARENESS         
Cx screen knowledge level          
below average 225 41.4  1.00 1.00  (referent) <0.0001 
above average 407 64.1  2.52 2.19  1.52 3.15  
Heard of HPV vaccine         
no 51 26.6  1.00 1.00  (referent) <0.0001 
yes 581 58.6  3.89 3.19  1.55 6.56  
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Table 5.10 continued 
 
ATTITUDES          
General vaccine attitudes          
negative 67 51.2  1.00 1.00  (referent) 0.74 
positive 565 56.6  1.24 0.90  0.48 1.68  
HPV vaccine attitudes          
negative 137 41.3  1.00 1.00  (referent) 0.03 
positive 495 60.1  2.14 1.69  1.05 2.73  
a 
Weighted sample N = 632 (who had heard of HPV before survey) 
b 
OR, odds ratios of having above average HPV knowledge 
c
 odds ratios mutually adjusted for all variables adjusted in table 
d
 C.I., confidence interval for true estimate of adjusted odds ratio 
e
 statistical significance of adjusted OR 
f 
outer reg, rem, vremote = outer regional, remote and very remote, inner reg = inner regional; disadvant = 
disadvantaged;
  
Ba degree = bachelor degree; sep/div/wid = separated, divorced, widowed 
 
5.5.2 Summary of HPV Knowledge and Factors Associated with Above and Below 
Average Knowledge 
In response to the research question, ‘What do Queensland women know about HPV 
and does this differ by socio-demographic factors, cervical screening history, awareness and 
attitudes?’, this study found that women had limited knowledge and high levels of 
uncertainty about HPV. 
Following mutual adjustment for all variables included in the model, the factors 
associated with above average HPV knowledge amongst women in this sample were age, 
marital status, cervical cancer/screening knowledge, HPV vaccination awareness and 
attitudes.  Women with below average HPV knowledge were most consistently found to be: 
aged over 50 years; in married or defacto relationships; have below average cervical 
cancer/screening knowledge; be unaware of the HPV vaccine and have negative attitudes 
towards HPV vaccination.  The model as a whole accounted for 18% of the variance in HPV 
knowledge amongst women in this sample. 
5.6 HPV VACCINE AWARENESS  
To determine how many Queensland women were aware of the HPV vaccine and 
where they heard about it, study participants completed questions pertaining to having heard 
of the HPV vaccine, the source of this information and if they had been vaccinated against 
HPV.  All women were asked if they had heard of the cervical cancer or HPV vaccine prior 
to being asked further questions.  The majority of study participants (86%) indicated they had 
heard of the vaccine, whilst less than one percent was unsure.  Of the 863 women who had 
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heard of the vaccine, 112 women (13%) said they had received the vaccine whilst three 
women were unsure whether they had been vaccinated (Table 5.11). 
 
Table 5.11. Knowledge of HPV Vaccine and Vaccination Status in a Community Sample of 
1002
a 
Women, Queensland, 2008 
HPV Vaccine Awareness and Status 
 Yes  No  
Don’t 
know 
 N %  N %  N % 
Before today, have you heard of the vaccine for 
cervical cancer or HPV? 
863 86.3  134 13.4  2 0.2 
Have you had the vaccine? 
b
 112 13.0  747 86.6  3 0.4 
a Weighted sample N = 999 
b N = 863 - Only asked this question if had heard of the vaccine 
 
Whilst 87% of women indicated they had heard of the cervical cancer or HPV vaccine 
when asked this question, it is interesting to note only 71% of women agreed there was a 
vaccine to prevent certain types of HPV in the HPV Knowledge Tool, which suggests the 
vaccine is more commonly recognised as preventing cervical cancer rather than HPV per se.   
Women were asked where they had heard of the vaccine and were able to give multiple 
responses.  Mass media was most commonly identified as the source of vaccine awareness 
with television being the highest reported source by 566 women followed by 208 women who 
had heard of it via the newspaper.  Doctors and clinics were the source of information listed 
by over 200 women, with nurses and health workers identified as sources of information by 
22 respondents.  The Internet, letters or workplaces were not frequently reported sources of 
information at the time of this survey.  Other sources uncommonly identified, included the 
back of toilet doors, through research studies or at university and Professor Ian Frazer (Figure 
5.7). 
5.6.1 HPV Vaccination Awareness and Differences by Socio-demographic Factors, 
Screening History and Knowledge 
Differences in HPV vaccination awareness following bivariate analysis were observed 
by age, country of birth, educational attainment, children, screening status, cervical screening 
knowledge and HPV awareness (Appendix K). 
Multivariable analysis was undertaken as a number of independent variables in the 
bivariate analysis were potential confounders of each other in their relationships with 
awareness of the HPV vaccine.   
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Figure 5.7. Sources of HPV Vaccine Information (n=863) 
 
Factors included in the final model explained 19% (Nagelkerke’s R Square = 0.193) of 
the variation in awareness of the HPV vaccine.  Following mutual adjustment for all variables 
included in the model, the factors associated with HPV vaccination awareness amongst 
women in this sample were age, country of birth and abnormal Pap smear history, cervical 
cancer/screening knowledge and HPV awareness.  Differences in awareness by educational 
attainment and having had children were no longer of statistical significance. 
When variables were removed from the model then added back individually to 
determine the shift in odds ratios of each variable, there was little confounding or variation in 
odds ratios for age, born in Australia, abnormal Pap history or having heard of HPV.  An 
increase in odds ratios of more than 10% was observed for cervical cancer/screening 
knowledge when HPV awareness was removed from the model and had a large impact on 
statistical significance (p = 0.002).  The odds ratios for educational attainment increased 
when HPV awareness was omitted from the model, although this did not reach statistical 
significance (p = 0.09).  Minor changes in odds ratios and significance were noted for marital 
status, none of which were significant when HPV awareness, Australian born and age were 
individually removed from the model, whilst the odds ratio for children became more 
significant (p = 0.10) when age was removed.  All variables were retained in the final model. 
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Table 5.12. Multivariable Relationships between Awareness of the HPV Vaccine and 
Demographic, Screening History and Knowledge Variables in a Community Sample of 1002
a 
Women, Queensland, 2008 
Awareness of the HPV vaccine 
 Number 
women 
% aware 
vaccine 
(86.3) 
 
Crude 
OR
b
 
Adjusted 
c
 
Sig 
e
 
 OR
c
  95% C.I. 
d
 
SOCIODEMOGRAPHIC          
Age in 10 yr groups          
20–29 249 91.7  1.00 1.00  (referent) <0.0001 
30–39 260 82.4  0.42 0.32  0.16 0.63  
40–49 230 91.3  0.95 0.83  0.39 1.79  
50–59 164 86.0  0.56 0.52  0.24 1.13  
60–69 96 71.8  0.23 0.24  0.11 0.54  
Locality          
outer reg, rem, vremote 
f 
252 84.1  1.00 1.00  (referent) 0.14 
major cities 450 88.2  1.42 1.67  0.98 2.83  
inner reg 
f 
297 85.4  1.11 1.11  0.67 1.86  
Socioeconomic status          
quintile 1 (most disadv 
f
) 176 84.0  1.00 1.00  (referent) 0.96 
quintile 2 184 84.7  1.05 0.92  0.49 1.72  
quintile 3 152 83.2  0.95 0.92  0.47 1.78  
quintile 4 194 88.6  1.48 1.16  0.59 2.27  
quintile 5 (least disadv) 294 88.9  1.52 0.95  0.49 1.85  
Australian born          
no 185 80.0  1.00 1.00  (referent) 0.001 
yes 814 87.8  1.80 2.27  1.39 3.71  
Educational attainment          
year 10 or below 175 81.3  1.00 1.00  (referent) 0.40 
year 11or 12 173 84.7  1.28 1.32  0.69 2.54  
cert or diploma 
f 
404 86.7  1.50 1.36  0.79 2.35  
Ba degree or higher 
f 
246 90.6  2.22 1.83  0.91 3.68  
Marital status          
never married 141 86.3  1.00 1.00  (referent) 0.54 
married 595 86.5  1.01 1.54  0.72 3.27  
defacto 167 89.2  1.30 1.59  0.68 3.70  
sep/div/wid 
f 
97 80.7  0.66 1.13  0.46 2.79  
Had children          
no 242 90.3  1.00 1.00  (referent) 0.42 
yes 757 85.1  0.61 0.77  0.41 1.45  
Smoking status          
yes 206 85.0  1.00 1.00  (referent) 0.91 
no 793 86.7  1.14 0.97  0.58 1.63  
CERVICAL SCREENING HISTORY        
Screening status          
underscreened 151 83.0  1.00 1.00  (referent) 0.96 
regularly screened 623 85.9  1.25 1.05  0.62 1.79  
overscreened 184 90.9  2.04 1.12  0.54 2.32  
Abnormal Pap history          
yes 293 93.2  1.00 1.00  (referent) <0.0001 
no 706 83.5  0.37 0.35  0.20 0.61  
KNOWLEDGE AND AWARENESS        
Cx screen knowledge level          
below average 445 82.3  1.00 1.00  (referent) 0.05 
above average 554 89.6  1.84 1.52  1.01 2.30  
HPV awareness          
no 367 76.7  1.00 1.00  (referent) <0.0001 
yes 633 91.9  3.45 2.73  1.79 4.17  
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Table 5.12 continued 
a
 Weighted sample = 999 
b 
OR, odds ratios of below average cervical cancer/screening knowledge 
c 
odds ratios mutually adjusted for all variables adjusted in table 
d 
C.I., confidence interval for true estimate of adjusted odds ratio 
e
 statistical significance of adjusted OR 
f 
outer reg, rem, vremote = outer regional, remote and very remote, inner reg = inner regional; disadvant = 
disadvantaged;
  
Ba degree = bachelor degree; sep/div/wid = separated, divorced, widowed 
 
Women aged over 60 years had lower odds (OR 0.24; 95% C.I. 0.11 – 0.54) as did 
women aged 30 to 39 years of age (OR 0.32; 95% C.I. 0.16 – 0.63; p < 0.0001) of having 
heard of the HPV vaccine relative to women 20 to 29 years old.  Women born in Australia 
had more than two-fold higher odds of having heard of the HPV vaccine relative to those 
born overseas, which gained significance when other factors were included in the model (OR 
2.27; 95% C.I. 1.39 – 3.71; p = 0.001).   
There was little change in variation following mutual adjustment of all variables in the 
model by abnormal Pap smear history with women who had not had a previous abnormality 
remaining at lower odds of having heard of the HPV vaccine relative to those who had (OR 
0.35; 95% C.I. 0.20 – 0.61; p < 0.0001).  A decrease in odds ratios was observed for cervical 
cancer/screening knowledge and HPV awareness.  Women with above average cervical 
cancer/screening knowledge had 1.5–fold higher odds of being aware of the HPV vaccine 
relative to those with below average knowledge (OR 1.52; 95% C.I. 1.01 – 2.30) and those 
who were aware of HPV had 2.7–fold higher odds of being aware of the vaccine relative to 
those who were not (OR 2.73; 95% C.I. 1.79 – 4.17; p = 0.05). 
5.6.2 Summary of Factors Associated with HPV Vaccine Awareness  
In response to the research question about Queensland women’s awareness of the HPV 
vaccine, the sources of this awareness and if awareness differed by socio-demographic 
factors, screening history, knowledge or awareness, over 86% of women had heard of the 
HPV vaccine and the most commonly cited sources of this awareness was through mass 
media.   
Following mutual adjustment for all variables included in the model, the factors 
associated with awareness of the HPV vaccine amongst women in this sample were age, 
country of birth, abnormal Pap smear history, awareness of HPV and cervical 
cancer/screening knowledge.   
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Women with lowest awareness of the HPV vaccine were most consistently found to be 
aged 30 to 39 years and 60 to 69 years, be born overseas, have never had an abnormal Pap 
smear, have not heard of HPV and have below average cervical cancer/screening knowledge.  
These factors were also of clinical significance, with the exception of cervical 
cancer/screening knowledge, although the confidence intervals for this factor were consistent 
with it being an independent predictor of HPV vaccination awareness.  The model as a whole 
accounted for 19% of the variance in HPV vaccination awareness amongst women in this 
sample. 
5.7 HPV VACCINATION ATTITUDES  
To determine Queensland women’s attitudes towards HPV vaccination and whether 
they differed by socio-demographic factors, screening history, cervical cancer/screening 
knowledge or awareness, study participants firstly completed questions pertaining to their 
attitudes towards vaccination in general followed by their attitudes towards the HPV vaccine 
itself.  This was to obtain a sense of women’s views about vaccination in general or whether 
there was a difference in their attitudes that could be attributed specifically to the HPV 
vaccine.  As described in Section 4.1, following a brief statement explaining the HPV 
vaccine, all participants in this study completed the attitude questions. 
5.7.1 Attitudes towards Vaccination in General 
The majority of women who responded to the survey reported positive attitudes to 
vaccination in general.  As outlined in Table 5.13, most respondents strongly agreed or 
agreed (96%) that “Prevention is better than cure for cervical cancer” with few women 
feeling neutral, negative or expressing uncertainty about this item.  Similar results were 
observed about whether “Vaccines are an important way to prevent disease” with similar 
numbers of women strongly agreeing and agreeing (n = 962) with this statement.   
Women also were positive about childhood vaccination with most respondents strongly 
agreeing or agreeing (92%) that “Everyone should be vaccinated against preventable diseases 
in childhood”, although five percent of women disagreed or strongly disagreed (n = 46) with 
this statement.  Eighty-six percent of women agreed or strongly agreed with the statement - 
“All children should be vaccinated against preventable conditions while they are still babies” 
(Table 5.13).   
There was less agreement with the statement “Vaccines that have been approved by the 
Health Department are safe” with 79% of women agreeing or strongly agreeing, 126 women 
 Chapter 5: What Queensland Women Know about Cervical Cancer/Screening, HPV and the HPV Vaccine 104 
(13%) neither agreeing nor disagreeing and seven percent of women disagreeing or strongly 
disagreeing with this statement.  Cost and access issues were important factors for about one 
fifth of respondents, with 23% of the sample agreeing or strongly agreeing that the cost of 
vaccination would influence their decision to have a child vaccinated and 40% indicating the 
convenience of the venue where the vaccine is given would also influence the decision to 
have a child vaccinated.  There were more polarised views regarding concern about side 
effects with 49% of the sample strongly agreeing or agreeing that they worried about the side 
effects of vaccines for children, 41% disagreeing or strongly disagreeing and nine percent 
indicating they neither agreed nor disagreed with this statement (Table 5.13). 
 
Table 5.13. General Vaccination Attitudes in a Community Sample of 1002 
s
 Women, 
Queensland, 2008 
General Vaccination Attitudes 
 
Strongly 
agree Agree 
Neither 
agree nor 
disagree Disagree 
Strongly 
disagree 
Don’t 
know 
Refused 
answer 
 
n  
(%) 
n  
(%) 
n  
(%) 
n  
(%) 
n  
(%) 
n  
(%) 
n  
(%) 
Prevention is better than cure 
for cervical cancer 
604 350 16 18 4 7 0 
(60.4) (35.1) (1.6) (1.8) (0.4) (0.7) 0.0) 
Vaccines are an important way 
to prevent disease 
557 405 16 15 4 1 0 
(55.7) (40.6) (1.6) (1.5) (0.4) (0.1) 0.0) 
Everyone should be vaccinated 
against preventable diseases in 
childhood 
513 404 32 34 12 2 1 
(51.4) (40.5) (3.2) (3.4) (1.2) (0.2) (0.1) 
Vaccines that have been 
approved by the Health 
Department are safe 
219 571 126 55 16 14 0 
(21.9) (57.1) (12.6) (5.5) (1.6) (1.4) 0.0) 
All children should be 
vaccinated against preventable 
conditions while they are still 
babies 
422 431 61 56 17 13 0 
(42.2) (43.2) (6.1) (5.6) (1.7) (1.3) 0.0) 
The costs involved would 
influence my decision to have a 
child of mine vaccinated 
66 158 28 412 326 7 2 
(6.6) (15.8) (2.8) (41.2) (32.6) (0.7) (0.2) 
The convenience of the venue 
where the vaccine is given 
would influence my decision to 
have a child of mine vaccinated 
105 291 46 357 182 17 2 
(10.5) (29.1) (4.6) (35.7) (18.2) (1.7) (0.2) 
I worry about the side effects of 
vaccines for children 
110 377 95 342 64 11 1 
(11.0) (37.7) (9.5) (34.2) (6.4) (1.1) (0.1) 
a Weighted sample = 999 
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5.7.2 General Vaccination Attitudes and Differences by Socio-demographic Factors, 
Screening History, Knowledge and Awareness 
An overall score for attitudes towards vaccination in general was obtained as outlined 
in Section 4.5.3, which was converted into a positive or negative score.  The sample was very 
positive towards vaccination in general (88% positive attitudes).  There was very little 
variation in attitudes towards vaccination in general observed by any variables with the 
exception of smoking status.  Eighty nine percent of non-smokers (Likelihood Chi
2
 = 4.35; df 
= 1; p = 0.04), were positive towards vaccination in general compared to 84% of smokers 
(Appendix K).  This difference was no longer statistically significant when adjusted for other 
variables following multivariable modelling (OR 1.43; 95% C.I. 0.88 – 2.32; p = 0.15) – data 
not shown.  
5.7.3 Attitudes towards the HPV Vaccine 
The second vaccination attitude scale related specifically to items concerning HPV 
vaccination.  As demonstrated in Table 5.14, the majority of women who responded to the 
survey reported positive attitudes to HPV vaccination.  Most respondents strongly disagreed 
or disagreed (84%) with the statement “If I had a 12 year old daughter I would not want her 
to be vaccinated against HPV” and 85% did not agree that “Vaccinating young women and 
girls against HPV would encourage them to become sexually active”.   
Many women (64%) felt they needed more information before deciding whether to 
vaccinate their daughter against HPV, although one third of the sample (33%) did not agree 
with this statement.  The role of medical practitioners in promoting the vaccine was important 
for 86% of the sample who strongly agreed or agreed with the statement “If I had a 12 year 
old daughter and my doctor thinks it is a good idea, I would have her vaccinated against 
HPV”.  The proportion of women who strongly agreed with this statement was the highest 
observed for any item in this scale. 
There was some uncertainty amongst the sample for the items “There is more risk 
involved in being vaccinated than in having HPV” and “The cervical cancer vaccine works 
best when it is given before a young woman becomes sexually active” with 11% and 19% 
(respectively) of  women responding “don’t know” to these items (Table 5.14). 
Of those who chose a category that indicated their attitudes to these items, 70% 
disagreed or strongly disagreed having the vaccine would be more risky than having HPV, 
although 11% agreed/strongly agreed this was the case and 11% were neutral in their 
 Chapter 5: What Queensland Women Know about Cervical Cancer/Screening, HPV and the HPV Vaccine 106 
response.  Sixty-five percent agreed or strongly agreed that the vaccine works best if given 
prior to sexual debut, with 10% responding neutrally to this item, six percent disagreeing or 
strongly disagreeing with this statement and 19% expressing uncertainty. 
 
Table 5.14. HPV Vaccination Attitudes in a Community Sample of 1002 
a
 Women, 
Queensland, 2008 
HPV Vaccination Attitudes 
 
Strongly 
agree Agree 
Neither 
agree nor 
disagree Disagree 
Strongly 
disagree 
Don’t 
know 
Refused 
answer 
 
n 
(%) 
n 
(%) 
n 
(%) 
n 
(%) 
n 
(%) 
n 
(%) 
n 
(%) 
If I had a 12 year old daughter I 
would not want her to be 
vaccinated against HPV 
16 53 38 549 296 46 2 
(1.6) (5.8) (3.8) (54.9) (29.6) (4.6) (0.2) 
Vaccinating young women and 
girls against HPV would 
encourage them to become 
sexually active 
12 75 39 585 265 22 1 
(1.2) (7.5) (3.9) (58.6) (26.5) (2.1) (0.1) 
If I had a 12 year old daughter I 
would need more information 
before I could decide whether 
she should be vaccinated 
against HPV 
245 398 24 240 87 4 1 
(24.5) (39.9) (2.4) (24.0) (8.7) (0.4) (0.1) 
If  I had a 12 year old daughter 
and my doctor thinks it is a 
good idea, I would have her 
vaccinated against HPV 
334 527 47 63 17 10 1 
(33.5) (52.7) (4.7) (6.3) (1.7) (1.0) (0.1) 
There is more risk involved in 
being vaccinated than in having 
HPV 
27 75 82 485 218 112 1 
(2.7) (7.5) (8.2) (48.5) (21.8) (11.2) (0.1) 
The cervical cancer vaccine 
works best when it is given 
before a young woman 
becomes sexually active 
177 470 102 44 14 191 1 
(17.7) (47.0) (10.3) (4.4) (1.4) (19.1) (0.1) 
a Weighted sample = 998 
 
A similar scoring system to that used for General Vaccination Attitudes was used for 
the scoring of attitudes towards the HPV vaccine as outlined in Section 4.5.3.  One 
respondent was excluded from this analysis as she responded “don’t know” to all items in this 
attitude scale and therefore did not have a score for this scale. 
Overall 74% of the sample had positive attitudes towards HPV vaccination.  A higher 
proportion of women had positive attitudes towards vaccination than the HPV vaccine with 
69% of women having positive attitudes to both.  One-hundred and seventeen women were 
negative towards vaccination in general; however more than twice as many women (n = 260) 
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expressed negative attitudes towards the HPV vaccine.  There were only seven percent of 
women in the study who had negative attitudes towards vaccination in general and the HPV 
vaccine.  Almost one fifth of study participants (193 women) had positive attitudes towards 
vaccination in general but was negative towards HPV vaccination (Figure 5.8).  
 
 
Figure 5.8. Attitudes towards General Vaccination and the HPV Vaccine (n=999) 
 
These findings should be viewed in the context of how negative attitudes were derived 
(Section 4.5.3) as there were higher proportions of women with uncertainty about some items 
in the HPV attitude scale who were allocated a score of zero (a negative score) for these 
responses (Figure 5.9, Figure 5.10).  These figures show much higher responses of ‘don’t 
know’ to HPV vaccination attitude items than general vaccination items indicating higher 
uncertainty amongst women in this study to the HPV vaccine than other vaccines. 
5.7.4 HPV Vaccination Attitudes and Differences by Socio-demographic Factors, 
Screening History, Knowledge, Awareness and Attitudes 
Attitudes towards HPV vaccination were found following bivariate analysis to differ by 
SES, country of birth, abnormal Pap smear history, cervical cancer/screening knowledge, 
having heard of HPV and the HPV vaccine and general vaccination attitudes (Appendix K). 
Multivariable analysis was undertaken as a number of independent variables in the 
bivariate analysis were potential confounders of each other in their relationships with 
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Figure 5.10. Proportion of ‘don’t 
know’ Responses to General 
Vaccination Attitude Items (n=999) 
1Item numbers listed in Appendix H 
Figure 5.9. Proportion of ‘don’t 
know’ Responses to HPV 
Vaccination Attitude Items (n=998) 
1Item numbers listed in Appendix H 
attitudes towards the HPV vaccine.  Factors included in the final model explained 24% 
(Nagelkerke’s R Square = 0.240) of the variation in attitudes towards the HPV vaccine.   
 
 
 
 
 
Following mutual adjustment for all variables in the model, the associations observed in 
bivariate analysis remained statistically significant for positive HPV vaccination attitudes for 
SES, country of birth, a history of an abnormal Pap smear, cervical cancer/screening 
knowledge, HPV vaccine awareness and attitudes towards vaccination in general but not for 
awareness of HPV (Table 5.15). 
When variables were removed from the model then added back individually to 
determine the shift in odds ratios of each variable, there was little confounding or variation in 
odds ratios for SES, born in Australia, HPV vaccine awareness and attitudes towards 
vaccination in general.  Variations in the significance of adjusted odds ratios were observed 
for abnormal Pap history when HPV awareness (p < 0.0001) and SES (p = 0.001) were 
removed from the model.  Odds ratios were also more significant for cervical 
cancer/screening knowledge when HPV awareness and HPV vaccine awareness (p = 0.0002, 
respectively) and screening status (p = 0.0004) were individually removed from the model.  
The odds ratios for HPV awareness increased when HPV vaccine awareness (p = 0.06) and 
cervical cancer/screening knowledge (p = 0.5) were each removed from the model.  The 
influence of these variables on other variables validated their inclusion in the final model 
even though there was not always a significant shift in odds ratios.  
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Table 5.15. Multivariable Relationships between HPV Vaccination Attitudes and 
Demographic, Screening History and Knowledge Variables in a Community Sample of 1002
a
 
Women, Queensland, 2008 
HPV Vaccination Attitudes 
 
Number 
women 
(998) 
% 
Positive 
attitudes 
(74.0) 
 
Crude 
OR 
b 
 
Adjusted 
c 
Sig e  OR
c  95 C.I 
d 
SOCIODEMOGRAPHIC            
Age in 10 yr groups          
20–29 249 77.1  1.00 1.00  (referent) 0.53 
30–39 260 73.2  0.81 0.77  0.46 1.29  
40–49 230 76.2  0.95 0.99  0.57 1.71  
50–59 163 71.9  0.76 0.69  0.38 1.25  
60–69 96 66.1  0.58 0.68  0.35 1.35  
Locality 
 
         
outer reg, rem, vremote 
f 
252 70.5  1.00 1.00  (referent) 0.53 
major cities 449 75.5  1.29 1.10  0.71 1.70  
inner reg 
f 
297 74.7  1.23 1.28  0.83 1.97  
Socioeconomic status          
quintile 1 (most disadv 
f
) 176 77.8  1.00 1.00  (referent) 0.001 
quintile 2 184 66.3  0.56 0.45  0.27 0.77  
quintile 3 152 64.9  0.53 0.50  0.28 0.88  
quintile 4 194 78.6  1.05 1.12  0.63 2.00  
quintile 5 (least disadv) 293 78.2  1.03 0.94  0.53 1.65  
Australian born          
no 185 63.5  1.00 1.00  (referent) 0.01 
yes 813 76.4  1.86 1.80  1.19 2.73  
Educational attainment          
year 10 or below 175 69.1  1.00 1.00  (referent) 0.33 
year 11or 12 173 75.6  1.38 1.20  0.68 2.10  
cert or diploma 
f 
403 76.2  1.43 1.43  0.89 2.29  
Ba degree or higher 
f
 246 73.1  1.22 1.02  0.59 1.77  
Marital status           
never married 141 76.6  1.00 1.00  (referent) 0.96 
married 594 74.1  0.88 1.03  0.56 1.90  
defacto 167 74.1  0.88 0.91  0.48 1.74  
sep/div/wid 
f 
97 69.0  0.68 0.98  0.45 2.10  
Had children          
no 242 76.7  1.00 1.00  (referent) 0.58 
yes 756 73.1  0.83 0.87  0.54 1.41  
Smoking status          
yes 206 72.7  1.00 1.00  (referent) 0.84 
no 792 74.3  1.09 0.96  0.63 1.46  
SCREENING HISTORY  
Screening status           
underscreened 151 67.8  1.00 1.00  (referent) 0.59 
regularly screened 623 75.0  1.43 1.15  0.74 1.78  
overscreened 183 77.6  1.64 0.92  0.52 1.62  
Abnormal Pap history          
yes 292 83.1  1.00 1.00  (referent) 0.0003 
no 706 70.2  0.48 0.46  0.31 0.70  
KNOWLEDGE AND AWARENESS 
Cx screen knowledge level          
below average 444 66.9  1.00 1.00  (referent) 0.001 
above average 554 79.7  1.94 1.80  1.28 2.52  
Heard HPV          
no 366 66.4  1.00 1.00  (referent) 0.26 
yes 633 78.3  1.83 1.23  0.86 1.75  
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Table 5.15 continued 
 
  
 
  
 
   
Heard HPV vaccine           
no 137 49.1  1.00 1.00  (referent) <0.0001 
yes 862 77.9  3.66 2.78  1.80 4.29  
ATTITUDES          
General vaccination attitudes         
negative 117 42.4  1.00 1.00  (referent) <0.0001 
positive 881 78.2  4.85 5.85  3.75 9.12  
 
a 
Weighted sample = 999 
b 
OR, odds ratios of below average cervical cancer/screening knowledge 
c
 odds ratios mutually adjusted for all variables adjusted in table 
d
 C.I., confidence interval for true estimate of adjusted odds ratio 
e
 statistical significance of adjusted OR 
f 
outer reg, rem, vremote = outer regional, remote and very remote, inner reg = inner regional; disadvant = 
disadvantaged; 
 
Ba degree = bachelor degree; sep/div/wid = separated, divorced, widowed 
 
When compared with women living in areas of most socio-economic disadvantage, 
women in quintiles two (OR 0.45; 95% C.I. 0.27–0.77) and three (OR 0.50; 95% C.I. 0.28–
0.88) had lower odds of having positive attitudes towards vaccination (p =0.001).  Variation 
in HPV vaccination attitudes by country of birth remained significant with women born in 
Australia having 1.8–fold higher odds of having positive HPV vaccine attitudes relative to 
women born overseas (OR 1.80; 95% C.I. 1.19–2.73; p =0.01).  Study participants who had 
never had an abnormal Pap smear history had lower odds of having positive HPV vaccination 
attitudes relative to those who had experienced an abnormal result (OR 0.46; 95% C.I. 0.31–
0.70; p <0.0001).   
A significant difference in knowledge, awareness and attitudes towards HPV 
vaccination was also confirmed through multivariate modelling.  Women who had above 
average cervical cancer/screening knowledge had 1.8–fold higher odds of having positive 
attitudes towards the vaccine (OR 1.80; 95% C.I. 1.28–2.52; p = 0.001) relative to those with 
below average knowledge.  A decrease in odds was observed by awareness of HPV and was 
no longer significant when adjusted for other factors included in the model (OR 1.23; 95% 
C.I. 0.86–1.75; p =0.26).  However, awareness of the vaccine remained a significant predictor 
of positive attitudes with women who had heard of the vaccine prior to participating in the 
survey having 2.8–fold higher odds of having positive HPV vaccine attitudes relative to those 
who had not (OR 2.78; 95% C.I. 1.80–4.29; p < 0.0001).   
A highly significant difference was also confirmed through multivariate modelling 
between participants who had expressed positive attitudes towards vaccination in general.  
These women had 5.8–fold higher odds of having positive attitudes towards the HPV vaccine 
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(OR 5.85; 95% C.I. 3.75–9.12; p <0.0001) relative to those who had negative attitudes about 
vaccination in general. 
5.7.5 Summary of Factors Associated with HPV Vaccination Attitudes  
In response to the question – ‘What are Queensland women’s attitudes towards HPV 
vaccination and does this differ by socio-demographic factors, screening history, cervical 
cancer/screening knowledge or awareness?’ 74% of women in this study were found to have 
positive attitudes towards HPV vaccination.  The majority of women would want their 
daughter to be vaccinated against HPV, especially if recommended by their doctor and did 
not believe vaccinating young girls would encourage them to become sexually active.  Most 
women indicated the need for more information about the vaccine and some expressed 
uncertainty about the vaccine in relation to its safety and whether the vaccine was more 
effective if given prior to sexual debut.   
Following mutual adjustment for all variables included in the model, the factors 
associated with positive attitudes towards the HPV vaccine were country of birth, abnormal 
Pap smear history, cervical cancer/screening knowledge and HPV vaccination awareness and 
positive HPV vaccination attitudes.   
Women with positive attitudes towards the HPV vaccine were most consistently found 
to be: born in Australia, were from the quintiles of most and least socio-economic 
disadvantage, had a past history of abnormal Pap smears, above average cervical screening 
knowledge, had heard of the HPV vaccine prior to participating in the study and had positive 
attitudes towards vaccination in general.  The model as a whole accounted for 24% of the 
variance in HPV vaccination attitudes amongst women in this sample. 
5.8 SUMMARY OF THE FINDINGS OF PHASE 1 
Queensland women who participated in this study had good knowledge of the purpose 
of the Pap smear and familiarity with the recommended NCSP screening interval; however 
there was poor knowledge of participants regarding the age range of the eligible population.  
There was also considerable uncertainty expressed by participants about some risk factors for 
cervical cancer, especially the role of HPV and sexual behaviours.  There was little variation 
in cervical cancer/screening knowledge with the only differences observed by screening 
status with underscreened women having lower knowledge compared to more regular 
screeners.  This was confirmed by multivariable analyses in which screening status was found 
to be an independent predictor of cervical cancer/screening knowledge.   
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Almost two thirds of women (63%) had heard of HPV.  Awareness of HPV was most 
common amongst women who were born in Australia, had completed post school 
qualifications, were married, who had an abnormal Pap smear in the past and who had above 
average knowledge about cervical cancer/screening.  There was limited knowledge and high 
levels of uncertainty amongst participants about HPV.  Lower knowledge was evident in 
older women, women in married and defacto relationships and those with poorer cervical 
cancer/screening knowledge, women who had not heard of the HPV vaccine and those who 
had negative attitudes towards HPV vaccination.   
A high proportion of participants had heard of the HPV vaccine (over 86%) and the 
most commonly cited sources of this awareness were mass media.  Women with lowest 
awareness of the HPV vaccine were aged 30 to 39 years and 60 to 69 years, had been born 
overseas, had never had an abnormal Pap smear, had not heard of HPV and had below 
average cervical cancer/screening knowledge.   
Women had positive attitudes towards HPV vaccination and those with positive 
attitudes towards the HPV vaccine were most commonly born in Australia, from SES 
quintiles of highest and lowest disadvantage, had a past history of abnormal Pap smears, 
above average cervical screening knowledge and had heard of the HPV vaccine prior to 
participating in the study.  Women with positive attitudes to vaccination in general were more 
consistently found to also have positive HPV vaccination attitudes.   
The implications of these findings are discussed further in Chapter 8: Discussion and 
Chapter 9: Conclusions.  The findings of Phase 1 informed Phase 2 of the study which aimed 
to explore the primary research questions in greater depth.  The research design for Phase 2 is 
described in the next chapter. 
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Chapter 6: Research Design Phase 2 
This chapter describes the design adopted by this research to achieve the aims of Phase 
2 of the study.  The methodology for Phase 2 of the study is described in Section 6.1; in 
Section 6.2 the aims of Phase 2 are outlined, and Section 6.3 contains details about how 
women were recruited for the focus groups.  In Section 6.4, the data collection instruments 
used in the focus groups are described, Section 6.5 provides an outline of how the focus 
groups were conducted and the timeline for completion; and in Section 6.6, how the data was 
analysed is discussed. 
6.1 METHODOLOGY AND RESEARCH DESIGN 
Phase 2 utilised focus groups to gather in-depth information about women’s 
knowledge, awareness and acceptance about cervical cancer prevention and further explore 
and explain the findings of Phase 1.  A qualitative approach was incorporated into this study 
to produce information rich data and answer questions not suited to the structured format of 
the telephone survey, particularly those relating to sensitive subjects for example, perceptions 
about barriers to screening (Liamputtong and Ezzy, 2005).   
The Health Belief Model (HBM) was used as the conceptual framework underpinning 
the study as described in Section 3.2.  The HBM was used to inform the topic guide used in 
focus groups, (Appendix L), and provided overarching themes for data analysis that were 
defined a priori, and the experiences and perceptions of participants as they related to these 
themes, were described from focus group transcripts. 
6.2 RESEARCH QUESTIONS 
The primary aim of the qualitative arm of the study was to ascertain what Queensland 
women say about cervical cancer, cervical screening, HPV and the HPV vaccine and what 
they perceive as the most effective methods of communication and health promotion should 
changes be made to the National Cervical Screening Program (NCSP).  
The research questions to be answered by this component were: 
 What do Queensland women know about cervical cancer/screening and what 
are their attitudes towards Pap smears? 
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 What do Queensland women know about human papillomavirus (HPV) and 
what are their attitudes towards the cervical cancer/HPV vaccine? 
 Where do Queensland women get their health information from and what do 
they women perceive as the most effective methods of communication and 
health promotion should changes be made to the NCSP? 
Focus groups were conducted to gather in-depth information for Phase 2 of the study 
and were facilitated by the research student.  This method has been adopted by a number of 
researchers exploring women’s attitudes and knowledge about HPV, cervical cancer/ 
screening and the HPV vaccine from which valuable information has resulted to inform 
policy decisions and further research (Mays, Sturm and Zimet, 2004; Mays et al., 2000; 
Olshen et al., 2005; Zimet et al., 2000; Brabin, Roberts and Kitchener, 2007; McClelland and 
Liamputtong, 2006).  Phase 2 built on the first phase of the study as it enabled in-depth 
exploration of what women thought caused cervical cancer, how serious it was as a condition, 
their experience of it, whether they perceived they were at risk of it and the purpose of and 
barriers to Pap smears.  It also enabled further exploration of their knowledge of HPV and the 
HPV vaccine and their attitudes to HPV vaccination.   
This study extends previous investigations given it is the first study conducted in the 
Queensland setting since the implementation of the National Human Papillomavirus 
Vaccination Program (NHPVP). 
Focus groups have also been reported to be useful following the analysis of  large-scale 
quantitative surveys as they facilitate interpretation of the results and add depth to structured 
survey responses (Stewart and Shamdasani, 1990).  They allow the researcher to interact 
directly with respondents, provide opportunities for the clarification of responses and the 
opportunity to obtain large and rich amounts of data in the respondent’s own words (Stewart 
and Shamdasani, 1990).  They are an effective forum for the discussion of ideas and the 
exploration of subjective issues, such as attitudes, feelings and beliefs (Dixon, year 
unknown).   
Focus group discussions were conducted in settings nominated by community women 
to ensure the research was conducted in a setting in which they would be familiar and feel 
comfortable.   
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6.3 PARTICIPANTS 
The snowball sampling technique was used to recruit women for focus groups with the 
assistance of service providers and key community women.  A priori sampling was used to 
select participants, that is, participants were chosen according to specific characteristics and 
structure, although this does not preclude the inclusion of participants with alternative 
characteristics as the study progresses (Ulin, Robinson and Tolley, 2005).  Women aged 20 to 
69 years who had not had a hysterectomy were invited to participate in focus groups in 
metropolitan, regional and remote settings.  
Participants were recruited through community organisations and services, including 
the Queensland Country Women’s Association (QCWA), Zonta International, Women’s 
Health Centres and three social groups.  The QCWA is a non party political, non sectarian 
organisation with 274 local branches throughout Queensland that offer a host of activities – 
such as cookery, dressmaking and public speaking, and friendship and support, not just to 
members but to the wider community.  Zonta International is a global organization of 
executives and professionals working together to advance the status of women worldwide 
through service and advocacy and has 47 Clubs throughout Queensland.  The social groups 
were a church group, a book club and a group of co-workers and friends from a metropolitan 
hairdressing salon.  These groups were selected as it was assumed women had existing social 
networks and would be comfortable participating in a focus group with their peers.  It was 
also assumed women at most risk for cervical cancer were members of these organisations, 
such as women residing in remote locations and low socio-economic status (SES) areas, 
women from culturally and linguistically diverse backgrounds, women over 50 years of age 
and women who were unscreened or underscreened for cervical cancer. 
Aboriginal and Torres Strait Islander women are also at increased risk of cervical 
cancer; however, due to the sensitivity of this topic and respect for the ownership of research 
conducted in Aboriginal and Torres Strait Islander communities, Aboriginal and Torres Strait 
Islander organisations were not specifically targeted for the purposes of this study.   
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Figure 6.1. Number of Women Participating in Focus Groups Conducted in Queensland, 
2009. 
Recruitment ceased at the end of the allocated time set for Phase 2 of the study.  
Twenty three focus groups were held across Queensland between February and December 
2009.  The number of women participating in the focus groups ranged from five to 31 with 
the ideal range being eight to 12 women as marked by dotted lines (Figure 6.1).  The 
recruitment information sheet specified women should be aged 20–69 years and have not had 
a hysterectomy; however women who had had a hysterectomy (number unknown), two 
women aged 18–20 years and 30 women over 70 years of age arrived ready to participate in 
the focus groups.  The number of focus groups was primarily driven by the need to access 
women from all localities and the enthusiasm of the organisations involved in participating in 
the focus groups.  No women were excluded as they had presented in good faith and were 
keen to participate. 
Whilst 23 focus groups was a large number of groups to achieve the aims of this study, 
women’s engagement and desire to participate was high and focus groups were conducted 
wherever interest was indicated within time and cost restrictions.   
6.4 FOCUS GROUPS TOOLS 
The HBM was used as the organising framework to guide the development of the topic 
guide for focus group discussions (Rosenstock, 1974; Connor and Norman, 2005; Brewer and 
Fazekas, 2007; Ulin, Robinson and Tolley, 2005).  The topics discussed and their relevance 
to the research questions of interest and aspects of the HBM are outlined in Table 6.1.  
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This topic guide was used to guide discussion and was modified during the course of 
qualitative data collection (Ulin, Robinson and Tolley, 2005; Brewer and Fazekas, 2007).  
Modifications to the topic guide included the addition of a question about a hypothetical test– 
‘If there was a test that you could do at home, say a tampon or swab you could insert yourself 
and send in the mail – do you think women who don’t go for Pap smears now might do it?’, 
as this emerged in the literature and media about one month after focus groups commenced 
and was worth exploring as there was no published data about this in the Australian context.  
The concept of embarrassment as a barrier to having a Pap smear was explored in greater 
detail than originally intended as it was so frequently raised in the first few focus groups. 
A question to explore women’s views about sending a letter about changes to the NCSP 
to women on the Pap Smear Register (PSR) was also added to the topic guide after it was 
suggested in one of the first groups.   
6.5 PROCEDURE AND TIMELINE 
6.5.1 Recruitment 
The researcher firstly engaged with the Cancer Screening Services Branch Consumer 
Representative Group to discuss the study and ascertain if the presidents of the QCWA and 
Zonta International were interested in assisting with recruiting women to participate in the 
study.  This group was consulted at all stages of the process and also participated in a focus 
group as an educational experience on completion of the focus groups, for their personal 
information, and to know how the process was conducted.  This focus group was not part of 
this study.  The researcher also attended two meetings of Women’s Health Centre Managers 
and provided information about the study and sought their involvement.  
These representatives were interested in assisting with the study and disseminated 
information about it to their organisations and the researcher was contacted by regional 
representatives and made arrangements with them to hold focus groups.  Regular contact was 
maintained with the organisers and where possible an attempt was made to ascertain the 
number of women likely to attend each group.  It was recommended the ideal size of a group 
was between eight and 12 women. 
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Table 6.1 Information Collected to Inform Phase 2 
Research Question HBM CONSTRUCTS HBM RELATED TO SUBJECT QUESTION 
What do women know about cervical 
cancer/screening and what are their 
attitudes towards Pap smears? 
 
 
Self-efficacy  
 
Women’s belief that they are able 
to influence their own health 
What do you think of the following statement: ‘Good health is largely a matter of 
good luck’? 
Perceived susceptibility to 
disease 
Perceived susceptibility to cervical 
cancer  
What do you think causes cancer of the cervix?  How common is it? 
Do you think every woman has the same risk of getting cancer of the cervix? 
Perceived seriousness of 
disease 
Perceived seriousness of cervical 
cancer 
If a woman gets cervical cancer, is there a cure?  Do you think it would have a 
big impact on a woman’s health? 
Perceived benefits of 
taking action 
Perceived benefits of cervical 
screening  
What do you know about Pap smears? 
How good are Pap smears at preventing cervical cancer?   
Perceived barriers to 
action 
Perceived barriers to cervical 
screening 
 
What do you think prevents some women from having Pap smears or putting 
them off?  
What do you mean when you say Pap smears are embarrassing?  Is it the same 
embarrassment as say having check-ups when you’re pregnant? 1 
Cues to action Alternatives that may be  more 
likely to prompt action  
Hypothetical - If there was a test that you could do at home, say a tampon or 
swab you could insert yourself and send in the mail – do you think women who 
don’t go for Pap smears now might do it? 1 
What do Queensland women know 
about HPV and what are their attitudes 
towards the cervical cancer/HPV 
vaccine? 
 
Perceived susceptibility to 
disease 
Perceived susceptibility to HPV 
infection 
What do you know about human papillomavirus or HPV?   
 
Perceived benefits  Perceived benefits of HPV  What do you know about the new vaccine for preventing cancer of the cervix? 
Cues to action  Information or advice that may 
trigger one to participate in cervical 
screening or vaccination, or consent 
for child to be vaccinated 
What do you think would prompt a woman to agree for her daughter to have the 
vaccine or to have the vaccine herself? 
What do they women perceive as the 
most effective methods of 
communicating and promoting new 
information should changes be made to 
the NCSP 
Cues to action Sources of knowledge that may 
trigger one to participate in a 
renewed NCSP. 
Where do you get your health information from? 
The QCSP has developed a number of ways to provide information about HPV 
and cervical cancer –If there was new information we wanted to provide to 
women - what do you think is a good way to do this?  
If the PSR sent a letter to women with information about changes to the NCSP, 
would this be a good idea? 1 
1 Added to the topic guide after focus groups commenced 
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The method chosen to disseminate information and recruit women was guided by the 
organiser and differed by organisation and group.  Information flyers were provided with 
details about the study and were posted on noticeboards or tabled at meetings for members to 
consider (Appendix B).  A colleague and work related associate who had heard about the 
study and a group of young women were recruited through ‘social networks’. 
6.5.2 Process 
Some groups were conducted as part of Women’s Health Events, such as Pamper Days 
(a women’s health expo where women can have a facial or massage and speakers present or 
display health information), in conjunction with regular meetings or events, or were held 
specifically for the purpose of the research project.  As a result it was not always possible to 
know the number of women likely to attend a focus group prior to the event.  The venues 
included QCWA halls, function rooms in hotels or clubs, women’s health centres, local halls 
or function venues, a church and individual homes.   
The process for conducting the focus groups was somewhat standard in terms of the 
format, although protocols differed according to the organisation and the event.  When the 
event was held as part of a formal meeting the researcher was often formally introduced or 
welcomed at a particular point in the meeting agenda by a senior person.  When formal 
meetings occurred with dinner, focus groups were conducted when formal proceedings had 
ended or after the meal.  At other times, the process was very informal and it was handed 
over to the researcher to coordinate.   
At the start of each focus group, the researcher would introduce herself to women and 
asked them to read the information sheet (Appendix B) and complete the consent form and a 
brief questionnaire if they wished to participate (Appendix C; Appendix M).   
Once this was completed women’s permission was sought to audio-tape the session and 
the researcher provided a brief overview of her background and the rationale for the study 
and the process to be followed for the focus groups.  She also advised women that no answers 
or corrections would be made during the focus group but that this would occur in the 
information session at the end, where answers to the questions and misconceptions or 
additional queries that arose during the session would be addressed.  Women were 
encouraged to talk about anything they had heard in relation to the questions asked, even if 
they were not sure if the answer was correct or not, in an attempt to prompt discussion rather 
than have women feel they were being assessed or examined. 
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The topic guide was used to guide the flow of the discussion, although at times women 
would move on to the next question without prompting.  The discussion was often informal, 
particularly in smaller groups and aimed to provide a relaxed atmosphere for women to share 
their stories and experiences. 
At the end of this discussion a brief clarification/education session was provided based 
on women’s responses to the questions asked during the focus group discussions.  This 
session was therefore individualised to each group; however similar topics were covered 
across all groups and an overview of these topics is provided in Appendix N.  This was 
especially important as women’s responses were not challenged during the focus group 
discussions when incorrect responses were given to ensure accurate information was 
provided at the end.  It was also a good opportunity to provide information for women who 
were very keen to know the answers to the questions and to respond to the questions women 
raised during the sessions. 
Women participating in focus group discussions were provided with refreshments 
(appropriate for the time of day in which the focus group discussions were held).  At the end 
of the focus groups they were given a thank-you gift bag, which included a small first aid kit, 
some beauty products, flower seeds, a candle, a notebook and other miscellaneous items.  
This gift bag also included some booklets reinforcing the information provided on cervical 
screening, Pap smears and HPV and a promotional pen “When did you last have a Pap 
smear” and a make-up mirror about the importance of regular Pap smears.   
Women were also asked if they would like to be informed of the outcomes of the focus 
groups and those who were interested wrote their contact details on a register which was kept 
separate to the questionnaires and used purely for this purpose. 
An observer was present when possible at most focus groups to record observations 
about the group.  These observers were frequently staff from the Queensland Cervical 
Screening Program (QCSP) or local organisers who were employees of the organisation and 
preferred to observe rather than participate.  These observers kept notes in a journal and were 
asked to document interesting things they noted about the process, the facilitator or the 
discussion. 
A reflective journal was kept in which the researcher described the context of her own 
knowledge, experiences and judgements and secondly recorded and acknowledged her 
experiences and observations during the focus groups (Sharkey, 2001).  This was usually 
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completed within 12 to 24 hours after the group was conducted.  An overview of the 
researcher’s personal reflections about the focus groups can be found in Appendix O. 
6.5.3 Timeline 
Focus groups were conducted between February and December 2009.   
6.6 QUALITATIVE DATA ANALYSIS 
6.6.1 Data Sources 
There were a number of data sources resulting from the focus groups.  Firstly, women 
were asked to complete a brief survey prior to participating in the focus groups to provide 
some demographic data and assess their previous experience with Pap smears and awareness 
of HPV and the HPV vaccine.  Additional sources of data from the focus groups were 
transcripts from the audio tapings of focus group discussions, observer notes and notes kept 
in a personal reflective journal.   
6.6.2 Survey Data Analysis 
The brief survey data were initially entered into Excel 2007 and analysed by a research 
assistant.  Data was reanalysed using SPSS Version 16 to verify the findings. Descriptive data 
is presented to provide a brief overview of the participants’ characteristics and groupings and 
was conducted in a similar manner to that described for the computer-assisted telephone 
interview (CATI) survey.  This is presented as counts and percentages with the exception of 
age, which is also described as mean age as it was normally distributed when a continuous 
variable.   
6.6.3 Analysis of Focus Group Discussions  
There were four key stages used to analyse the data from the focus groups as outlined 
by Hennink (2007), namely: 
 Stage 1: Data preparation 
 Stage 2: Identifying themes in the data 
 Stage 3: Labelling the data by themes 
 Stage 4: Using the framework for analysis. 
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Stage 1: Data Preparation 
The statistical software package NVivo version 9 was utilised for the analysis of focus 
group data.  NVivo was used to assist with managing focus group data from multiple sources, 
was the tool used to code themes in the data and provided a tool for querying the data and 
developing models (Bazeley, 2007).   
The observer notes were transcribed by a research assistant and entered into NVivo.  
The majority of audio-tape recordings (16) were transcribed verbatim by the researcher with 
the remainder transcribed by three research assistants.  Transcribing the data was a very time 
consuming process as the audio-tapes were at times difficult to hear as outlined in Section 
9.3, and required extensive effort in listening and re-listening to the tapes to capture the data 
accurately.  The researcher reviewed all audiotapes and corresponding transcriptions to clean, 
label and anonymise the data.  Data cleaning was undertaken to ensure there were no errors in 
the transcripts and that they were accurate and also reflected emotive responses, such as 
laughter or emphatic tones, for example, R3: “Ooooh, oh my God!” (gasps).  Labels were 
assigned where possible to different speakers to track what individual speakers were saying 
and identify if one person was dominating the conversation or whether a passage included 
statements from a number of different women (Hennink, 2007).  The transcriptions were also 
anonymised to remove any names of people, locations, health clinics or hospitals or any 
identifying information that may compromise the confidentiality of women or the focus 
groups in which they participated (Hennink, 2007).  This was particularly important as a 
number of focus groups were conducted in small community settings. 
Stage 2: Identifying Themes in the Data 
Willig (2008), describes four steps in analysing transcripts with the first stage involving 
immersion in the data by reading and rereading transcripts and recording initial thoughts and 
observations about the text.  The second stage involves the identification of conceptual 
themes followed by the third stage in which structure is incorporated into the analysis and 
themes are clustered into natural clusters of concepts (Willig, 2008; Chan, Benner and 
Brykczynski, 2010).  In the fourth stage of analysis a summary table of structured themes is 
produced with quotations or exemplars that illustrate each theme (Willig, 2008).   
Themes are topical markers of various parts of the discussion and can be issues, 
concepts, influences, explanations, ideas or other topics which mark the focus of the 
discussion (Hennink, 2007).  In this stage of the analysis, the transcripts of each focus group 
 Chapter 6: Research Design Phase 2 123 
were read and re-read.  The overarching themes in the analysis were identified from the 
explicit areas of the topic guide and the main constructs of the HBM as described in Section 
6.1 to highlight the parts of the discussion devoted to each specific topic.  A deductive, semi-
structured approach to data analysis was therefore used, whereby the constructs of the HBM 
provided predetermined overarching themes and the questions underpinning them to structure 
the analysis (Morgan, 1997).   
The process of developing themes began through the identification of themes from the 
specific issues discussed under each topic by systematically working through a number of 
focus group transcripts (Bazeley, 2007; Hennink, 2007).  This first step in the  process 
resulted in many themes, which were refined through a process of developing, reviewing and 
building and collapsing themes until key themes were identified (Bazeley, 2007).  The 
process of developing and collapsing themes continued through the analysis until data 
saturation was reached whereby no new themes were identified from the data (Miles and 
Huberman, 1994).   
Other codes not relevant to the HBM were also generated in this process that related to 
group dynamics, emotive responses and factors impacting on the quality of data collection 
and recording, such as background noise, which were noted and are reported in Appendix O 
(Ulin, Robinson and Tolley, 2005). 
Stage 3: Labelling the data by themes 
Once a core list of themes were identified and entered into NVivo, the whole data set 
was indexed against these themes through a systematic process of reading and re-reading the 
transcripts, examining the content and marking each segment of text with the appropriate 
theme labels until the whole data set was labelled where appropriate (Hennink, 2007).  
Stage 4: Using the framework for analysis 
The final stage was the descriptive analysis of the data in which the theme labels were 
used to identify all segments of the text relating to a specific theme and examining the 
discussion of that theme across the entire data set (Hennink, 2007).  This was done by 
focusing on one theme a time and was facilitated by the use of NVivo whereby each theme or 
node could be displayed across all focus groups at once (Bazeley, 2007).   
From this process, summary tables of the themes that emerged for each topic where 
produced including exemplars of what women said that led to these interpretations, which 
were used to describe the findings (Chapter 7).  The final stage of analysis involved the 
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synthesis of research findings as they relate to the research objectives, which are described in 
Chapters 8 and 9. 
6.6.4 Establishing Rigour 
Whilst debate exists about the appropriateness of specific criteria to validate the 
authenticity of findings in qualitative research (Miles and Huberman, 1994), the researcher 
has aimed to establish trustworthiness in this findings of this study.  The principles described 
by Liamputtong and Ezzy (2005), for establishing theoretical, procedural, interpretative and 
evaluative rigour and rigorous reflexivity were used to guide this process.   
a) Theoretical rigour relates to the rationale and choice of methods for addressing the 
research question.  The HBM is considered appropriate to explore individuals’ knowledge 
and attitudes towards screening and preventative behaviours as outlined in Section 3.2.  
Coherence in the presentation of findings and integration with the underlying theoretical 
framework was also used to demonstrate this (Willig, 2008).  Theoretical rigour will also 
be proven when publication of the findings from focus groups are available for peer 
review (Liamputtong and Ezzy, 2005).   
b) Procedural or methodological rigour in this study is demonstrated by clear documentation 
of methodological and analytical decisions, which are discussed throughout this methods 
section and have also been documented during the research process in a reflective journal.  
This includes situating the sample by describing participants and their life circumstances 
(Section 7.1) to allow the reader to assess transferability or the relevance and applicability 
of the findings to other settings (Willig, 2008).  An audit trail of analytical decisions was 
also recorded in a coding journal (Miles and Huberman, 1994).  The findings of these 
focus groups have been presented in multiple settings including a national conference, a 
national forum of professional peers (Program Managers), and three local meetings of 
consumers, clinicians and cervical screening experts and positive feedback was received 
on the process, findings and deductions (Appendix E). 
c) Interpretative rigour is reflected by clearly demonstrating how interpretation was 
achieved and through accurate representation of the events and actions that led to 
interpretation (Liamputtong and Ezzy, 2005).  Direct quotes (exemplars), have been 
included to provide the reader with insight into how data was interpreted and described 
and establish trustworthiness in the analytical process.  Inter-rater reliability is another 
method used to demonstrate interpretative rigour; although this is questioned by some 
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qualitative researchers (Liamputtong and Ezzy, 2005).  A colleague, who had been an 
observer at five focus groups, reviewed a sample of transcripts for the purpose of 
credibility checking (Willig, 2008).  A random sample of three focus group transcripts 
was selected (by pulling names out of a hat), which were coded separately by hand.  The 
researcher then reviewed the codes assigned to these transcripts and there were high 
levels of consistency such that the coding framework was considered credible. 
The use of mixed methods as in this study also facilitates interpretative rigour as 
triangulation provides a more complex picture of the phenomenon being studied 
(Liamputtong and Ezzy, 2005).  The qualitative phase in this study was designed to 
explore the findings of the quantitative survey and as the methods complement each 
other, should also contribute to trustworthiness if there is consistency between the 
findings. 
d) Evaluative rigour relates to the ethical and political aspects of the study and relate to 
procedural processes such as obtaining ethical approval and consideration of the political 
and social consequences of the research (Liamputtong and Ezzy, 2005).  The ethical 
processes used for this research are described in Section 3.3. 
There were no anticipated political consequences of this research; however there was a 
potentially sensitive social issue that emerged during the focus groups that needed to be 
managed carefully.  As discussed in the literature review, cervical cancer and its association 
with a sexually transmitted disease has not been widely promoted in the Australian setting 
until the introduction of the HPV vaccine.  Women often disclosed in the focus groups that 
they had either had cervical cancer or abnormal Pap smears in the past.  When HPV was then 
discussed as being the cause of cervical cancer, this potentially placed these women in a 
difficult and shameful situation given the stigma associated with sexually transmitted 
infections (STIs).   
This was actively managed by de-stigmatising HPV and describing it as ‘the common 
cold of sexual activity’, (Hammond, 2006) and women did not appear to suffer any distress 
resulting from the discussions.  This also highlighted, the value of using established social 
networks for this type of research as these women knew each other very well and frequently 
discussed quite intimate details with each other during the focus groups. 
e) The final aspect of establishing rigour is reflexivity which acknowledges the researcher is 
part of the setting, context and culture they are trying to understand and analyse and 
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therefore has to be honest about their role (Liamputtong and Ezzy, 2005).  The 
researcher’s role and experience is described in Appendix P. 
The key findings relevant to the aims of Phase 2 of this study as described in Section 
6.2 are described in the next chapter, ‘What Queensland Women Say about Cervical 
Cancer/Screening, HPV and the HPV Vaccine’. 
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Chapter 7: What Queensland Women Say about 
Cervical Cancer, Pap Smears, HPV 
and the HPV Vaccine 
This chapter describes the findings from Phase 2, the qualitative component of this 
study.  The research questions to be addressed by this phase of the study are described in 
Section 6.2. 
In Section 7.1, the characteristics of women attending the focus groups are described 
including their screening history and awareness of human papillomavirus (HPV) and the 
HPV vaccine.  The findings from the focus groups are then described in the following 
sections: self-efficacy in Section 7.2, perceived susceptibility to cervical cancer in Section 
7.3, perceived seriousness of cervical cancer in Section 7.4, benefits of screening in Section 
7.5 and barriers and enablers in Section 7.6.  Women’s perceptions about their susceptibility 
to HPV are described in Section 7.7 followed by benefits of HPV vaccination in Section 7.8.  
Cues to action including where women obtain health information and their recommendations 
for information dissemination are described in Section 7.9 with the findings of the focus 
groups summarised in Section 7.10.   
7.1 CHARACTERISTICS OF WOMEN ATTENDING FOCUS GROUPS 
Overall, 256 women consented to participate in the focus groups.  The average age of 
participants was 55 years (SD 14.89; range 18 to 88 years) with one third of women in the 
60–69 year age group (Table 7.1).  Focus groups were held in the following locations, some 
of which are not named specifically to maintain women’s confidentiality as these were small 
communities: Fraser Coast, Townsville, Gympie, Atherton, Goodna, Gladstone, Laidley, 
regional areas around Rockhampton, Childers (and surrounding areas), the Gold Coast, 
Morayfield, Caboolture, Mt Isa, a regional town near Roma, Roma, Charters Towers, two 
inner Brisbane suburbs and Redland Bay (Figure 7.1). 
The majority of women (41%) were recruited through the Queensland Country 
Women’s Association (QCWA), were from inner regional areas (45%), were married (63%) 
and 88% had children (Table 7.1). 
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Table 7.1. Characteristics of Women Attending Focus Groups in Queensland, 2009 
Socio-demographic Characteristics  N=256
1 
% 
Recruitment (n=255)   
QCWA 104 40.8 
WHC 70 27.5 
ZONTA 62 24.3 
Social 19 7.5 
Age (n=249)   
< 20 years 2 0.8 
20–29 16 6.4 
30–39 28 11.2 
40–49 38 15.3 
50–59 49 19.7 
60–69 83 33.3 
70–79 28 11.2 
80–89 5 2.0 
Locality (n=255)   
remote, very remote 29 11.4 
outer regional 69 27.1 
inner regional 115 45.1 
major cities 42 16.5 
Country of Birth (n=251)   
UK  13 5.2 
NZ & Oceania 4 1.6 
Other 11 4.4 
Australia  220 88.7 
Aboriginal or Torres Strait Islander (n=218
2
)
 
  
Yes 6 2.8 
No 212 97.2 
Marital status (n=250)   
never married 15 6.0 
married 158 63.2 
defacto 25 10.0 
separated/divorced/widowed 52 20.8 
Children (n=249)   
no 30 12.0 
yes 219 88.0 
Schooling (n=248)   
still at school 1 0.4 
less than year 10 42 16.9 
year 10 or equiv  76 30.6 
greater than year 10 128 51.6 
don’t know/not stated 1 0.4 
Post school qualifications ( n = 234)   
yes 131 56.0 
no 103 44.0 
Post school qualifications – stated (n = 131)   
diploma or certificate 68 51.9 
bachelor degree or higher 47 35.9 
don't know/ not stated 16 12.2 
1 Missing data for some questions; denoted by (n= x)  
2Excludes those born overseas 
 Chapter 7: What Queensland Women Say about Cervical Cancer, Pap Smears, HPV and the HPV Vaccine 129 
 
Figure 7.1.  Locations of Focus Groups in Queensland, 2009 
 
Table 7.2. Screening History of Women Attending Focus Groups in Queensland, 2009 
Screening history N
 
% 
Ever had a Pap smear (n = 245)   
yes 253 95.5 
no 12 4.5 
Number of times had Pap smear 
 
(n = 245)   
never 12 4.9 
once 11 4.5 
twice 5 2.0 
3–5 times 22 9.0 
6–10 times 55 22.4 
11–20 times 93 38.0 
more than 20 times 27 11.0 
don't know / can't remember 20 8.2 
Last Pap smear (n = 234) 
a 
  
< 1 year ago 71 30.3 
1 year to < 2 years ago 94 40.2 
2 years to < 3 years ago 23 9.8 
3 years to < 5 years ago 10 4.3 
5 or more years ago 27 11.5 
don't know 9 3.8 
Usual time between Pap smears (n
 
= 225) 
a 
  
1 year or less 7 3.1 
1 year  27 12.0 
2 years  158 70.2 
3 years 10 4.4 
4 years  2 0.9 
5+ years 8 3.6 
don't know/refused 13 5.8 
Heard of HPV (n=247)   
Yes 149 60.3 
No, don’t know 98 39.7 
Heard of HPV vaccine (n=247)   
Yes 222 89.9 
No, don’t know 25 10.1 
a Excludes women who had never or had only had one Pap smear when asked the number of times 
they had had a Pap smear. 
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Most women attending the focus groups had had at least one Pap smear (95%) and most 
had had between 11 and 20 in their lifetime.  Eighty percent of women said their last Pap 
smear was less than three years previously and 70% reported they had a Pap smear every two 
years.  Just over 60% of women attending the focus groups had heard of HPV and 90% had 
heard of the vaccine prior to participating in the study (Table 7.2).   
In the following sections, the findings of the focus groups are discussed and as 
described in Section 6.6.2, the constructs of the Health Belief Model (HBM) provide 
predetermined overarching themes with women’s responses relevant to these themes 
described.  Key exemplars that reflect women’s responses and how they were clustered under 
these themes are described in Section 6.6.2. 
Each focus group commenced with a general discussion about health and the role of 
luck, which relates to self-efficacy in the HBM (Rosenstock, 1974).  This enabled women to 
talk about a neutral topic and ease them into the process rather than commencing with a topic 
they may be less familiar or comfortable with, such as risk factors for cancer.  It also 
provided a sense of whether women in the groups considered they had some control over 
their own health. 
7.2 SELF-EFFICACY  
‘What do you think of the following statement:  “Good health is largely a matter of 
good luck?’ 
When first asked about the statement, ‘good health is largely a matter of good luck’, 
some women opposed it quite strongly, “Definitely not, no!”  Most women did not consider 
health was related to luck and they talked about the things within their internal locus of 
control - self management, and those they could not control - external factors (Table 7.3).  
Good self management included choices about diet, exercise, smoking etc and having regular 
health checks.  Some women did talk about the importance of being aware of your own body 
but lifestyle factors were the main focus of discussion. 
When the role of luck was discussed in relation to health, this largely related to external 
factors, such as acute events like accidents or women’s reflections about people they knew, 
that refuted the amount of influence an individual may have on their own health.   
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Table 7.3. Themes Related to Self-Efficacy from Focus Groups Conducted with Queensland 
Women, 2009 
SELF EFFICACY 
Themes Exemplars 
Self Management 
 Health 
protection 
 FG2: When services are available we should be using them shouldn’t we? 
 FG16: Yeah, it’s the way you look after yourself – as long as you get everything done. 
 Self 
awareness 
 FG2: I have a feeling that I won’t get it – I just have this feeling mmm… 
 FG6: Sometimes you rely on your gut feeling too that something’s wrong, you know 
something is nagging – I said what’s going on here – I’d rather have peace of mind 
 Lifestyle  FG10: I don’t believe that good health is good luck. It’s how you look after your body. 
What you put into your body - It’s your lifestyle, you are what you eat. 
 FG19: I would go along with lifestyle, whether you exercise, what you eat, how you 
sleep, stress  
 FG22: Because it’s up to you - weight and smoking and drinking and all that 
External Factors 
 Luck  FG9: I think luck has got a lot to do with it as well because you can’t choose your 
disease can you? 
 FG15: Well sometimes bad luck can lead to acute events, which can lead to bigger and 
worse things - car accidents. You know events like that, you have literally no control 
over, can lead to a coma or morbidities later down the track. 
 FG22: I was initially going to say no as well, (inaudible), but you are right I know too 
many people who don’t smoke, never drink and then have died at 40 without a say, I 
think yeah you can say it is bad luck. 
 Family 
history / 
genetics 
 FG14: Well she never made the choice to have diabetes because she always  she looked 
after her health, and ate and did it right,  and that’s the genes – that family’s very much 
like that isn’t it ... 
 Fg22: But then also some people get, you know it’s either hereditary or they get different 
cancers and they are perfectly fine and to me that is just rotten luck you know. People 
who have lived a good life and all that sort of thing... 
 Environment   FG10: It’s your environment too.  Being in X with the air pollution hasn’t – there is a lot 
of sickness up there. 
 
Women generally considered they could control some factors of their health but other 
factors, such as genetic factors and family history, environmental factors and acute events, 
were beyond their control and these latter factors were more often associated with luck.   
These themes were similar across all groups and discussion of this topic was fairly brief 
as women were generally consistent in their beliefs about good health, the role of self 
management and that a person had control over the choices they made that influenced their 
health, except when genetic factors and acute events were responsible. 
After discussing this statement we moved on to specific topics related to the main 
research questions, the first of which was, ‘What do Queensland women know about cervical 
cancer/screening and what are their attitudes towards Pap smears?’  The key themes that 
described women’s responses to this question are discussed in the following section. 
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7.3 PERCEIVED SUSCEPTIBILITY TO CERVICAL CANCER  
To determine women’s perceived susceptibility to cervical cancer, women were asked 
what they thought caused cervical cancer and increased a woman’s risk for developing 
cervical cancer.   
7.3.1 Causes of Cervical Cancer   
Uncertainty - But I have no idea!  
The most common response from women’s comments at the beginning of this 
discussion was uncertainty, which was evident in 12 of the 23 focus groups (Table 7.4).  
There were two sub-themes within uncertainty, the first was ‘don’t know’, and the second 
was ‘haven’t thought about it’.  Women said they did not know what the cause of cervical 
cancer was and this was sometimes discussed within the notion that no-one knew the cause of 
cancer (“they don’t know”).  There were also some women who believed it was information 
not given to them, that is, they were not told about it (Table 7.4). 
When women discussed causes, trigger factors, a relationship with sex, lifestyle factors, 
infection, other gynaecological problems and family history were described. 
Triggers - You just need something to trigger it off  
Women talked about triggers in relation to cancer cells, which was not always 
associated with HPV and for these women there was the notion that the abnormal cells were 
present in everyone’s bodies but something makes the cells mutate, which some women 
attributed to sexual activity.  These women suggested in their discussion of trigger factors 
that they had no control over the development of cancer (Table 7.4). 
Sexual encounters 
Another theme was that women thought there was a link between cervical cancer and 
sexual activity but there was uncertainty as to what it was about these sexual encounters that 
led to cancer.  There were aspects described that related firstly to sexual activity as a physical 
act, and secondly to factors that increased the risk of infection, such as ‘playing around’ or 
multiple partners.  Sexual activity as a physical act was described in terms of the mechanics 
of sex and was sometimes linked to the trigger concept, although some women thought 
sexual activity was a protective factor.  Infection and behaviours that increased women’s risk 
of acquiring an infection were also described.  Having multiple partners was frequently raised 
as something that caused cervical cancer, although at times women debated this, especially 
when they reflected on the stories they had heard from women who had developed cervical 
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cancer.  There was also some uncertainly about women who had never been sexually active 
and whether they were at risk. 
Infection - the virus 
The theme that there was an infective agent was evident in most groups and human 
papillomavirus (HPV), was identified but more often it was referred to as ‘the virus’ or 
sometimes ‘the wart virus’.  Whilst HPV was often mentioned, it was common for women to 
say this was all they knew.  Women also referred to HPV as a trigger factor for cervical 
cancer and although often sure about where it came from, thought the activity of sex or 
something to do with the male triggered it (Table 7.4). 
There were only five focus groups where the ‘virus’ was not mentioned as a cause, 
although in many of the groups not all women had heard of this which led to the theme 
‘virus, what virus?’.  In addition to HPV, other STIs and broad terms, such as ‘disease’, were 
also raised as possible causes for cervical cancer (Table 7.4). 
Lifestyle factors, other gynaecological issues and all in the family  
Lifestyle factors were also discussed and included hygiene and personal cleanliness, 
stress, environmental factors and smoking.  There was some debate about smoking as some 
women did not think it had any relationship with cervical cancer and thought it was mainly a 
risk for respiratory problems.  Some women referred to keeping your immune system healthy 
and associated a weak immune system and stress with cervical cancer.   
The other group of causes women raised were related to other gynaecological 
conditions or issues, such as endometriosis, hormones and childbirth.  Genetic predisposition 
or family history was another common theme discussed, although at times women seemed 
unsure about this.  On occasion they referred to breast cancer or cancer in general and the role 
of genetics and family history and questioned if cervical cancer ran in families, although 
some women gave examples to support why they believed a familial link was possible (Table 
7.4). 
Women’s beliefs about the possible causes of cervical cancer were common across all 
groups with the exception of a small group of five older women who were all uncertain about 
what caused cervical cancer and had not heard of HPV.   
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Table 7.4. Perceived Susceptibility to Cervical Cancer (Causes) from Focus Groups Conducted with Queensland Women, 2009 
PERCEIVED SUSCEPTIBILITY - CAUSES OF CERVICAL CANCER 
Themes Exemplars 
Uncertainty  
 Don’t know  FG17: No, I don’t know what happened with me – out of the blue 
 FG13: They don’t tell you!  They don’t explain it to you or why you...  
 Not thought about  FG5: It’s very strange isn’t it because we know so much about breast cancer and checking your breasts and we know we have to have a Pap 
smear every two years but you don’t delve any deeper and find out about it. 
Triggers  FG13: I’m assuming from what I know of cancer that some people will get it just because their own cells will mutate, but there will be some 
mutation or change that will induce the cancer, the same as breast cancer has multiple causes– 
 FG3: Yes but what if you already have the cancer cells in your body and you just need something to trigger it off? 
Sexual encounters  FG7: Yes but can I ask a question, people, single ladies, who don’t have sex, I mean, you know what I mean. I’ve got a cousin, who’s my age, 
who’s never been married and has never had sex. Can they get cancer? 
 Sexual activity 
 
 FG3: Could it have anything to do with say ... sexual partners that are very aggressive? 
 FG18: Well I thought after you were sexually active then you could get it, not necessarily via sex but I thought once you were sexually active, 
then the virus could develop in your body by having sex. 
 FG6: Is that sleeping around because it increases your exposure to potential dangers or is it the physical activity of a lot of sex? 
 Playing around 
 
 FG1: I had a lady at work that I didn’t disagree with it but she said that she’d been told cervical cancer came from having multiple partners 
and she’s only had one partner and yet she’s had cervical cancer. 
 FG10: I knew you got a lot of things from playing around with other people but I didn’t know that’s what you got from it. 
 FG3: I don’t think so.  No, I’ve had multiples of multiples and I don’t – 
Infection  
 The Virus 
 
 FG8: It’s one of the cancers caused by viruses 
 FG13: But I don’t know if that’s the only ... I have a belief that it’s a mutation of the virus that becomes the cancer but I don’t know if there was 
other ways of getting the cancer. 
 Virus, what virus?   FG18: I was going to say “what in the?” what is that? 
 Other   FG21: Other, I mean, diseases maybe  
Lifestyle   FG5: Not cleaning yourself properly I suppose 
 FG11: I heard years ago that women can get it from men but it depends on the kind of work men do – that would have to be 20–25 years 
ago...yeah, type of work can pass it on - I don’t know if that’s right or not – I just heard it. 
 FG12: I know because I was a smoker and when I went through it they kept telling me to give up smoking because it does not help ...  
Other gynaecological 
issues 
 FG1: Possibly contraception, as in IUDs, I don’t know the name – (Mirena – from another participant) - Mirenas, thank you 
 FG21: A lot of young girls now, my daughter’s got polycystic ovaries ...what about endometriosis – does that have similar?   
 FG19: I thought cervical cancer - childbirth had a lot to do with it 
All in the family  FG21: I think there is - my mother-in-law, who I didn’t know, she died of cervical cancer – her eldest daughter has sight of it, another one – 
she had it too – I think it might be hereditary 
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7.3.2 Risks of Cervical Cancer   
Women were then asked about if they thought there was anything that may increase a 
women’s risk of getting cervical cancer.  Whilst there was some overlap with the previous 
topic, this topic aimed to determine whether women perceived certain behaviours placed 
them at greater or less risk for cervical cancer.  The main themes relating to risk factors are 
outlined in Table 7.5.   
There were similar responses to those identified as causes of cervical cancer, such as 
infection with ‘the virus’ (HPV), an association with sex and lifestyle factors; however, risks 
were assigned to categories within women’s internal and external locus of control.  Another 
theme identified from these discussions was ‘assumptions’ as women frequently talked about 
the beliefs or behaviours of others, particularly young women. 
External locus of control   
 ‘Nothing’ was an external locus of control theme as some women felt everyone was at 
risk and there were no factors that placed one woman at more risk than another.  Additional 
external locus of control factors related to age, family history and cultural issues. Many 
variations were discussed about who was at most risk.  Although age was identified as a risk 
factor, there was uncertainty about this and women debated whether it was a disease of older 
women, younger women or that age was irrelevant (Table 7.5).  However there was concern 
expressed about young women, which was related to women’s assumptions about young 
women’s sexual behaviours as described below and the target age for the vaccine. 
Cultural issues were also seen as a factor that may increase a woman’s risk for 
developing cervical cancer and this was themed within external locus of control, as women 
talked about these issues as factors women did not necessarily have control of (Table 7.5). 
Internal locus of control 
Internal locus of control factors related to behaviours women raised that they thought 
placed some women at greater risk of cervical cancer than others, such as lifestyle factors, 
early sexual debut, multiple partners and unsafe sexual practices.  There was also mention of 
protective behaviours women could engage in, such as safer sexual practices and cervical 
screening.  Lifestyle factors not associated with sexual activity were infrequently raised and 
included factors such as diet and smoking. 
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Table 7.5. Perceived Susceptibility to Cervical Cancer (Risks) from Focus Groups Conducted with Queensland Women, 2009 
PERCEIVED SUSCEPTIBILITY (RISKS FOR CERVICAL CANCER) 
Themes Exemplars 
External locus of control 
 Nothing   FG13: My view was that there was no prevention other than ...the immunisation but beyond that I didn’t have a sense of a lifestyle factor that could 
prevent it or anything... some people being more prone than the other. 
 FG13: I’m not sure, it’s just your number comes up and I’m not sure, um I have no thoughts as to why it’s there or why some are more at risk. 
 Age  FG17: Yeah, I wouldn’t think age would make much difference 
 FG10: I wonder though if say by your 40’s, 50’s or so when our bodies have less resistance to a lot of things 
 FG17: Why else are they giving the young children now, the vaccine? 
 FG4: I think probably as teenagers ... thirteen, fourteen, I think it starts really young 
 Family history 
/ genetics  
 FG10: I tend to think along the lines of HPV and then the genetic, very much genetically based 
 FG14: So obviously that group is more susceptible towards, to whatever so that comes back to the genes 
 Cultural issues  FG9: And if you are Aboriginal/Islander you are high risk. (Facilitator - Do you have any understanding as to why that might be?)  Yeah, the shame 
factor – a lot of our mob won’t go and get their cervix looked at ... 
 FG15: I’m just thinking of [developing country] where women ...30% of the female population ... has HIV. They don’t know about condoms, they 
don’t know about preventative measures, simply because it’s against their religion. So that may have an impact. ‘Cause I mean also there is, I’m 
pretty sure that it is a fact, that uncircumcised males are more likely to carry the virus and pass it on to their partner or partners, than circumcised 
men.  
Internal locus of control 
 Lifestyle 
factors  
 FG18: Diets is another thing, I mean certain diets, some people don’t get, I mean this is generalisation from what I’ve read about, I mean anything 
that’s around  general cancers like that you know. 
 FG15: I think smoking makes all cancers more prevalent. So I suppose yes. 
 Risky business  FG14: I think I heard that the earlier a female engages in sex the higher the rate she has of having cervical cancer.  Now I’m not saying that that’s 
correct, that’s what I remember and I probably remembered that because I have a teenage daughter and it gave me a reason to say don’t!  
 FG10:  It is more likely if you’ve had multiple partners or your partner has had multiple partners.  
 FG9: That’s what’s the ‘girls of the night’ have to do, don’t they? They regularly have to get checked. 
 Health 
protection 
 FG9: So then I think you are more at risk with more partners and then I think if people want to lead, you know, activities like that then I still think 
there needs to be more preventative measures so if you want to have multiples partners as such, if you are not on top of your screening and those 
sorts of things then you can’t really cry at the end of the day if you happen to end up with cervical cancer. It’s like well, that’s what you can do so 
for those people that are ignorant then that’s a consequence. 
 FG13: Well I would have thought so because I always just assumed that it was from the virus so if you have protected sex you are reducing your risk  
 FG15: Isn’t it a risk that some women simply don’t see the need to have Pap smears? 
Assumptions  FG18: Well you know, not like the young kids, like they’re at it like stoats aren’t they! 
 FG10: I hear in country areas that people are often more sexually active because as one person once said to me “there is nothing better to do in the 
town” 
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There were some sexual behaviours that women believed increased the risks of getting 
cervical cancer, although at times these risks were debated such as early sexual debut (Table 
7.5).  Having multiple partners was frequently referred to and sex work was identified as a 
risky occupation.   
There were also protective behaviours, such as using condoms, which women felt 
decreased the risk of developing cervical cancer and Pap smears were also discussed within 
this context.  Some women believed condoms would protect against HPV and cervical cancer 
and also talked about how not participating in screening could increase the risk of developing 
cervical cancer. 
Assumptions - They’re at it like stoats aren’t they! 
The making of assumptions about others’ behaviour, particularly young women, was 
identified in many focus group discussions.  This most likely reflected the older age profile of 
women in the focus groups whose average age was 55 years.  There was a perception that 
young women were more sexually active than women in previous generations.  At times 
words like ‘promiscuity’ were used - but this was rare and women often used non-
judgemental terms, just as often, such as referring to sex workers as 'girls of the night'.   
There were similar themes including assumptions identified across all focus groups 
with the exception of three groups, one which was a young women’s group, where no 
assumptions were made about young women.  There was increasing discussion and debate 
amongst women during this topic as women became more engaged in the focus group 
process. 
7.4 PERCEIVED SERIOUSNESS OF CERVICAL CANCER  
When asked ‘If a woman gets cervical cancer, is there a cure or do you think it would 
have a big impact on a woman’s health?’, women talked about the impact of cervical cancer, 
discussed their personal experience with it or lack of awareness and spoke about how it was 
rarely discussed.   
Life threatening 
Women perceived that cervical cancer was extremely serious.  It was very sad at one of 
the groups when a number of women attending left a little early to attend the funeral for one 
of their members who had died recently from cervical cancer.  Cervical cancer was described 
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as a disease that had serious and negative consequences, and two themes described this, 
namely, fatalism and early detection.   
Women with a fatalistic view of cervical cancer did not believe it was treatable or that 
Pap smears could detect it early enough.  More commonly though women talked about the 
importance of early detection and believed cervical cancer could be detected early and 
treated.  Women discussed different treatment options that their friends or relatives had had, 
such as laser treatment, hysterectomy, radiotherapy and how these women lived many years 
after treatment.  The Pap smear was frequently raised as an early detection method that was 
important in reducing the impact of cervical cancer especially as women often did not have 
symptoms in the early stages of the disease.  Although a few women referred to detecting 
precancerous changes, Pap smears were primarily viewed as a method for the early detection 
of cervical cancer and it was rarely discussed as a way to prevent cervical cancer in this 
context.   
Within this discussion, women frequently talked about how they did not know of 
anyone who had had cervical cancer.  The themes ‘personal experience’ and ‘closet cancer’ 
were used to describe women’s experience with cervical cancer and community awareness of 
this disease.  Women frequently spoke of how cervical cancer was not talked about very often 
and they were not highly aware of the disease or of women who had had cervical cancer 
(Table 7.6).   
Personal experience 
There were a number of women in the focus groups who knew friends or relatives with 
cervical cancer and two women talked about their own personal experiences with cervical 
cancer.  Other women disclosed they had had some personal experience with cervical cancer 
through their own experiences or from friends, family or through extended networks.  At 
times it seemed some women may have confused cervical abnormalities with cervical cancer 
per se when recounting these experiences due to the treatment they described, such as laser 
treatment. 
Closet Cancer - I can’t see women out there with t-shirts on you know  
Secrecy was also discussed and the notion of not talking about ‘down there’ and terms, 
such as ‘hush, hush’ and ‘taboos’, were raised.  This was linked to stigma and the association 
with sexual activity and how others may make assumptions about you if you disclosed having 
cervical cancer.   
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Table 7.6. Perceived Seriousness of Cervical Cancer from Focus Groups Conducted with Queensland Women, 2009 
PERCEIVED SERIOUSNESS (CONSEQUENCES OF CERVICAL CANCER) 
Themes Exemplars 
Life 
threatening 
 FG10: Yes, people don’t have any signs at all and then by the time they do start to have symptoms, bleeding, pain, whatever ... of course, it is too late and it is 
already spreading or it’s picked up its swag and then traced back.  
 FG11: That’s what they say – if you get it early enough it can be cured but most times you don’t get it early enough – I’ve heard not many women survive it. 
 Fatalism  FG14: If I had a choice I’d choose breast cancer because you can get rid of that. 
 FG7: It’s a bit hard to check though, like even in Pap smears they don’t always pick it up until late. 
 Early 
detection 
 
 FG18: Well see, there is cancer and there is abnormal cells isn’t there? So the abnormal cells that are pre-cancerous, they just do those cone biopsies where 
they just, you know, whatever they do, burn it out or whatever, and that removes the damaged cells and that’s as far as they go. But if it’s not abnormal cells, if 
it’s later on - then it is cancer of the cervix. 
 FG13: But my understanding is that if you detect it early then the treatments are pretty effective. 
 FG10: But it is very quiet because there is no pain and it just quietly goes about its disaster and very often, it’s too late which is why there is so much 
importance on keeping up with your Pap smears.  
Personal experience 
 Close to 
home 
 FG17:  Well as I was telling x before , I just went out one day to a function and when I came home I noticed something on my underwear, so the next day 
straight to the doctor to find out what was happening and he sent me straight to the hospital and the next week I was in hospital having my operation.   
 FG1: Yes - both my grandmothers died from cervical cancer before I sort of knew them. 
 A friend of 
a friend 
 FG16: My friend in [x], um, her girlfriend’s just been diagnosed it and she’s devastated.  I think they got it too late – I don’t ask questions. 
 FG11: It can kill you can’t it?  “Cause I know a lady died of cervical cancer less than a year ago and she was 80.  
Closet cancer 
 Secrecy   FG21: No, I’m totally naive because I’ve had no connections – know nobody... 
 FG17: No, I don’t recall hearing anyone talking about cervical cancer at all 
 FG13: And I just think that, I think because you talk about ‘down there’ as well I think if someone has it they are not as willing to talk about it because there still 
are a lot of taboos about certain parts of your body.   
 Stigma  FG18: All the things about breast cancer – there’s groups ... people making breast cancer quilts and motor cycle rides and walks and  dragon boating -  I can’t 
see women out there with t-shirts on - “I’ve had cervical cancer” you know? It’s not the sort of thing that’s going to be bandied about is it? 
 FG19: I think people think it might portray that you might be loose. 
 FG8: Because of stigma, the possible association with the virus. 
 Pinked out  FG17: There’s not enough discussion about it - it’s there, it’s there but they’re not talking about it because some of the other cancers are overshadowing it. 
 FG10: Well, breast cancer is everywhere isn’t it.  
Talking about 
my generation 
 FG10: You never heard about all of these in our days when we were young. 
 FG23: Within my age group they’re only just starting to discuss it amongst each other and anyone older, no, it’s something you don’t talk about it. And I think 
you need to because a lot of them are saying ‘no, once I’ve stopped having children end of story’. 
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It was also interesting that women perceived breast cancer to be much more socially 
acceptable to discuss and at times referred to the overexposure of breast cancer, which was 
termed ‘pinked out’.   
Talking about my generation  
Within this context, women’s uncertainty about whether it was as prevalent as breast 
cancer was also apparent.  Older women in particular talked about how such issues were not 
readily discussed when they were growing up, although they felt things were changing and it 
was becoming more acceptable to discuss cervical cancer in the current environment where 
breast and prostate cancer were commonly talked about.  
There were similar themes identified across all focus groups with debate and discussion 
about treatment and early detection.  This was at times a somewhat sad and reflective topic 
within the focus groups as women reflected on family and friends who had died from cervical 
cancer or recounted their own experiences.   
7.5 PERCEIVED BENEFITS OF CERVICAL SCREENING 
To determine the perceived benefits of screening, women were asked what they knew 
about Pap smears in relation to the recommended interval between Pap smears, the age 
women should commence and cease screening, the purpose of the Pap smear, what an 
abnormal Pap smear meant and how good they considered the test was at preventing cervical 
cancer.  The exploration of these aspects of cervical screening provided insight into which 
women were thought to benefit most from cervical screening as well as the benefits 
associated with Pap smears.  Discussion in this topic related to the current  National Cervical 
Screening Program (NCSP) recommendations, beliefs about the purpose and accuracy of Pap 
smears and women’s attitudes towards the test itself (Table 7.7).   
NCSP Recommendations 
When asked about the recommended interval between Pap smears, women’s knowledge 
was high as they generally believed that the current recommendation was to have a Pap smear 
every two years unless there were abnormalities detected; however family history was raised 
as some women thought this increased women’s susceptibility to cervical cancer and 
subsequently thought these women should have more frequent screening.  In all groups the 
commencement of screening was rarely linked with age, although some women had heard 
they could stop having Pap smears at 70 years of age as they had been advised by their 
provider or received a letter from the Pap Smear Register (PSR).  Women did not mention 
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that Pap smears could stop at 70 years of age if the woman had had two negative results in 
the previous five years.  Some women disputed that it was safe to cease screening at 70 years 
of age and felt age was not relevant and that women were entitled to continue having Pap 
smears irrespective of their age as they considered them beneficial. 
It was commonly believed that it was recommended for women to start screening when 
they became sexually active (sexual debut).  There was discussion and debate about this 
though and on a few occasions women, although believing sexual debut was the 
recommended time to start screening, worried about girls having to have a Pap smear so 
young - ‘those poor young things’.  Women strongly perceived Pap smears were beneficial 
for young women given they perceived them to be at risk based on the assumptions they 
expressed about the sexual practices of younger generations.  Other concepts raised about 
screening eligibility, that were related to sex, were uncertainty about whether women who 
had never been sexually active would benefit from screening and if Pap smears could stop 
when women were no longer sexually active.  The HPV vaccine was also discussed within 
the context of starting Pap smears and some women thought both primary and secondary 
prevention should commence simultaneously.  Women were also asked whether Pap smears 
were still necessary after vaccination and many women believed they were, although some 
women were concerned young women were not aware that they still needed to have Pap 
smears as highlighted in Table 7.7. 
There were other beliefs, including the belief that screening should commence at 
menses or stop at menopause, or when starting the Pill as this had been a number of women's 
experience.  There was also discussion about the need for Pap smears after a woman had had 
a hysterectomy and women gave differing views and accounts of their beliefs about this and 
what they had been told. 
Purpose 
When women were asked 'What do you think a Pap smear is a test for?' women talked 
about abnormal cells, changes, irregularities and cancer cells.  There was some uncertainty 
apparent and some women used very broad terms or terms associated with a pelvic 
examination such as ‘...to see if you’ve got any lumps...’ 
When asked about efficacy, it became clear the concept of the Pap smear as a 
preventative test was poorly understood.  When asked ‘How good do you think Pap smears 
are at preventing cervical cancer?’ some women were adamant they did not prevent cervical 
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cancer (Table 7.7).  It appeared that many women’s understanding of the benefits of Pap 
smears was early detection and from this it appeared they understood abnormal cells to 
primarily be cancerous cells rather than precancerous changes in the cells.  The notion of the 
Pap smear being for early detection rather than prevention was raised in 16 of the 23 groups.  
There was very little mention about precancerous changes, although uncertainty was evident 
and often women were seeking clarification even when they had been treated previously for 
abnormalities. 
Trust 
Women overall were confident in and trusted the Pap smear as a method for detecting 
early changes and cervical cancer – ‘Saved my life, fair dinkum’!  Women also talked about 
the benefit of the Pap smear in the context that cervical cancer was a 'silent cancer' that 
showed no symptoms until it was quite advanced.  There were some women though, who 
were uncertain or did not think the Pap smear was able to detect cancer early and there were 
concerns raised about the time it offered protection for and whether cancer could develop 
before their next test in two years time.  It was clear from these discussions that women knew 
there were limitations of the Pap smear and did not perceive it to be perfect.  Some women 
spoke of shortfalls of the Pap smear which related to false readings, having to return for a 
repeat test if they weren’t ‘done right’ and two women in different focus groups referred to a 
laboratory issue that occurred a decade earlier (Table 7.7).   
During discussions about the accuracy of the Pap smear many women spoke of how 
they were offered an 'extra' test (liquid-based cytology).  Women had this test on their 
provider's recommendation because they were told it improved the accuracy of the Pap 
smear.  They rarely seemed to know what this test was and often did not know what it was 
called or why you had to pay for it if it was a better test.  There was some concern raised in 
some focus groups, firstly as some women had not heard of it before and secondly, as others 
thought it was inequitable that not all women could afford this test and they felt it should be 
available for all women if it was more accurate.   
Compliance 
Another theme identified during this discussion was compliance.  Women talked about 
how they little they knew about Pap smears despite having had many in the past and 
attributed this to ‘doing as they were told’ (Table 7.7). 
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Table 7.7. Perceived Benefits of Cervical Screening from Focus Groups Conducted in Queensland, 2009. 
PERCEIVED BENEFITS OF CERVICAL SCREENING 
Themes Exemplars 
NCSP Recommendations 
 Family history  FG5: If there’s something in the family – they’ll say come every 12 months. 
 Age   FG19: When you’re too old you don’t want to do it [cease screening]. 
 FG2: When you’re say 70, they said ‘well, you don’t need it’ - I said ‘well I know people were 80 who’ve got cancer, so I’m staying every 2 years.’ 
 FG20: We’re not important when we’re over 70. 
 Related to sex  FG22: Well why do they say have Pap smears when you become sexually active?  
 FG1: I was just thinking those poor young things – having to go through that [Pap smears] 
 FG12: I know my girlfriend’s never had a Pap smear ‘cause she’s never had sex and I’ve always said to her I think you should still go  
 FG21: We’re just wondering if you’re not sexually active – when you stop having sex can you stop having them? 
 Vaccination  FG19: I think with the virus injection now and I mean and you’re only 12 or 13 - it must be going to come in line with that. 
 FG2: I worry about with this wonderful new vaccination – the younger women are going to say,’ I’ve been vaccinated, I won’t bother going’   
 FG18: Like some people will go and have the injection and think ‘I’m fine now for the rest of my life’, but you have to know whether that... 
 Other  FG13: When I went to uni ..., I was seeking contraception and she gave me a Pap smear and she told me I had to have one every year so I did. 
 FG22: But if you’ve had the hysterectomy then you don’t have a Pap smear do you? 
 FG2: I thought when you finished your menses, then you could stop. 
Purpose  FG16: I wouldn’t have a clue! 
 FG8: To see if the virus is there or change in the structure of the cells in the lining. 
 FG16: I didn’t think – I don’t know – maybe sexually transmitted infections – I thought it was for everything – I don’t know – cancer. 
 FG20: No ... maybe to see if you’ve got any lumps and all that 
 Prevention 
versus early 
detection 
 FG7: You can’t prevent it but you can find out...  
 FG15: But it doesn’t prevent the cancer does it? It just identifies it. 
 FG8: Yes, it can pick up in a Pap smear, cervical cancer if it’s early, yes 
 FG19: It may not be there now but in 10 months time it could be.  
Trust  FG20: Saved my life, fair dinkum. As I had the final stage type of cancer, so if it wasn’t acted on I might not be here today. 
 FG8: You have to trust it, because what is the alternative – is there any other test? 
 Accuracy  FG21: It’s not always fool-proof. 
 FG10: About 10 or 11 years ago if I remember right, there was quite a scandal about one of the pathology firms or something and their results 
were all incorrect, do you remember that? 
 ‘That extra 
test’ 
 FG2: There’s an extra test that um, the patient has to pay for.  If they want to go ahead and I always say yes ... I’m not sure exactly what it shows  
 FG13: To me it doesn’t make sense – cause if that’s a bigger, better test to do, why aren’t they doing it as stock standard – I don’t understand that.  
Compliance  FG10: I think our generation were sort of, the ones that when they were told to do something, we went and done it. 
 FG5: It’s to do with one of those unspoken places – you get on and do – if you’re told to go and have a Pap smear very two years you just rock 
along. 
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 The themes relating to the benefits of screening were consistent across all groups with 
the exception of liquid-based cytology that was raised in only half of the groups.  There was 
much debate throughout this discussion as women seemed to have more familiarity with the 
subject given their previous experience with Pap smears. 
7.6 PERCEIVED BARRIERS TO CERVICAL SCREENING 
The question, ‘What do you think prevents some women from having Pap smears or 
putting them off?’ prompted much discussion and women often laughed and joked about 
some barriers and shared anecdotal tales about their experiences.  It was not uncommon for 
the whole group to break into laughter at some women’s comments or stories, although at 
times there were also moments of anger or disbelief about others’ experiences. 
The most commonly identified perceived barriers to screening related to practical 
barriers, cultural barriers, fear and denial, dislike and discomfort - both physical and 
psychological, as outlined in Table 7.8.  In the context of this discussion women also talked 
of how the Pap smear was often one part of a comprehensive women’s health check, their 
prior negative experiences and how this procedure was largely different for them compared to 
their experience when having children. 
Women also spoke about enablers that helped them to overcome some of these barriers 
including what they did, what the provider could do and system related enablers, such as 
reminder systems and services. 
Women talked about competing pressures on their time, such as family and work 
commitments, difficulties accessing bulk billing for the consultation, financial pressures, 
being charged for pathology and having to pay for that 'extra test' which were themed 
‘practical barriers’.  Access issues related to service continuity especially in country areas 
where doctors providing the service changed frequently or their regular provider retired.  
Having access to a female provider was important for some but not all women (Table 7.8). 
Cultural barriers 
Women referred to cultural barriers that they perceived may impact on some women.  
As the majority of women in the focus groups were born in Australia, these barriers were 
raised by women reflecting on the barriers women from other cultures may face (Table 7.8). 
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Table 7.8. Perceived Barriers to Cervical Screening from Focus Groups Conducted in Queensland, 2009. 
PERCEIVED BARRIERS TO CERVICAL SCREENING 
Themes Exemplars 
Practical barriers   FG2: You don’t get any bulk billing done up here. 
 FG19: And we’ve gotta wait three months for Dr x and pay $150 bucks for a double appointment plus your extra pathology on top  of that –so if you can’t 
afford it.  
 FG19:You get up the guts and you ring the bloomin’ doctor and they can’t fit you in for three weeks. 
 FG7: If you can get into a female GP, a lot of them aren’t taking any new cases! 
 FG2: Probably because I was too busy working, and I was rearing children and I just didn’t seem to find the time.  
Cultural barriers  FG6: The idea of modesty in a lot of cultures would be really hard to overcome – that barrier of exposure – like women who can only expose their face – 
how would they feel exposing their vagina? 
Fear/denial  FG12: Not wanting to know either way. 
 FG20: Fear, yeah, fear of what you might find out.  
 FG3: Or they are in denial, they don’t really want to know, bury my head! 
 FG15: A lot of the young ones too it’s again, ‘I’m too young, it’s not going to happen to me it’s going to happen to somebody else’. 
Dislike  FG19: It’s horrible. 
 FG8: It’s degrading.  
 FG19: It’s a) embarrassing, b) very invasive – you don’t like it.  
 FG22: But it’s just that it is something very personal and private – thank you!  
Physical Discomfort 
 Pain 
 
 FG2: Yes, one woman hurt me so much I never went back for five or six years! 
 FG22: And the scraping... 
 FG5: With me I had a male doctor and he hurt!  He really didn’t care that he hurt and when I said ‘that hurts’ he goes ‘oh that’s just normal’ – I changed 
doctors after that and I’ve had no pain since and I just thought no, he’s just too rough. 
 Cold instruments  FG14: That bloody cold silver thing! (laughs) 
 FG18: And poking those horrible cold instruments there – 
  FG13: I don’t feel particularly embarrassed but it’s just uncomfortable.  Yeah, the cold speculum and that sort of screwing thing.  
Psychological Discomfort 
 Vulnerability  FG12: Uncomfortable - that is the main thing because I don’t think it has a whole lot to do with the pain because there is no pain, it’s uncomfortable but it 
is more uncomfortable if you are in a very vulnerable position I guess. 
 FG18: Well you are pretty vulnerable aren’t you? 
 Invasiveness  FG18: The one factor that I find is I don’t like is the invasiveness - even though I’m aware of it. 
 FG11: Very intruding indeed – invasive - I feel. 
 Embarrassment  FG7: Ah, no it’s more the embarrassment I think, you’ve got time to lay there and think about what’s happening. 
 FG21: Yeah, sticking our legs up in the air! (laughs) 
 FG21: The thing is, it’s embarrassing to us, but the doctor doesn’t like having to do it either – like he doesn’t want to have people’s legs stuck up in the air 
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– it’s part of the job, so, it‘s embarrassing on both sides. 
 FG2: Although my doctor said ‘it’s just like looking at the engine of a car love so don’t worry’ 
 FG9: Well that’s actually true because we get really sweaty and that and you just think, well I’m not going there, it’s too hot, not only is it uncomfortable 
for me but it’s not really nice for the lady so. 
 FG7: But sometimes they used to have a nurse in the doctor’s surgery if they had a male doctor.  I think that was more embarrassing – a young girl! 
 modesty/ 
privacy 
 FG10: I did go to another GP and I felt so embarrassed at how he treated me. He stripped me off, I had this little skimpy sheet and the way I was treated I 
would have never gone back.  
 FG12: And letting somebody do that, you know it’s a private thing. 
 FG23: Some people think I don’t want a doctor looking down there! (inaudible and laughter) 
 FG18: Or they are going to see your rolls of fat. Or they are going to see something that you don’t want people looking at. 
 FG20: It might be part of the job but still it’s personal - I don’t think you do ever get over that sort of thing and it seems to get worse as you get older. 
 FG16: You put your body somewhere and open your legs and say have a look at the most intimate part of my body – there you go! 
 familiarity  FG6: I feel really uncomfortable going to a doctor because I don’t have a GP or anything like that – when I go to the doctor I see a different person every 
time. 
 FG21: That’s it – it doesn’t matter if it’s a man or a woman I just don’t feel comfortable with some strange person fiddling around. 
 FG5: I think it’s embarrassing if you’ve got a family doctor, and you know that doctor’s seeing you. 
 FG22: Goodness me, my GP is a female but I would never go to her for a Pap smear but I went to her birthday party the other week so that’ s why – no 
way I would do that. 
 intimacy  FG13: It’s a very intimate sort of thing – ‘cause you know most people at work haven’t seen your vagina!   
 FG10: My father did not like my Mother going…anything done down there. That’s the ‘down there’, it’s a clear area - it’s his private territory. 
 FG22: Well it is very personal isn’t it, for a woman, and I only do that with my husband, you know I don’t look at the doctor as my husband. 
 FG5: Well I’ve only ever had one partner and he’s the only other person who’s ever touched … and that’s why, you know. 
 FG6: I actually think a lot of women sort of hold back because it’s the actual thought – well it’s not my husband  looking down on there – it’s someone 
strange so you actually going to see and you’re sort of thinking well it’s not going to be private anymore.  
Well women’s 
check 
 FG13: Participant 1: That feeling; Participant 2: And you think it’s over and it’s not! 
 FG5: Do you know what I often laugh about this- they say I’ll just pop out of the room while you get undressed and then...  you know it’s like a 
picnic...He’s got it all laid out and then he’s got a little blanket that you cover yourself, you know, and then whatever end  he’s doing or both... you go 
through the whole rigmarole then, ‘cause my doctor does the whole, you know, full head to toe 
Negative 
experiences 
 FG5: Actually I had a male doctor - when he did the Pap smear , made a comment and I thought that was really inappropriate. 
 FG14: Everyone knows Dr x, he says ‘get your arse up here, sticks his coldest, hardest bloody... and says relax!  Relax!  What’s wrong with ya?’ 
 FG15: I had one of my daughters and she didn’t want to have a Pap smear and had never had a Pap smear as she had been sexually abused and had this 
absolute fear of you know anything sexual basically and I’m sure there are other people out there – 
Akin to childbirth  FG7: I wouldn’t think that after you have a baby anything could be embarrassing. 
 FG18: Yes but when you are my age, I mean that was 30 years ago, sort of thing, so that’s sort of long gone – 
 FG5: When you get in that labour ward you don’t give a damn- you don’t care – when I was having a breech they needed the students to come and have a 
look and you don’t care – do what you like – just get the thing out ! (laughs) 
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Fear and Denial 
Fear and denial were also barriers for some women.  Fear did not just relate to having a 
Pap smear but was also associated with fear of being diagnosed with cancer and fear about 
having to have treatment (Table 7.8).   
Dislike - It’s yuk but we’re still fronting up 
Women consistently talked about this test very negatively as a health procedure that 
they endured because of the perceived benefits.  The terms they used to describe the Pap 
smear included ‘degrading’, ‘horrible’, ‘invasive’, ‘uncomfortable’ and ‘embarrassing’. 
In-depth discussions occurred about discomfort and embarrassment which provided 
good insight into what these factors pertained to.  These factors were discussed by women of 
all ages. The term ‘uncomfortable’ was used by women to describe both physical and 
psychological discomfort.   
Women referred to physical discomfort and spoke of the provider as being ‘rough’, as 
hurting them and described pain associated with the Pap smear.  It was not uncommon in 
these discussions for women to also describe how the provider often dismissed their 
discomfort telling them it was normal to feel pain.  Women also spoke of the discomfort they 
experienced when a cold speculum was used and for some women; the position itself caused 
them discomfort.  
Embarrassment 
Psychological discomfort was a more complex theme which included sub-themes of 
vulnerability, invasiveness and embarrassment (Table 7.8).  Embarrassment was an area 
explored in detail, as this is a frequently cited barrier in many studies and this provided 
insight into what women perceived as embarrassing within the context of having a Pap smear.   
Sticking our legs up in the air!  
Women often referred to the position as embarrassing and this was linked for some 
women to vulnerability.  Women also referred to hygiene and how they were less inclined to 
have a Pap smear when the weather was hot.  They often spoke of having their ‘legs in the 
air’ and closely linked to this was feeling exposed and the theme – modesty/privacy was used 
to describe this.  Privacy and modesty issues included concerns about others being present, 
such as a chaperone and having others see parts of their body that they would not normally 
expose in public.  Women also thought it must be an unpleasant examination for the provider 
and that it ‘was embarrassing on both sides’.   
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Some strange person fiddling around! 
Familiarity with the provider was important for some women but for others this was a 
barrier.  If women were too familiar with their local general practitioner (GP), for example, 
they socialised with them, they did not want to have a Pap smear with them.  However they 
also did not feel comfortable seeing a stranger. 
It’s a very intimate sort of thing  
One concept that women described was intimacy and it was raised by women of all 
ages.  Intimacy was described in terms of having someone else see or touch what they 
considered a special part of themselves with someone who was not their partner.  On a couple 
of occasions this was raised as a control issue by some women, where they talked about how 
some men may prevent their partners going for the test.   
Well women’s check - It’s like a picnic 
Some women also described how the Pap smear procedure was often conducted as part 
of an overall health check and in conjunction with a breast and pelvic examination.  These 
were referred to as a ‘well women’s check’ (Table 7.8). 
Negative Experiences  
There were also recounts of negative experiences and inappropriate behaviours that 
women described as barriers, which included derogatory comments and the physical 
examination itself.  Barriers associated with previous sexual assault were also raised by 
women and were included in this theme.  
Akin to childbirth  
The other thing discussed was whether the embarrassment experienced during a Pap 
smear was the same or different to that experienced during antenatal checks and this was a 
topic of much debate and discussion.  For most women they felt more embarrassed having 
Pap smears than antenatal examinations as their focus at the time (the perceived benefit) was 
having a healthy baby.  
7.6.1 Enabling Strategies to Assist Women Overcome Barriers to Cervical Screening 
During the focus groups, strategies were also discussed to reduce embarrassment and 
enabling factors that made having a Pap smear easier (Table 7.9).   
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Provider - It’s in the skill of their hands. 
When women spoke about having Pap smears, provider related issues were described.  
Women referred to the provider’s technique and the importance of having the procedure 
explained to them and their privacy respected, for example, locking the door, “I’ve had some 
doctors not lock the door and the receptionist come in!”  There was a gender preference with 
many women preferring a female provider; however women who had either had a negative 
experience with a female provider or conversely, a positive experience with their male 
provider, did not prefer female providers.   
Disengagement - Down there  
Some women overcame their embarrassment by trying to disassociate themselves with 
what was happening ‘down there’ and wanted the procedure to be over and done with as 
quickly as possible.  They often spoke of switching off as if their head and body were 
separated during the procedure. 
System issues 
Women also discussed alternative options which were themed ‘system issues’, as 
access to a nurse Pap smear provider and the one-stop shop concept where women could have 
a breastscreen and Pap smear at the one visit.  These options were considered enablers that 
may assist some women to access cervical screening, particularly if they were free or offered 
at low cost. Women also liked to receive reminders from the PSR or GP rather than be faced 
with a Pap smear when they went to the doctor for something else (opportunistic screening) 
as this did not give them time to prepare for the procedure (Table 7.9).  
Education - a lot of young people don’t know  
Education and awareness raising in schools about reproductive health and screening 
were other strategies raised by women that they thought would assist young women to 
understand the benefits of screening and what to expect.   
New technologies - Find some other way of doing it 
Women questioned why there had been little technological advancements in screening 
for cervical cancer such as a blood test.  Within this context, women were asked about self 
collection and asked about a hypothetical test as follows: “If there was a test you could do at 
home, say a tampon or swab you could insert yourself and send off in the mail, do you think 
women who don't go for Pap smears now might do it”?  
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Table 7.9. Perceived Enablers for Cervical Screening from Focus Groups Conducted in Queensland, 2009. 
PERCEIVED ENABLERS FOR CERVICAL SCREENING 
Themes Exemplars 
Provider  
 Technique  FG7: I don’t think gender, in that it comes up – it’s in the skill of their hands. 
 FG20: I know years ago I had one and I had a doctor there and he was always so nice he’d say ‘now come on I’ve done this before’ and you know, say 
just enough to make you relax and your body would relax too. 
 FG9: Yeah if they go through what they are doing instead of shoving things inside and out.  
 Gender issues  FG13: I don’t care – it doesn’t bother me – I don’t care. 
 FG13: And if you only have a male doctor – I go to my female GP who’s excellent – I know she gets bored to death ...But I think women on the whole, 
feel a lot more comfortable with a female GP. 
 FG10: I had a female and she was rough. 
 FG18: Well I think the guys explain it more because they know the sensitive nature. Whereas the girls think “oh yeah, we all know what it’s all about”  
Disengagement  FG5: I just umm, I almost switch off – like as if I’m up here and what’s down there is separate...  
 FG5: Disengage the head and think this is something you’ve got to do – get it over and done with as quickly as possible, get the instrument warm. 
System issues  FG10: Well why can’t they have a Pap smearing clinics with the breast screening clinics? 
 FG15: Yes I think the cervical screening nurses do a good job, (inaudible), you know the amount of kilometres they travel is phenomenal.  
 FG1: Respondent 1: I know with me they don’t send you a letter or anything to warn you, you turn up and the nurse says “by the way you’re due” and 
you’ve got no time to think about it or mentally prepare or anything like that - Respondent 2: Or wear your good undies! 
 FG13: The Pap Smear Register is a real reassurance – you know people are chased up rather than trying to remember which year it was. 
Education  FG8: I think it might also be a lack of education, particularly amongst young women as to what it involves, what it’s for, and even what age to start at 
because I still don’t know what age you’re supposed to start having a Pap smear, but I don’t know what it involves, I don’t know a lot about cervical 
cancer either to understand the push to have that testing regularly – and I think for a lot of young people that don’t know about it 
New technologies  FG18: I say let’s have research and find some other way of doing it, why do we have to have it like that, it’s time - because it’s been going on for years 
like that, we need something new and different that will do the exact same thing. 
Self collection  
 Acceptability  FG21: From my point of view I wouldn’t have gone so long without it if I had something like that. 
 FG7: I think the majority would say oh forget about it.  
 Practical issues  FG2: Contamination. 
 FG13: Not do it properly and then sticking it in the mail – you get somebody else’s mail and somebody might open it and good God! 
 Prefer clinician  FG13: I think I feel be more comfortable if I knew a professional was doing it, I’m not a professional at that.  
 FG19: I would have a bit of a problem with that actually - If you’ve had procedures done during your life and then you go for this type of test – it’s 
probably one of those things that when you go to the doctor, he or she always goes through different other you know, examinations  
 Options  FG9: I reckon the best thing would be it to get different options to people so they can get the doctor to do it or decide to do it themselves and then 
maybe you’d get more people to do them.  
 FG21: I think it’s probably a good idea , for people who aren’t going to doctors in the first place –there’s no negatives I suppose. 
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Self collection 
I think that would be wonderful! 
It was surprising the number of women who supported this concept and how 
enthusiastic they were when it was first put to them.  However there were also strong 
opinions against this option.   
Practical issues were identified, such as whether they would contaminate the specimen 
or hurt themselves, and issues relating to the mailing and receiving of results.  Women were 
also concerned that they may not do the test properly as “I’m not a professional at that”, and 
whether the test would be as effective as one collected by a health professional.  Despite 
differing views about self collection, there was the view that underscreened women may 
participate if they had access to this test, although not everyone thought this.  Women also 
felt it was important to give women a choice so they could still attend a practitioner for 
screening if this was their preference (Table 7.9). 
Women participated actively in discussions about barriers and enablers and some 
women disclosed openly they did not participate in screening.  Women were highly engaged 
and motivated at this stage of the focus groups.  Access issues and cost barriers were most 
often raised in areas of lower SES and in more remote communities. 
7.7 PERCEIVED SUSCEPTIBILITY TO HPV  
To ascertain women’s perceptions about HPV, they were asked to describe what they 
knew about HPV through an open-ended question “What do you know about human 
papillomavirus or HPV?”  The main themes identified under this topic were uncertainty, the 
natural history of HPV infection, how it was transmitted and whether it was preventable 
(Table 7.10). 
Uncertainty was as a common theme when HPV knowledge was explored.  There were 
three sub-themes of uncertainty.  There were women who had not heard of HPV (‘don’t 
know’), many others who knew nothing more than the name and those who primarily had 
queries about HPV and requested clarification.   
Of those who knew something about HPV, there was recognition that it was common 
and that HPV was an asymptomatic infection and frequently passed on without the infected 
person aware they were transmitting it.   
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Table 7.10. Perceived Susceptibility to HPV from Focus Groups Conducted in Queensland, 2009. 
PERCEIVED THREAT OF AND SUSCEPTIBILITY TO HPV AND HPV KNOWLEDGE 
Themes Exemplars 
Uncertainty  
 Don’t know  FG12: I dunno, I haven’t heard anything about it! 
 FG11: I’ve never heard about it  
 In name only  FG7: I’ve heard about it but I don’t know anything about it – I’ve only heard the name and that’s it. 
 FG21: And when you don’t know what it stands for, it doesn’t mean much - I thought I must find out  
 Queries  FG11: Isn’t papilloma a wart? – Ok that’s what I know (lots of laughter) ... Only ‘cause my little dog just had it and the vet called it papilloma! 
 FG14: I don’t understand the link between the whole cervical cancer and the HPV thing – sorry! 
Natural History 
 Prevalence  FG18: I think it would be very, very common, I think a lot of people would have it.  
 FG15: It’s an epidemic. 
 Symptoms  FG4: Males carry it and give it to females and don’t even know they’ve got it. 
 FG18: Like a lot of the population would have it and a lot of them wouldn’t know they had it. 
 Impact  
 link with cancer  FG12: Well it goes through stages; the virus goes through stages until it turns to cancer, I assume. 
 FG6: I’m not sure – my understanding of HPV is that you can suffer HPV and it can never convert over to a cancer, but on other occasions it will  
 misconceptions  FG22: That’s the virus that, women are concerned about for when you have German measles when you are pregnant ...  
 FG18: And it’s just lurking in there waiting until you are 35 are trying to have a baby and they say ‘sorry you’ve had HPV since you were 15 and sorry’ 
 Warts or not  FG18: I would say no - I know it’s a wart virus but I don’t think you have to have the warts – I reckon you could have HPV without the warts.  
 FG13: It’s a different virus to the papillomavirus - the HPV.  
 Treatment  FG15: Oh no, you can treat the warts but you can’t treat the HPV. 
 FG9: That’s what I was going to ask in relation to treatment, what about the vaccine? 
 FG12: No, I don’t know actually but maybe not – not always because it can go away – stop. 
Transmission  
 Related to sex  FG18: Well I thought after you were sexually active you could get it, not necessarily via sex but ... the virus could develop in your body by having sex. 
 FG19: If you haven’t had sex you’re not at risk as much and I think that’s why they are giving the vaccine to young girls. 
 FG10: It’s a virus.  It is more likely if you’ve had multiple partners or your partner has had multiple partners.  
 FG8: The guys don’t get problems but they give it to the girls. 
 Other  FG11: So if you are in the shopping centre and you shake someone’s hand you’re not going to get the virus? 
Prevention  
 Safer sex  FG13: I always just assumed that it was from the virus so if you have protected sex you are reducing your risk of ... 
 Vaccination  FG22: Isn’t that what the girls are getting their injections for? So that is what it is stopping is it? 
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There were often more questions than answers raised particularly about the impact of 
HPV and its association with cervical cancer, although it was not assumed that everyone 
infected with HPV would develop cervical cancer.  There were also misconceptions about the 
impact of HPV on women’s reproductive health such as infertility. 
There was limited understanding about different types/strains of HPV and a few women 
questioned whether it was the same virus that caused genital warts (Table 7.10).  There was 
also uncertainty and confusion about whether it was treatable, although some women were 
aware the body could clear the virus.   
When talking about how HPV was transmitted, women often thought it was related to 
sex and most often a sexually transmitted infection, although there was uncertainty about 
whether the virus developed once a woman became sexually active or if males were the 
source of infection.  Other modes of transmission were queried and classified as ‘other’ such 
as vertical transmission (from mother to baby during pregnancy or birth).  Women queried if 
HPV could be prevented through the vaccine or if the vaccine was a treatment for HPV 
infection and safer sexual practices were also thought to help prevent HPV infection.   
The age of participants was not necessarily indicative of women's knowledge about 
HPV as reflected in one observer’s notes – ‘Older women appeared more informed’ and 
uncertainty was widespread.  Uncertainty was commonly expressed about this topic in almost 
half of the focus groups where most women did not know of HPV or had not heard anything 
other than its name. 
7.8 PERCEIVED BENEFITS OF HPV VACCINATION 
When discussing the perceived benefits of taking action through vaccinating against 
HPV, the main themes were awareness of the vaccine, acceptability, practicalities and 
concerns (Table 7.11).  Cues to action were also discussed within the context of the 
information women would require to assist them to make an informed choice about 
consenting for the vaccine.   
Awareness 
Women were more aware of the vaccine than HPV, although there was still a lot of 
uncertainty expressed by some women and a number of older women had promoted the 
vaccine to their daughters and granddaughters (Table 7.11).  Awareness of the vaccine was 
evident in all focus groups.  Experience with the vaccine was also described as some young 
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women attending the focus groups had been vaccinated; others had consented for their 
daughters to have it whilst others spoke about their adult daughters having had it. 
Acceptability 
There was general acceptance of the vaccine, although vaccinating girls against HPV 
did raise some concerns about how this may promote sexual activity; however this was rare 
(Table 7.11).  When consent was discussed, concern was raised by some women that parents 
were making decisions on behalf of their daughters and the importance of including girls in 
the decision-making process about vaccination was commonly raised.   
Practicalities 
Women knew girls/young women were eligible to receive the vaccine for free but gave 
varying ages and discussed whether or not it should be given before sexual activity as some 
heard it was only offered to girls before they became sexually active whilst others spoke of 
how young women in their 20s were able to have the vaccine for free.  Women were 
uncertain about the number of injections in the course of the vaccine and even vaccinated 
women and those who had consented for their daughters, seemed unsure of this.  The role of 
the vaccine in preventing genital warts was not raised in the context of the benefits of HPV 
vaccination in any focus group. 
Concerns 
Older women often wanted to know why they were not eligible for the free vaccination 
program and at times raised concerns about equity.  This was sometimes linked with 
confusion about the effect of the vaccine as some women thought it had a therapeutic effect 
and so saw the vaccine as having benefits that were therefore not available to them unless 
they paid to have it (Table 7.11).  The most commonly cited concern about the vaccine 
related to side effects.  Women wanted to know about short term effects but also raised 
concerns about long term side effects that they believed may not have yet been identified 
given the vaccine is relatively new.   
Cues to action 
Women often spoke of Professor Ian Frazer and occasionally his colleague, Dr Zhou 
(who was not named specifically) when the vaccine was first mentioned and his role as a 
champion in raising awareness of the vaccine was evident even in remote areas.  Women 
were also sceptical of anti-vaccine messages including negative media coverage.  
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Table 7.11. Perceived Benefits of HPV Vaccination from Focus Groups Conducted in Queensland, 2009. 
PERCEIVED BENEFITS OF HPV VACCINATION 
Themes Exemplars 
Awareness 
 Uncertainty  FG21: Is that possible, is there one? 
 FG21: I’ve heard about it but that’s all. 
 Experience  FG18: Yes, well mine fainted for the first one and she made me come for the second and third. 
Acceptability  FG14: I’m Grandma to 8 girls and I’m saying – ‘get in there and get it, get in there and get it, get in there and get it!’ 
 FG18: And if I thought it was something that would help prevent cervical cancer I would be in there like a shot. 
 FG5: Some people might feel – oh you’re encouraging my child to have sex. 
 Decision-
making 
 FG11: I think it’s a big ask for a child of that age to, you know, for their parents to say you’ve got to have this, you know, because it could affect their life. 
 FG20: We are not even sure whether to advise the girls to get it or not, we’ve left the decision up to them because it’s their body and their future 
Practicalities 
 Eligibility  FG2: They want young people to have it before they’re sexually active. 
 FG13: They are not really recommending the vaccine for women  in their forties say who have been married for a long time... 
 How many?  FG12: Yeah- They had them at school – the first one was at school and the second one was at work so then they sent me to some clinic down here.  
 FG1: You just have one needle. 
 Treat or 
prevent 
 FG20: I want to know if they can give a vaccine like that why can’t they give us a vaccine to stop ... problems? 
 FG15: Yeah so if you’ve already got it, bad luck, if you have the vaccine you’ve got a ring of confidence. 
Concerns 
 Inequity  FG22: Yes but what does happen to the older women, is there something for us or, are we open to have that or is it only young women ...? 
 Side effects  FG5: Well I ‘m not concerned about all vaccines – I gave all my kids their vaccines – it’s just that one.  It’s the unknown I think. 
 FG11: You’d worry about the side effects I guess...if there’s been enough research or time to know if there’s side effects. 
 FG19: There was some reaction – the one girl who died... 
Cues to action 
 Champion  FG13: The cancer vaccine was very much helped by the profile of Ian Frazer - for me.  
 FG1: Like when he became Australian of the Year and something like that 
 anti-vaccine  FG1: There was a smear campaign going on about the immunisation. 
 FG8: There’s been some controversy around the side-effects with it.  The media jumped onto that one. 
 Trusted source  FG10: I want to see a lot more research with the truth about it  ... perhaps it’s too late to say, you know, so many years on  ‘oh gee, sorry girls you were 
the first batch and we forgot to tell you that there is a problem’ 
 FG14: I also don’t think the medical profession would bring out something like the vaccine if it had not been tested over a long period of time 
 Benefits  FG10: And I’d like to know is how many people are affected from the vaccine? Is it 1 in 100, is it 1 in 1000 or is it 1 in 1000000. I mean what is it? 
 FG11: ... they say you’re supposed to get it – but where’s the proof that it has worked  
 Pay more 
attention 
 FG13: It’s comes with the information and consent and so on – I mean I would presume the child’s been told about it at school.  But I’m thinking – gosh 
maybe I should be telling them about it. 
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The role of providers as a trusted source of advice was raised in focus groups and 
influenced some women’s decisions about having the vaccine.  Some women questioned why 
they put so much faith in the medical profession whilst others trusted the vaccine because it 
would not be supported by doctors unless it was safe.  
When discussing the information they wanted to know about the vaccine, the 
effectiveness and proof that the vaccine worked was considered important and women 
wanted information upon which to balance the benefits versus the harms of the vaccine, 
including the risks if a girl was not vaccinated.   
Pay more attention 
There was recognition amongst women about how little they knew about vaccinations 
and a realisation that they had become somewhat complacent about them as although 
information was sent home from school, they did not always read it and just signed the 
consent forms.  Specific to the HPV vaccine though, was that for many women it was not 
seen to be relevant to them as they did not have daughters or were not eligible for it and 
therefore had not sought or accessed further information – “Isn’t it terrible? I didn’t pay 
much attention, because I don’t have daughters”. 
Discussion about the vaccine was not as lengthy or detailed as the previous discussion 
about Pap smears and highlighted women’s uncertainty about specific details related to the 
vaccine.  Knowledge about the vaccine differed across groups with some older groups 
knowing very little about the vaccine but this was not consistent. Overall women were highly 
accepting of the vaccine, had limited knowledge about the eligibility criteria and were mostly 
concerned about side effects, especially in light of this being a relatively new vaccine. 
7.9 CUES TO ACTION – INFORMATION SOURCES AND ACTIVITIES 
The final topic discussed in the focus groups related to cues to action and sources of 
knowledge about cervical cancer prevention.  The first question women were asked in this 
section was ‘Where do you get your health information from?’ Women described the sources 
they trusted, which included their GP and the pharmacy.   
Women also talked about 'word-of-mouth' and those who were members of women’s 
organisations (QCWA and Zonta International) or women’s health groups spoke of how they 
often had guest speakers talking about health topics.  They had varying views of the Internet 
but considered health websites were a reliable source of health information. 
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Few women accessed magazines for health information as many women thought they 
were expensive and did not consider them a reliable source of advice. Women recalled 
television advertising and posters they had seen about cervical screening and referred to the 
key message in the recent QCSP campaign, although they had varying views about it.  
 The ad on TV I’m sure it says you can get this HPV virus even if you’ve only had sex just once it said. 
 With that revolting picture. 
 I don’t like seeing that on television. It’s just too personal and for the whole world to see. You don’t 
want every man and his dog virtually seeing that sort of thing. 
 With TV if it comes through as an ad, I’m sorry, the ad can be there in front of me and I wouldn’t have 
a clue what it’s about – I turn off – but as soon as the program comes on – yeah! 
 But those Pap smear ads when you sit down at night and you’re having your cup of coffee – it’s made 
me twice go and have my Pap smear. 
 
Women were then asked how they thought the Queensland Cervical Screening Program 
(QCSP) should disseminate new information for women about cervical screening – ‘There is 
a possibility that there will be major changes to the Pap smear program over the next few 
years so what do you think would be a good way for us to get new information out to 
women’?  Women talked about the sources of information they had previously discussed as 
sources of reliable health advice, such as mass media, networks, schools, health providers and 
the Internet but novel approaches, and sending letters to women on the PSR were also 
discussed (Table 7.12).  There was also a notable change in women’s description of strategies 
whereby they used more active language about how the QCSP could engage with women and 
successfully communicate policy changes. 
Diversity - There’s not one way  
Women frequently referred to the need for multiple approaches due to the diversity of 
women by age, culture, location and other factors including literacy as women showed 
concern about specific groups or areas when suggesting strategies and were not just focused 
on their own needs. 
Mass media - Go to the masses 
 Women felt mass media was relevant and it was deemed important to ensure optimal 
reach.  Women recalled television advertising and posters they had seen about cervical 
screening, although they felt there was little exposure and discussion about cervical cancer in 
the public domain especially compared to other cancers, particularly breast cancer.  
Television programs in particular were considered effective and women thought they were a 
good way to promote health messages, especially when the topic was integrated into the 
storyline or a real life story was portrayed.  Women did not think advertisements in women's 
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magazines would be that effective; however magazines that focused on health issues or 
specific groups, such as young women or girls, may have a role to play.  Convenience 
advertising, such as notices on the back of toilet doors were considered an effective strategy 
that they recommended as they were a captive audience and often read these messages when 
using public facilities. In addition, having a high profile media personality was thought to be 
effective, although they did acknowledge it might be difficult to find someone who would be 
prepared to publicly announce they had cervical cancer. 
Networks 
Women also felt they had a role to play in disseminating knowledge via word-of-mouth 
and how women's groups, such as the ones they were members of, were effective especially 
as older women often provided health advice to younger women (Table 7.12).   
Novel approaches 
There were a number of novel approaches raised including mail drops, advertising in 
women's change rooms and having specific events for prompting awareness of cervical 
cancer.  Women did caution on over-exposure though and commented on occasion that 
women were tired of breast cancer messages, especially at special events such as Mother’s 
Day, and also acknowledged the limitations of promoting cervical screening given the 
sensitivities involved. 
Trusted sources 
Women also felt health providers and services including pharmacies were important 
and were well placed to provide cues to action, especially as highlighted earlier, they 
considered them to be a common source of reliable health information.  Putting information 
in school newsletters and education in schools was also raised as an important place to begin 
education and awareness raising in the community and not just amongst girls (Table 7.12). 
Internet 
Websites and the Internet were considered relevant for young women, particularly a 
focused health website and women also thought social media sites such as Facebook may be 
relevant for younger women.   
Targeted strategies 
When asked about sending a letter via the PSR, it was readily accepted.  Women were 
concerned, though, that not all women would be reached this way, especially those who did 
not have Pap smears, as this was an important group to reach.  It was also apparent women 
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were unsure if they were registered on the PSR and some felt it was not as effective as the 
BreastScreen Queensland Register who sent invitation letters, as the PSR only sent a letter if 
they were overdue. 
If a letter was sent via the PSR, women felt they would be more likely to open it if it 
looked official with a logo and was personally addressed to them.  They wanted the content 
to be simple, clear and concise and felt something to catch their eye, for example a header 
‘Important health information for women’, would encourage them to read the contents. 
Early communication 
Women also felt it was important to begin communicating with them early if changes 
were to be made to the NCSP, rather than trying to convey a lot of information in a short time 
frame as they did not think this would be very effective. 
Women were very engaged throughout this discussion and suggested many methods to 
communicate new messages and cautioned against relying on one or two ways to reach 
women given the diversity of ages, cultures, geographical locations and literacy levels of the 
target audience.   
There were similar themes identified across all groups, although it was evident in a few 
groups that there were participants with marketing or health promotion expertise, which was 
reflected in their responses.   
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Table 7.12. Cues to Action – Recommendations to Disseminate New Information from Focus Groups Conducted in Queensland, 2009. 
CUES TO ACTON – DISSEMINATION OF NEW KNOWLEDGE 
Themes Exemplars 
Diversity  
 Multiple 
strategies 
 FG1: No, because some people can’t read, some people haven’t got TV – you just need the media and have different formats and a cross-section of 
ages and cultures and having stuff in different languages. 
 FG19: Yes, I think there’s not one way – hit it as many times as possible. 
Mass media  FG2: I believe the media is one way to push health messages. 
 FG7: I don’t think there’s ever enough advertising of things like that.  
 FG1: If it’s something new then go to the masses, maybe radio, TV and –eventually you think, oh OK, there’s something I do need to know about 
that. 
 Television  FG5: I think TV coverage for the illiterate parents; they can’t read so they’re not going to sign a form for an injection if they don’t know what it’s 
for. 
 FG10: Well I found I often watch A Current Affair or those types of programs and if something takes my interest on that I will look into it further, I 
will use the Internet to find out more. 
 Radio  FG11: They have radio talkback and they have different – they have a topic - we’re going to talk about this topic today – get your views.  But they 
also have a professional there and you can ask him questions, talk back and it’s all thrown over.  You have to be willing to talk about the virus – 
but then you have the ones that are private and they don’t want to talk but... 
 Print  FG19: Major newspapers like the Australian or the Courier Mail. 
 FG7: I was just thinking, there’s a couple of good magazines that have good health things in them.  
 FG22: Yeah, I don’t buy women’s health magazines. 
 FG1: I wouldn’t get it from New Idea – I’d get it from my doctor 
 Convenience  FG12: I think the fact that we all have seen advertising is pretty good feedback – you know we’ve all seen the ad on the back of the toilet doors, 
so... 
 Champion  FG4: But I do think it needs to be open more in the broader community. The way Sarah Henderson came across with breast cancer. 
 FG1: You have to have a famous person who’s actually a survivor of cervical cancer who’s a well known identity  
Networks  FG10: I think word of mouth – go back to our branches and talk about this and it will then spread to the wider community and word of mouth is 
always far better for education than something on the TV. 
 FG4: We need more education in private groups like this, where you feel more comfortable to talk about it. 
 FG18: Women talk, women get together and talk. 
 FG1: I’m thinking of informing the older women... not for their benefit but informing the older woman’s benefit but for the benefit of the younger 
women. If they are worded up they can help people who are younger – 
Novel  FG19: Do you put it in the power bill like they put your bloody ambulance letter– I mean everyone seems to get one of those. 
 FG1: Why don’t you send something to people to catch the market you don’t already have – (inaudible) – it might cost a bit to send it to all the 
houses - like just a postcard (inaudible) like one side of the thing says ‘have you had a check” call this number – something little – short and 
sharp. 
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 FG19:The Melbourne Cup luncheon here was breast cancer but I’ve never seen a Melbourne Cup lunch for cervical cancer... 
 FG1: Participant 1: What does everyone do?  we shop – so even if you had like Katies, your underwear stores or things like that – have it in an 
appropriate place …: Same as a woman from a different culture – she might be afraid to talk to her mother or father or husband about it but she 
goes shopping – she’s gotta buy clothes.  So that pamphlet will be there for her in the change room 
Participant 3: But I really like the change room idea – what a great idea!  Because you can close the curtain / door and no-one knows you’re 
reading it  
 FG15: Well you’re not going to stick it on the side of a bus. 
 FG5: In the libraries when I get my books I bring free leaflets of what’s on.  If there’s a free DVD there I’ll take it home and watch it that night 
and my husband will too. 
 FG5: Participant 1: Maybe you get Woolies and Aldi and Coles to put them in their bags as you go through the checkout– well you get a wider 
audience.  Participant 2: I can just imagine this little old man coming home with his shopping! 
Trusted sources  
 Clinics  FG2: I think we’re better to continue the education that this is thing to do, you know, go to the doctor and push the education side for young 
women. 
 FG22: Well doctors would know of course. Doctors themselves would have that information. 
 FG15: Indigenous Health Workers, our Indigenous Health Workers. 
 Schools  FG15: Yes it really sticks in your mind when it’s at school. 
 FG5: If you were trying to go for the younger group you could go probably look at your local schools 
Internet  FG13: More information on a reliable website 
 FG5: No. I don’t think so. My daughter isn’t going to go to the website unless she knows there was something wrong with her then she would go. 
But most young ones aren’t going to look up cervical cancer. 
 FG18: Yeah, Facebook has all those ads down the side and every time you log on you have a whole column of ads and they are targeted to the age 
group because as soon as you do something then suddenly you get ads relevant to that so it’s very cleverly put together. 
 FG15: But for the X and Y generation it might need to be YouTube, Twitter... 
Targeted  FG18: But I think with a lot of the Pap Smear Register is... well are you aiming for the women who aren’t getting them? 
 FG13: To me the key would be that the information is particularly important for your age bracket – maybe focused on your decade. 
 FG13: If it’s addressed to you personally by name so I’m sure you know, women within your age group, blah, blah, blah. 
 FG10: Not necessarily the Queensland Health but from a symbol quite pertinent to Pap smears. 
 FG21: You usually come out with the government logo on it so you know it’s from the department so you usually open it up to see what’s in it 
before you throw it away. 
 FG12: Not to the householder – its junk mail – my husband would throw it. 
 FG16: Say if you said ‘what every woman needs to know’. 
Early 
communication 
 FG14: So if you’re changing the program because you’re gonna have to do a lot of lead up work rather than just saying we’re changing in a few 
ads and that ‘s it – this is going to have to be a big education program around whatever changes there are.  
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7.10 SUMMARY OF FINDINGS 
Women participating in the focus groups provided in-depth insight into their 
perceptions about their ability to have some control over their own health, their susceptibility 
to cervical cancer and HPV, the seriousness of it to their health and its impact on their lives, 
the benefits of participating in screening and vaccination, the barriers to participation in 
cervical screening and the cues that would enhance their ability to participate in screening 
and vaccination.  The main themes identified from the focus groups are outlined in Figure 
7.2. 
Overall, women had very positive attitudes towards cervical screening and vaccination.  
Despite their negative attitudes towards the Pap smear procedure they felt it was important in 
protecting their health and therefore were accepting of it and compliant with screening even 
though they had limited knowledge about the purpose of the Pap smear as a secondary 
prevention strategy, when to start and stop screening and what an abnormal Pap smear meant.  
Trust, particularly of their health provider was an important factor that shaped their attitudes 
towards both cervical screening and vaccination. 
Women’s knowledge of the causes of cervical cancer and the associated risks of 
acquiring disease were limited.  There was a great deal of uncertainty and misconceptions 
associated with this and women acknowledged they had not thought much about it and 
related this to limited personal experience with, or community awareness about cervical 
cancer, particularly when compared to breast cancer.   
Women had heard of HPV, although often they had heard of the name but little else.  
They had also heard of the vaccine and again had limited knowledge about this, which they 
considered was due to their limited experience with vaccination given they were not eligible 
for it or did not have daughters. 
Women’s beliefs were strongly influenced by their experience, attitudes and knowledge 
about cervical cancer, screening and vaccination and they expressed concerns about the long 
term side effects of the vaccine, the harms versus benefits of Pap smears and the vaccine, and 
discussed factors, within and outside their control, that impacted on their health and their 
ability to participate in screening.  Within their discussions, women also made many 
assumptions throughout the discussions, particularly about young women and their sexual 
behaviour and perception of risk for cervical cancer.   
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Figure 7.2 Summary of themes from focus group data  
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One of the most fruitful parts of the discussion was the issue of barriers and enablers 
associated with cervical screening.  These related to individual barriers, such as discomfort, 
embarrassment, fear, denial, and revealed that the Pap smear is a test most women would 
prefer not to have.  Within the context of this discussion, women were empathetic to those 
who did not participate and had many ideas about enabling factors to assist women to 
participate more easily, including the one-stop shop concept and the need for a less invasive 
procedure. 
Participants also had many ideas on ways to communicate new information about 
changes to the NCSP.  They considered it very important to use multiple methods of 
communication including personalised letters, mass media using a high profile personality 
and social media to ensure reach and accommodate the diversity of women in the target 
population. 
The findings of both phases of this study are discussed in the next chapter with reference to 
relevant literature. 
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Chapter 8: Discussion 
This chapter discusses the combined research findings from Phases 1 and 2 of 
this study in the context of the Health Belief Model (HBM) and how they relate to 
the findings of existing research.  The characteristics of women who participated in 
this study are described in Section 8.1, women’s perceived susceptibility to cervical 
cancer and human papillomavirus (HPV) is described in Section 8.2, and their 
perceptions about the seriousness of cervical cancer and HPV are described in 
Section 8.3.  The benefits women perceive to result from cancer prevention strategies 
are discussed in Section 8.4, followed by the barriers they describe when considering 
screening and vaccination in Section 8.5.  Cues to action including enablers for 
screening and information needs about new technologies, where women get their 
health information from and what they recommend for communicating and 
promoting information in their communities is described in Section 8.6 and the 
chapter concludes with a discussion about the applicability of the HBM to this study 
in Section 8.7. 
This descriptive study provides unique insight into the beliefs underpinning 
Queensland women’s knowledge about the causes of and associated risks for cervical 
cancer, their perceptions about cervical screening and HPV and their attitudes and 
concerns about the HPV vaccine.  There was consistency between the results of each 
phase of the study with the findings of the computer-assisted telephone interview 
(CATI) survey, supported and expanded upon in the focus groups.  The following 
sections highlight the meaning of these findings as they apply to the future of 
primary and secondary prevention of cervical cancer in Australia. 
8.1 CHARACTERISTICS OF WOMEN IN THIS STUDY 
Women who participated in this study ranged in age from 18–88 years and 
were middle aged and came from differing geographical locations across Queensland 
(Table 5.1; Table 7.1).  Women participating in the focus groups were older and 
more likely to be from inner regional areas than CATI survey participants. Women 
were predominantly born in Australia and a representative number of women were 
Indigenous Australians.  Most women were well educated and had completed post 
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school qualifications, the majority of which were at the certificate/diploma level.  
The majority of women were in married or defacto relationships and had children.   
8.2 PERCEIVED SUSCEPTIBILITY TO CERVICAL CANCER 
8.2.1 Causes and Risks 
Perceived susceptibility to cervical cancer amongst women in this study was 
found to be based on limited knowledge and high levels of uncertainty of its causes 
and risk factors, which is a common finding in the literature.  Marshall et al (2007) 
reported 79% of participants (both male and female) responded ‘don’t know’ to an 
open-ended question about the cause of cervical cancer in a South Australian 
telephone survey.  English women involved in clinical trials for HPV testing also 
knew little about cervical cancer and did not tend to talk about cause in the context of 
cervical cancer whilst 51% of British women in another study were also found to be 
uncertain about what caused cervical cancer (Waller et al., 2005; Marlow, Waller and 
Wardle, 2007). 
In both phases of this study uncertainty about risk factors associated with 
cervical cancer was found, a common finding irrespective of where the study is 
conducted (Wong, 2011; Shand, Burney and Fletcher, 2010; Moreira et al., 2006; 
Waller, McCaffery and Wardle, 2004a; Mays et al., 2000; Pearlman et al., 1999).   
Family history was incorrectly considered a risk factor for cervical cancer by 
almost 90% of the women in this study.  Family history and its potential link to 
cervical cancer is not frequently documented in Australian studies (Agius et al., 
2010a; Shand, Burney and Fletcher, 2010).  It was reported as a risk factor by 74% of 
Thai immigrant women who participated in a study in Brisbane and has been 
frequently reported in a number of overseas studies, although in studies using 
unprompted recall, family history is uncommonly identified by women (Jirojwong 
and Manderson, 2001; Oscarsson, Wijma and Benzein, 2008; Cooper, Polonec and 
Gelb, 2011; Vanslyke et al., 2008; Marlow, Waller and Wardle, 2007; Waller et al., 
2005; Waller, McCaffery and Wardle, 2004a; Mays et al., 2000; Baay et al., 2004).  
The implications of this is that if women do not have a family history of cervical 
cancer, which is highly likely in the Australian context, they may perceive 
themselves to be less susceptible to it, despite there being no links with family 
history or genetic factors in current cervical screening health promotion messages. 
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The relationship of smoking as a cofactor in the development of cervical cancer 
for HPV positive women was poorly understood by women in this study, consistent 
with previous findings (Agius et al., 2010b; Armstrong and Murphy, 2008).  Similar 
to previous findings, women who reported they were smokers in the CATI survey 
were more likely to be underscreened and to have had a history of an abnormal Pap 
smear (Agius et al., 2010a; Smith et al., 2011). 
Women in this study were uncertain about the contribution of other lifestyle 
factors, such as stress, being overweight and hygiene to the risk for cervical cancer. 
Immigrant Thai women also associated poor hygiene with cervical cancer despite the 
lack of evidence to support this (Jirojwong and Manderson, 2001).  In unprompted 
studies, hygiene and dietary factors are also rarely cited as risk factors (Marshall et 
al., 2007; Waller, McCaffery and Wardle, 2004a). 
Most women in the CATI survey did not consider high parity and oral 
contraceptive pill use to increase the risk of cervical cancer although these factors 
have been linked with cervical cancer in previous studies (Bosch and de SanjosÃ, 
2003; Bosch and Muñoz, 2002).  Most women identified not having regular Pap 
smears as a risk factor for developing cervical cancer in both the CATI survey and 
focus groups, a similar finding to a study of rural Victorian women (Hancock et al., 
1996).  This suggests that most women are aware not having regular Pap smears 
increases a woman’s risk of cervical cancer; however almost a quarter of the women 
in this study did not think this.  The underlying reasoning behind this finding is 
described in more detail later in Section 1.4.1 in relation to the perceived benefits of 
cervical screening.   
In summary, this means that compared to previous work, uncertainty about the 
causes and risks for cervical cancer amongst women remains high, and there is a 
common misconception that family history increases risk.  Future educational 
materials and strategies need to highlight HPV as the necessary cause of cervical 
cancer and the risk factors associated with the acquisition of HPV to increase 
women’s knowledge of cervical cancer and assess their own personal risk. 
8.2.2 HPV Awareness 
There was high awareness of HPV with just over 60% of women in this study 
having heard of HPV previously, which was higher than found in Victoria in 2006, 
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but similar to that found in an Australian CATI survey of men and women, 
conducted  in 2008 (Pitts et al., 2007; Pitts et al., 2010b).  Higher awareness of HPV 
has been found in Australian studies when compared with overseas studies, which 
has been attributed to the introduction of the HPV vaccine in 2007, although 
awareness amongst younger women has been found to be limited in high school and 
university students, despite many having had the HPV vaccine (Pitts et al., 2010b; 
Shand, Burney and Fletcher, 2010; Wong, 2011; Huang et al., 2008; Marlow, Waller 
and Wardle, 2007; Agius et al., 2010a; Juraskova et al., 2011).  Juraskova et al 
(2011), attributed this finding to the marketing of the vaccine as a cervical cancer 
vaccine rather than a vaccine against HPV. 
There have been limited studies that have explored factors influencing HPV 
awareness that is, having heard of HPV, as most have investigated predictors of 
knowledge.  Education was found to be an independent predictor of HPV awareness 
in this study, which was also found in a British study of women aged 16–97 years of 
age and a study of older women (50–80 years) in America (Marlow, Waller and 
Wardle, 2007; Huang et al., 2008).  This difference observed in HPV awareness by 
education suggests that the communication strategy used for promoting the HPV 
vaccine in Australia, which primarily consisted of print media, the Internet and radio, 
may have been more effective amongst women with higher education levels and 
subsequent high health literacy (von Wagner et al., 2009; Leask et al., 2009).   
Although not statistically significantly different, somewhat lower proportions 
of women over 60 years of age had heard of HPV than younger women (Table 5.8), 
which has also been observed in two overseas studies (Marlow, Waller and Wardle, 
2007; Huang et al., 2008).  Awareness amongst CATI survey participants was also 
impacted by women’s prior experience of an abnormal Pap smear and their 
knowledge of cervical cancer/screening and reflects the findings of studies conducted 
with women attending dysplasia clinics or participating in vaccine trials (Giles and 
Garland, 2006; Waller et al., 2003).  Pitts et al (2010b), found differential awareness 
depending on cervical screening status; however this could not be assessed in this 
study due to the low proportion of unscreened women.   
Whilst there was high awareness of HPV in this study, the findings of both the 
CATI survey and focus groups indicate HPV awareness does not equate with good or 
correct knowledge, which is consistent with the findings of other studies (Shand, 
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Burney and Fletcher, 2010; Pitts et al., 2007; Waller et al., 2003).  Whilst awareness 
appears to have increased somewhat over time from 12% in 2006 to 51% in 2007 and 
63% in 2008, uncertainty about HPV persists in the community (Pitts et al., 2010b).  
In focus group discussions, it was not uncommon for women to say they had heard of 
HPV or articulate the name but no further knowledge was available about its role in 
cervical cancer or its functionality, which was consistent with the findings of other 
qualitative research conducted with Australian women (Cooper Robbins et al., 
2010a; Rosenthal et al., 2007).  Uncertainty about HPV in this study is consistent 
with the findings of other studies in which ‘don’t know’ is a common response to 
knowledge items in HPV knowledge scales (Agius et al., 2010b; Shand, Burney and 
Fletcher, 2010; Pitts et al., 2010b).  This suggests women had superficial awareness 
of ‘the virus’ but this awareness of HPV did not equate to knowledge to inform 
decision making about screening for HPV.   
Uncertainty about the role of HPV as a causal or risk factor for cervical cancer 
has been identified in numerous studies conducted in Australia both prior to and 
following the introduction of the HPV vaccine (Agius et al., 2010a; Pitts et al., 
2010b; Shand, Burney and Fletcher, 2010; Marshall et al., 2007; Pitts et al., 2007).  
HPV was identified as a risk factor for cervical cancer by almost 74% of women in 
Phase 1 of this study, which suggests awareness of the link with HPV and cervical 
cancer is increasing in the community.  This was slightly higher than the 54% of 
women who associated it with cervical cancer in the 2007 Victorian CATI survey, 
but was consistent with the findings of another Australian study conducted during a 
similar time period, (2008), in which 72% of women associated HPV with cervical 
cancer (Pitts et al., 2010b; Pitts et al., 2007).  Despite increasing awareness of HPV, 
uncertainty about its link with cervical cancer has been found to be higher in very 
young women, even if vaccinated against HPV, and older women (Pitts et al., 2010b; 
Agius et al., 2010a).   
A large proportion of women surveyed (83%) indicated that certain types of 
HPV cause cancer of the cervix in the HPV Knowledge Tool, also consistent with 
other studies conducted after the introduction of the National Human Papillomavirus 
Vaccination Program (NHPVP) (Gerend, Lee and Shepherd, 2007; Juraskova et al., 
2011; Pitts et al., 2010b).  The proportion of women in this study who thought 
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certain types of HPV caused cervical cancer was almost four times that of young 
American women surveyed in 2003 (Table 8.1),  (Kahn et al., 2003).   
 
Table 8.1: Comparisons between HPV Knowledge in Current Study and Kahn et al, 
2003 
  
Current study 
 (Kahn 
et al., 
2003) 
  
Correct  
Don’t 
Know 
 Correct 
 %  %  % 
 
A person may be infected with HPV and not know it 94  5  51 
Those with HPV may need Pap smears more often 85  10  49 
HPV is spread through sexual intercourse 77  13  45 
There is a vaccine to prevent some types of HPV 71  22  n/a 
a 
Women can often clear HPV without treatment 12  18  n/a
a 
HPV can cause problems with pregnancy 9  27  16 
HPV can be cured with antibiotics 49  34  41 
HPV causes women to have abnormal periods 32  39  37 
If you have HPV, smoking can increase your chance of 
cervical cancer 
58  26  n/a 
a
 
Condoms do not always help protect you against HPV 61  16  34 
Certain types of HPV cause cancer of the cervix 83  13  21 
The Pap smear is a test for HPV 54  15  44 
a  n/a  items not measured by Kahn et al(2003) 
 
Whilst many women surveyed knew HPV was associated with cervical cancer, 
as in other studies, women had varying understanding of the aetiology of cervical 
cancer and their perceptions about their susceptibility to infection with the virus were 
therefore based on uncertainty and misconceptions (Cooper Robbins et al., 2010a; 
Waller et al., 2005; Vanslyke et al., 2008).  There was considerable uncertainty about 
a number of HPV knowledge items, although women in this study were more likely 
to identify risk and protective factors than those participating in the study from which 
the HPV Knowledge Tool (Table 8.1) was derived (Kahn et al., 2003).  However, 
women in the Kahn et al (2003), study were younger and varied in all socio-
demographic characteristics to women in this study, and the study was conducted 
prior to the introduction of the vaccine. 
A smaller proportion of young women, similar to that found by Kahn et al 
(2003), were aware of the asymptomatic nature of HPV in a recent study of 
psychology students in NSW; however this was a small, non-representative sample 
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(Juraskova et al., 2011).  Increased knowledge of the sexual transmission of HPV 
and the limitations of condom use is evident in the present study when compared 
with studies conducted prior to the introduction of the vaccine (Pitts and Clarke, 
2002; Waller et al., 2005; Baer, Allen and Braun, 2000; Giles and Garland, 2006).  
The relationship of HPV with sex and the notion that sexual activity is a trigger that 
activates the virus was also discussed in a previous study involving adolescent girls 
who had been vaccinated (Cooper Robbins et al., 2010a).   
There was also uncertainty expressed about genital warts as a risk factor 
amongst women in this study which has been reported in other studies where the use 
of the term ‘wart virus’ was found to increase the stigma surrounding HPV 
(McCaffery and Irwig, 2005; Friedman and Shepeard, 2007).  Uncertainty was also 
evident amongst high school students with 80% of students not knowing if HPV 
caused genital warts, although in a study of adult Victorian women, over 60% of 
women knew of this association (Agius et al., 2010a; Pitts et al., 2007).  Of note is 
that only 45% of women surveyed in the 2008 Australian CATI survey knew HPV 
caused warts, despite this study occurring after the introduction of the HPV vaccine 
in Australia.  This suggests the prevention of genital warts is not a widely recognised 
benefit of the vaccine and that there is limited community awareness that genital 
warts are associated with HPV (Pitts et al., 2010b).   
The finding that women in the CATI survey with lower HPV knowledge were 
also more likely to have below average cervical cancer/screening knowledge and 
lower awareness of and negative attitudes towards the HPV vaccine is consistent 
with other studies (Shand, Burney and Fletcher, 2010; Pitts and Clarke, 2002; Mays 
et al., 2000; Kahn et al., 2003; Marshall et al., 2007). 
Confusion about HPV and its relationship with cervical cancer and the vaccine 
was evident in this study and has also been reported in a recent Australian study of 
girls and parents post vaccination implementation.  These authors suggested this 
could have been caused by the absence of information about HPV in public health 
messages about the ‘cervical cancer vaccine’ (Cooper Robbins et al., 2010a; 
Juraskova et al., 2011).  Further discussion about the avoidance of explicit messages 
about the vaccine’s role in preventing HPV, a sexually transmitted infection, has 
therefore been seen to have negatively impacted on community awareness about 
HPV and its link with cervical cancer and is a missed opportunity for raising 
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awareness within the context of promoting the vaccine (Cooper Robbins, Pang and 
Leask, 2011; Leask et al., 2009). 
Placing the present study into context thus suggests that uncertainty and poor 
knowledge of the natural history of HPV infection persists in the community despite 
evidence of increased awareness of HPV.  Education is required to inform the 
community and reduce uncertainty about HPV through, for example, patient 
information materials and mass media activities, and should be monitored in 
subsequent studies to determine the effectiveness of these strategies. 
8.2.3 Sexual Behaviours as Risk Factors 
Women, whether they knew about HPV or not, often linked cervical cancer 
with sexual activity, although there was uncertainty about whether it was the 
mechanical act of sex, sex as a trigger or the acquisition of a sexually transmitted 
infection.  Trauma-based explanations, such as frequent sex or childbirth, and 
triggers including hormonal changes during menopause or pregnancy, have been 
identified by women as risk factors for cervical cancer in other studies (Armstrong 
and Murphy, 2008).   
Limited knowledge that early sexual debut increased risk has also been found 
in a study of high school students who reported lower awareness of this as a risk 
factor and much higher levels of uncertainty than the women in this study (Agius et 
al., 2010a).  Women in the focus groups assumed girls today were much more likely 
to engage in sexual activity at a younger age than they did, which is supported by 
research showing earlier sexual debut amongst younger cohorts of Australians 
(Boyle et al., 2003; Agius et al., 2010b).   
There was discussion and debate about whether having multiple partners 
increased women’s cervical cancer risk, which is consistent with the findings of a 
United Kingdom (UK) study (Armstrong and Murphy, 2008).  Thai women in a 
Brisbane study reported similar levels of agreement with the women in this study 
about multiple partners as a risk factor for cervical cancer (77% and 72% agreement, 
respectively), as did Year 10 and 12 students (74%) in the high school study (Agius 
et al., 2010a; Jirojwong and Manderson, 2001).  These findings suggest women 
associate sex-related behaviours with cervical cancer, however there is much 
uncertainty about who is at most risk, especially within the context of HPV. 
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Waller et al (2005), reported similar findings about the relationship between 
cervical cancer, HPV and sex in a qualitative study of women in the UK.  There were 
three main groups of beliefs identified, those who believed cervical cancer to be 
unrelated to sex, others who thought it could possibly be related to sex and those who 
linked both cervical cancer and HPV to sexual activity (Waller et al., 2005).  Those 
who knew of the link between cervical cancer and HPV as a sexually transmitted 
infection were more readily able to integrate new information about HPV into their 
existing causal framework than other women in the study (Waller et al., 2005).  
Armstrong and Murphy (2008), stressed the importance of health authorities being 
open about HPV as a sexually transmitted infection, as women otherwise weave their 
own meanings from health messages that are not explicit.  
Failure to openly talk about sex-related risks for cervical cancer and normalise 
the risk of acquiring HPV was found in a New Zealand study to promote the notion 
that cervical cancer was linked to ‘promiscuity’.  This was found to lead to increased 
stigma but also led to some women not perceiving themselves to be at risk, 
particularly women in long-term monogamous relationships or those who have only 
had one or two partners (Braun and Gavey, 1999).  Married women in an American 
study also did not perceive themselves to be at risk of HPV or consider information 
about it to be relevant on hearing it was a sexually transmitted infection (Friedman 
and Shepeard, 2007). 
In a number of studies, when faced with a positive HPV DNA test, women 
have been reported to respond with shock, anxiety or fear, which has been attributed 
to poor knowledge about HPV and the stigma associated with the diagnosis of a 
sexually transmitted infection (Brown et al., 2007; McCaffery et al., 2006; Maissi et 
al., 2004; Kahn et al., 2007; Braun and Gavey, 1999b).  The uncertainties expressed 
by women in this study reflect the information women desire when diagnosed with 
HPV, which should ideally be discussed with them prior to testing.  These include 
high prevalence and the likelihood of spontaneous regression of HPV, that cervical 
cancer is slow to develop and that the subtypes of HPV associated with cervical 
cancer differ from those that cause genital warts (McCaffery and Irwig, 2005).   
Within focus groups discussions, women raised concern about the potential 
stigma associated with being diagnosed with an abnormality.  Some women believed 
that there was already limited disclosure about being diagnosed with cervical cancer 
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due to stigma, some referred to ‘promiscuity’, ‘sleeping around’ or not using 
condoms as risk factors and at times used language that placed the blame on women, 
particularly young women and their sexual behaviour.  The avoidance of discourse 
about sexual activity, HPV and cervical cancer by health professionals has been 
found to perpetuate this uncertainty and potentially increases the stigma associated 
with cervical cancer as a disease associated with promiscuity.  It was therefore 
recommended that clear messages need to be conveyed about the prevalence of HPV 
and that it is a very common outcome of sexual activity rather than the result of 
sexual impropriety (Waller et al., 2005; Braun and Gavey, 1999; Juraskova et al., 
2011).   
Women in focus group discussions expressed the need for increased 
community awareness about the risks and causes associated with cervical cancer and 
thought it was becoming more acceptable to talk about it openly, given other 
sensitive topics were more openly discussed, such as breast and prostate cancer.  The 
desire for more open information about these issues has been found in other studies 
with the proviso that messages do not increase stigma but help normalise HPV 
(Waller et al., 2005; McCaffery et al., 2006; Brown et al., 2007; Kahn et al., 2007; 
McCaffery et al., 2003; Donders et al., 2009; Marlow, Waller and Wardle, 2007).  
Using a public health approach in messages about HPV that emphasises the high 
prevalence of the virus and how it is commonly found amongst sexually active adults 
has been suggested as an appropriate method to reduce stigma about HPV in the 
community (Friedman and Shepeard, 2007; Waller, McCaffery and Wardle, 2004a). 
The primary finding in relation to perceived susceptibility amongst women in 
this study is that they are uncertain of the causes and risks of cervical cancer.  
Women in the focus groups talked about how they had been having Pap smears for 
many years without questioning why and some were surprised at how little they 
knew about what caused cervical cancer.  Whilst knowledge alone is not thought to 
bring about behaviour change; perceived susceptibility to and the threat of cervical 
cancer is thought to be a precursor to participation in risk reduction activities and 
necessary for change to occur (Pitts and Phillips, 1998; Hancock et al., 1996; 
Rosenstock, 1974).   
In light of these findings, which are well supported by previous reports in the 
literature, women need to be provided with accurate information about the causes 
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and risks of cervical cancer and the link between HPV, sexual activity and cervical 
cancer.  Future studies should assess whether an increased range of information will 
lead to improved perceptions of women about their susceptibility to cervical cancer 
and in turn, the adoption of risk reduction strategies and preventative behaviours 
such as screening and vaccination, appropriate for their level of risk. 
8.3 PERCEIVED SERIOUSNESS OF CERVICAL CANCER AND HPV 
8.3.1 Perceived Severity of Cervical Cancer 
Despite high levels of uncertainty about perceived susceptibility to cervical 
cancer, women participating in the focus groups were aware cervical cancer had 
serious consequences, which is consistent with the findings of other studies based on 
the HBM (Burak and Meyer, 1997; Jirojwong and Manderson, 2001; Baay et al., 
2004).  Whilst women’s perception of cervical cancer as a serious disease is an 
important motivating factor for them to participate in cervical screening, there is also 
the risk that having too fatalistic a view towards cervical cancer may deter some 
women from participating in screening, especially if they believe the test is for the 
detection of cancer (Baay et al., 2004).  In a study conducted in Belgium, the 
majority of women underestimated the chance of surviving cervical cancer.  The 
authors concluded, that in the context of an organised program, accurate knowledge 
of the chance of survival may in fact prompt women to participate, if the fear of an 
abnormal result is lessened due to increased awareness that the result is likely to be 
preinvasive disease (Baay et al., 2004).  Awareness of the purpose and meaning of 
the Pap smear therefore plays an important role within the context of perceived 
severity, as both a motivating factor or a potential barrier and is discussed further in 
the next section (Baay et al., 2004; Wardle, Pernet and Stephens, 1995). 
8.3.2 Severity of Human Papillomavirus Infection 
Women’s perceptions about the severity of an HPV infection were found to be 
based on a number of misconceptions in both the CATI survey and focus groups.  
Their knowledge about the clearance of HPV without treatment was poor in the 
CATI survey (Table 8.1), and almost half the women surveyed believed antibiotics 
would cure HPV, suggesting as in other studies, confusion about whether cervical 
cancer is associated with a viral or bacterial infection (Kahn et al., 2003; Baay et al., 
2004).  Limited knowledge about the severity of HPV is also reflected in the 
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Victorian CATI survey in which 25% of women thought there was no cure for HPV 
and Kahn et al (2003), also reported only 32% of women thought HPV would go 
away with the right treatment (Pitts et al., 2007).   
The misconception that HPV causes abnormal periods was consistent with the 
study from which the HPV knowledge scale was derived (Table 8.1), and slightly 
less commonly identified as causing problems in pregnancy (Kahn et al., 2003).  The 
perception that HPV caused problems in pregnancy was also found amongst young 
women in which 72% believed HPV caused infertility and this belief was also 
expressed in some focus groups, for example, ‘And it’s just lurking in there waiting 
until you are 35 and are trying to have a baby and they say - sorry you’ve had HPV 
since you were 15 - sorry’  (Shand, Burney and Fletcher, 2010).   
These misconceptions about the severity of HPV may have potential 
ramifications, especially if the age of commencement of screening is increased and 
HPV DNA testing becomes the primary screening test.  If women are not 
appropriately informed about HPV and its largely transient nature, there may be 
subsequent alarm about potential changes to the National Cervical Screening 
Program (NCSP), given the concerns women have about its impact on reproductive 
health.  There may be concerns if young women do not get screened until they are 25 
years of age that they are being placed at risk, as many will not have yet started a 
family.  A lack of understanding about the transient nature of HPV may also lead to 
increased alarm about a diagnosis of HPV, especially in light of the belief there was 
no cure.  These misconceptions about the severity of HPV highlight the need to raise 
community awareness about the link between cervical cancer and HPV prior to 
changes to the NCSP. 
8.4 PERCEIVED BENEFITS OF SCREENING AND VACCINATION 
8.4.1 Screening 
The findings of this study reveal some interesting nuances about women’s 
perceptions and beliefs about the benefits of screening and in particular, Pap smears.  
When participants of both the CATI survey and the focus groups were asked, without 
prompting, about the purpose of the Pap smear, women’s knowledge appeared high 
with most responding the purpose of the Pap smear was to detect abnormal cells.  
Fewer women in this study identified the test was to look for abnormal cells than 
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those reported by Giles and Garland (2006), who used a similar measure; however 
most of the women in their study were involved in clinical trials or being treated for 
abnormal Pap smear results.  This suggests young women in their study may have 
been exposed to more information than women in the general community, and was 
reflected in the finding that none of the women in Giles and Garland’s study (2006), 
indicated the Pap smear was a treatment for cervical cancer. 
Another explanation for this difference may also relate to the method by which 
the survey was administered.  Self-administered questionnaires with prompted 
responses were used, whereas women in this CATI survey were asked this question 
unprompted and could give multiple responses, which resulted in more response 
categories, such as ‘general women’s health’.  These responses were at times very 
broad, such as ‘to see if something is wrong’ or ‘prevent disease’, and were similar to 
those found by Mays et al (2000) and Moreira (2006).   
  Only 40% of American adults identified the purpose of the Pap smear as the 
detection of changes in the cervix suggestive of precancerous or cancerous 
conditions when this specific terminology was used (Mays et al., 2000).  In this 
study, it became evident that the meaning of the term ‘abnormal cells’ was a broad 
term that potentially incorporated more than precancerous cells and that more 
specific terms should be used in surveys.  In the CATI survey, almost 50% of women 
indicated that an abnormal Pap smear meant there were abnormal or precancerous 
cells; however over one quarter of women thought an abnormal test most commonly 
meant cancer.  This suggests many women perceive that cervical screening is for the 
early detection of cancer, like breast cancer screening, and not for precancerous 
changes which is similar to the findings of a Swedish study in which one third of 
women thought the main purpose of the Pap smear was to detect already developed 
cancer (Eaker, Adami and Sparen, 2001).  It also helps explain why one quarter of 
women, as previously discussed, did not consider having regular Pap smears would 
reduce their risk of cervical cancer and why women in focus group discussions 
refuted that Pap smears were for preventing cervical cancer -‘You can’t prevent it but 
you can find out...’  
High uncertainty about the purpose of the Pap smear has also been reported 
amongst American women and adolescents where over two thirds of the participants 
thought the Pap smear was synonymous with a pelvic examination (Blake, Weber 
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and Fletcher, 2004).  In other studies, women often believed the Pap smear was for 
detecting other gynaecological cancers (Cooper, Polonec and Gelb, 2011; Hawkins et 
al., 2011; Mays et al., 2000; Eaker, Adami and Sparen, 2001; Shand, Burney and 
Fletcher, 2010).  Confusion was also expressed by more than half the women in the 
CATI survey (Table 8.1), who thought the Pap smear was a test for HPV, which was 
slightly higher than the reported findings in a previous study (Kahn et al., 2003).  
This suggests that many women, despite extensive experience with cervical 
screening are unaware of the true benefits of Pap smears and as previously discussed, 
the perception of early detection versus the prevention of cervical cancer is a 
potential barrier for some women who fear the receipt of a cancer diagnosis.   
Women’s knowledge about the recommenced frequency for screening was 
found to be high, which is supported by the findings of a number of Australian 
studies (Shand, Burney and Fletcher, 2010; Giles and Garland, 2006).  However, 
their knowledge and beliefs about other recommendations such as the age range of 
the eligible target population was limited.  This was consistent with the finding in 
another Australian study conducted more than a decade ago, suggesting this belief 
has remained unchanged over time (Hancock et al., 1996).   
Very few women knew Pap smears were not necessary for most women after a 
hysterectomy, although this was debated in the focus groups.  These findings indicate 
low community awareness and misconceptions about the benefits of cervical 
screening within the context of an organised screening program amongst this well-
screened population.  As reported in Section 5.3.3, variation in cervical screening 
knowledge amongst women in the CATI survey was evident by screening status, 
although there were no independent predictors of cervical screening knowledge 
identified in a similar study conducted in the United Kingdom (UK) by Pitts and 
Clarke (2002).  This suggests that women in the general population, who are 
unscreened and underscreened, may have even lower levels of knowledge than 
women in this study. 
With proposed changes to the eligible population for cervical screening 
following the Renewal of the NCSP, concerns are likely to be raised given the 
limited understanding of the lack of benefits of screening for younger and older 
women amongst the participants in this study. 
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Most women participating in the focus groups believed the Pap smear was 
reliable although there was some concern that cancer could develop between tests, 
which supports the finding that women may be underestimating the time for 
precancerous changes to develop into cervical cancer.  They were realistic about the 
effectiveness of the Pap smear and understood it was not 100% reliable, which they 
attributed to both laboratory issues and the provider’s skill and that no test offered 
perfect protection, which was also found in an on-line sample involving young 
women aged 18–26 years by Shand et al (2010).   
Misconceptions are common – even by women with extensive screening 
experience, including that Pap smears are an early detection strategy and do not 
prevent cervical cancer, and that young women and older women should be included 
in the eligible population despite the lack of benefit of screening for women aged 
less than 25 years and those over 70 years of age (IARC, 2005).  Women also 
believed liquid-based cytology was superior to the conventional Pap smear, which 
was not confirmed when this technology was reviewed for inclusion in the NCSP 
(AHTAC, 1998).  These misconceptions will need to be addressed prior to or while 
communicating any changes to the NCSP to ensure women understand the eligible 
age range and a potential change in screening test and schedule.  This is particularly 
relevant if HPV DNA testing is introduced, given the interval between tests is most 
likely to be extended to five years for women with a negative result, as currently 
discussed (Meijer, 2011). 
8.4.2 HPV Vaccination 
High levels of awareness of the HPV vaccine were found in this study, 86% 
and 89% of women in the CATI survey and focus groups, respectively.  This is 
consistent with other Australian studies conducted post vaccine implementation 
(Shand, Burney and Fletcher, 2010; Juraskova et al., 2011).  High awareness of the 
vaccine has been attributed to widespread media attention surrounding the 
introduction of the vaccine when Professor Ian Frazer was named Queenslander and 
then Australian of the Year during the course of this study (Garland, Skinner and 
Brotherton, 2011b).   
Lower awareness of the vaccine amongst women born overseas reflects 
previous findings among Victorian women born overseas, which led these authors to 
recommend specific strategies to ensure effective communication with women from 
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culturally diverse backgrounds (Pitts et al., 2007).  A statistically significant 
difference in awareness of the vaccine by educational attainment was not found in 
this study, but was apparent in a Belgian study in 2007; however, this was overcome 
by an intensive mass media and education campaign (Donders et al., 2009).  Women 
who had never had an abnormal Pap smear were also less aware of the vaccine, 
which could reflect their lower exposure to messages about cervical cancer than 
those with increased risk of disease, consistent with the findings by Giles and 
Garland (2006).   
Table 8.2 Agreement with General Vaccination and HPV Vaccination Attitudes 
within the Current Study and Victorian CATI Survey 
Attitude Item 
Current 
study 
(Pitts et al., 
2007) 
Vaccination in General % % 
Prevention is better than cure for cervical cancer 96.2 97.7 
Vaccines are an important way to prevent disease 96.4 97.6 
Everyone should be vaccinated against preventable diseases in 
childhood 
92.1 89.5 
Vaccines that have been approved by the Health Department are safe 79.1 82.1 
All children should be vaccinated against preventable conditions while 
they are still babies 
86.5 79.9 
The costs involved would influence my decision to have a child of 
mine vaccinated
 a 
74.5 76.5 
The convenience of the venue where the vaccine is given would 
influence my decision to have a child of mine vaccinated 
a 
54.9 65.7 
I worry about the side effects of vaccines for children 
a 
41.1 51.6 
HPV Vaccination 
If I had a 12 year old daughter I would not want her to be vaccinated 
against HPV 
a, b 
89.1 n/a 
Vaccinating young women and girls against HPV would encourage 
them to become sexually active 
a 
87.2 90.6 
If I had a 12 year old daughter I would need more information before I 
could decide whether she should be vaccinated against HPV 
64.4 84.0 
If  I had a 12 year old daughter and my doctor thinks it is a good idea, 
I would have her vaccinated against HPV 
86.2 83.8 
There is more risk involved in being vaccinated than in having HPV 
a, c 
81.5 79.6 
The cervical cancer vaccine works best when it is given before a 
young woman becomes sexually active 
b 
64.7 n/a 
 
a These items were reverse scored i.e. participants disagreed with these items 
b Different items measured - not directly comparable 
c Positive item in Pitts et al (2007) study but comparable 
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In addition to high awareness, there was high acceptance of the vaccine 
amongst focus group participants and positive attitudes towards the vaccine 
expressed by women in the CATI survey, consistent with the findings of numerous 
studies both in Australia and overseas (Juraskova et al., 2011; McClelland and 
Liamputtong, 2006; Kahn et al., 2007; Marshall et al., 2007; Pitts et al., 2007; 
Cooper Robbins et al., 2010b; Dempsey et al., 2006; Gerend, Lee and Shepherd, 
2007; Zimet et al., 2005b).  CATI survey participants also had positive attitudes 
towards vaccination in general, although their attitudes towards the HPV vaccine 
were less positive, driven by high levels of uncertainty about some items in the HPV 
Vaccination Attitude Scale (Figure 5.9).   
Attitudes of Victorian and Queensland women differed in three items (Table 
8.2).  Queensland women were more positive about vaccinating babies than their 
Victorian counterparts and more concerned about the side effects of vaccines for 
children.  Queensland women were also more concerned about the convenience of 
the venue for vaccination, reflecting the geographically dispersed population in 
Queensland (CSSU, 2007c).   
Women born in Australia were more likely to have positive attitudes towards 
HPV vaccination, which is consistent with the findings of the Victorian CATI survey 
(Pitts et al., 2007).  Socio-economic status (SES) was a significant predictor in this 
study, with those living in the quintiles of most and least socio-economic 
disadvantage more positive towards the vaccine, but this was not a significant 
predictor in other studies, although different measures of SES were used (Brabin et 
al., 2006; Pitts et al., 2007; Marshall et al., 2007).  As the vaccine is free in Australia 
and there were no differences in general vaccination attitudes observed by SES in 
this study, this finding warrants further exploration in the Australian setting. 
More positive attitudes towards vaccination were also observed amongst 
women with a past history of an abnormal Pap smear, consistent with the findings of 
two American studies (Crosby et al., 2007; Dempsey et al., 2006; Zimet et al., 
2005b).  In these studies, experience with an abnormal Pap smear or a previous 
diagnosis of a sexually transmitted infection including genital warts, was found to 
impact on parents’ perceptions of perceived benefits of the vaccine and susceptibility 
to HPV (Dempsey et al., 2006).  However, screening status was not related to 
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vaccine acceptance amongst Mexican women aged 15–49 years (Lazcano-Ponce et 
al., 2001). 
Cervical cancer/screening and HPV knowledge were also independent 
predictors of HPV vaccination attitudes and reflect the findings of other studies in 
which perceived benefits of vaccination and susceptibility to HPV were associated 
with vaccine intent (Juraskova et al., 2011; Kahn et al., 2003; McClelland and 
Liamputtong, 2006).  Having heard of HPV was not associated with more positive 
attitudes towards vaccination; however awareness of the HPV vaccine prior to 
participating in the study was.   
As expected, women with positive attitudes to vaccination in general were 
more likely to also have positive HPV vaccination attitudes, consistent with the Pitts 
et al, study (2007).  Vaccine acceptance is considered essential for high levels of 
vaccine adherence and the positive attitudes expressed by women in this study reflect 
high community acceptance, which has been linked to relatively high levels of 
vaccine uptake in this country (Katz et al., 2010; Garland, Skinner and Brotherton, 
2011b; National Immunisation Program, 2012). 
The primary benefit of the HPV vaccine was seen to be the prevention of 
cervical cancer.  Prevention against genital warts was not raised in focus group 
discussions, which could reflect poor media coverage of the dual protection offered 
by the quadrivalent vaccine used in the NHPVP (Cooper Robbins, Pang and Leask, 
2011).  The added benefit of protecting against genital warts was found to be a 
significant predictor of vaccination intent in a recent study of young women, who 
preferred a vaccine that had multiple benefits (Juraskova et al., 2011).  
Uncertainty was also evident about who was most likely to benefit from 
vaccination with women unsure about the ages girls/women could be vaccinated for 
free, how many doses were recommended and whether the vaccine was prophylactic 
or therapeutic.  There may be less confusion about eligibility now that the catch up 
programs for older women have ceased.  Uncertainty about how the vaccine works 
and what it protects against was also found in a study of vaccinated school girls and 
their parents (Cooper Robbins et al., 2010a).  Women in the present study 
acknowledged they often did not read vaccine information before consenting for their 
children’s vaccinations, but did not judge themselves as critically as the mothers in 
the Cooper Robbins et al study (2010a), who referred to themselves as ‘bad parents.’  
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Most women participating in the focus groups thought vaccinated young women 
should still have Pap smears, although there was some discussion about this amongst 
women, consistent with other studies conducted post implementation of the vaccine 
(Cooper Robbins et al., 2010a; Juraskova et al., 2011; Shand, Burney and Fletcher, 
2010).   
Despite high awareness and acceptance of the vaccine amongst women in this 
study, widespread uncertainty about the full benefits of the HPV vaccine is still 
present in the Australian context.  Whilst current vaccination uptake is high, with 
73% of 12–13 year old girls fully vaccinated in 2007–2009, increasing awareness of 
the benefits of vaccination may further improve vaccination uptake, especially the 
completion of the three course schedule (Garland, Skinner and Brotherton, 2011b). 
8.5 PERCEIVED BARRIERS TO SCREENING AND VACCINATION 
8.5.1 Screening 
Despite regular participation in cervical screening, within the focus group 
discussions, women identified multiple barriers they face to Pap smears, many of 
which are cited in the literature, such as embarrassment, discomfort and the ‘yucky 
factor’ (Jirojwong and Manderson, 2001; Blomberg et al., 2008; Vanslyke et al., 
2008; Van Til, MacQuarrie and Herbert, 2003; Fernbach, 2002; Orbell, 1996; Smith, 
French and Barry, 2003).  These barriers suggest most women dislike Pap smears 
and find them embarrassing. 
Cost was a barrier for women, particularly those from regional and lower SES 
areas, which was consistent with the findings of another Queensland study (Stewart 
and Thistlethwaite, 2010).  Screening status however, did not differ by SES in a 
recent study, despite ecological evidence that Australian cervical screening 
participation and cervical cancer rates differ by SES (Smith et al., 2011; AIHW, 
2011). 
Access to services, particularly to a regular provider, was raised as a barrier by 
rural women and is consistent with the findings in other studies (Eaker, Adami and 
Sparen, 2001; Oscarsson, Wijma and Benzein, 2008; Wendt, Fridlund and Lidell, 
2004; Van Til, MacQuarrie and Herbert, 2003).  Other barriers described by women 
related to being time-poor and competing priorities, which are frequently described 
in the literature and relate to the multiple roles women have in modern day life 
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(Stewart and Thistlethwaite, 2010; Oscarsson, Wijma and Benzein, 2008; Smith, 
French and Barry, 2003; Waller et al., 2009; Waller et al., 2012; Kwok, White and 
Roydhouse, 2011).  Increased flexibility in appointment times, services provided 
close to women and technological advances, such as SMS messaging appointment 
reminders, may play a role in facilitating women’s attendance for screening, 
particularly young women (Waller et al., 2012). 
Pelvic examinations are perceived by most women negatively and often times 
are described as invasive, degrading, embarrassing and uncomfortable (Waller et al., 
2012; Wendt, Fridlund and Lidell, 2004; Smith, French and Barry, 2003; Orbell, 
1996; Kwok, White and Roydhouse, 2011; Waller et al., 2009; Blomberg et al., 
2008; Moore et al., 2000).  Both physical and psychological factors may contribute 
to this.   
Physical pain was caused by some providers described as ‘rough’, irrespective 
of gender, and the cold metal speculum and ‘scraping’ feeling when cells were being 
collected from the cervix were perceived as painful by some women, also described 
previously in a number of studies (Burak and Meyer, 1997; Kwok, White and 
Roydhouse, 2011; Orbell, 1996; Waller et al., 2009; Waller et al., 2012).  Of note is 
that perceived pain has been found to differ between women by screening status, 
with women less likely to screen more likely to perceive the procedure as painful 
(Burak and Meyer, 1997).   
Psychological discomfort included feeling vulnerable, (‘legs in the air’) or 
perceiving the procedure as an invasion of privacy (Oscarsson, Wijma and Benzein, 
2008; Kwok, White and Roydhouse, 2011; Wijma and Siwe, 2004; Waller et al., 
2012; Blomberg et al., 2008).  In addition to previously described barriers, insight 
into the concept of embarrassment was revealed through the focus groups. 
Embarrassment is commonly identified by local and international studies, 
irrespective of age (Alder and Foxwell, 1999; Waller et al., 2009; Waller et al., 2012; 
Orbell, 1996; Kwok, White and Roydhouse, 2011; Smith, French and Barry, 2003; 
Van Til, MacQuarrie and Herbert, 2003; Burak and Meyer, 1997; Moore et al., 2000) 
and was related to issues, such as women having to expose themselves (modesty), 
whether they were clean, issues about intimacy and concern about the provider being 
embarrassed.   
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Modesty is raised in a number of studies, including a study of Chinese 
Australian women (Kwok, White and Roydhouse, 2011).  In other studies, women 
also expressed concern about exposing private parts of their bodies, especially if they 
had suffered prior physical or sexual abuse (Oscarsson, Wijma and Benzein, 2008; 
Blomberg et al., 2008; Smith, French and Barry, 2003).  Negative body image has 
also been raised as a barrier in other studies (Fagan et al., 2011; Waller et al., 2012), 
particularly obesity, but not this study, with the exception of one comment -“Or they 
are going to see your rolls of fat?” 
The role of a chaperone present during the Pap smear procedure was 
ambiguous, with some women seeing this as an important option, particularly if their 
regular doctor is unavailable or the provider is male; however, many prefer privacy 
for pelvic examinations and do not wish a chaperone to be present, particularly when 
this is the receptionist (Khan and Kirkman, 2000; Baker et al., 2007).   
An unexpected and new barrier identified in this study was related to intimacy, 
in terms of women viewing their body as part of their sexual being and feeling 
uncomfortable exposing themselves and being touched by someone other than their 
partner.  A number of Swedish papers discuss how pelvic examinations potentially 
blur the boundaries between the public and private spheres in a woman’s life and 
how the interaction between the woman and the examiner results in both parties 
cognitively restructuring and defining a situation that would normally be sexual in 
nature, to that of a medical investigation (Wijma and Siwe, 2004; Oscarsson, Wijma 
and Benzein, 2008; Blomberg et al., 2008).  In previous studies, intimacy was not 
always discussed in the same context as it was in this study, whereby some women 
described how the procedure could potentially compromise a relationship, for 
example, “I actually think a lot of women sort of hold back because it’s the actual 
thought – well it’s not my husband  looking down on there – it’s someone strange so 
you’re actually going to see and you’re sort of thinking well it’s not going to be 
private anymore” or “Well it is very personal isn’t it, for a woman, and I only do 
that with my husband, you know I don’t look at the doctor as my husband”. 
For some women though, this was discussed as a control issue where men were 
perceived to prevent their partners having these procedures.  Partner violence has 
been identified as a predictor of lower cervical screening uptake amongst middle 
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aged Australian women, and a later stage of cancer diagnosis in an American study 
(Loxton et al., 2009; Modesitt et al., 2006).   
Fear and denial was also discussed in the focus groups and has been identified 
in other studies (Smith, French and Barry, 2003; Oscarsson, Wijma and Benzein, 
2008; Waller et al., 2009).  Denial as a barrier was raised primarily by older women 
who assumed young women did not perceive themselves to be at risk of cervical 
cancer, which was consistent with health professionals’ perceptions of why young 
women’s cervical screening participation rates were declining in the UK (Waller et 
al., 2012).  There is evidence suggesting young women do not perceive themselves to 
be at high risk of cervical cancer or HPV in a number of studies or have become 
apathetic towards cervical screening, which highlights the need for accurate 
perceptions of risk (Baer, Allen and Braun, 2000; Burak and Meyer, 1997; Waller et 
al., 2012).  
In this study as in others, a prior negative experience, whether physically or 
psychologically unpleasant, is a commonly cited barrier (Smith, French and Barry, 
2003; Waller et al., 2012; Waller et al., 2009; Blomberg et al., 2008).   
Despite an extensive number of barriers, most women reported they attended 
regularly for a Pap smear, which may be associated with personal moral obligation.  
Personal moral obligation suggests women comply with screening recommendations 
because they perceive it to be socially desirable or following the recommendation of 
their general practitioner (GP) or health authority, and has not been included in 
existing health behaviour models but should be explored in future studies (Tacken et 
al., 2007; Orbell, 1996). 
Increased efforts are needed to promote participation if the gains witnessed in 
Australia are to be maintained and if unvaccinated women, in particular, are to be 
afforded the protection of the NCSP in the future.  With the Renewal of the NCSP, 
the primary test may change, however, the method by which it is collected is similar 
to that of the Pap smear and will be no less embarrassing.  The Renewal does offer 
the opportunity though, to address cost as a barrier, investigate the feasibility of self 
collection for women who do not currently participate in the NCSP and introduce a 
less intensive screening program, whereby women are required to undergo this 
unpleasant procedure much less frequently.  It also provides the opportunity for the 
educational preparation of Pap smear providers to be reviewed and for quality 
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standards in training and competency to be standardised across health disciplines.  
These opportunities may assist in addressing the barriers described by women in this 
study to optimise women’s participation in the NCSP in the future.  
8.5.2  HPV Vaccination 
Relatively few barriers or concerns were raised by women about vaccination, 
and mainly related to the vaccine being new with little long-term effectiveness data, 
and concerns about side effects of vaccines in general (Shand, Burney and Fletcher, 
2010; Juraskova et al., 2011; Marshall et al., 2007; Rosenthal et al., 2007).  This may 
reflect media coverage in which the Government was accused of using Australian 
girls as guinea pigs, despite the evidence from extensive clinical trials that 
demonstrated the safety of the vaccine (Garland, 2007b; Cooper Robbins, Pang and 
Leask, 2011; Koutsky and Harper, 2006).  
Concern about vaccinating girls against a sexually transmitted infection was 
not found to be a barrier in this and other Australian studies, although the attitudes of 
culturally diverse Australians are not widely represented in existing research 
(Juraskova et al., 2011; Cooper Robbins et al., 2010b; Cooper Robbins et al., 2010a; 
Shand, Burney and Fletcher, 2010; Marshall et al., 2007).  In more conservative 
countries, such as the USA, parental surveys showed concern that the vaccine may 
promote sexual activity in young girls (Olshen et al., 2005; Krishnan, 2008; Zimet et 
al., 2005b; Brabin et al., 2006).  For Australian parents, how to discuss the 
association between HPV as a sexually transmitted infection was seen as a challenge 
by some (Cooper Robbins et al., 2010b).   
8.6 CUES TO ACTION 
Within the focus group discussions, women provided extensive insight into 
cues to action for both screening and vaccination and strategies for communicating 
changes following the Renewal of the NCSP. 
8.6.1 Enablers to Cervical Screening Including Self Collection 
Education of young women in schools was one strategy to help normalise 
cervical screening as an activity women engage in to keep healthy and was 
previously identified as a motivating factor for having had a Pap smear in a study of 
American college students (Burak and Meyer, 1997).  The importance of reminder 
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systems, such as a letter from a health professional or the Pap Smear Register (PSR), 
was raised as a preference to opportunistic screening where the examination was 
sprung upon women when attending a GP for an unrelated issue and they had no time 
to prepare or as one woman said ‘wear your good undies’.  This is particularly 
relevant in the Queensland context where the temperature in summer can reach more 
than 40
o
 Celsius.  Reminder systems and invitation letters have been found to be 
effective cues to action that prompt women to participate in screening, although in a 
Swedish study, Blomberg et al (2008), found some women interviewed thought an 
invitation letter from the government was coercive and akin to a ‘Big Brother’ 
approach to healthcare (Kwok, White and Roydhouse, 2011; Smith, French and 
Barry, 2003; Day, van Dort and Tay-Teo, 2010).  Paternalism was also identified in a 
recent study in which health staff, such as practice nurses and GPs, described 
coercive attitudes towards encouraging women to participate in cervical screening, 
especially where GP incentives were in place (Waller et al., 2012).   
Women discussed strategies they thought providers could adopt that would 
reduce discomfort and embarrassment during the Pap smear procedure, although 
these were somewhat individualised and at times contradictory, for example, some 
women wanted the provider to explain what they were doing, whilst others wanted 
them to talk about something else or did not want to think about it and tried to block 
out what was happening ‘down there’.   The importance of explaining the procedure 
as it was being conducted was deemed important by 95% of women in an Australian 
study of women’s views about intimate examinations and was closely linked with 
women’s perceptions of comfort and trust during the procedure (Moore et al., 2000).   
A consistent theme from focus group discussions, often irrespective of the 
provider’s gender, was that women wanted a skilled practitioner they could trust, 
which has been found in other studies (Moore et al., 2000; Blomberg et al., 2008).  
The establishment of trust and describing the procedure before, during and 
afterwards has been described as important in creating confidence, being engaged 
and respectful towards the woman and essential if the woman is to be an active 
participant in the process (Wendt, Fridlund and Lidell, 2004; Stewart and 
Thistlethwaite, 2010).   
Women also supported the role of nurse Pap smear providers and often talked 
about the Mobile Women’s Health Service or their local practice nurse which reflects 
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the acceptability of nurse Pap smear providers found in the literature (Christie, 
Gamble and Creedy, 2005; Victorian Cervical Cytology Registry, 2012).  The ‘one 
stop shop’ concept was raised as an enabler in a number of focus groups, where 
women could have their breastscreen and Pap smear at one visit.   
Women in the focus groups were supportive of a hypothetical self collected 
test; however raised concerns about the safety and efficacy of self testing and 
worried they may not do the test properly or contaminate the specimen.  Similar 
concerns were also reported in a study where  women’s comfort with self collection 
was lower compared to a physician collected sample, attributed to women’s concerns 
about whether they had done the test properly (Quincy, Turbow and Dabinett, 2012).    
However, in a UK study, women attending for a Pap smear were provided with a kit 
containing written instructions for a HPV DNA self collected sample and no other 
information.  More than 90% of women felt confident they had done the test properly 
and over 70% indicated a preference for doing a test at home in the future, if it were 
offered, rather than having a clinician administered test, although cultural differences 
were observed in acceptability (Waller et al., 2006).   
Women in the focus groups felt self collection was a good option for 
underscreened women, provided the test had clear instructions, and although most 
women reported regular participation in screening, some comments indicated women 
who did not participate regularly would consider this option – ‘From my point of 
view I wouldn’t have gone so long without it if I had something like that’. Self 
collection was not supported as a replacement to health provider collected samples 
by women in this study, but was considered a viable option for those women who 
could not overcome their embarrassment to have a Pap smear.   
8.6.2 Sources of Information  
Although most women said they had heard about the HPV vaccine through 
mass media, particularly television, health professionals were frequently cited as 
sources of HPV vaccine awareness, which is similar to the sources described 
elsewhere (Juraskova et al., 2011; Rosenthal et al., 2007).  Women in the Victorian 
CATI survey also identified mass media as the primary source of awareness of HPV 
(Pitts et al., 2007).  The influence of mass media on community knowledge was 
measured in an American study in which those exposed to health media were found 
to be more likely to learn about the cause of cervical cancer following increased 
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media coverage post approval of the HPV vaccine by the Food and Drug 
Administration (Kelly et al., 2009).  Mass media strategies have been found be an 
effective strategy for increasing screening participation; however one-off media 
campaigns do not result in sustained increases over time (Day, van Dort and Tay-
Teo, 2010). 
Health professionals were also considered to be reliable sources of health 
information amongst women in the focus groups and pharmacists were included 
amongst this group.  In the limited research about health professionals’ knowledge 
and attitudes to HPV vaccination in the Australian setting, GPs and gynaecologists 
were found to be positive about HPV vaccination and perceive their knowledge to be 
high; however self rated knowledge about HPV and the vaccine was found to be 
considerably higher than measured knowledge amongst GPs (Brotherton, Leask, et 
al., 2010; Tan, Farrell and Allen, 2010; Leask et al., 2009).  Women’s health nurses 
and Aboriginal and Torres Strait Islander health workers have also been found to 
support the benefits of the HPV vaccine and in a Victorian focus group, 
demonstrated good knowledge and considered they were well placed to educate 
women about HPV (Leask et al., 2009; Rosenthal et al., 2007).   
The capacity of Australian pharmacists to provide women with information 
about HPV test results has been questioned; however in other countries their role in 
infection prevention through vaccination, including HPV vaccination, has been 
recognised (Blank, 2009; Woodford Guegan, 2010).  School was identified as a 
source of awareness of the HPV vaccine and identified in focus groups as a good 
source of information.  The role of teachers and school staff has been found to be 
important for uptake of vaccination and the need to educate teachers about HPV and 
the vaccine has been identified in the literature (Cooper Robbins et al., 2010c; 
Garland, Skinner and Brotherton, 2011b).  These findings suggest health 
professionals including pharmacists, and teachers are important sources of 
information and therefore need to be supported in this role.   
Word-of-mouth and family and friends were frequent sources of awareness of 
the HPV vaccine in the CATI survey, which is a consistent finding in other studies 
(Pitts et al., 2007; Rosenthal et al., 2007).  Women also found having guest 
presenters at their meetings beneficial, especially if the speaker had a high profile, 
for example, some had attended a session with Professor Ian Frazer.  This study 
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highlights the role women’s organisations play in disseminating information through 
their regular networks and peer support.  Community interventions have been found 
to have a positive impact on knowledge and screening participation at the local level, 
although are not associated with increasing participation rates at the population level 
(Day, van Dort and Tay-Teo, 2010). 
Web-based information was not highly utilised by women in the focus groups 
and was not a frequent source of HPV awareness at the time the study was 
conducted; however this may be due to age profile of participants as the average age 
of women was 55 years.  There has been increased usage of the Internet in general 
society over time and reported use of the Internet as a source of information by 
women following a positive HPV DNA test (Livesley, 2010; McCaffery and Irwig, 
2005).  As evident in both the CATI survey and focus groups, women obtain health 
information from a number of sources, therefore it is important to develop 
communication strategies that utilise a number of approaches for the broad age range 
of women eligible for cervical screening. 
8.6.3 New Technologies 
With the renewal of the NCSP, there is a real possibility HPV DNA testing 
may be introduced either as a primary screening test or as part of alternative 
screening pathways in a cytology-based program.  Liquid-based cytology is likely to 
be introduced in conjunction with HPV DNA testing and women will therefore be 
offered alternative tests to the Pap smear.  Women, when asked what they would 
need to know to trust any new test introduced into the NCSP, wanted to be assured 
the test was as safe and as reliable as the Pap smear.  In preference studies, women 
who were informed about the benefits of HPV DNA testing compared to the Pap 
smear chose the former given its higher sensitivity (Brown et al., 2007; Huang et al., 
2008).   
Trust and safety issues also apply to extending the screening interval or 
changing the age range for screening as many women in the CATI survey perceived 
the Pap smear to be for the early detection of cervical cancer and some raised 
concerns that a two yearly screening interval was risky, as they perceived cancer 
could develop in the intervening period.  In a study of older ethnically diverse 
women aged 50–80 years, women were not willing to have Pap smears less often, 
even if their HPV DNA test was negative and their physician recommended it 
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(Huang et al., 2008).  In addition, nearly two thirds of women wanted between two 
and four Pap smears per year if they received a positive HPV DNA test result (Huang 
et al., 2008).  These findings indicate the importance of increasing community 
knowledge and awareness about HPV and the benefits of HPV DNA testing, prior to 
the introduction of changes to the current NCSP, to ensure women trust that any new 
recommendations will not place them at harm.   
The information women wanted to know about the HPV vaccine also 
highlights that safety is at the forefront of women’s minds  and is consistent with the 
findings of focus groups conducted prior to the implementation of the NHPVP 
(Rosenthal et al., 2007).  Women also felt more information should be available 
about the risks of vaccination versus contracting HPV, how effective the vaccine was 
and what the risk of cancer was for a girl who was not vaccinated, which were issues 
identified in a study of vaccinated girls and their parents (Cooper Robbins et al., 
2010a).  Widespread information should be considered, as although mothers 
commonly provide consent for the vaccine or discuss it with their daughters, fathers 
who have more information may be better placed to support their children in 
decision-making about the vaccine, which will be increasingly important with the 
recent inclusion of HPV vaccination in the NHPVP for boys (Cooper Robbins et al., 
2010b; Katz et al., 2010).   
8.6.4 Recommended Methods for Communication Strategies 
The recommendations women in the focus groups made for disseminating new 
information about cervical cancer prevention provide insight into what women 
perceive are effective methods in their communities.  This discussion was framed in 
terms of communicating changes to the NCSP and did not explore issues associated 
with HPV as a sexually transmitted infection, which has been discussed in existing 
studies (Friedman and Shepeard, 2007; Rosenthal et al., 2007; Waller, Marlow and 
Wardle, 2007; Szarewski, 2011; Smith et al., 2011). 
Women supported sending a letter to all women registered on the Queensland 
Health PSR, provided it was appropriately branded and contained concise 
information that would grab their attention, whilst cautioning about the limitations of 
this method as unscreened women would not receive it.  Whilst mass mail outs via 
the PSR results in a high volume of return to sender mail, increases in phone calls to 
the register and cervical screening participation rates suggest this is an effective 
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strategy for reaching many women (Queensland Cervical Screening Program, 2012; 
Morrell et al., 2005). 
Women in the focus groups suggested multiple strategies and methods to 
ensure women with diverse needs have access to information, which has been 
identified in previous studies (Kirk et al., 1998; Rosenthal et al., 2007; Wollin and 
Elder, 2003; Pitts et al., 2007; Webster, 2007; Leask et al., 2009; Jirojwong and 
Manderson, 2001).  The limitations associated with mass media were raised by 
women in the focus groups and reflect those identified in content analyses of 
newspaper and television articles; however, content in television programs or talk 
back shows with a relevant expert was thought to be effective.  This was observed in 
the UK when cervical screening participation rates increased after the fictional death 
of a main character in a popular television soap opera, Coronation Street, and after a 
young women, Jade Goody, who appeared on a reality television show, Big Brother, 
died from cervical cancer (Cooper Robbins, Pang and Leask, 2011; Kelly et al., 
2009; Howe, Owen‐Smith and Richardson, 2002; Bowring and Walker, 2010). 
Women in the focus groups spoke of other novel strategies for disseminating 
information that were linked to social marketing and require further investigation, 
piloting and evaluation to determine their effectiveness.  The cues to action described 
by women in this study provide extensive insight into what motivates them to 
participate in screening, such as provider recommendations and reminder letters, and 
where they obtain health information that they trust.  They considered cervical cancer 
to have low prominence in the community, especially compared to other cancers and 
that more information should be readily available to increase women’s knowledge 
about cancer, screening and vaccination. 
The findings of this study have been described in this chapter as they relate to 
the HBM and are summarised in the final section. 
8.7 THE HEALTH BELIEF MODEL 
The HBM provided an ideal framework for exploring what women know and 
say about cervical cancer/screening, HPV, the HPV vaccine and their attitudes 
towards Pap smears and is presented in Table 8.3.  
Utilising this theoretical framework revealed that despite extensive experience 
with screening, the women in this study had misconceptions and knowledge gaps 
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directly related to their perceived susceptibility to cervical cancer due to high levels 
of uncertainty about the causes and risks of cervical cancer, including HPV.   
Self-efficacy and taking control over one’s own health was reflected in 
women’s statements about what causes good health, but also highlighted how 
common misconceptions, for example, that cervical cancer runs in families, impacts 
upon women’s sense that preventing cervical cancer is within their locus of control.  
With decreased incidence of cervical cancer in the Australian setting, few women 
will have a relative with cervical cancer and therefore may wrongly perceive they are 
not at risk of cervical cancer and do not need to participate (AIHW, 2011).   
Low perception of risk due to poor knowledge has been identified as a 
potential barrier to participation in both cervical screening and HPV vaccination 
programs, although knowledge is not always a reliable predictor of behaviour and 
should be viewed in the context of other factors (Braun and Gavey, 1999; Waller et 
al., 2009; Waller et al., 2012; Baileff, 2000; Burak and Meyer, 1997; Jirojwong and 
Manderson, 2001; McClelland and Liamputtong, 2006).  Lack of knowledge about 
HPV and its link with cervical cancer may present a significant barrier to women’s 
acceptance of changes to the NCSP if HPV DNA testing is introduced as part of the 
screening pathway, as research has found significant psychological distress results 
from a positive HPV diagnosis when women have limited knowledge of these issues 
(Maissi et al., 2004; McCaffery et al., 2006).  This distress has been found to be 
time-limited and to decrease with the provision of accurate information, and 
demonstrates the need to increase community awareness about HPV (Maissi et al., 
2005). 
The HBM also provided insight into how limited community awareness and 
personal experience with cervical cancer impacted upon women’s perceived 
susceptibility to disease.  Despite limited exposure to women with cervical cancer, 
women still perceived cervical cancer to be a serious disease that had serious 
consequences if not detected early, which is a consistent finding in other research 
(Burak and Meyer, 1997; Baay et al., 2004).  Women also had misconceptions about 
the seriousness of HPV as an infection, which could potentially lead to unnecessary 
anxiety about a positive diagnosis, including concerns about infertility and a lack of 
awareness of the transient nature of infection amongst most women.   
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Exploration of the perceived benefits of cervical screening in this study 
revealed that despite extensive experience with cervical screening many women did 
not know the true benefit of Pap smears as a prevention strategy for cervical cancer, 
which has been attributed in the literature to result from providers’ assumptions that 
women who attend regularly for screening have adequate knowledge about the 
screening program (Szarewski, 2011).  The notion that Pap smears were for the early 
detection of cancer presents a potential barrier for women who fear receiving a 
cancer diagnosis and who have a fatalistic view that cervical cancer is untreatable 
and is worse than breast cancer (Baay et al., 2004; Jirojwong and Manderson, 2001; 
Chavez et al., 1997). 
This study also highlights the benefits of HPV vaccination are not well 
understood, with uncertainty expressed about the effectiveness of the vaccine and 
little reference to it as a preventative against genital warts.  
The barriers to Pap smears women described in focus group discussions are 
consistent with those described in other studies, although the concept of 
embarrassment was described in greater detail.  These barriers will persist 
irrespective of the screening test used in the NCSP as the collection method is the 
same unless self testing is provided as an option for women who continue to be 
unscreened and may be the most effective cue to action for these women (Sanner et 
al., 2009). 
Enquiring about cues to action for screening also highlighted women’s 
compliance with their health providers’ recommendations about cervical screening 
including paying to have additional tests despite not fully understanding the role of 
these tests or being able to name them and in most instances, disliking the test 
intensely.   
Women provided extensive insight into cues to action for screening and 
vaccination, such as providers’ recommendations and reminder systems.  The role of 
providers as a trusted source of advice was raised in focus groups and influenced 
some women’s decisions about having the vaccine.  Some women questioned why 
they put so much faith in the medical profession whilst others trusted the vaccine 
because it would not be supported by doctors unless it was safe. 
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Table 8.3: Relationship of Research Questions and Study Findings to HBM 
Research Questions HBM FACTORS FINDINGS 
What do women know about cervical 
cancer/screening and what are their attitudes 
towards Pap smears? 
 
 
Self-efficacy  
 
Self management  
Aspect of luck related to genetics 
Potential external locus of control given high level of response that genetics or family history is 
associated with increased risk of cervical cancer in both CATI survey and focus groups 
Perceived susceptibility to 
disease 
Potential for not considering susceptible or a threat due to high uncertainty in focus groups re 
cause 
Family history most common cause in CATI survey 
HPV identified but uncertainty high in CATI survey  
Potential for not considering at risk due to high uncertainty about the links between cervical 
cancer, HPV and sexual activity including behaviours that are known to increase risk in both 
CATI survey and focus groups 
Smoking not considered a risk factor by 28% of women in CATI and women in focus groups nor 
high parity or  OCP 
Hygiene considered a risk factor by more than half of participants 
Sexual behaviours linked with ‘promiscuity’ in both studies that potentially could leave some 
women not perceiving themselves to be at risk 
Perceived seriousness of 
disease 
Perceived cervical cancer to be serious 
Some indication of fatalistic view that was impacted by view that Pap smears detect cervical 
cancer as opposed to secondary prevention 
Early detection decreased impact 
Overall low community awareness or experience with cervical cancer 
Perceived benefits of 
taking action 
Perceived benefits impacted by perception that NCSP was an early detection program – 19% 
thought it was a treatment of  cancer; 27% of women in CATI saw this as an early detection 
program 
CATI survey did not reveal this as ‘abnormal cells’ was assumed to be a correct response; 
however in the focus groups this was revealed to be interpreted by many as abnormal cancer 
cells not precancerous abnormalities 
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Research Questions HBM FACTORS FINDINGS 
Poor knowledge of the current NSCP target age group 
Perceived barriers to 
action 
Multiple barriers identified and explored in-depth although given women’s experience with Pap 
smears these did not prevent many women from attending 
Cues to action Identified enablers/cues to action to reduce embarrassment 
Women were receptive to an alternative option provided concerns were addressed and thought 
this may encourage women who did not have Pap smears to participate in screening 
What do Queensland women know about 
HPV and what are their attitudes towards 
the cervical cancer/HPV vaccine? 
 
Perceived susceptibility to 
disease 
Perceived susceptibility potentially low given high levels of uncertainty in both CATI survey and 
focus groups and the link with sexual activity and sex-related risk factors poorly understood, i.e. 
if not ‘promiscuous’ not at risk 
Perceived seriousness of 
disease 
HPV was thought to have serious implications for fertility and menstrual problems 
Low awareness HPV could resolve spontaneously 
Perceived benefits  Perceived benefits not well understood due to uncertainty about the vaccine and whether it was 
prophylactic or therapeutic and the risks associated with not being vaccinated; however high 
levels of acceptance  
No mention of benefit of protection against genital warts 
Cues to action  More information required about side effects, safety efficacy, benefits and how it works 
What do they women perceive as the most 
effective methods of communicating and 
promoting new information should changes 
be made to the NCSP 
Cues to action Mass media most common source of information although not always considered a reliable 
source 
Health professionals including pharmacists considered a trusted source of information  
Recommended multiple and novel strategies to ensure diversity of women in target age group 
reached through communication strategies 
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CATI surveys in recent times, similar to that used in Phase 1 of this study, have 
explored knowledge about cervical cancer/screening, HPV and attitudes towards the 
HPV vaccine; however Phase 2 of this study added an extra dimension by providing 
insight into women’s beliefs about HPV and the HPV vaccine and exploring the links 
between knowledge, attitudes and beliefs as this can identify misconceptions or 
knowledge gaps that are not explicit when fragments of knowledge are assessed 
(Brown et al., 2007). 
The HBM also provided a rich source of information about cues to action 
should a new test be introduced, ways to encourage parents to consent for their 
daughter to be vaccinated and how to communicate changes to the NCSP following 
the Renewal of the Program.  The use of the HBM in this study enabled the 
exploration of knowledge, attitudes, beliefs and experiences that were not possible 
through the CATI survey alone and confirmed the relevance of this model in 
understanding women’s perceptions of primary and secondary prevention strategies.   
The conclusions drawn from this research are described in the next chapter. 
  
 
Chapter 9: Conclusions 199 
 
Chapter 9: Conclusions 
This study provides unique insight into the beliefs underpinning Queensland 
women’s knowledge about the causes of and associated risks for cervical cancer, 
their perceptions about cervical screening and human papillomavirus (HPV) and 
their concerns about the HPV vaccine.  This thesis has described the literature 
surrounding cervical cancer/screening, HPV and the HPV vaccine and women’s 
knowledge of these concepts, their attitudes towards Pap smears and vaccination, the 
rationale and methods used to explore the key research questions and the findings of 
this study and their place within existing research.  This final chapter provides an 
overview of the conclusions drawn from this study (Section 9.1), the strengths of the 
study (Section 9.2), its limitations (Section 9.3) and finally the recommendations 
resulting from this research (Section 9.4).   
9.1 CONCLUSIONS 
This study reveals that Queensland women have insufficient knowledge about 
the causes and risks of cervical cancer on which to accurately determine their 
perceived susceptibility to this disease.  There was considerable uncertainty about the 
link between cervical cancer, HPV and sexual activity amongst women in this study. 
Women had limited knowledge about their susceptibility to HPV and the severity of 
it as an infection, despite most (over 60%), having heard of it prior to the study.  
Women also had limited understanding of the benefits of screening as a prevention 
strategy, with many women thinking the purpose of the Pap smear was for the early 
detection of cancer, and considerable uncertainty about the benefits of the HPV 
vaccine.  Despite high awareness of the vaccine (over 86%), women were uncertain 
about the number of doses, whether the vaccine was therapeutic or prophylactic and 
in the focus groups, did not discuss or acknowledge that the HPV vaccine could also 
prevent genital warts.   
Women in this study described extensive barriers they experience when 
participating in cervical screening and provided in-depth insight into the physical and 
psychological discomfort they experience when having Pap smears.  The most 
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common barriers to vaccination were concern about side effects and a lack of 
information upon which to make a decision about consent.   
Women described cues to action, including enablers for screening 
participation, such as reminder systems and practitioner characteristics, and 
expressed positive views towards self collected testing, particularly for women who 
did not attend screening.  They also provided extensive insight into their information 
needs about HPV vaccination and other new technologies, such as HPV DNA 
testing, that may be introduced into the  National Cervical Screening Program 
(NCSP) following the Renewal.  This information is most relevant for promoting the 
benefits and addressing some barriers related to these new technologies, including 
concerns about potential side effects or safety issues.  Women also provided 
recommendations and innovative strategies for disseminating new information about 
changes to the NCSP to inform future communication strategies in Queensland.  
The only significant predictor of cervical cancer/screening knowledge was 
screening status with underscreened women having lower knowledge than 
regular/overscreened women.  Above average cervical cancer/screening knowledge 
was associated with above average HPV knowledge, having heard of and having 
positive attitudes towards the HPV vaccine.  
HPV awareness and knowledge differed by age and was higher in younger 
women.  Women who had no post-school qualifications, were not married and had 
never had an abnormal Pap smear, had lower odds of having heard of HPV.  Marital 
status was a significant predictor of HPV knowledge with lower knowledge observed 
in married women and those in defacto relationships relative to those who had never 
married.  Above average HPV knowledge was also associated with high awareness 
and positive attitudes towards the HPV vaccination.  Women aged over 60 years and 
those aged 30 to 39 years of age were at lower odds of having heard of the HPV 
vaccine than younger women, as were women born overseas and those had 
completed less than Year 10 at school.  Women who had never had an abnormal Pap 
smear were also at lower odds of having heard of the HPV vaccine than those who 
had.   
High acceptance of the HPV vaccine was found amongst women in this study, 
although women’s knowledge deficits impacted on their perception of the benefits of 
vaccination, as predictors of positive attitudes were above average cervical 
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cancer/screening and HPV knowledge.  Women born overseas and those living in 
average areas of socio-economic well-being had less positive attitudes than those in 
the highest and lowest areas of socio-economic disadvantage.  Having had an 
abnormal Pap smear was a significant predictor of a positive attitude towards the 
HPV vaccine as was being positive about vaccination in general. 
This study reveals significant gaps in Queensland women’s knowledge that 
require innovative and effective communication strategies to address.  Failure to 
increase women’s knowledge about cancer prevention strategies will impact upon 
their perceived beliefs about cervical cancer and HPV including their perceptions of 
risk and susceptibility, their views about the benefits of screening and HPV 
vaccination and may ultimately impact upon their acceptance of changes and 
participation in the NCSP. 
The use of mixed methods enabled the exploration of knowledge and attitudes 
by socio-demographic factors and screening history through the CATI survey, the 
findings of which were explored further in the focus groups, and found to be 
consistent.  The Health Belief Model (HBM) enabled the exploration of knowledge, 
attitudes, beliefs and experiences that were not possible through the CATI survey 
alone and confirmed the relevance of this model in understanding women’s 
perceptions of primary and secondary prevention strategies.  The findings of this 
study and their relationship to the HBM utilising a framework developed by Waller 
et al (2012) is demonstrated in Figure 9.1. 
This model includes an additional construct to the original HBM, intention 
formation, as failure to consider this when assessing health behaviours has been 
identified as a limitation of the HBM (Sheeran and Orbell, 2000).  The findings of 
this study have contributed to understandings about factors relevant to individual 
perceptions, modifying factors, intention formation and action within this model.  
This study has therefore contributed to the knowledge about these factors in 
accordance with its aim to describe and explore what Queensland women know and 
say about cervical cancer/screening, HPV, Pap smears and the HPV vaccine.  Despite 
not aiming to assess intention to participate in screening, this study has also 
contributed somewhat to intention formation as described by Waller et al (2012) in 
this model, that is worth exploring further in future studies.  
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 Figure 9.1 Factors Influencing the Impact of Primary and Secondary Prevention Strategies for Cervical Cancer among Queensland Women  
(adapted from Waller et al, (2012) 
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The strengths of this study and the contribution it makes to the body of 
knowledge about cervical cancer prevention are described further in the next section. 
9.2 STRENGTHS 
This study is the first large study about HPV knowledge and vaccine attitudes 
conducted in Queensland that has used a mixed methods approach and a largely 
representative sample of women.  It is also the first large study to explore women’s 
perceptions of the Pap smear and barriers to screening across a range of locations and 
areas of differing socio-economic disadvantage in a state that consistently reports 
differences in cervical screening uptake by rurality and socio-economic status (SES) 
(QCSP, 2012).  The inclusion of women from more regional and remote areas 
identified minimal impact of locality on knowledge and attitudes amongst women 
surveyed but provided insight into specific issues impacting on rural women who 
face different challenges and barriers than their city counterparts.  The oversampling 
by women from areas of socio-economic disadvantage in the CATI survey also 
enabled exploration of knowledge and attitudes by socioeconomic status and 
demonstrated limited impact of SES on these factors.  In the focus groups, the cost of 
screening was raised as a barrier by women living in areas of lower SES, suggesting 
this may be one contributing factor that impacts on their participation in screening. 
The HBM provided a useful framework to explore knowledge, beliefs and 
attitudes to screening and vaccination and highlighted considerable uncertainty about 
many aspects of cervical cancer and primary and secondary prevention strategies 
available in the Australian setting, which need to be considered in the context of 
anticipated changes to the NCSP over the next few years. 
The study has also highlighted that community perceptions about the NCSP are 
often inaccurate(AIHW, 2011)(AIHW, 2011)(AIHW, 2011)(AIHW, 2011)(AIHW, 
2011).  Although the NCSP has recently celebrated its 20 year anniversary, many 
women view the role of Pap smears as an early detection strategy and not a method 
of prevention.  The incorporation of qualitative research has also contributed to 
greater understanding as to what influences women’s beliefs and the misconceptions 
women have about when women should start and cease screening.  It also highlights 
the limitations in quantitative measures for assessing women’s knowledge about the 
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purpose of Pap smears and the meaning of an abnormal Pap smear result used in this 
and previous studies in the Australian setting. 
A unique contribution of this study is the in-depth exploration of the concept 
‘embarrassment’, which is a commonly identified barrier described by women when 
asked about Pap smears.  This study provides insight into this concept rarely 
described in the literature, particularly the concept of ‘intimacy’.  In addition, this is 
the first study in the Queensland context to seek women’s views about a self 
collected test for cervical cancer prevention.  This research also contributes to local 
knowledge about Queensland women’s knowledge of HPV and its role in the 
development of cervical cancer and what they think about the HPV vaccine.   
This study also provided unique insight into the knowledge, attitudes and 
beliefs of an older cohort of women, as recent studies conducted in Australia have 
largely focused on younger women (Giles and Garland, 2006; Shand, Burney and 
Fletcher, 2010; Agius et al., 2010b; McClelland and Liamputtong, 2006).  Although 
the age range for both the computer-assisted telephone interview (CATI) survey and 
focus groups was 20–69 years, the mean age of women who participated in the CATI 
survey was 43 years and women who attended focus groups were on average, 55 
years of age.  The inclusion of older women in research about HPV is considered 
important, as they have been poorly represented in previous research and the impact 
of introducing HPV DNA testing is anticipated to impact on this group considerably, 
given they are more likely to be in long-term monogamous relationships and have 
had extensive experience with screening (McCaffery et al., 2003; Cooper, Polonec 
and Gelb, 2011).  In addition, women in their forties are highly likely to have 
children in their early teens who are eligible for the HPV vaccine and therefore will 
be asked to provide consent for their children to be vaccinated.   
Gaining insight into what older women know and believe about cervical cancer 
prevention strategies is also beneficial given the influential role they have in their 
communities and families as sources of advice as mothers, grandmothers, and aunties 
etc, given their life experiences.  Women in their fifties are also an important group 
to include in research, as Pap Smear Register (PSR) data reveals cervical screening 
participation rates start to decrease from the age of 55 years in Queensland (QCSP, 
2012).  This study also reveals information about other age groups including the 
youngest and oldest cohorts and in the quantitative phase enabled comparisons 
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between age groups and revealed age as an independent predictor of HPV knowledge 
and awareness of the vaccine.  Information about women across all age groups is 
beneficial in identifying gaps in knowledge or misconceptions that may influence 
these women’s participation in cervical cancer prevention strategies, especially given 
the advances in technology that are impacting on the NCSP including vaccination 
and new tests.  Women in this study were also more likely to have children and 
therefore their attitudes towards vaccination are highly relevant in the context of 
understanding the issues for women who are called on to consent for their children to 
be vaccinated.  This study also provides insight into the knowledge, beliefs and 
attitudes of women who have extensive experience with cervical screening over 
many years. The majority of women had had at least one Pap smear and 27% of 
women in the CATI survey and 38% of women attending focus groups, reported they 
had had between 11 and 20 Pap smears.  They also reported in both the CATI survey 
and the focus groups that most of them had regular Pap smears every two years, and 
therefore by their own admission, are very experienced participants of NCSP. 
The other valuable contribution the women in this study make relates to the 
timing of the study.  This study was conducted in the first two years of the National 
Human Papillomavirus Vaccination Program (NHPVP) and potentially the only 
Queensland study conducted during the implementation phase of the vaccine in the 
Australian setting.  Finally, the findings of this study describe where Queensland 
women seek health information they trust and what they consider are effective 
strategies for communicating new information about cervical cancer prevention 
strategies in their communities.  This advice will assist the Queensland Cervical 
Screening Program (QCSP) and potentially the NCSP, in the development of 
effective communication and health promotion strategies informed by women 
themselves.  The limitations of this study are described in the next section. 
9.3 LIMITATIONS   
9.3.1 Study Design 
Response bias 
CATI survey 
There are a number of limitations that have been identified with the use of 
computer-assisted telephone interviews.  Random digital dialling was chosen to 
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ensure the sample frame included potential participants with unlisted or new numbers 
and therefore addressed one limitation associated with CATI surveys that arises from  
white pages sampling (Dal Grande, Taylor and Wilson, 2005).  Another limitation of 
CATI surveys irrespective of the sampling frame used is that with increased mobile 
phone usage, surveys relying on landline telephones may be more likely to reach 
older and retired or unemployed persons who stay at home, and less likely to reach 
young and more socio-economically disadvantaged people who cannot afford a 
telephone (Choi, 2004; Smith et al., 2009).   
The use of quotas for age and oversampling to enable meaningful comparisons 
by SES reduced the impact of potential sample bias as a result of these limitations.  
Households were also contacted in the first instance, between 17.00 and 20.00 on 
Monday – Friday evenings and between 10.00 and 17.00 on Saturday and Sundays to 
ensure coverage of times when women, with the exception of shift workers, were 
least likely to be at work.   
Another limitation of the study was the response rate of 47% when non-
qualifiers were excluded.  One reason for this may have been women’s reluctance to 
participate in the survey given the sensitivity of the topic, especially as a number of 
hoax Pap smear surveys have occurred in the Queensland context in the past, one of 
which led to the conviction of a male caller (Thompson, 2006). 
The response rate was also impacted by the one week timeframe in which the 
survey was conducted, which was necessary to assess the impact of the media 
campaign before the next media burst.  The CATI facility recommended for future 
surveys, a minimum of two weeks in field to allow for call-backs to be better utilized 
for the sample size required.  An overview of the call analysis conducted by the 
CATI facility is provided in Appendix Q. 
The CATI facility also incorporated the following to minimise non-response 
bias: 
 call algorithms to enhance the probability of making contact with 
sample items using customised call cycles to deal with engaged and 
not-answered calls 
 scheduling and keeping appointments for call backs were made with 
respondents 
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 questionnaire routing and skipping to minimise respondent workload 
and eliminate the need for asking unnecessary questions 
 applying logic and range checks on question responses where 
appropriate 
 ensuring that every question is asked and is answered by the respondent 
 reduction of respondent comprehension errors, and interviewer error 
addressed through the use of clear interviewer instructions and piloting 
 processing errors including illegible responses have been minimised 
through the use of verbatim entry of open-ended responses, and 
interviewing and coding of survey responses by experienced, trained I-
view staff  (I-View Pty Ltd, 2008). 
The consistency between HPV and vaccine awareness amongst women who 
participated in computer-assisted telephone interviews and focus groups and that 
found in other Australian studies conducted at a similar period in time, suggests there 
was limited response bias impacting on the findings of the CATI survey, despite the 
methods used and limited response rate. 
Another limitation of CATI surveys is response fatigue bias; however this was 
limited through the study design by ensuring the survey was less than 20 minutes as 
recommended in the literature (Choi, 2004).  The mean time for survey completion 
was 17 minutes and 45 seconds (I-View Pty Ltd, 2008). 
Focus Groups 
The use of snowball sampling and a priori recruitment of focus group 
participants may be considered a limitation in a quantitative study; however is 
considered appropriate for qualitative research (Liamputtong and Ezzy, 2005).  The 
large number of participants in some focus groups also had the potential for more 
vocal participants to dominate the discussion in focus groups; however the 
facilitation skills of the researcher ensured all women contributed as noted by a 
number of observers and described in Appendix O.   
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Measurement Issues 
CATI Survey 
The use of prompted versus unprompted questions is associated with a higher 
apparent knowledge of risk factors than simple recall (Waller, McCaffery and 
Wardle, 2004b).  In this survey, both prompted and unprompted questions were used 
and responses to prompted questions, such as risk factors for cervical cancer, 
revealed they also help identify misconceptions.  For example, most women 
incorrectly believed family history to be a risk factor, which has not been revealed in 
unprompted studies, and high levels of uncertainty were revealed through inclusion 
of a ‘don’t know’ response category (Waller, McCaffery and Wardle, 2004a). 
A limitation of using unprompted questions used in this study was revealed in 
the focus groups when the term ‘abnormal cells’ was explored further.  Women 
frequently responded that the purpose of the Pap smear and the meaning of an 
abnormal result was about detecting abnormal cells; however many women in the 
focus groups believed these abnormal cells were cancer cells not precancerous 
changes.  Without the use of mixed methods and exploration of this in the focus 
groups, the findings of this study based on CATI survey results alone would have 
indicated high knowledge and awareness of the purpose of the Pap smear and the 
meaning of an abnormal result, when this was not necessarily the case.  The use of 
prompted questions may provide more detailed assessment of this in future CATI 
surveys to determine if the results of this survey are more widespread than this study. 
The use of non-validated instruments to measure knowledge and attitudes in 
the CATI survey is an additional limitation as the validity of these measures is not 
assured.  These instruments need to be appropriately validated to fully discount the 
potential for systematic bias in future studies where these tools are used.  
Another potential limitation of this study is the use of dichotomous categorical 
outcome variables, which have been criticised for leading to a loss of information 
and may potentially lead to a serious loss of power to detect real relationships 
between variables (Royston, Altman and Sauerbrei, 2006).  The outcomes of this 
study that were derived from multivariable modelling using binary logistic regression 
rather than linear regression of continuous outcome variables therefore should be 
considered in light of this limitation.   
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Focus Groups 
The use of the HBM, may also be considered a limitation of this study.  More 
recent health behaviour theories such as the Transtheoretical (stages of change) 
Model, the theories of reasoned action and planned behaviour and social cognitive 
theory could have been considered more relevant to this study as they also account 
for a person’s intention to engage in a particular health behaviour (Carpenter, 2012; 
National Cancer Institute, 2005; Sheeran and Orbell, 2000).  Intention has been 
identified as a key predictor of behavioural performance and the lack of assessing a 
person’s intention has been described as a significant limitation of the HBM 
(Sheeran and Orbell, 2000).  Waller et al (2012), has proposed a model which 
illustrates the relevance of the HBM to cancer screening research that includes 
intention to perform the behaviour and the applicability of the findings of this study 
to this model and how it has contributed to intent is outlined in Figure 9.1.  Despite 
this, it is relevant to reinforce that this study did not aim to measure screening 
intention; rather it was a descriptive, exploratory study about women’s knowledge, 
attitudes and beliefs about primary and secondary cervical cancer prevention 
strategies to inform future communication strategies following the Renewal of the 
NCSP.  The HBM provided an ideal framework for this study as previously 
discussed and therefore did not limit the achievement of the aims of this study. 
Recall bias 
Women who participated in this study were more likely to report they were 
regular screeners than women in the general Queensland population.  Multiple 
attempts were made in the design of this study to attract un/underscreened women 
through the use of the CATI survey and oversampling in remote areas and areas of 
higher SES disadvantage where screening participation is found to be lower.  Focus 
groups were also held with women across a range of locations and SES areas to 
attract a wide range of women to the study.   
This may have been associated with the reliance on self-reporting of cervical 
screening status and history of abnormalities.  There is evidence that women tend to 
over-report their screening status when self reported status is compared with 
laboratory or medical records, although consistency has been found between self 
reported abnormalities and registry data in NSW (Bowman, Sanson-Fisher and 
Redman, 1997; Howard, Agarwal and Lytwyn, 2009; Canfell et al., 2006).   
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There is evidence of potential over-reporting of screening participation in this 
study, whereby women may have under-estimated the length of time that had lapsed 
since their last Pap smear and over-reported their participation in cervical screening.  
Eighty nine percent of women in the CATI survey (Section 5.1) and 80 % of women 
in the focus groups (Section 7.1), reported they had had a Pap smear in the previous 
three years, whereas PSR data indicates only 69% of the eligible population in 
Queensland had a Pap smear in the triennial period  2007–2009 (QCSP, 2012).  
Alternatively this may reflect sample bias in both the CATI survey and focus group 
samples whereby women who consented to participate in this study were more likely 
to be regular screeners than women in the general population.   
The implications of this on the results of the study are firstly, that the findings 
of this study may not be truly generalisable to the Queensland population and may 
not be fully representative of women who are unscreened or underscreened.  In 
particular, the difference observed by screening status for cervical cancer/screening 
knowledge and the lack of association with other factors should be viewed with 
caution.  Despite this, the findings of this study reveal that amongst women who 
report they are regular screeners, low levels of knowledge about cervical 
cancer/screening and HPV are common.  If the women in this study are indeed more 
likely to be regular screeners and both samples are biased and unrepresentative of 
un/underscreened women, it is assumed, given the associations found between 
knowledge and attitudes, these women will have even lower levels of knowledge and 
less positive attitudes towards Pap smears and the HPV vaccine.   
In addition, women in this study provided in-depth insight into a number of 
barriers, such as embarrassment, which have not been as comprehensively explored 
in many previous studies.   They also discussed barriers experienced by women when 
attending for Pap smears that are supported by other studies including those that 
focused specifically on un/underscreened women (Van Til, MacQuarrie and Herbert, 
2003; Blomberg et al., 2008; Smith, French and Barry, 2003; Waller et al., 2009).  
This suggests potential sample bias or over-reporting of screening status by women 
in the focus groups did not impact on the perceived barriers women reported when 
having Pap smears, and reflects despite a high number of women reporting regular 
screening status, one in five women in the focus groups were not regular screeners.  
It is therefore suggested the screening status of women in this study should be 
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viewed in terms of the limitations described above, which is more likely to result in 
an overestimation of women’s knowledge if the sample is indeed truly biased 
towards regularly screened women. 
In addition, there was potential bias due to self reporting of previous 
abnormalities, as women were not asked to specify the abnormality, therefore 
findings related to abnormal Pap smear history should be considered with this in 
mind, as women may also be referring to benign or insignificant abnormalities 
including technically unsatisfactory smears, candida albicans (thrush) and atrophic 
smear results as discussed in Section 5.2.3.   
Data Quality – Focus Groups 
There were some issues with data quality due to background noise or recording 
issues as described in Appendix O; however as there were consistent themes 
identified across groups and an observer present at the majority of focus groups, the 
impact on data quality was anticipated to be minimal given the number of groups that 
were conducted. 
Methodological Triangulation 
In hindsight, the use of focus groups to further explore issues that were 
identified in the CATI survey, such as misconceptions regarding screening 
recommendations, may not have been the ideal design for this study.  Had the focus 
groups been used in the formative phase of the study, a number of the limitations 
described above regarding the CATI survey design may have been addressed (Ulin, 
Robinson and Tolley, 2005).  In addition, issues raised in the focus groups, for 
example the cost of screening, could have been investigated further by other factors 
such as SES, which would have provided valuable insight into this emerging barrier 
in the Queensland context.  This is worth consideration in future mixed methods 
studies. 
9.3.2 Representativeness 
This study was conducted with Queensland women and is therefore not 
representative of women from other parts of Australia, although some findings of the 
CATI survey are similar to those found amongst Victorian women (Pitts et al., 2007).  
Women in both phases of the study were more likely to be born in Australia than 
women in the overall Queensland population and women from countries other than 
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the United Kingdom, New Zealand and Oceania are underrepresented.  This is likely 
to have been due to the inclusion criteria for the CATI survey as women were 
required to be able to understand and speak English and 100 women were identified 
as not having sufficient language to complete the survey as specified in Appendix Q.  
Focus groups were also purposively held with mainstream groups of women.  
Therefore, the findings of this study are not representative of women born in 
overseas countries other than the United Kingdom, New Zealand and Oceania. 
The age of women in this study may be considered a limitation in that women 
on average were older than women in the Queensland population but this can also be 
considered a benefit as discussed in Section 9.2, as there are limited studies with 
older women.  Women were also more likely to be from regional and remote areas 
that the Queensland population and to be more educated than women in the 
Queensland population, to be married or in defacto relationships and to have had 
children.  The findings of this study therefore need to be considered in light of these 
limitations.   
It is prudent to note, this study was not designed for exploring differences by 
ethnicity or Indigenous status.  Additional studies have been undertaken or are in the 
planning phase with women from culturally and linguistically diverse backgrounds, 
lesbian women and Aboriginal and Torres Strait Islander women, which have or will 
be conducted by culturally appropriate researchers to inform the activities of the 
QCSP in the future.   
Despite these limitations, this study has valuable contributions to make to this 
area of research, especially in light of the in-depth information obtained from the 
focus groups, which complemented the findings of the CATI survey, as this is the 
first large mixed methods study of women from remote, regional and major cities of 
Queensland since the implementation of the HPV vaccine. 
The recommendations emerging from this study are described in the final 
section of this chapter. 
9.4   RECOMMENDATIONS 
The landscape of the prevention of cervical cancer in Australia is swiftly 
changing with the introduction of primary prevention within the context of a long-
standing secondary prevention program, the NCSP.  The Renewal of the NCSP aims 
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to ensure that all Australian women have access to an evidence-based program that 
continues to improve health outcomes of Australian women (NCSP, 2012b).  
Evidence suggests this renewed NCSP will include HPV DNA testing within the 
cervical screening pathway, although its role is still to be determined.  Before 
changes are made to the NCSP, it is imperative that the uncertainties and 
misconceptions that are evident amongst women in this study and the wider 
Australian community, as found in other studies, are addressed.  Failure to increase 
community knowledge of the risks associated with cervical cancer and HPV may 
lead to decreased perception of risk or increase the barriers to screening, especially if 
women suffer distress from a positive HPV DNA test.  This  may in turn impact on 
screening participation rates in this country, which have decreased significantly in 
recent years in many Australian states and territories (AIHW, 2012). 
This study highlights the need for the following: 
 Increased community education to raise awareness and knowledge of 
HPV as the necessary cause of cervical cancer and the benefits of 
primary and secondary prevention strategies. 
 Clear and concise screening policy statements that are easy to interpret 
and communicate to women, the community and health professionals 
following the Renewal of the NCSP.  
 Consistent training of cervical screening providers in sensitive 
examination techniques and informed consent, and education about 
HPV, cervical cancer and the NCSP. 
 Increased access to cervical screening through a reduction in costs 
associated with screening, the exploration of alternative service models 
and access to an appropriate provider. 
 Further research into: 
 factors that impact upon women’s participation or non-
participation in cervical cancer prevention strategies  
 women’s acceptability of HPV DNA testing and self collected 
testing for women who currently do not participate in the NCSP 
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 women’s views about alternative screening policies including 
increasing the age of the commencement of cervical screening 
and screening interval 
 culturally sensitive exploration of the above issues with women 
from minority populations  
 further exploration of knowledge and awareness of cervical 
cancer, HPV and the HPV vaccine and attitudes towards 
vaccination amongst men and boys 
 health providers’ and relevant others’ knowledge about cervical 
cancer/screening, HPV and attitudes towards the HPV vaccine.  
 Utilisation of methods women recommend to inform communication 
plans for disseminating information about changes to the NCSP. 
These recommendations are outlined in Table 9.1, and described in greater 
detail in the following sections. 
9.4.1 Community Education 
The findings of this study highlight high levels of uncertainty and significant 
knowledge gaps amongst women in Queensland about cervical cancer, the current 
cervical screening program, HPV and the HPV vaccine.  In particular the link 
between sexual activity, HPV and cervical cancer needs to be explicit rather than 
suppressed as it has in the past (Cooper Robbins et al., 2010a; Juraskova et al., 2011; 
Braun and Gavey, 1999).  There is a need to convey accurate information about 
cervical cancer and its association with HPV, in a sensitive way to avoid increasing 
stigma.    
This is essential if women are to have accurate information upon which to base 
their decisions about screening, and for parents and their children to make informed 
decisions about HPV vaccination (Marlow, Waller and Wardle, 2007).  This also 
aims to reduce the stigma associated with the diagnosis of a sexually transmitted 
infection for women who receive a positive HPV DNA test should this be introduced 
in the near future (Waller et al., 2005; Braun and Gavey, 1999; Juraskova et al., 
2011).   
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Table 9.1 Recommendations: The Impact of Primary and Secondary Cervical Cancer Prevention Strategies Amongst Queensland Women 
Key Finding Strategy Recommendations 
High levels of uncertainty 
and knowledge gaps about 
cervical cancer/screening, 
HPV and the HPV vaccine 
Increased community 
education 
 Make explicit links between cervical cancer, HPV and sexual activity to: 
 Enable women to adequately assess their susceptibility to and the severity of cervical cancer and HPV 
 Promote benefits of screening and vaccination  
 Reduce stigma and normalise HPV infection as a likely outcome of sexual activity rather than the result of 
deviant sexual behaviour 
 Reduce anxiety associated with a positive HPV DNA test 
Misconceptions about the 
current NCSP policy 
Clear and concise 
policy statements 
 Ensure policies are easy to interpret, communicate and implement to avoid confusion that currently exists, 
particularly in relation to the eligible population 
Extensive physical and 
psychological barriers to 
screening 
Consistent training of 
Pap smear providers 
 Ensure providers are appropriately trained to: 
 Provide adequate information to ensure informed consent by those participating in screening or vaccination 
 Provide screening in a sensitive manner that aims to  reduce discomfort and embarrassment for women 
 Recommend tests that are proven to be effective within the Australian context including new technologies  
 Avoid the use of examinations that are not evidence-based and potentially increase embarrassment e.g. PVE 
Increased access to 
cervical screening 
 Reduction of costs for women for screening 
 Exploration of alternative service delivery models, e.g. non-medical Pap smear providers and the one-stop shop 
concept 
Limitations and areas 
identified for further 
exploration 
Further research  Factors that impact on women’s participation, especially unscreened/underscreened women 
 Women’s acceptability of HPV DNA testing and self collected tests 
 Women’s acceptability of changes to the age range and screening interval 
 Culturally sensitive exploration of these issues with women from minority populations 
 Exploration of these issues with men and boys 
 Review of health providers and other relevant key informants such as teachers and pharmacists knowledge of 
cervical screening, HPV and the HPV vaccine 
Women’s views about how 
to communicate changes 
following the Renewal of 
the NCSP 
Informed 
communication 
planning 
 Utilise multiple methods of communication to ensure adequate reach given this study found awareness and 
knowledge differed by age, country of birth, educational, marital status and a previous history of an abnormality 
 Consider women’s information needs when developing communication plans about new technologies and 
changes to the NCSP 
 Seek women’s advice about ways to effectively communicate messages about prevention strategies within their 
local communities  
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With changes proposed to the NCSP in the future that will require women and 
the wider community to have increased understanding about HPV, it is increasingly 
important to address these uncertainties.  These findings indicate that making the link 
between cervical cancer, HPV and sexual activity explicit is unlikely to cause alarm 
and will enable increased knowledge about individuals’ perceived risks and 
susceptibility to cervical cancer and address the uncertainty that prevails.   
This is especially relevant in supporting the rationale behind girls receiving the 
vaccine pre sexual debut, as some parents do not perceive that their daughters are at 
risk of HPV based on their belief that they will not engage in premarital sex.  
However, they may be unaware of the risk posed by prospective partners who have 
had previous partners, which is especially relevant in cultures where it is socially and 
culturally acceptable for males to have premarital sexual relationships (Braun and 
Gavey, 1999).  Parents should also be informed about the benefits of vaccinating 
girls when they are young given the increased immunogenic effects of the vaccine 
when they are teenagers (Wright, Bosch, et al., 2006).  Given the low level of 
concern expressed by women in this study about the vaccine promoting sexual 
activity, it is timely to talk openly about the relationship between HPV, sexual 
activity and cervical cancer, rather than avoid this discussion within the Australian 
context.   
Community education also needs to address women’s uncertainties about 
smoking and misconceptions about perceived risks, such as family history and 
hygiene.  It is especially important for HPV positive women to be aware of the 
synergistic role of smoking given evidence suggesting smoking can increase the 
probability that an HPV infection will become chronic and potentially malignant 
(Vaccarella et al., 2008).   
Misconceptions associated with HPV and cervical cancer, such as family 
history as a risk factor or that HPV causes infertility, need to be addressed to ensure 
women have accurate information upon which to assess the threat of HPV and their 
susceptibility to cervical cancer.   
Community education also needs to address uncertainty about the purpose of 
cervical screening and highlights the importance of being very clear in health 
promotion messages that prevention is the main purpose of the NCSP.  The use of 
the term ‘early detection’ occurs frequently in cervical screening literature and health 
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promotion resources, for example, the primary NCSP cervical screening resource is 
titled ‘Early Detection is Your Best Protection’; however women perceive early 
detection differently to the intent of these messages (Cancer Council Qld, 2012; 
NCSP, 2012a; Jirojwong and Manderson, 2001; Hancock et al., 1996).  Further 
research is warranted about whether women who do not have Pap smears out of fear 
they are going to be told they have cancer and subsequent cancer treatment, will be 
more inclined to participate if they know the test is for identifying precancerous 
changes caused by HPV, rather than cancer. 
Ensuring cervical cancer and HPV is discussed more openly is essential if 
knowledge is to be disseminated more effectively and uncertainty is to be reduced, 
especially amongst women who have not been vaccinated against HPV.  The 
vaccinated cohort in Australia are at less risk for cervical cancer; however they are 
primarily young women under 30 years of age, therefore older women must not be 
forgotten, given their risk of developing cervical cancer remains unchanged and the 
NHPVP is unlikely to impact on cervical cancer incidence and mortality for at least 
another decade (Brotherton, 2008). 
9.4.2 Clearly Articulated NCSP Screening Policy 
This study highlights widespread misconceptions amongst women in the 
community about eligibility in the screening program and the current NCSP 
screening policy.  Many women erroneously believed Pap smears should commence 
at sexual debut despite this never being part of the policy in Australia.  This 
misconception also reflects the complexity and ambiguity of the current NCSP 
screening policy and how difficult it has been to communicate this policy effectively 
given most women do not relate commencement of screening with an age per se.  
The policy for commencement combines age and sexual activity as follows:  All 
women who have ever been sexually active should start having Pap smears between 
the ages of 18 and 20 years, or one or two years after first having sexual intercourse, 
whichever is later (NCSP, 2012a).  This complex message was poorly understood by 
women in this study and reflects the need for clear policies and messages for women 
and the community.  In most other countries with organised cervical screening 
programs the policy recommendation is simple and there is only one age, for 
example, 25 years of age and the requirement for having commenced sexual activity 
(National Health Service, 2012; Tacken et al., 2007).   
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Women in this study were also uncertain about ceasing screening at age 70 
years.  Women over 60 years of age are the least likely to have Pap smears, therefore 
it is important to engage with older women and provide them with accurate 
information about the benefits of participating in the NCSP, especially as older 
women have been found to perceive themselves to be at lower risk of cervical cancer 
than other women (Orbell, 1996).     
This study has highlighted considerable confusion about eligibility for cervical 
screening and the renewal of the NCSP provides a window of opportunity to ensure a 
clear policy statement is developed.   
9.4.3 Health Professional Education 
High uncertainty and lack of knowledge about cervical cancer and the NCSP, 
raises questions about whether women attending for Pap smears are provided with 
the appropriate information upon which to make informed consent about screening.  
Health providers have been found to provide inadequate information about cervical 
screening as they assume women know about it given their experience with 
screening (Chew-Graham et al., 2006).  Women need to know the benefits, 
limitations and harms associated with screening to make informed choices (Barratt et 
al., 2005).  They also should be informed about the meaning of potential abnormal 
results and appropriate information about HPV prior to testing, given a considerable 
proportion of women in this study believe the result means cancer and anxiety and 
distress  have been linked with poor knowledge of what an abnormal Pap smear 
means (Posner et al., 2006; Wardle, Pernet and Stephens, 1995; McCaffery and 
Irwig, 2005).  Providers also need to be appropriately prepared to be able to discuss a 
positive HPV DNA test result with women to ensure this occurs in a sensitive 
manner that allays anxiety and reduces the stigma associated with receiving this 
result (McCaffery and Irwig, 2005). 
The barriers and attitudes towards Pap smears that women described in the 
focus groups highlight that most women dislike this test.  It also indicates that many 
women (almost six out of every 10 women in Queensland) present regularly every 
two years, to have a test they find embarrassing, uncomfortable and invasive, which 
suggests they perceive the benefits of the test to outweigh these factors (CSSB, 
2011).   
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Women’s compliance with regular screening, despite their dislike of Pap 
smears, and the presence of multiple barriers and limited knowledge about Pap 
smears was a key finding in this study.  It was consistently found that women wanted 
a skilled provider they could trust, and this was often irrespective of gender.  This 
reinforced the importance of establishing a relationship with a provider (familiarity) 
beforehand and ensuring Pap smear providers are appropriately trained and sensitive 
to women’s needs (Robertson et al., 2003; Moore et al., 2000; Blomberg et al., 
2008).   
In addition to addressing physical discomfort, Pap smear providers need to be 
sensitive to women’s psychological needs during the procedure and be aware that 
there is often a fine line between women’s perceptions of appropriate and 
inappropriate behaviour in the context of ‘intimate’ examinations (Moore et al., 
2000).  There were many things women discussed that made them uncomfortable 
that could easily be addressed if providers were appropriately trained in sensitive 
examinations.  For example, observing women to identify if the procedure is causing 
them pain, providing them with a reasonably sized sheet to cover themselves with, 
locking the door before starting the procedure and using an appropriately sized 
speculum.  It was surprising how often women complained about ‘the cold metal 
speculum’ in this study, given the increased availability of high quality disposable 
plastic speculums or the ease at which a metal speculum can be warmed under a tap.   
These interactional skills are included in most cervical screening training 
programs however there are substantial differences in the educational preparation of 
Pap smear providers (Robertson et al., 2003; NCSP, 1997).  Non-medical Pap smear 
providers undertake competency based training to become Pap smear providers and 
must abide by national competency standards; however medical practitioners are not 
required to complete specific training in cervical screening and are not always 
educated in sensitive examination techniques when medical students (Robertson et 
al., 2003; NCSP, 1997).  This discrepancy in training requirements and quality 
standards should be addressed to ensure women are provided with a client focused 
service that takes into account their physical comfort and psychological safety during 
the procedure (Robertson et al., 2003). 
Embarrassment and discomfort were frequent barriers described in this study. 
However, what was unclear was whether embarrassment was only experienced by 
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women during the Pap smear procedure itself, i.e. the speculum examination, or 
associated with having to completely undress for a breast examination and/or the 
digital penetration associated with the pelvic examination (PVE).  This was not 
explored as it was not appropriate within the context of focus groups.  There is ample 
evidence that physical breast examination compared to mammography has no benefit 
in the detection of breast cancer in asymptomatic women and the role of the PVE in 
screening for ovarian cancer is also not supported; however these procedures are still 
often included as part of the Pap smear procedure in the Australian setting (Westhoff, 
Jones and Guiahi, 2011; Cancer Australia, 2012).   
This raises two questions, does subjecting women to these additional 
procedures further increase their embarrassment and vulnerability given they need to 
remove most of their clothing if a breast check is also performed, and does the PVE 
cause more embarrassment than just a speculum examination, which is all that is 
required for the collection of a Pap smear?  Providers should be educated about the 
lack of evidence associated with these adjunctive procedures that may potentially 
cause women harm given the intimacy and vulnerability issues raised in this study, 
and deter them from having the most effective screening test, the Pap smear or its 
alternative following the Renewal.   
9.4.4 Increased Access 
Cost 
The cost to women to participate in the program and access issues, such as a 
‘one-stop shop’ where women could access breast and cervical screening at the one 
service, should be explored further.  The NCSP is the only population-based cancer 
screening program in which most participants pay to be screened.  Women 
participating in the NCSP can access free services if they know about them, for 
example, the Mobile Women’s Health Service, which operates in rural and remote 
regions or some Sexual Health Clinics, but the majority of women access the general 
practice setting, at which they are required to pay a consultation fee.  Women spoke 
of how this was often charged as a long consultation unless they were bulk-billed, 
which was often only available for health care card holders.   
In addition, many women in this study discussed how they were encouraged to 
pay for the ‘extra test’, liquid-based cytology, and at the time the study was 
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conducted, one major pathology laboratory in Queensland was charging women a 
pathology fee, unless they were advised by the woman’s GP she was financially 
disadvantaged.  The marketing of new technologies for cervical screening, as 
superior to cytology, to health providers in Australia has been based on international 
studies where cytology is neither as sensitive nor specific and is therefore misleading 
especially when these providers may fear legal liability if they do not offer a 
supposedly more reliable test (Medical Services Advisory Committee, 2009; Qiagen, 
2012).  This highlights the importance of ensuring health providers receive advice 
about new technologies from the screening program and not just pharmaceutical 
companies with vested interests, particularly given the costs for these technologies 
are currently borne by women in the Australian setting.   
These costs when combined can be quite hefty, up to $200 up front, and 
although most can be claimed back through Medicare, provides some explanation as 
to why cervical screening participation rates in Australia differ significantly by SES 
and question how equitable the NCSP is.  Cost as a barrier to screening therefore, 
needs to be addressed as part of the Renewal of the NCSP.   
Appropriate provider 
Access to a familiar provider was also identified in this study given the high 
turnover of doctors, particularly in rural areas.  This supports the need for alternative 
Pap smear providers, such as nurses who either travel to the area to provide cervical 
screening, including the Mobile Women’s Health Service in Queensland, or local 
general practice nurses, health centre nurses or Aboriginal and Torres Strait Islander 
health workers who are trained and competent in cervical screening.   
Nurses have consistently demonstrated their competence in obtaining high 
quality specimens and been found to be highly acceptable to women (Christie, 
Gamble and Creedy, 2005; Victorian Cervical Cytology Registry, 2012; Robertson, 
2006).  This role needs to be supported nationally with the cost of the pathology 
initiated by these providers funded through Medicare Australia or an alternative 
source.  This will enable equitable access for women irrespective of where they live 
and increase the availability of appropriate providers for women. 
The ‘one-stop shop’ concept was also raised in a number of focus groups as an 
enabler to cervical screening, where women could have their breastscreen and Pap 
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smear at the one visit.  This currently is available in a number of settings in 
Queensland where the Mobile Women’s Health Service works in conjunction with 
BreastScreen Queensland but has not been formalised so that it is available in all 
areas (QCSP, 2005).  This model was explored in Victoria where BreastScreen 
nurses trained as Pap smear providers, and was positively evaluated by women and 
very successful in engaging with underscreened women who had not had a Pap 
smear for more than four years (Grainger, 2011).  The ‘one-stop shop’ concept may 
therefore be a key strategy for encouraging older women to have Pap smears given 
the decrease in participation that is observed in women over 60 years of age, and is 
worth further exploration (AIHW, 2011). 
9.4.5  Further Research 
Factors impacting upon women’s participation  
Women’s compliance with regular screening, despite their dislike of Pap 
smears, and the presence of multiple barriers suggests the notion of personal moral 
obligation warrants further investigation in future studies to determine if differences 
between women’s perceived moral obligation impacts upon their participation in 
cancer screening (Tacken et al., 2007; Orbell, 1996).   
Questions raised about barriers, including intimacy issues and whether the 
breast examination and PVE cause higher level of embarrassment, also warrant 
further investigation.  As identified in Section 9.3.2, this study potentially was non-
representative of un/underscreened women, therefore further exploration of factors 
associated with non-attendance amongst Queensland women is also warranted. 
Acceptability of HPV DNA testing 
With the renewal of the NCSP, there is a real possibility HPV DNA testing 
may be introduced either as a primary screening test or as part of alternative 
screening pathways in a cytology based program.  It is unclear in the Australian 
context whether women will be comfortable with a different test to one they have 
become accustomed to and consider to be relatively reliable, especially as the test 
will detect HPV.  Women’s acceptance of being tested for a sexually transmitted 
infection rather than precancerous cell changes needs to be explored further (Maissi 
et al., 2004; Waller et al., 2005; McCaffery et al., 2006).   
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The role of self collected HPV DNA within an organised program, such as the 
NCSP, should also be considered, particularly for women who do not currently 
participate.  Self collection could be an option in the clinic setting, which is a 
common practice for the collection of chlamydia and gonorrhoea tests in sexual 
health clinics (Costa et al., 2009).  Another role for HPV DNA self collection could 
be targeted interventions for women who are not screening or have not screened for 
many years, which has been trialled with varying success in Europe and is in the 
process of being introduced into the Netherlands cervical screening program 
(Szarewski et al., 2011; Sanner et al., 2009; Kenter, 2011).  Cervical screening 
programs could implement an intervention to send these women, identified through 
electoral roll matching, a self collection kit, which they can perform at home and 
send to the laboratory.  Further research into both the technology for self collection 
and women’s acceptance of collecting their own sample in the specific scenarios 
described above and the efficacy of self collected HPV DNA tests to validate the role 
of this technology across diverse populations, is warranted.   
Women’s views about alternative screening policies  
With the Renewal of the NCSP, the screening interval for cervical screening 
may be extended from two yearly to every three or five years if the policy is to be 
based on international guidelines (Meijer, 2011; IARC, 2005).  When the NCSP was 
formally introduced in 1991, a change in recommendations from one to two yearly 
Pap smears caused concern amongst women and providers.  Women may not be 
comfortable with this change unless they are presented with information to reassure 
them this is a safe recommendation.  It also highlights the need to review the role of 
Pap smear registers, which are currently back-up systems that send reminder letters 
to women when they are overdue for screening.  If the screening interval is extended, 
the Registers will play an important role in inviting women to screen regularly as not 
all providers have invitation systems in place. 
The reliability of the Pap smear did not appear to concern women in the focus 
groups, although this may be of greater concern if the interval between Pap smears is 
extended, as the silent nature of cervical cancer was an issue for some women and 
prompted them to have regular tests.  This change may be even more dramatic, if 
both the type of test and interval change, and women may fear it given their lack of 
understanding about HPV, especially if they perceive it to be a cost cutting exercise. 
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Women may also be deeply concerned about raising the age of the 
commencement of screening, fearing young women will be placed at risk and 
highlights the need to explore women’s attitudes towards changes to screening 
eligibility, especially as many currently believe screening should commence at 
sexual debut and do not think screening should cease, irrespective of age.   
Culturally sensitive exploration  
As this study was conducted primarily with women born in Australia, research 
needs to be conducted in a culturally sensitive manner with women from minority 
populations including lesbian, bisexual, transgender and intersex women, women 
with disabilities, women from culturally and diverse backgrounds and Aboriginal and 
Torres Strait Islander women as they may have differing knowledge, attitudes and 
barriers to screening.  They may also have different sensitivities about HPV as a 
sexually transmitted infection and recommendations for disseminating information in 
their communities.  
Further exploration of knowledge, awareness and attitudes amongst men 
and boys 
Research into men’s and boys’ knowledge and attitudes about cervical cancer, 
HPV and the HPV vaccine is also warranted to gain community insight into these 
issues, especially given the recent inclusion of boys in the NHPVP in Australia. 
Health providers’ and relevant others’ knowledge, awareness and attitudes 
Women in this study consider health providers including pharmacists to be 
trusted sources of health information.  In another Australian study the support of 
teachers for HPV vaccination has also been raised as important when parents are 
making decisions about vaccination for their daughters (Cooper Robbins et al., 
2010b).  Information about HPV and changes to the NCSP following the renewal 
will need to be communicated effectively to these providers to ensure they are well 
placed to provide accurate information for women and the wider community.  The 
knowledge level of these providers is unknown and needs to be assessed to ensure 
they have access to appropriate information to assist them as key informants. 
Understanding the crucial role health of providers play in promoting women’s 
participation in screening and as sources of health information, highlights the 
importance of including them in any future communication strategies about the 
Renewal of the NCSP. 
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9.4.6 Communication Planning 
It is important to consider how messages about HPV have been disseminated 
and consider health literacy given poorer knowledge of cervical cancer/screening is 
also associated with limited awareness of HPV, especially for women who have not 
had previous abnormalities or been reached by current messages and campaigns.  
Lower knowledge about HPV in women over 60 years of age may be viewed as 
somewhat irrelevant compared to younger women who may be seen to be benefit 
more from both screening and vaccination.  However, the role of HPV DNA testing 
for women exiting the NCSP is being explored in the Renewal of the NCSP (NCSP, 
2012b).  If HPV DNA testing is to be incorporated into a new screening policy in 
Australia, it will be important to bear in mind that the results of this study suggest 
older women and married/defacto women’s knowledge about HPV is limited.  
Therefore clear communication about the role of the virus will need to occur if these 
women are to have faith in an alternative test to the Pap smear and not suffer 
psychological harm in the advent of a positive test, especially as many of these 
women are likely to be in long-term monogamous relationships.   
Education was found to be an independent predictor of HPV vaccine awareness 
in this study, which suggests that the communication strategy used for promoting the 
HPV vaccine may have been more effective amongst women with higher education 
levels and subsequent health literacy (von Wagner et al., 2009).  The majority of 
information relevant to HPV has focused on the vaccine in Australia and has 
occurred through print, such as newspaper articles, brochures and posters, with 
limited television advertising, although there was substantial media coverage of 
adverse events (Cooper Robbins, Pang and Leask, 2011).  Limitations associated 
with mass media strategies about the vaccine have been linked to the short lead time 
between the licensure of the vaccine and the roll out of the program in April 2007 
(Moore et al., 2010).  This has important implications for the Renewal of the NCSP 
and supports the use of multiple methods of communication if information is to have 
adequate reach. 
The findings described above in relation to the HPV vaccine, suggest 
information about the vaccine has not been widely disseminated throughout the 
community and as documented, the media whilst raising awareness of the HPV 
vaccine, has provided limited factual content about HPV (Cooper Robbins, Pang and 
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Leask, 2011).  In addition, variations in attitudes towards HPV vaccination that were 
not evident for general vaccination, also suggest mass media strategies may not have 
been effective for certain groups, such as women born overseas or those in areas of 
moderate socio-economic disadvantage.  The majority of mass media promoting the 
HPV vaccine was print based, which suggests multiple strategies for disseminating 
information are necessary to reach all groups within the population.   
During discussions about the PSR, it became evident that the register needs to 
be promoted more actively as a number of women were unaware of it.  This could be 
the result of them forgetting they received a welcome letter, especially if they were 
registered in the 1990s and had never been overdue for a Pap smear, and therefore, 
have never been sent an overdue reminder letter.  If the PSR becomes a ‘prompt’ 
register following the Renewal of the NCSP, it will be important to bear this in mind 
and develop a communication strategy to ensure women understand its functions. 
The education of young women in schools suggested by women in this study to 
help normalise cervical screening as an activity women engage in to keep healthy, 
was identified as a motivating factor for having had a Pap smear in a study of 
American college students (Burak and Meyer, 1997).  This may be less relevant if 
the age of commencement for screening is increased to 25 years of age following the 
Renewal given the time lag between education in schools and the first screening test; 
however there will need to be some mechanism, including a communication strategy 
for young women so they commence cervical screening at the appropriate age and do 
not consider it unnecessary if they have been vaccinated (Brotherton, Fairley, et al., 
2010).  
Communication strategies that utilise a number of approaches are necessary to 
reach the broad age range of women eligible for cervical screening.  Web-based 
information, although not a frequent source of HPV vaccination awareness at the 
time the study was conducted; should be considered given the increased usage of the 
Internet particularly by young women.  Word-of-mouth and the role women’s 
organisations play in disseminating information through networks and peer support 
also needs to be considered in future communication plans. 
Women in focus group discussions suggested multiple strategies and methods 
and felt it was important to ensure women with diverse needs would have access to 
information relevant for their comprehension, as no one method was considered 
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appropriate for all women.  These strategies should be utilised and evaluated to 
determine their effectiveness and reach.  Women’s advice about effective ways to 
communicate and promote information about cervical screening and any future 
changes to the NCSP should also be sought in other parts of Australia and utilised.  
Women know their communities and how information is disseminated effectively.  
The importance of communicating any future changes to the NCSP should also 
commence in a timely manner to ensure women are comfortable with any future 
changes before they happen. 
The recommendations from this study about the impact of primary and 
secondary cervical cancer prevention strategies amongst Queensland women are 
outlined in Table 9.1 and represented in Figure 9.2.  The recommendations from this 
study (green boxes in Figure 9.2) are relevant to each step of the cervical screening 
pathway (purple boxes in Figure 9.2) and as demonstrated relate to multiple steps in 
the pathway and also to the NHPVP (blue boxes in Figure 9.2).  This is particularly 
relevant to an organised screening program such as the NCSP as each step is 
important to ensure a successful population based screening pathway (CSSU, 2007c). 
The findings of this study therefore, have the potential to contribute to every aspect 
of the NSCP screening pathway and make contributions to the NHPVP as 
demonstrated in Figure 9.2, if the recommendations described above are considered 
within the context of the Renewal of the NCSP.  This will maximise the impact of 
future communication strategies and potentially, the impact of primary and 
secondary prevention strategies for cervical cancer among women in Queensland, 
and potentially other parts of Australia. 
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Appendices 
Appendix A 
Print Media Campaign and HPV Questionnaire 
Final Draft June 2008 
Hello, my name is … I'm calling from I-View on behalf of the Qld Health Department. 
The Health Department is currently conducting interviews with women aged 20 to 69 years on aspects 
of health and health screening. May I please speak to the youngest woman living in the household 
who is aged 20 to 69 years.? 
[INTERVIEWER NOTE: For people who express concerns or wish to have more information.]  
If you would like more information about this survey or to check the validity of this survey you can 
telephone the Program Manager for the Queensland Cervical Screening Program within Queensland 
Health. You can contact her on 3234 1596.  
Alternatively I can email, fax or post you a letter confirming that Queensland Health is currently 
conducting this survey. Would you like me to send this information, or would you like to continue the 
survey now? 
[INTERVIEWER NOTE: If the respondent wants further information, make an appointment to call 
back and pass the details on to your supervisor. Confirm fax number, email address or postal address 
depending on the method of contact requested] 
The interview is completely confidential and only takes about 15 to 20 minutes.  
Can I just check, you said you are aged between 20 and 69 years? 
  1      Yes 
  2      No      -      Terminate 
  3      Refused to continue interview      -      Terminate 
 
Good, thank-you.  Before we begin, I should stress the importance of answering the questions as 
accurately as possible. 
So please feel free to take as much time as you need before responding.  If there are any questions you 
would rather not answer, just say so. 
Some calls are monitored by my supervisor for training and quality purposes. 
(INTERVIEWER: If R is concerned about someone 'listening in' on their conversation, tell them that - 
"My supervisor sometimes listens to check that I am conducting the interview properly, and reading 
the questions correctly.") 
 
We may at any time during this interview be listened to by my supervisor for quality control 
procedures.   
Today we are seeking information that will assist us to reduce the number of women who suffer from 
cervical cancer each year.   
This means that we only need to interview women who have not had a hysterectomy. 
A hysterectomy is an operation in which a woman's womb or uterus is removed.  Have you had a 
hysterectomy? 
1 Yes 
2 No  
3 Don't know 
4 Refused to answer 
IF 1 (YES) DISPLAY TEXT BELOW 
As the survey is designed for women who have not had a hysterectomy I am not able to proceed with 
the interview but thank-you very much for offering to be involved.    -    Terminate 
TERMINATION SCRIPT:  
Once again, my name is ___________ calling on behalf of  the Queensland Health Department.                                                    
 GOOD-BYE! 
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KN31 So that we can establish the boundaries of our interviewing area, can I ask what is the suburb, 
that you live in? 
 
Insert SEIFA Code frame – assign to quintile and check quotas 
 
 
KN 19a Could you please tell me your date of birth? 
(INTERVIEWER: If respondent is hesitant about answering this question say: "We ask date of birth 
because most people find it easier to remember their date of birth than their age."). 
 
1 Gave date of birth (type in date) 
2 Refused to answer 
 
IF (ANS = 1) SKIP TO Q1 
IF (ANS = 2) SKIP TO KN19B 
 
 
KN19b Well, could you please tell me: what was your age last birthday? 
 
1  Gave exact age (type in age) ASSIGN TO AGE BAND FOR MONITORING 
2  Refused to answer 
 
IF (ANS = 1) SKIP TO Q1 
IF (ANS = 2) SKIP TO KN19C 
 
KN19c Would you be willing to say which of the following categories your age is in ? 
(INTERVIEWER:  Read out highlighted categories 1 to 6) 
1 20 – 24 
2 25 – 29 
3 30 – 34 
4 35 – 39 
5 40 – 44 
6 45 – 49 
7 50 – 54 
8 55 – 59 
9 60 –64 or 
10 65 – 69 
11 No response 
 
(Questions removed not relevant to this study) 
 
The next few questions are about Pap smears.  
KN1. Firstly, what do you think a Pap smear test is for? 
 
(INTERVIEWER: Do not prompt.  Multiple responses allowed. Probe fully) 
 
1 A test to look for abnormal cells  
2 Treatment for cancer  
3 A test for a sexually transmitted infection  
4 Other (specify) 
5 Don’t know  
6 No response 
 
 
KN2. A Pap smear is a test carried out by a doctor or health professional to check if a woman has 
early signs of cancer of the cervix. 
How often do you think a woman should have a Pap smear? 
 
(INTERVIEWER: If R having trouble answering, do not prompt with categories, just choose ‘Don’t 
know’. ) 
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1 Every year  
2 Every 2 years  
3 Every 3–5 years  
4 Every 10 years 
5 Some other time period (specify) 
6 Don’t know  
7 No response 
 
 
KN3 When or at what age do you think it is recommended women should start having Pap smears? 
 
(INTERVIEWER: Do not prompt) 
 
1 16 years of age 
2 18 years of age 
3 21 years of age 
4 When they become sexually active 
5 Other (specify) 
6 Don’t know 
7 No response 
 
KN4 When do you think it is recommended women should stop having Pap smears?  
 
(INTERVIEWER: Do not prompt) 
1 70 years of age  
2 At menopause  
3 When they are no longer sexually active 
4 No specific time recommended 
5 Other  (specify) 
6 Don’t know 
7 No response 
 
 
KN5 What do you think an abnormal Pap smear most commonly means? 
 
(INTERVIEWER: Multiple responses allowed.  Do not prompt with options.  Probe with “Anything 
else”) 
 
1 Abnormal, precancerous cells 
2 Cancer 
3 Infection 
4 Other (specify) 
5 Don’t know  
6 No response 
 
KN6a I am now going to read out a list of items.  For each one please say if you think they might 
increase the risk of cervical cancer. 
The first item is ……. 
Having many pregnancies/children 
Do you think this might increase the risk of cervical cancer? 
 
1 Yes 
2 No 
3 Don’t know 
 
KN6b The next item is:  Being infected with human papillomavirus or HPV 
Do you think this might increase the risk of cervical cancer? 
 
1 Yes 
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2 No 
3 Don’t know 
 
KN6c–n Cycle through the list 6a–6n with the same question. 
 RANDOMISE STATEMENT ORDER. 
6c Poor hygiene 
6d Starting sex at a young age 
6e Smoking  
6f Having genital warts 
6g Stress  
6h Having lots of sex  
6i Having lots of sexual partners  
6j A family history of cervical cancer  
6k Not having regular Pap smears  
6l Taking the oral contraceptive pill  
6m Not using condoms 
6n Being overweight  
 
Cervical screening behaviours 
The next few questions are about you personally. 
Q5  Have you ever had a Pap smear? 
 SINGLE RESPONSE 
1 Yes 
2 No 
3 Not sure 
4 Don't know about this test 
5 Refused to answer 
 
IF NOT CODE 1 (YES) IN Q5 SKIP TO Q8   
 
KN7 How many times have you had a Pap smear? 
 
(INTERVIEWER: Prompt with categories if necessary) 
 
1 Once 
2 Twice 
3 3–5 times 
4 6–10 times 
5 11–20 times 
6 More than 20 times 
7 Don’t know / can’t remember 
8 Refused to answer 
 
Q6  When did you last have a Pap smear? 
 (INTERVIEWER: Prompt with categories if necessary)  
 SINGLE RESPONSE 
1 Less than 1 year ago 
2 1 year to less than 2 years ago 
3 2 years to less than 3 years ago 
4 3 years to less than 5 years ago 
5 5 or more years ago 
6 Don't know 
 
Q7. What is the USUAL time between your Pap smears? 
 SINGLE RESPONSE   
1 Less than a year 
2 One year 
3 18 months 
4 Two years 
5 Three years 
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6 Four years 
7 Five years or more 
8 Only ever had 1 test 
9 Don't have a regular test 
10 Other (specify) 
11 Don't know 
12 Refused to answer 
 
 
KN9 Have you ever had an abnormal Pap smear result in the past? 
 
1 Yes 
2 No 
3 Not sure 
4 Refused to answer 
 
(Questions removed not relevant to this study) 
 
The following questions are about vaccines including childhood vaccines and vaccines for adults to 
prevent infections such as measles, mumps and rubella or influenza (the flu) 
I am going to read you a list of statements.  Please tell me to what extent you agree or disagree with 
each one. 
 RANDOMISE STATEMENT ORDER 
KN12a   
The first statement is: Prevention is better than cure for cervical cancer 
 
Do you……….: 
(INTERVIEWER: Read out the highlighted categories 1 to 5) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN12b The next statement is: Vaccines are an important way to prevent disease  
Do you……….:  
(INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN12c (The next statement is):  Everyone should be vaccinated against preventable diseases in 
childhood  
 
(INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
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Refused to answer 
 
KN12d (The next statement is):  Vaccines that have been approved by the Health Department are 
safe  
 
(INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN12e (The next statement is):  All children should be vaccinated against preventable conditions 
while they are still babies  
 
(INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN12f (The next statement is):  The costs involved would influence my decision to have a child of 
mine vaccinated  
 
(INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN12g (The next statement is):  The convenience of the venue where the vaccine is given would 
influence my decision to have a child of mine vaccinated 
 
(INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN12h (The last statement is):  I worry about the side effects of vaccines for children  
 
(INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
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Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN13 The following questions are about HPV or Human Papillomavirus. 
Firstly, before today had you heard of HPV? 
 
1 Yes  
2 No 
3 Don't know 
4 Refused to answer 
 
IF (ANSWER > 1) SKIP TO KN15   
Next I am going to read you some statements about HPV and ask if you think they are true or false.   
RANDOMISE STATEMENT ORDER 
 
KN14a The first statement is:   
A person may be infected with HPV and not know it  
Do you think this is true or false? 
 
1 True  
2 False 
3 Don't know 
 
KN14b The next statement is:  Those with HPV may need Pap smears more often.  
True or false? 
 
(INTERVIEWER: CYCLE THROUGH STATEMENTS IN THIS MANNER) 
 
KN14c HPV is spread through sexual intercourse  
KN14d There is a vaccine to prevent some types of HPV 
KN14e Women can often clear HPV without treatment 
KN14f HPV can cause problems with pregnancy 
KN14g HPV can be cured with antibiotics 
KN14h HPV causes women to have abnormal periods 
KN14i If you have HPV, smoking can increase your chance of cervical cancer  
KN14j Condoms do not always help protect you against HPV 
KN14k Certain types of HPV cause cancer of the cervix 
KN14l The Pap smear is a test for HPV 
 
KN15 Have you heard of the vaccine for cervical cancer or HPV? 
 
1 Yes  
2 No 
3 Don't know 
4 Refused to answer 
 
If (ANSWER > 1) SKIP TO KN18 
 
KN16 Where did you hear about the vaccine? 
(INTERVIEWER: DO NOT READ OUT. MULTIPLE RESPONSES ALLOWED – DO NOT 
PROMPT.  PROBE WITH 'ANYWHERE ELSE?')  
1 TV 
2 Magazines / books 
3 Newspaper  
4 Radio 
5 Doctor 
6 Nurse 
7 Health worker  
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8 Family / friends 
9 Other (specify)  
10 Don't know  / can’t remember 
11 Refused to answer  
 
KN17 Have you had the vaccine? 
 
1 Yes  
2 No 
3 Don't know 
4 Refused to answer 
 
KN18 (INTERVIEWER: PLEASE READ OUT). A vaccine has been developed against two types 
of the virus, HPV or human papillomavirus that cause up to 70% of cervical cancer.  This free 
Cervical Cancer vaccine is primarily targeted at girls aged 12 to 13 years of age who are attending 
school. 
 
I’ll now read you a list of statements that relate to this cervical cancer or HPV vaccine.  Please tell me 
to what extent you agree or disagree with each one. 
 
KN18c The first statement is: If I had a 12 year old daughter I would need more information 
before I could decide whether she should be vaccinated against HPV  
Do you……….:  
(INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN18d The next statement is: If  I had a 12 year old daughter and my doctor thinks it is a good 
idea, I would have her vaccinated against HPV  
 (INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN18e (The next statement is): There is more risk involved in being vaccinated than in having 
HPV  
 (INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN18a (The next statement is): If I had a 12 year old daughter I would not want her to be 
vaccinated against HPV 
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 (INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN18f (The next statement is): The cervical cancer vaccine works best when it is given before a 
young woman becomes sexually active  
 (INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
KN18b The last statement is: Vaccinating young women and girls against HPV would 
encourage them to become sexually active  
 (INTERVIEWER: Read out the highlighted categories 1 to 5 if necessary) 
 
Strongly agree 
Agree 
Neither agree nor disagree 
Disagree 
Strongly disagree 
Don’t know 
Refused to answer 
 
The next question is about tobacco smoking. This includes cigarettes, cigars and pipes. 
Q23 Which of the following best describes your smoking status?  
 Would it be . . . . . 
 INTERVIEWER: READ OUT HIGHLIGHTED OPTIONS 1–5 
 SINGLE RESPONSE  
 
1 I smoke daily 
2 I smoke occasionally 
3 I don't smoke now but I used to 
4 I've tried it a few times but I never smoked regularly or 
5 I've never smoked 
6 Don't know / can't say – DO NOT READ OUT 
7 Refused to answer – DO NOT READ OUT 
 
 
Now we are coming to the last section of the study.  
I am going to ask some routine questions about your background.  
(INTERVIEWER: If R is hesitant about answering this sort of question say: 'These questions are 
important as they enable us to look at different groups within the community, for example younger 
people, those who are married, employed or retired and see whether those groups have different 
experiences.  Remember all your answers remain confidential.’) 
 
Dem1 And what is your current marital status? Are you........ 
INTERVIEWER: READ OUT CODES 1–6 
1 Married 
2 De facto 
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3 Separated 
4 Divorced 
5 Widowed, or 
6 Never married 
7 Don't know – DO NOT READ 
8 Refused to answer – DO NOT READ  
 
KN10 Do you have any children? 
1 Yes 
2 No 
3 Refused to answer 
 
IF ANSWER > 1 SKIPTO Dem3 
 
KN11a How many children have you given birth to?  
 
1 Enter number stated ________ 
2 Refused to answer 
 
KN11b How many of these children are?  
 
1 Males 
2 Females 
3 Refused to answer 
 
(Questions removed not relevant to this study) 
 
KN21 What is the highest level of primary or high school you have completed? 
(INTERVIEWER:  Prompt with categories if necessary) 
1 Never attended school 
2 Currently still at school 
3 Year 8 or below (age 12 – 13 years) 
4 Year 9 or equivalent (age 13 – 14 years) 
5 Year 10 or equivalent (age 14 – 15 years) (Junior) 
6 Year 11 or equivalent (age 15 – 16 years) 
7 Year 12 or equivalent (age 16 – 17 years) (Senior) 
8 Don’t know 
9 Refused to answer 
 
IF (ANS = 2) SKIP TO DEM7 
 
Dem 5 Since leaving school have you completed any further qualifications? 
1 Yes 
2 No 
3 Don't know 
4 Refused to answer 
IF NOT 1 IN DEM5 SKIP TO DEM 7 
 
Dem6 What is the highest qualification you have completed? Is it... 
  (INTERVIEWER: Read out categories 1–4 
Use categories 5 & 6 only if R offers - don't probe for this information) 
1 Bachelor Degree or higher 
2 Trade Certificate (4 years duration) 
3 Diploma or Certificate taking 12 months or more full time 
4 Diploma or Certificate taking less than 12 months full time 
5 Enrolled Nurse 
6 Registered Nurse 
7 Don't know 
8 Refused to answer 
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KN26 Were you born in Australia? 
 
1 Yes 
2 No 
3 Refused to answer 
IF (ANS = 1) SKIP TO KN27 
IF (ANS = 2) SKIP TO KN28 
IF (ANS = 3) SKIPTO KN31 
 
KN27 Are you of Aboriginal or Torres Strait Islander origin? 
 
1 Yes 
2 No 
3 Refused to answer 
ALL SKIPTO KN31   
 
KN28 Which country were you born in? 
 
1 UK & Ireland (includes England, Wales, Scotland and Northern Ireland) 
2 New Zealand and Oceania (you will need to define Oceania) 
3 Other (specify) 
4 Don't know 
5 Refused to answer  
 
KN33 What is the postcode of your residence? 
 
Well that's the end of the questionnaire.  I just have one last thing to ask.  Occasionally my supervisor 
will call some people back to check that I have conducted the interview properly. 
Would you be willing to give me your first name only in case she wishes to call you? 
 1       Yes 
 2       No 
That's the end of the interview.                                                               
THANK-YOU VERY MUCH FOR ALL YOUR HELP. 
Once again, my name is ___________ calling on behalf of the Queensland Health Department.    
GOOD-BYE! 
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Appendix B 
Focus Group Information Sheet  
 
PARTICIPATE IN RESEARCH 
Information for Prospective Participants 
The following research activity has been reviewed via QUT arrangements for the 
conduct of research involving human participation.  If you choose to participate, you 
will be provided with more detailed participant information, including who you can 
contact if you have any concerns. 
 
“Factors influencing the impact of primary and secondary prevention strategies for cervical 
cancer among Queensland women.” 
 
Research Team Contacts 
Leane Christie, Researcher Monika Janda,  
Phone: 3328 9456 Phone: 3138 9674 
Email: Leane_Christie@health.qld.gov.au Email: m.janda@qut.edu.au 
Please contact the research team if you have any questions or require more information about the 
project 
 
What is the purpose of the research? 
The purpose of this research is to find out what women in the community know about the risk 
factors for cervical cancer and what they know and think about the new cervical cancer vaccine as 
this will guide future health promotion activities in Queensland.  
Who is funding this research? 
The project is funded by Queensland Health.  The funding body will not have access to personally 
identifying information about you that may be obtained during the project. 
Are you looking for people like me? 
The research team is looking for women aged between 20 and 70 years who have not had a 
hysterectomy. 
What will you ask me to do? 
Your participation will involve being part of a focus group with other women where cervical 
cancer, cervical screening and the cervical cancer vaccine will be discussed. 
Are there any risks for me in taking part? 
The research team does not believe there are any risks for you if you choose to participate in this 
research.  It should be noted that if you do agree to participate, you can withdraw from 
participation at any time during the project without comment or penalty. 
Are there any benefits for me in taking part? 
It is expected that this project will benefit you as each participant will be provided with 
information about cervical cancer and the vaccine to increase their understanding and knowledge 
about preventing this disease. It may benefit other women in Queensland as this study will be used 
to inform future programs and health promotion activities aimed at preventing cervical cancer. 
Thank You! 
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Appendix C 
Focus Group Consent Form 
 
CONSENT FORM for QUT RESEARCH PROJECT 
 
“Factors influencing the prevention strategies of cervical cancer among 
Queensland women.” 
 
Statement of consent 
 By signing below, you are indicating that you: 
 have read and understood the information document regarding this project 
 have had any questions answered to your satisfaction 
 understand that if you have any additional questions you can contact the 
research team 
 understand that you are free to withdraw at any time, without comment or 
penalty 
 understand that you can contact the Research Ethics Officer on 3138 2340 or 
ethicscontact@qut.edu.au if you have concerns about the ethical conduct of 
the project 
 agree to participate in the project 
 understand that the project will include audio recording 
By signing below, you are indicating that the project has been discussed with 
you and you agree to participate in the project. 
Name  
Signature  
Date /        / 2009 
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Appendix D 
Research Assistant Confidentiality Agreement 
 
 
CERVICAL CANCER RESEARCH STUDY 
 
 
I ..................................................., agree to the following confidentiality requirements 
for the cervical cancer research study: 
1. All information will remain confidential and will not be disclosed to another 
party without the approval of the researcher, Leane Christie 
2. Confidential information includes: 
a. The names and contact details of participants 
b. Tape recordings of focus groups 
c. Written notes pertaining to focus groups 
d. Transcriptions and electronic files pertaining to focus groups 
e. The password of relevant computers 
f. All written information, tapes and data files pertaining to focus groups 
3. All study materials will be kept in a secure place and returned to the 
researcher when transcription is completed. 
 
 
Signed:..............................................................  
 
 
Date:........./...../20 
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Appendix E 
Presentations Relevant to Study 
Presentation Title Event Location Date 
Cervical cancer prevention: 
primary and secondary 
prevention strategies: does one 
size fit all? 
Professional doctorate 
seminar QUT 
Brisbane March 2007 
Promoting cervical screening 
following the implementation 
of the HPV vaccine in 
Queensland, Australia 
2008 World Congress of 
Cervical Pathology and 
Colposcopy 
New Zealand October 2008 
What Queensland women know 
about cervical cancer, cervical 
screening and HPV 
21
st
 Scientific Meeting of 
the Australian Society for 
Colposcopy and Cervical 
Pathology Inc 
Darwin August 2009 
What Queensland women know 
about cervical cancer, cervical 
screening and HPV 
National Cervical 
Screening Program 
Managers Meeting 
Brisbane December 2010 
What Queensland women say 
about cervical cancer, Pap 
smears, HPV and vaccination 
Queensland Cervical 
Screening Program Quality 
Management Committee 
Meeting 
Brisbane July 2011 
What Queensland women say 
about cervical cancer, Pap 
smears, HPV and vaccination 
CSSB 20 Year Symposium Brisbane August 2011 
What Queensland women say 
about cervical cancer, Pap 
smears, HPV and vaccination 
National Cervical 
Screening Program 
Managers Meeting 
Melbourne November 2011 
What Queensland women say 
about cervical cancer, Pap 
smears, HPV and vaccination 
Preventing Cervical Cancer 
2011 Conference 
Melbourne November 2011 
What Queensland women say 
about cervical cancer, Pap 
smears, HPV and vaccination 
Cancer Screening Services 
Branch (CSSB) Consumer 
Reference Group 
Brisbane March 2012 
What Queensland women say 
about cervical cancer, Pap 
smears, HPV and vaccination 
Mobile Women’s Health 
Service Annual Workshop 
Brisbane March 2012 
Factors influencing the impact 
of primary and secondary 
prevention strategies for 
cervical cancer among women 
in Queensland 
Final Seminar Brisbane May 2012 
What Queensland Women say 
about Self Collected Testing for 
the Prevention of Cervical 
Cancer 
Poster presentation – 
International Cancer 
Screening Network 
Sydney October 2012 
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Appendix F 
Focus Groups Report  
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Appendix G 
Variables Collected to Inform Phase 1 
Variables 
Dependent* 
/Independent 
Research 
Question 
How Measured 
Type in 
survey 
Knowledge of 
cervical cancer 
/screening 
Dependent 
Independent 
 
Q1&2 
Q2&4 
Individual items  
(choose answer) 
Categorical 
Knowledge of 
HPV 
Dependent 
 
Q1&2 Individual items  
(true/false) 
Categorical 
Awareness of HPV Dependent  
Independent 
Q1 
Q2&4 
Yes/no/don’t know/refused Categorical 
Awareness of HPV 
vaccination  
Dependent 
Independent 
Q3 
Q4 
Yes/no/don’t know/refused Categorical 
Attitudes towards 
vaccination in 
general  
Independent Q4 Individual items (Likert-type 
response) 
Categorical 
Attitudes towards 
HPV vaccination 
Dependent 
 
Q4 Individual items (Likert-type 
response) 
Categorical 
 
Age Independent Q2 &4 Age at last birthday (years) Continuous 
Location Independent Q2 &4 Postcode of residence Categorical 
SES Independent Q2 &4 Postcode of residence mapped to 
SEIFA index  
Categorical 
Australian born Independent Q2 &4 Yes/no/don’t know/refused Categorical 
Indigenous status Descriptive  Yes/no/don’t know/refused Categorical 
Educational  
attainment 
Independent Q2 &4 Highest level of schooling & 
post school qualifications  
Categorical 
Marital status Independent Q2 &4 Married, single, divorced etc Categorical 
Parity Independent Q2 &4 Yes/no/don’t know Categorical 
Smoking status Independent Q2 &4 Smoker (current/previous/never) Categorical 
Screening status Independent Q 2 &4 Length of time since last Pap & 
usual time between Paps- combo 
Categorical 
History of previous 
abnormalities 
Independent Q2 &4 Yes/no/don’t know/refused Categorical 
Where heard of 
HPV vaccine 
Descriptive Q4 Nominated source Categorical 
Had the HPV 
vaccine 
Descriptive Q4 Yes/no/don’t know/refused Categorical 
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Appendix H 
Knowledge and Attitude Measures 
Cervical Cancer/Screening Knowledge Tool 
Knowledge Item Score  
(1 = correct answer) 
What is a Pap smear? 
A test to look for abnormal cells 1 
Treatment for cancer 0 
A test for a sexually transmitted infection 0 
Don’t know 0 
How often should a woman have a Pap smear? 
Every year 0 
Every 2 years 1 
Every 3–5 years 0 
Every 10 years 0 
Don’t know 0 
When do you think it is recommended women should start having Pap smears? 
16 years of age   0 
18 –20 years of age 1 
21 years of age 0 
When they become sexually active 0 
When do you think it is recommended women should stop having Pap smears? 
70 years of age   1 
At menopause 0 
When they are no longer active 0 
No time recommended 0 
What do you think an abnormal Pap smear most commonly means? 
Abnormal, precancerous cells 1 
Cancer  0 
Infection 0 
Don’t know 0 
Which of the following might increase the risk of cervical cancer? 
Not using condoms 1 
Being infected with human papillomavirus (HPV) 1 
Starting sex at a young age 1 
Smoking 1 
Having genital warts 0 
Stress 0 
Having frequent sex 0 
Having lots of sexual partners 1 
A family history of cervical cancer 0 
Not having regular Pap smears 1 
Taking the oral contraceptive pill 1 
Having many pregnancies/children 1 
Being overweight 0 
Poor hygiene 0 
TOTAL 13 
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HPV Knowledge Tool* 
 
Item Answer 
A person may be infected with HPV and not know it T 
Those with HPV may need Pap smears more often T 
HPV is spread through sexual intercourse T 
The Pap smear is a test for HPV F 
HPV can cause problems with pregnancy F 
HPV can be cured with antibiotics F 
HPV causes women to have abnormal periods F 
If you have HPV, smoking can increase your chance of cervical cancer  T 
Condoms do not always help protect you against HPV T 
Women can often clear HPV without treatment T 
Certain types of HPV cause cancer of the cervix T 
There is a vaccine to prevent some types of HPV T 
Highest Possible Score 12 
* These items were only asked of respondents who had heard of HPV 
 
Vaccination Attitude Scales 
       
Vaccination in General      
Item 
 strongly 
agree 
agree uncertain disagree strongly 
disagree 
1 
Prevention is better than cure for 
cervical cancer 
5 4 3 2 1 
2 
Vaccines are an important way to 
prevent disease 
5 4 3 2 1 
3 
Everyone should be vaccinated against 
preventable diseases in childhood 
5 4 3 2 1 
4 
Vaccines that have been approved by 
the health department are safe 
5 4 3 2 1 
5 
All children should be vaccinated 
against preventable conditions while 
they are still babies 
5 4 3 2 1 
6 
The costs involved would influence 
my decision to have a child of mine 
vaccinated 
1 2 
 
3 4 5 
7 
The convenience of the venue where 
the vaccine is given would influence 
my decision to have a child of mine 
vaccinated 
1 2 
 
3 4 5 
8 
I worry about the side-effects of 
vaccines for children 
1 2 
 
3 4 5 
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HPV Vaccination Attitudes 
Item 
 strongly 
agree 
agree uncertain disagree strongly 
disagree 
1 
If I had a 12 year old daughter, I 
would not want her to be vaccinated 
against HPV 
1 2 
 
3 4 5 
2 
Vaccinating young women and girls 
against HPV would encourage them 
to become sexually active 
1 2 
 
3 4 5 
3 
If I had a 12 year old daughter, I 
would need more information before 
I could decide whether she should be 
vaccinated against HPV 
1 2 
 
3 4 5 
4 
If I had a 12 year old daughter, and 
my doctor thinks it is a good idea, I 
would have her vaccinated against 
HPV 
5 4 3 2 1 
5 
There is more risk involved in being 
vaccinated than in having HPV 
1 2 
 
3 4 5 
6 
The cervical cancer vaccine works 
best when it is given before a young 
woman becomes sexually active 
5 4 3 2 1 
 
 
The ratings above have been recorded in accordance with positive or negative 
statements.  Positive responses (rated 5 or 4) were allocated a score of 1 for the 
purposes of analysis for each item and summed to give a total score (Pitts et al., 
2007). 
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Appendix I 
Variable Derivations 
 
Variable How collected in survey Refinement/Construction Required 
Age  Continuous 
 
Converted from continuous  to categorical 
10 year age groups 
Locality Postcode of residence Mapped  to statistical local area (SLA) and 
then mapped to ASGC classifications – 5 
categories.  Further collapsed into 3 
categories – metropolitan cities, inner 
regional and outer regional, remote and very 
remote. 
SES Postcode of residence converted 
to SEIFA categories by the 
CATI facility into deciles and 
quintiles of relative socio-
disadvantage.   
Quintiles used for analysis. 
Education Highest year of formal 
schooling completed (9 
categories) 
Completion of further 
qualifications 
Highest qualification completed 
(8 categories) 
Converted into educational status by 
transforming three variables. 
Highest year of schooling grouped to 2 
categories, less than year 10 and greater 
than year 10. 
Highest qualification completed grouped 
into 2 categories, Bachelor Degree or 
Higher and Certificate/Diploma. 
Marital status 8 categories Converted to 4 categories – married; 
defacto; separated,/divorced/ widowed; 
never married 
Australian-born 3 categories Converted to dichotomous variable – yes/no 
Indigenous status 3 categories No change 
Parity 3 categories Converted to dichotomous – yes/no 
Screening status Length of time since last Pap 
smear (6 categories) 
Usual time between Pap smears 
(12 categories) 
Converted into screening status by 
combining two variables - Length of time 
since last Pap & usual time between Paps – 
categorical – 
unscreened/underscreened/regularly 
screened/ overscreened/other  
History of 
abnormal Pap 
smear 
3 categories Converted to dichotomous – yes/no 
 
Smoking status 7 categories  Converted to dichotomous – current 
smoker- yes/no 
Heard of HPV 
vaccine  
4 categories Converted to categorical dichotomous – 
yes/no  
Where heard of 
HPV vaccine 
Multiple responses No change 
Had HPV vaccine 4 categories Converted to categorical dichotomous – 
yes/no  
Heard of HPV 4 categories Converted to categorical dichotomous – 
yes/no  
 Appendices 309 
Knowledge of 
cervical 
cancer/screening 
Purpose (6 categories) 
Recommendations – Frequency, 
start screening, cease screening 
(7categories per item) 
What results mean (6 
categories) 
Risks (12 items)  
Risk factor items combined to form a score 
for this item and then combined with correct 
responses of other items  to form a score 
then converted to above/below average 
levels 
Categorical to Continuous to Categorical 
Knowledge of HPV  
 
True /false items (12 items) Correct responses compiled to form a score 
then converted to above/below average 
levels 
Categorical to Continuous to Categorical 
Attitudes towards 
vaccination in 
general  
Attitude scale 
 
Positive responses compiled to form a score 
then converted to positive and negative 
attitudes 
Categorical to Continuous to Categorical 
Attitudes towards 
HPV vaccine 
Attitude scale 
 
Positive responses compiled to form a score 
then converted to positive and negative 
attitudes 
Categorical to Continuous to Categorical 
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Appendix J 
Multicollinearity Diagnostics 
Coefficients
a
 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity 
Statistics 
B 
Std. 
Error Beta Tolerance VIF 
1 (Constant) .551 .125  4.416 .000   
Age in 10 yr groups -.003 .014 -.009 -.245 .807 .841 1.189 
Locality -.026 .022 -.039 -1.204 .229 .987 1.013 
SES  .003 .011 .009 .265 .791 .936 1.068 
Australian born -.025 .043 -.019 -.590 .555 .962 1.039 
Educational attainment -.004 .017 -.009 -.256 .798 .882 1.134 
Marital status -.009 .021 -.015 -.445 .656 .928 1.077 
Had children -.007 .042 -.006 -.173 .863 .845 1.183 
Smoking status .041 .041 .034 1.006 .314 .946 1.058 
Screening status .052 .029 .062 1.808 .071 .898 1.114 
Abnormal Pap history -.027 .037 -.025 -.729 .466 .897 1.115 
a. Dependent Variable: Cx screening knowledge level  
 
 
Coefficients
a
 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity 
Statistics 
B 
Std. 
Error Beta Tolerance VIF 
1 (Constant) .026 .116  .222 .824   
Age in 10 yr groups .009 .013 .024 .720 .472 .841 1.189 
Locality .037 .020 .057 1.838 .066 .986 1.014 
SES  .013 .010 .041 1.298 .195 .936 1.068 
Australian born .092 .040 .072 2.316 .021 .962 1.040 
Educational attainment .084 .015 .179 5.482 .000 .881 1.134 
Marital status -.006 .019 -.010 -.318 .750 .928 1.077 
Had children -.037 .039 -.032 -.946 .344 .845 1.183 
Smoking status .074 .038 .062 1.952 .051 .945 1.059 
Screening status .035 .026 .042 1.305 .192 .895 1.118 
Abnormal Pap history -.076 .034 -.073 -2.247 .025 .897 1.115 
Cx screening knowledge 
level  
.221 .030 .227 7.374 .000 .991 1.009 
a. Dependent Variable: Heard of HPV  
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Coefficients
a
 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity 
Statistics 
B 
Std. 
Error 
Beta Tolerance VIF 
1 
(Constant) .346 .172  2.012 .045   
Age in 10 yr groups -.037 .017 -.092 -2.173 .030 .844 1.185 
Locality .020 .026 .030 .759 .448 .974 1.026 
SES .011 .014 .032 .780 .436 .913 1.095 
Australian born -.068 .054 -.051 -1.256 .210 .929 1.077 
Educational attainment .027 .021 .054 1.309 .191 .882 1.134 
Marital status -.045 .026 -.070 -1.743 .082 .940 1.064 
Had children -.056 .049 -.048 -1.141 .254 .860 1.162 
Smoking status .014 .053 .011 .265 .791 .927 1.079 
Screening status -.001 .035 -.001 -.015 .988 .879 1.137 
Abnormal Pap history -.082 .044 -.077 -1.848 .065 .860 1.163 
Cx screening 
knowledge level 
.191 .041 .184 4.667 .000 .974 1.027 
Heard of HPV vaccine .224 .074 .123 3.040 .002 .917 1.091 
General vaccine 
attitudes 
-.025 .067 -.016 -.370 .711 .849 1.178 
HPV vaccine attitudes .112 .053 .092 2.093 .037 .783 1.278 
a. Dependent Variable: HPV knowledge level 
 
 
 
Coefficients
a
 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity 
Statistics 
B 
Std. 
Error Beta Tolerance VIF 
1 (Constant) .744 .084  8.881 .000   
Age in 10 yr groups -.021 .009 -.079 -2.313 .021 .841 1.189 
Locality .003 .014 .007 .233 .816 .982 1.018 
SES  .009 .007 .039 1.213 .225 .935 1.070 
Australian born .081 .029 .089 2.800 .005 .957 1.045 
Educational attainment .017 .011 .050 1.494 .135 .854 1.171 
Marital status -.002 .014 -.005 -.161 .872 .928 1.077 
Had children -.020 .028 -.024 -.697 .486 .844 1.184 
Smoking status -.003 .027 -.004 -.126 .900 .941 1.063 
Screening status .008 .019 .014 .413 .679 .893 1.120 
Abnormal Pap history -.086 .025 -.116 -3.504 .000 .892 1.121 
Cx screening 
knowledge level  
.039 .022 .056 1.739 .082 .937 1.067 
Heard of HPV  .116 .023 .164 4.936 .000 .888 1.126 
a. Dependent Variable: Heard of HPV vaccine 
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Coefficients
a
 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity 
Statistics 
B 
Std. 
Error Beta Tolerance VIF 
1 (Constant) .764 .086  8.912 .000   
Age in 10 yr groups .007 .009 .028 .799 .424 .836 1.196 
Locality .020 .014 .047 1.434 .152 .982 1.018 
SES  .002 .007 .011 .338 .735 .933 1.072 
Australian born .020 .028 .024 .714 .475 .949 1.054 
Educational 
attainment 
-.004 .011 -.012 -.343 .732 .852 1.173 
Marital status -.030 .014 -.074 -2.212 .027 .928 1.077 
Had children .012 .028 .015 .440 .660 .844 1.185 
Smoking status .048 .027 .059 1.781 .075 .941 1.063 
Screening status .026 .019 .047 1.369 .171 .893 1.120 
Abnormal Pap history .000 .024 .000 .010 .992 .881 1.136 
Cx screening 
knowledge level  
.018 .022 .028 .842 .400 .934 1.071 
Heard of HPV  .022 .023 .033 .942 .346 .866 1.155 
Heard of HPV 
vaccine 
-.018 .032 -.019 -.566 .571 .920 1.087 
a. Dependent Variable: General vaccine attitudes 
 
 
Coefficients
a
 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity 
Statistics 
B 
Std. 
Error Beta Tolerance VIF 
1 (Constant) .148 .111  1.331 .183   
Age in 10 yr groups -.011 .011 -.033 -1.014 .311 .835 1.197 
Locality .023 .018 .040 1.309 .191 .980 1.020 
SES  .011 .009 .037 1.200 .230 .933 1.072 
Australian born .095 .035 .083 2.686 .007 .948 1.055 
Educational 
attainment 
.002 .014 .005 .169 .866 .852 1.174 
Marital status -.005 .017 -.010 -.312 .755 .923 1.083 
Had children -.013 .034 -.013 -.385 .700 .844 1.185 
Smoking status -.010 .033 -.010 -.313 .755 .938 1.066 
Screening status -.005 .023 -.007 -.231 .818 .892 1.120 
Abnormal Pap history -.099 .030 -.105 -3.292 .001 .881 1.135 
Cx screening 
knowledge level  
.096 .027 .109 3.517 .000 .934 1.071 
Heard of HPV  .036 .029 .040 1.240 .215 .864 1.157 
Heard of HPV 
vaccine 
.221 .040 .174 5.557 .000 .919 1.088 
General vaccine 
attitudes 
.346 .040 .258 8.545 .000 .981 1.019 
a. Dependent Variable: HPV vaccine attitudes 
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Appendix K 
Bivariate Results 
Table K1.  Bivariate Relationships between Cervical Cancer Screening Knowledge Levels and Socio-
demographic and Screening History in a Community Sample of 1002
a
 Women, Queensland, 2008 
Cervical Cancer/Screening Knowledge Levels 
 
below 
average 
 above 
average 
   
 
N 
(445) 
% 
(44.6) 
 N 
(554) 
% 
(55.4) 
 
X2 
b 
P 
c 
SOCIO-DEMOGRAPHIC        
 Age in 10 yr groups       0.46 0.98 
20–29 111 44.5  138 55.5   
 30–39 116 44.6  144 55.4   
 40–49 105 45.6  125 54.4  
  50–59 74 45.0  90 55.0  
 60–69 40 41.4  56 58.6   
 Locality       4.88 0.18 
remote,very remote 16 53.6  14 46.4    
outer regional 95 42.5  129 57.5    
inner regional 145 49.0  151 51.0    
major cities 189 42.0  261 58.0    
Socioeconomic status       2.43 0.66 
quintile 1 (most disadv) 76 43.0  100 57.0    
quintile 2 91 49.3  93 50.7    
quintile 3 66 43.6  86 56.4    
quintile 4 87 45.0  107 55.0    
quintile 5 (least disadv) 125 42.7  168 57.3    
Australian born       0.31 0.58 
no 79 42.9  106 57.1    
yes 366 44.9  448 55.1    
Educational attainment
  
      0.31 0.96 
year 10 or below 80 45.7  95 54.3    
year 11or 12 76 43.8  97 56.2    
certificate or diploma 177 43.9  227 56.1    
Ba degree or higher 112 45.5  134 54.5    
Marital status       0.19 0.98 
never married 64 45.4  77 54.6    
married 262 44.1  333 55.9    
defacto 76 45.4  91 54.6    
sep/div/wid 44 44.9  53 55.1    
Had children       0.01 0.93 
no 109 44.8  134 55.2    
yes 337 44.5  420 55.5    
Smoking status       2.10 0.15 
yes 101 49.2  105 50.8  
  no 344 43.4  449 56.6  
 SCREENING HISTORY  
  Screening status
 d 
     6.66 0.04 
underscreened 81 53.5 
 
70 46.5    
regularly screened 266 42.6 
 
358 57.4    
overscreened 76 41.2 
 
108 58.8    
Abnormal Pap history      1.78 0.18 
yes 121 41.4 
 
172 58.6   
 no 324 45.9 
 
382 54.1   
 a Weighted sample N = 999
 
b c
 Likelihood ratio - Chi square 
c
 p = significance at p <0.05 
d 
N=958 excludes women in the 'other' category 
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Table K2. Bivariate Relationships between HPV Awareness and Socio-demographic, Screening 
History and Knowledge in a Community Sample of 1002
a
 Women, Queensland, 2008 
Awareness of HPV 
 
No/Don't 
know 
 
Yes 
 
  
 
N 
(366) 
% 
(36.
6) 
 
N 
(633) 
% 
(63.4) 
 
X
2 
p 
SOCIO-DEMOGRAPHIC   
  
 
  
Age in 10 yr groups  
 
 
  
 4.25 0.37 
20–29 91 36.5  158 63.5  
  
30–39 95 36.5  165 63.5  
  
40–49 81 35.4  148 64.6  
  
50–59 55 33.5  109 66.5  
  
60–69 44 46.1  52 53.9  
  
Locality 
  
 
  
 3.77 0.15 
outer reg, rem, vremote 101 39.7  153 60.3  
  
major cities 170 37.9  279 62.1  
  
inner reg 96 32.3  201 67.7  
  
Socioeconomic status   
  
 8.80 0.07 
quintile 1 (most disadv) 68 38.7  108 61.3  
  
quintile 2 73 39.5  111 60.5  
  
quintile 3 67 43.9  85 56.1  
  
quintile 4 68 35.0  126 65.0  
  
quintile 5 (least disadv) 91 31.1  202 68.9  
  
Australian born  
 
 
  
 1.10 0.30 
no 74 40.2  111 59.8  
  
yes 292 35.9  522 64.1  
  
Educational attainment
  
 
  
 33.09 <0.0001 
year 10 or below 88 50.4  87 49.6  
  
year 11or 12 73 42.2  100 57.8  
  
cert or diploma 146 36.2  258 63.8  
  
Ba degree or higher 60 24.2  187 75.8  
  
Marital status  
 
 
  
 4.47 0.21 
never married 57 40.2  84 59.8  
  
married 203 34.1  392 65.9  
  
defacto 69 41.7  97 58.3  
  
sep/div/wid 38 38.8  59 61.2  
  
Had children  
 
 
  
 4.61 0.03 
no 75 30.9  167 69.1  
  
yes 292 38.6  465 61.4  
  
Smoking status  
 
 
  
 7.75 0.01 
yes 93 45.0  113 55.0  
  
no 274 34.5  519 65.5  
  
SCREENING HISTORY   
  
 
  
Screening status  
 
 
  
 7.87 0.02 
underscreened 68 45.3  82 54.7  
  
regularly screened 229 36.8  394 63.2  
  
overscreened 56 30.6  128 69.4  
  
Abnormal Pap history 
  
 
  
 5.15 0.02 
yes 92 31.3  201 68.7  
  
no 275 38.9  431 61.1  
  
KNOWLEDGE  
 
 
  
 
  
Cx screen kn level  
 
 
  
 55.86 <0.0001 
below average 220 49.4  225 50.6  
  
above average 147 26.5  407 73.5  
  a
 Weighted sample N = 999
 
b 
Likelihood Ratio – Chi square 
c
 p = significance at p <0.05 
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Table K3. Bivariate Relationships between HPV Knowledge and Socio-demographic, Screening 
History and Knowledge in a Community Sample of 1002
a
 Women, Queensland, 2008 
HPV kn level 
 
below 
average 
 
above 
average 
 
  
 
N 
(278) 
% 
44.0 
 
N 
(354) 
% 
56.0 
 
X
2b
 P
 c
 
SOCIO-DEMOGRAPHIC 
  
 
  
  
 Age in 10 yr groups 
  
 
  
 17.26 0.002 
20–29 52 32.7  106 67.3  
  30–39 72 43.7  93 56.3  
 40–49 67 45.4  81 54.6   
 50–59 55 50.1  54 49.9   
 60–69 32 62.6  19 37.4   
 Locality 
d 
  
 
  
 7.16 0.03 
outer reg, rem, vremote 75 49.0  78 51.0   
 major cities 106 38.0  173 62.0   
 inner reg 97 48.3  104 51.7   
 Socioeconomic status 
  
 
  
 7.14 0.13 
quintile 1 (most disadv) 51 47.7  56 52.3   
 quintile 2 54 48.9  57 51.1   
 quintile 3 41 47.9  44 52.1   
 quintile 4 58 46.2  68 53.8   
 quintile 5 (least disadv) 74 36.4  129 63.6   
 Australian born 
  
 
  
 0.69 0.41 
no 45 40.3  66 59.7   
 yes 234 44.8  288 55.2   
 Educational attainment 
  
 
  
 7.50 0.06 
year 10 or below 49 56.9  37 43.1   
 year 11or 12 43 43.5  57 56.5   
 cert or diploma 110 42.8  147 57.2   
 Ba degree or higher 74 39.5  113 60.5   
 Marital status  
  
 
  
 23.22 <0.0001 
never married 18 21.4  66 78.6  
  
married 185 47.3  206 52.7  
  
defacto 48 49.7  49 50.3  
  
sep/div/wid 27 45.1  33 54.9  
  
Had children 
  
 
  
 10.24 0.001 
no 56 33.5  111 66.5   
 yes 222 47.8  243 52.2   
 Smoking status 
  
 
  
 0.03 0.86 
yes 51 44.7  63 55.3   
 no 228 43.9  292 56.1   
 CERVICAL SCREENING HISTORY  
  
  
 Screening status  
  
 
  
 1.56 0.46 
underscreened 34 41.8  48 58.2   
 regularly screened 183 46.5  211 53.5   
 overscreened 52 41.0  75 59.0   
 Abnormal Pap history 
  
 
  
 3.88 0.05 
yes 77 38.4  124 61.6   
 no 201 46.6  230 53.4   
 KNOWLEDGE AND AWARENESS  
  
  
 Cx screen kn level 
  
 
  
 30.57 <0.0001 
below average 132 58.6  93 41.4   
 above average 146 35.9  261 64.1   
 Heard of HPV vaccine  
 
 
  
 19.64 <0.0001 
no 38 73.4  14 26.6   
 yes 241 41.4  341 58.6   
 ATTITUDES 
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General vaccine attitudes 
  
 
  
 0.81 0.39 
negative 33 48.8  34 51.2   
 positive 246 43.4  320 56.6   
 HPV vaccine attitudes 
  
 
  
 14.79 <0.0001 
negative 80 58.7  57 41.3   
 positive 198 39.9  298 60.1   
 a N = 633 (weighted and excludes those who have not heard of HPV) 
b 
Likelihood Ratio – Chi square 
c
 p = significance at < 0.05 
d
 outer regional, remote and very remote categories combined 
 
Table K4. Bivariate Relationships between Awareness of the HPV Vaccine and Socio-demographic, 
Screening History and Knowledge Variables in a Community Sample of 1002 
a 
Women, Queensland, 
2008 
  Heard HPV vaccine 
 
No  Yes  
  
N 
(137) 
% 
(13.7) 
 
N 
(863) 
% 
(86.3) 
 X
2 b 
P 
c 
SOCIO-DEMOGRAPHIC 
  
 
  
 
  
Age in 10 yr groups 
  
 
  
 29.00 <0.0001 
20–29 21 8.3  228 91.7  
  
30–39 46 17.6  214 82.4  
  
40–49 20 8.7  210 91.3  
  
50–59 23 14.0  141 86.0  
  
60–69 27 28.2  69 71.8  
  
Locality 
d 
  
 
  
 5.16 0.16 
outer reg, rem, vremote 40 15.9  212 84.1  
  
major cities 53 11.8  397 88.2  
  
inner reg 43 14.6  254 85.4  
  
Socioeconomic status 
  
 
  
 4.60 0.33 
quintile 1 (most disadv) 28 16.0  148 84.0  
  
quintile 2 28 15.3  156 84.7  
  
quintile 3 25 16.8  126 83.2  
  
quintile 4 22 11.4  172 88.6  
  
quintile 5 (least disadv) 33 11.1  261 88.9  
  
Australian born 
  
 
  
 7.01 0.01 
no 37 20.0  148 80.0  
  
yes 100 12.2  715 87.8  
  
Educational attainment 
  
 
  
 8.27 0.04 
year 10 or below 33 18.7  142 81.3  
  
year 11or 12 26 15.3  146 84.7  
  
cert or diploma 54 13.3  350 86.7  
  
Ba degree or higher 23 9.4  223 90.6  
  
Marital status 
  
 
  
 3.86 0.28 
never married 19 13.7  122 86.3  
  
married 81 13.5  514 86.5  
  
defacto 18 10.8  149 89.2  
  
sep/div/wid 19 19.3  78 80.7  
  
Had children 
  
 
  
 4.22 0.04 
no 24 9.7  219 90.3  
  
yes 113 14.9  644 85.1  
  
Smoking status 
  
 
  
 0.39 0.53 
yes 31 15.0  175 85.0  
  
no 106 13.3  688 86.7  
  
CERVICAL SCREENING HISTORY  
  
 
  
Screening status 
  
 
  
 5.00 0.08 
underscreened 26 17.0  125 83.0  
  
regularly screened 88 14.1  536 85.9  
  
overscreened 17 9.1  167 90.9  
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Abnormal Pap history 
  
 
  
 18.58 <0.0001 
yes 20 6.8  273 93.2  
  
no 117 16.5  590 83.5  
  
KNOWLEDGE AND AWARENESS  
  
 
  
Cx screen kn level 
  
 
  
 10.90 0.001 
below average 79 17.7  367 82.3  
  
above average 58 10.4  496 89.6  
  
Heard of HPV  
  
 
  
 43.45 <0.0001 
no 85 23.3  281 76.7  
  
yes 51 8.1  581 91.9  
  a 
Weighted sample = 999 
b Likelihood Chi square 
c p = significance at < 0.05 
d outer regional, remote and very remote categories combined  
 
Table K4: Bivariate Relationships between General Vaccination Attitudes and other Factors in a 
Community Sample of 1002 
a
 Women, Queensland, 2008 
General vaccination attitudes 
 
negative  positive  
  
 
N 
(117) 
% 
(11.7) 
 
N 
(882) 
% 
(88.3) 
 X
2 b 
P 
c 
SOCIO-DEMOGRAPHIC  
 
 
  
 
  
Age in 10 yr groups  
 
 
  
 4.68 0.32 
20–29 29 11.7  220 88.3  
  
30–39 29 11.2  231 88.8  
  
40–49 33 14.3  197 85.7  
  
50–59 19 11.8  145 88.2  
  
60–69 6 6.7  89 93.3  
  
Locality 
d 
  
 
  
 2.69 0.26 
outer reg, rem, vremote 37 14.6  216 85.4  
  
major cities 48 10.6  402 89.4  
  
inner reg 32 10.9  265 89.1  
  
SES 
  
 
  
 7.41 0.12 
quintile 1 (most disadv) 21 11.7  155 88.3  
  
quintile 2 20 11.1  164 88.9  
  
quintile 3 20 13.2  132 86.8  
  
quintile 4 31 16.1  163 83.9  
  
quintile 5 (least disadv) 24 8.3  269 91.7  
  
Australian born  
 
 
  
 0.11 0.74 
no 23 12.4  162 87.6  
  
yes 94 11.5  720 88.5  
  
Educational attainment  
 
 
  
 6.63 0.08 
year 10 or below 23 13.4  151 86.6  
  
year 11or 12 11 6.6  161 93.4  
  
cert or diploma 53 13.2  351 86.8  
  
Ba degree or higher 29 11.8  217 88.2  
  
Marital status 
  
 
  
 6.38 0.09 
never married 13 9.4  128 90.6  
  
married 62 10.5  532 89.5  
  
defacto 23 14.1  143 85.9  
  
sep/div/wid 18 18.3  79 81.7  
  
Had children 
  
 
  
 0.10 0.76 
no 27 11.2  215 88.8  
  
yes 90 11.9  667 88.1  
  
Smoking status  
 
 
  
 4.35 0.04 
yes 33 16.0  173 84.0  
  
no 84 10.6  709 89.4  
  
SCREENING HISTORY         
Screening status  
 
 
  
 5.73 0.06 
underscreened 27 18.1  123 81.9  
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regularly screened 66 10.6  557 89.4  
  
overscreened 22 11.7  163 88.3  
  
Abnormal Pap history  
 
 
  
 0.00 0.95 
yes 34 11.6  259 88.4  
  
no 83 11.8  623 88.2  
  
KNOWLEDGE AND AWARENESS  
  
 
  
Cx screening knowledge level  
  
 0.95 0.33 
below average 57 12.9  388 87.1  
  
above average 60 10.7  495 89.3  
  
Heard of HPV  
 
 
  
 2.02 0.16 
no 50 13.5  317 86.5  
  
yes 67 10.6  565 89.4  
  
Heard of HPV vaccine  
 
 
  
 0.09 0.77 
no 15 11.0  122 89.0  
  
yes 102 11.8  761 88.2  
  a Weighted sample = 999 
b Likelihood Chi square 
c p = significance at < 0.05 
d outer regional, remote and very remote categories combined 
 
Table K5: Bivariate Relationships between HPV Vaccination Attitudes and other Factors in a 
Community Sample of 1002 
a
 Women, Queensland, 2008 
HPV vaccination attitudes 
 
negative  positive  
  
 
N  
(260) 
% 
(26.0) 
 N  
(738) 
% 
(74.0) 
 
X
2 b
 P 
 c 
SOCIO-DEMOGRAPHIC 
  
 
  
 
  
Age in 10 yr groups 
  
 
  
 
  
20–29 57 22.9  192 77.1  5.55 0.24 
30–39 70 26.8  191 73.2  
  
40–49 55 23.8  175 76.2  
  
50–59 46 28.1  118 71.9  
  
60–69 33 33.9  63 66.1  
  
Locality 
d 
  
 
  
 2.32 0.31 
outer reg, rem, vremote 75 29.5  178 70.5  
  
major cities 110 24.5  339 75.5  
  
inner reg 75 25.3  222 74.7  
  
Socioeconomic status 
  
 
  
 17.56 0.002 
quintile 1 (most disadv) 39 22.2  137 77.8  
  
quintile 2 62 33.7  122 66.3  
  
quintile 3 53 35.1  98 64.9  
  
quintile 4 42 21.4  152 78.6  
  
quintile 5 (least disadv) 64 21.8  229 78.2  
  
Australian born 
  
 
  
 12.78 <0.0001 
no 68 36.5  117 63.5  
  
yes 192 23.6  621 76.4  
  
Educational attainment 
  
 
  
 3.43 0.33 
year 10 or below 54 30.9  121 69.1  
  
year 11or 12 42 24.4  131 75.6  
  
cert or diploma 96 23.8  307 76.2  
  
Ba degree or higher 66 26.9  180 73.1  
  
Marital status 
  
 
  
 1.69 0.64 
never married 33 23.4  108 76.6  
  
married 154 25.9  440 74.1  
  
defacto 43 25.9  124 74.1  
  
sep/div/wid 30 31.0  67 69.0  
  
Had children 
  
 
  
 1.34 0.25 
no 56 23.3  186 76.7  
  
yes 203 26.9  553 73.1  
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Smoking status 
  
 
  
 0.18 0.67 
yes 56 27.3  150 72.7  
  
no 204 25.7  589 74.3  
  
CERVICAL SCREENING HISTORY  
  
 
  
Screening status 
  
 
  
 4.66 0.10 
underscreened 49 32.2  102 67.8  
  
regularly screened 156 25.0  468 75.0  
  
overscreened 41 22.4  142 77.6  
  
Abnormal Pap history 
  
 
  
 19.15 <0.0001 
yes 49 16.9  243 83.1  
  
no 210 29.8  496 70.2  
  
KNOWLEDGE AND AWARENESS  
  
 
  
Cx screen kn level 
  
 
  
 20.59 <0.0001 
below average 147 33.1  297 66.9  
  
above average 113 20.3  441 79.7  
  
Heard HPV 
  
 
  
 16.80 <0.0001 
no 123 33.6  243 66.4  
  
yes 137 21.7  495 78.3  
  
Heard HPV vaccine 
  
 
  
 46.25 <0.0001 
no 70 50.9  67 49.1  
  
yes 190 22.1  671 77.9  
  
ATTITUDES 
  
 
  
 
  
General vaccination 
attitudes   
 
  
 58.97 <0.0001 
negative 67 57.6  50 42.4  
  
positive 193 21.8  689 78.2  
  a 
Weighted sample = 998 
b 
Likelihood Chi square 
c
 p = significance at < 0.05 
d
 outer regional, remote and very remote categories combined 
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Appendix L 
Focus Group Topic Guide 
 
 INTRODUCE SELF, WELCOME, HOUSEKEEPING AND OUTLINE OF 
PROCESS 
 CONSENT (WRITTEN) AND FOR RECORDING 
 INTRODUCTIONS OF PARTICIPANTS 
 
Today we are going to be talking about cervical cancer, screening for this cancer and 
the new vaccine that was developed to prevent cancer of the cervix.   So firstly,  
 
What do you think of the following statement:  “Good health is largely a matter 
of good luck” 
(self-efficacy – prompt to determine if women consider they are able to influence 
their own health) 
 
What do you think causes cancer of the cervix? 
(Perceived susceptibility to cervical cancer) 
 
Do you think every woman has the same risk of getting cancer of the cervix? 
(Perceived susceptibility to cervical cancer) 
 
If a woman gets cervical cancer, is there a cure?  Do you think it would have a 
big impact on a woman’s health? 
(Perceived seriousness of cervical cancer; belief that cervical cancer would have 
serious negative consequences on health and well-being) 
 
What do you know about Pap smears? (what are they testing for, how often do 
you have them, when should women start and stop, how good are they at preventing 
cervical cancer) 
(Perceived benefits of cervical screening, perception cervical screening decreases 
threat of disease)  
 
What do you think prevents some women from having Pap smears or putting 
them off?  
(Perceived barriers to cervical screening) 
 
If there was a test you could do at home, say a tampon or swab you could insert 
yourself and send off in the mail, do you think women who don't go for Pap 
smears now might do it? 
(Cues to action that may trigger one to participate in screening) 
 
What do you know about human papillomavirus or HPV?   
(Perceived susceptibility to HPV - knowledge of HPV and its link with cervical 
cancer) 
 
What do you know about the new vaccine for preventing cancer of the cervix? 
 Appendices 321 
(Perceived benefits of HPV vaccination of school aged girls/self) 
 
What do you think would prompt a woman to agree for her daughter to have 
the vaccine or to have the vaccine herself?  
(Cues to action that may trigger one to participate in vaccination, or consent for child 
to be vaccinated) 
 
Where do you get your health information from? 
(Cues to action) 
 
The QCSP has developed a number of ways to provide information about HPV 
and cervical cancer such as ads on TV, in magazines, brochures, posters and 
reminder letters.  If there was new information we wanted to provide to women 
- what do you think is a good way to do this?  
(Cues to action) 
 
SUMMARY (points to cover): 
 
Today’s session has been very beneficial in assisting our Program to gain a better 
understanding of what women know about cervical cancer, HPV, Pap smears and the 
new vaccine.  Thank you to everyone who participated today.  As mentioned earlier, 
no original names will be used in any of the reports or documents produced from 
today’s group. 
 
If you would like feedback about the focus groups or more information about what 
we talked about today, please refer to the brochures and information we have for 
you.  There is also information about who to contact if you want to discuss the focus 
group or research project further. 
 
I have a list here where you can write your contact details if you would like a copy of 
the research findings from this project, although this will not be ready until early next 
year.  
 
We have a small thank-you gift on the table for each of you and again thank-you for 
participating in today’s focus group. 
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Appendix M 
Focus Group Participant Questionnaire 
The following questions are to assist the researcher to describe the 
characteristics of the group.  No identifying information is required on this 
form.  You do not have to answer any question if you would prefer not to. 
 
Q1. Can you please tell me your age at your last birthday? 
   
 years   
 
 
If you are less than 20 years of age or over 70 years of age please come and see 
the researcher now.  You should also see the researcher if you have had a 
hysterectomy. 
 
Q2. What is your current marital status?  Are you….. 
   
Married   
De facto   
Separated  
Divorced  
Widowed  
Never married  
Don’t know  
 
 
 
 
Q3. What is the highest level of primary or high school that you have 
completed? 
Never attended school      
Currently still at school      
Year 8 or below (age 12–13 years or less)   
Year 9 or equivalent (age 13–14 years)   
Year 10 or equivalent (age 14–15 years / Junior)  
Year 11 or equivalent (age 15–16 years)   
Year 12 or equivalent (age 16–17 years / Senior)  
Don’t know       
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Q4. Have you completed any qualifications since completing school? 
YES      
NO      
Don’t know    
 
If yes, what is the highest qualification you have completed? 
Bachelor degree or higher       
Trade Certificate (4 years duration)     
Diploma or Certificate (taking 12 months or more full time)   
Diploma or Certificate (taking less than 12 months full time)   
Other: please specify ……………………………..    
 
 
Q 5. Were you born in Australia? 
     
YES    NO  (please go to Question 7 now)  
 
 
 
 
Q 6. Are you of Aboriginal or Torres Strait Islander origin? 
 
YES       
NO     
 
Please go to Question 8 now. 
 
 
 
Q 7. If you were not born in Australia, in which country were you born? 
 
United Kingdom & Ireland    New Zealand & Oceania   
Other (please state)  _______________________________ 
 
 
 
 
Q 8. Do you have any children?  
 
YES    NO  
 
If yes, how many children have you given birth to?   ______ 
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Q9. How many times have you had a Pap smear test? 
 
NEVER    (please go to QUESTION 12 now)  
ONCE     (please go to QUESTION 11 now)  
TWICE     3–5 TIMES    6–10 TIMES    
11–20 TIMES    >20 TIMES   Don’t know   
      
 
 
 
Q 10. What is the usual time between your Pap smear tests? 
 
Less than 1 year   1 year       
18 months    2 years     
3 years     4 years    
5 years or more    Don’t know   
 
 
 
 
Q 11.  When did you last have a Pap smear? 
  
Less than 1 year ago   
1 year to less than 2 years ago  
2 years to less than 3 years ago  
3 years to less than 5 years ago  
5 or more years ago   
Don't know    
 
 
 
Q 12. Have you heard of HPV? 
 
YES       
NO      
 
 
Q13. Have you heard of the vaccine for cervical cancer or HPV? 
 
YES       
NO      
 
 
 
Q 14. So that we can establish the boundaries of our interviewing area, can 
I ask what is your suburb, town or community?   
Brisbane   
Cairns   
Gold Coast  
Ipswich   
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Logan   
Mackay   
Redcliffe  
Redlands  
Rockhampton  
Sunshine Coast  
Toowoomba  
Townsville  
Other (please state) ______________________________ 
 
 
 
 
Q15. Which suburb do you live in?  
  
……………………………………………. 
 
 
 
Q 16. What is the postcode of your residence?  
 
 
 
 
 
There are no further questions.  Thank you for completing this information.  
Would you please return this form to the researcher. 
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Appendix N 
Topics Covered in Information Sessions Post Focus Groups 
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Appendix O 
Personal Reflections from Phase 2 
When I reflect on Phase 2 of the study, the processes I used for recruitment 
were very effective although I needed to be very proactive to get the involvement of 
women from more remote areas and approached more than one organisation to 
achieve this.  Despite specifying the ideal size of a focus group was eight to 12, there 
was a wide variation from this range with some groups of only five or six 
participants and others with over 20 or more women (Figure 7.1).   
There was only one group that did not eventuate which was due to it being 
included as part of a major community women’s health expo and a high profile 
speaker scheduled to speak at the same time as the proposed focus group.  In 
addition, a major weather event, a cyclone was looming at sea.  I learnt a lot from 
this as it was the fourth group scheduled and was more proactive in obtaining in-
depth details about planned events after reflecting on my preparation. 
However I did not have much control over the number of women attending and 
ill health, funerals and women’s enthusiasm to attend (often positive), were the 
unknowns that impacted on focus group numbers.  
The preliminary activities prior to the focus groups getting underway were not 
always straight-forward.  On a couple of occasions, the consent to participate was an 
issue for some women as described in section 3.3.2.  Another preliminary issue 
related to protocol and the situation in which the focus group was held.  Protocols 
differed according to the organisation and the event and I needed to be flexible and 
patient.  When the event was held as part of a formal meeting such as those often 
held with QCWA and Zonta groups, there was sometimes a specified protocol which 
I learnt to enquire about before commencing.  At times I was formally introduced or 
formally welcomed at a particular point in the meeting agenda by a senior person and 
on one occasion had to introduce myself and the project to a room of over 200 
women at a regional event.  At women’s health events, I was provided a space, 
which at times was not optimal due to noise, and the organisers then directed women 
to the table or room.   
When formal meetings occurred with dinner, we either conducted the focus 
group during the meal when formal proceedings had occurred or after the meal.  At 
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other times, the process was very informal and it was handed over to me to run the 
show which when at women’s homes felt a bit like a Tupperware party!  These 
differing processes were important to follow as joining women for a meal or morning 
tea and often helping with preparations and cleaning up aided my acceptance and 
helped me feel I was contributing too.  It did however, often make it a long day and 
this combined with travel was often a challenge. 
The actual process of the focus groups worked well and I found by providing 
women with information about my role and my experience as a women’s health 
nurse they trusted me to provide them with accurate information and I was a trusted 
source of knowledge.  My perception was they viewed my role not only as a 
researcher but as someone with influence given the outcomes of the focus groups 
were to inform the work I coordinate.  
The dynamics of focus groups is described from my reflective personal journal, 
from observer notes recorded at the time of the session and reflections when 
transcribing the recordings.  Group dynamics differed between groups and I drew on 
all my facilitation skills especially when groups were large.  I frequently used 
paraphrasing and reflecting to ensure I was interpreting women’s meanings correctly 
and verify their intent.  I tried to ensure all women participating had the opportunity 
to contribute and achieved this by directly asking women questions as they wore 
name tags.  At times there were very vocal and dominant women in groups, however 
I asked women to wear name tags and would directly seek the views of other women 
to ensure more reserved women had the opportunity to contribute.  I also sought the 
assistance of organisers for the very large groups and on one occasion co-opted a 
very vocal young woman as ‘crowd control’.  Their role was to remind women to 
speak one at a time and was arranged and agreed to prior to commencement of 
discussions.   
Observer’s notes reinforced my perception that groups were facilitated 
effectively: 
 Good participation from all. 
 Leane good at managing participation from quieter participants. 
 Liked the way she repeated answers for the whole group to digest.. 
 Asked quieter people to contribute. 
 Women where all heard & listening. 
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Humour featured highly in the majority of focus groups and words associated 
with laughter appear in the transcriptions 332 times.  Women seemed to enjoy 
participating and as they were often friends or members that met regularly were 
comfortable with each other and often joked particularly when Pap smears and 
barriers to screening were being discussed.  They were very open and this was 
reflected in my journal, observer notes and on listening to the tapes when at times it 
was difficult to hear what was being said due to laughter: 
 [People laughed a lot during this discussion] 
 Gorgeous open bunch of women! 
 I used to think it was once a year until you told me it was every two years and I was being 
ripped off by my gynaecologist! (lots of laughter) 
 Lots of laughter and joking (inaudible) 
 Participant 1: Our doctor used to send a letter on your birthday and Happy Birthday X, - it’s 
that time.(laughter).  I thought that’s one way a woman would always remember. 
 Participant 2:  Did you have it with a candle? (laughter). 
 
 I felt immensely privileged to have been so welcomed and accepted by the 
organisations and women in the groups and in turn they thanked me for coming to 
speak with them.  It was good to be part of something that was mutually beneficial 
and I reflected often about this in my journal: 
 They thanked me at the end and expressed how much they enjoyed it which was lovely. 
 Got email letter from group asking who could send a donation to for Cervical Ca research – 
I suggested xx. How lovely! 
 Lots of positive feedback from women following the group. 
 Got email later, thanking for attendance and saying how much women enjoyed it. 
 Thoroughly enjoyed the session and we were given a QCWA cookbook each! 
 They gave me an Anniversary mug which was very special. 
 Women loved the thank you gift. 
 They also were pleased I came to them - I wish I could go more remote but how long is a 
piece of string? 
 
There were a number of challenges in conducting the focus groups.  These 
related to distractions and this was often related to the venue or event at which the 
focus group was held.  As an invited guest I had little control over the venue or the 
meetings I was invited to despite providing information beforehand and speaking 
with the organisers about needing a quite space.  At one focus group a play group 
was also in progress with the mothers participating which at times was disruptive and 
it was very difficult to hear women and transcribe the recordings due to noise.  This 
was also the case at a women’s health day as a designated room was not provided 
and other activities were underway in the same room which at times were noisy.  
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Dinner meetings were also a challenge with noise again a factor and the 
configuration of the room although at one event the younger women rearranged the 
room after the meal.  
Other distractions related to women arriving after the focus group had 
commenced or were noise related such as children, dogs barking or passing trains.  
Heavy rain also caused pauses in discussions as the sound on the tin roofs in two 
remote communities was deafening and women could not hear each other so we 
paused and listened with joy to the breaking of the drought! 
 Dog barking- inaudible 
 (inaudible – baby in the background) 
 Crows caw (inaudible) 
 (inaudible) due to rain. 
 
Taping also led to some distractions with the tape recorder turning off at times 
or the cassette running out.  I used two recorders and became pretty adept at 
changing tapes quickly whilst talking but it still caused some issues.  The other 
technical issue was the digital recorder I specifically purchased for recording the 
focus groups.  Despite specifying what I needed it for, I was sold an inadequate 
recorder which meant I was not able to have the tapes transcribed by a transcription 
service.  Although this caused a delay in my timelines as I had to transcribe the 
majority of tapes myself, it also enabled me to re-immerse myself in the data as a 
number of months had passed between conducting the focus groups and final 
analysis.  I used two recorders and was able to hear most recordings albeit it a slow 
process at times!  The recorders used did not assist in reducing the impact of 
background noise but it was rare not to capture what women said and the majority of 
tapes were reasonable with only seven requiring intensive work to successfully 
transcribe.  There was one group however where not all the information was 
recorded due to technical issues with both recorders however this was at a site where 
two groups were held and the majority of the discussion was taped.  There were 
consistent themes identified across groups and I therefore did not think there was a 
great impact on data quality by these issues given the number of groups that were 
conducted. 
The other challenge was personal and related to me as the facilitator.  I was 
working full-time, travelling a lot and was quite unwell at times, however I did not 
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cancel any bookings and managed to conduct a total of 23 focus groups over a nine 
month period due to the support of the participants, their organisations, my work 
colleagues and family. 
In summary, the dynamics of these focus groups was positive and the women 
participating, myself and those observing appeared to enjoy the process and the 
experience.  I remain in awe of the way I was welcomed by the organisations and 
women who attended the groups and had the pleasure of being at an event attended 
by a number of women from previous focus groups.  They came up and introduced 
themselves and reinforced how much they had enjoyed being part of the research. 
Despite the logistics and hard work involved in conducting so many focus 
groups, each group had something to offer and I enjoyed listening to the tapes and 
transcribing the recordings and at times laughed until I cried!  I will never forget this 
experience and the wonderful information women shared with me to inform this 
project and future activities in my professional undertakings.  
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Appendix P 
Acknowledgement of Role 
I acknowledge my role in the qualitative phase of this study by using the 
pronoun ‘I’ in qualitative research reporting, asserting that my own experiences and 
view of the world have influenced my interpretation of data and that the findings of 
the focus groups do not represent ‘truth’ but are the views and experiences of the 
women involved and how I interpreted them.  I also acknowledge my previous 
experience and professional role and agenda in conducting this research.  I grew up 
in the southern Bayside suburbs of Brisbane and began nursing at the age of 17 at the 
Royal Brisbane Hospital when nursing education was hospital-based.  My nursing 
experience at this large metropolitan hospital was primarily medical, surgical and 
oncology nursing and after completing my midwifery training on the same campus 
and having two children, I started working in the gynaecology-oncology unit in 
1999.  At the time, women from all over Queensland were sent to this unit where as a 
senior nurse, I primarily cared for women post-operatively with cervical, ovarian, 
endometrial, vulval and other gynaecological cancers.    
Also during this time, I completed a nursing degree and this experience 
expanded my view of health beyond the bio-medical model.  I became restless in the 
acute health sector and was successful in securing a position in the primary health 
care sector at Family Planning Queensland as the state-wide Nursing Services 
Manager.  In this position, I was instrumental in the expansion of the scope of 
practice of registered nurses in the organisation to enable them to become Pap smear 
providers and provide contraceptive services for women such as emergency 
contraception and ongoing oral contraception under health management protocols.   
Given my experience caring for women dying from cervical cancer, I felt this would 
help increase women’s access to female Pap smear providers and with the support of 
the FPQ education section, we began training nurses from other organisations, 
including Queensland Health, in these skills.   I also completed a Master of Nursing 
during this time in which I focused on the acceptance of registered nurses as Pap 
smear providers and majored in women’s health (Christie, Gamble and Creedy, 
2005). 
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After seven years, it was time for a challenge and I then spent three years in 
roles as a manager of school-based nurses and a regional sexual health coordinator; 
however, I did not have the same passion for these roles as my previous positions 
that had women’s health as the primary focus.   Fortuitously a position became 
available in 2003 in the Queensland Cervical Screening Program which led to my 
current role as Program Director.  In this role, my focus is the prevention of cervical 
cancer and the promotion of women’s participation in the program.  My experience 
and educational preparation, including studies in feminism and post-structuralism, 
cause me to challenge the language we use in our resources, for example, nurses and 
doctors do not ‘take’ Pap smears, they ‘provide’ them, and led me to this study where 
I hope to gain a greater understanding about women’s knowledge, attitudes and the 
barriers they experience to regular participation in the program as I am in a position 
to make a difference. 
I would like to make clear my rationale and intent for the use of value-laden 
language in this thesis such as ‘promiscuity’ and ‘compliance’.  I have used these 
terms to describe what women said or to reflect community perceptions when using 
the term ‘promiscuity’ and this does not reflect my personal view that sexual 
behaviour should be judged in this way as this is not my role nor my intent given the 
stigma and gender-specific labels frequently used to describe women’s sexuality 
(Braun and Gavey, 1999).  I also dislike the word ‘compliance’ as this for me has 
connotations of the ‘good’ versus the ‘bad’ patient and is paternalistic; however I 
have used this term when women spoke about having Pap smears or the vaccine 
because they were told to, rather than through a process of informed consent. 
I acknowledge I have never lived or worked in rural and remote Queensland 
but I have travelled extensively by car through these areas and have seen the tyranny 
of distance where you may pass only a few vehicles in a whole day.  This was why I 
felt it was so important to survey these women and go to these areas to talk with 
women face-to-face.  I also acknowledge I am deeply passionate about this topic 
because this cancer can be prevented and although it was such a long time ago, 
having cared for women who suffer a horrendous death from cervical cancer, if this 
research and my role can help reduce cervical cancer even further than the gains to 
date, I have done what I set out to do.  
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As described by Liamputtong and Ezzy (2005), the opportunity to conduct this 
research was a privilege and I have made every attempt to deal with participants and 
their contributions to this process with honesty, integrity and fairness.  I provided the 
women who expressed the desire to receive it, a summary report of the findings from 
the focus groups and have offered to present at their meetings and conferences in the 
future so I can share the findings with them and complete the research cycle 
(Appendix F). 
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Appendix Q 
Call Analysis 
 
Table Q1: Final Call Result 
  Total 
Not connected Telstra message  7363 
Appoint 1369 
Business 1049 
Complete 1002 
Called 5 times without contact 471 
Engaged 65 
No women aged 20–69 2454 
Respondent has had Hysterectomy 276 
Respondent away duration 309 
Not in survey area 3 
Deaf / Drunk / Senile 69 
Language 100 
No answer 4769 
Refused 1123 
Quota full 274 
Total 20696 
 
 
Table Q2: Total attempts 
  Total 
Not connected Telstra message  7363 
Appointments / answering machines 9227 
Business 1049 
Complete 1002 
Called 5 times without contact 471 
No women aged 20–69 2454 
Respondent has had Hysterectomy 276 
Respondent away duration 309 
Not in survey area 3 
Deaf / Drunk / Senile 69 
Language 100 
No answer / engaged 13842 
Refused 1123 
Quota full 274 
Total Attempts 37562 
 
 
 
